# ::snt Cloning and characterization of mr-s , a novel SAM domain protein , predominantly expressed in retinal photoreceptor cells .
# ::tok Cloning and characterization of mr-s , a novel SAM domain protein , predominantly expressed in retinal photoreceptor cells .
# ::alignments 17-18|0.0.1.1 16-17|0.0.1.1.0 15-16|0.0.1.1.1 13-14|0.0.1 12-13|0.2 10-11|0.0.1.2 9-10|0.0.1.2.0.0 8-9|0.0.1.2.0.1.0+0.0.1.2.0.1+0.0.1.2.0 7-8|0.0.1.0 4-5|0.0.0 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:46.461
(a / and 
      :op1 (c3 / clone-01 
            :ARG1 (m / mr-) 
            :purpose (e / express-01 
                  :ARG0 (n2 / novel) 
                  :ARG1 (c / cell 
                        :mod (p / photoreceptor) 
                        :mod (r / retinal)) 
                  :ARG2 (p3 / protein 
                        :mod (t / thing 
                              :mod-of (d / domain) 
                              :name (n / name 
                                    :op1 "SAM"))))) 
      :op2 (c2 / characterization) 
      :op3 (p2 / predominant))

# ::snt Sterile alpha motif ( SAM ) domains are ~ 70 residues long and have been reported as common protein-protein interaction modules .
# ::tok Sterile alpha motif ( SAM ) domains are ~ 70 residues long and have been reported as common protein-protein interaction modules .
# ::alignments 20-21|0.0.2 19-20|0.0.2.1 17-18|0.0.2.0 15-16|0.0 12-13|0 11-12|0.0.1.0 10-11|0.0.1.0.0 9-10|0.0.1.0.0.0 6-7|0.0.1 4-5|0.0.2.1.2.0.0+0.0.2.1.2.0+0.0.2.1.2 2-3|0.0.2.1.0 1-2|0.0.0 0-1|0.0.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:46.976
(a / and 
      :op1 (r / report-01 
            :ARG0 (a2 / alpha) 
            :ARG1 (d / domain 
                  :ARG1-of (l / long-03 
                        :ARG2 (r2 / residu 
                              :quant 70))) 
            :ARG2 (m / module 
                  :mod (c / common) 
                  :mod (i / interact-01 
                        :ARG0 (m2 / motif) 
                        :ARG2 (s / sterile) 
                        :topic (t / thing 
                              :name (n / name 
                                    :op1 "SAM"))))))

# ::snt This domain is found in a large number of proteins , including Polycomb group ( PcG ) proteins and ETS family transcription factors .
# ::tok This domain is found in a large number of proteins , including Polycomb group ( PcG ) proteins and ETS family transcription factors .
# ::alignments 22-23|0 21-22|0.0 20-21|0.0.0 19-20|0.0.0.0 18-19|0.1 17-18|0.1.1 13-14|0.1.1.0 12-13|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 9-10|0.1.0.1.1 7-8|0.1.0.1 6-7|0.1.0.1.0 3-4|0.1.0 1-2|0.1.0.0 0-1|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:47.421
(f / factor 
      :mod (t / transcription 
            :mod (f2 / family 
                  :mod (e / et))) 
      :op2-of (a / and 
            :ARG0-of (f3 / find-01 
                  :ARG1 (d / domain 
                        :mod (t3 / this)) 
                  :location (n2 / number 
                        :mod (l / large) 
                        :quant-of (p2 / protein))) 
            :op1 (p / protein 
                  :mod (g / group 
                        :mod (t2 / thing 
                              :name (n / name 
                                    :op1 "Polycomb"))))))

# ::snt In this work , we report the cloning and functional characterization of a novel SAM domain-containing protein , which is predominantly expressed in retinal photoreceptors and the pineal gland and is designated mouse mr-s ( major retinal SAM domain protein ) .
# ::tok In this work , we report the cloning and functional characterization of a novel SAM domain-containing protein , which is predominantly expressed in retinal photoreceptors and the pineal gland and is designated mouse mr-s ( major retinal SAM domain protein ) .
# ::alignments 39-40|0 38-39|0.0.0.1 36-37|0.0.0.1.0 35-36|0.0.0 33-34|0.0.1.1.0.1.1.1 32-33|0.0.1.1.0.1.1.1.0 31-32|0.0.1.1.0.1.1 29-30|0.0.1.1.0.1 28-29|0.0.1.1.0.1.1.2.0 27-28|0.0.1.1.0.1.1.2.0.0 25-26|0.0.1.1.0.1.1.2 24-25|0.0.1.1.0.1.0.0 23-24|0.0.1.1.0.1.0.0.0 21-22|0.0.1.1.0.1.0 20-21|0.0.1.1.0.1.0.1 16-17|0.0.1.1.0.1.1.0 15-16|0.0.1.1.0.1.1.0.1 14-15|0.0.1.1.0.1.1.0.0.0.0+0.0.1.1.0.1.1.0.0.0+0.0.1.1.0.1.1.0.0 13-14|0.0.0.0 10-11|0.0.1.1 9-10|0.0.1.0 8-9|0.0.1 7-8|0.0 5-6|0.0.1.1.0 4-5|0.0.1.1.0.0 2-3|0.0.1.1.0.0.0 1-2|0.0.1.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:49.678
(p / protein 
      :ARG0-of (c2 / clone-01 
            :ARG1 (m / major-02 
                  :ARG0 (n2 / novel) 
                  :ARG1 (d / domain 
                        :mod (r / retinal))) 
            :op1-of (a3 / and 
                  :op2 (f / functional) 
                  :op3 (c / characterization 
                        :ARG1-of (r3 / report-01 
                              :ARG0 (w / we 
                                    :ARG0-of (w2 / work-01 
                                          :mod (t2 / this))) 
                              :op1-of (a / and 
                                    :op2 (e / express-01 
                                          :ARG1 (p3 / photoreceptor 
                                                :mod (r2 / retinal)) 
                                          :mod (p4 / predominant)) 
                                    :op3 (d2 / designate-01 
                                          :ARG0 (p5 / protein 
                                                :mod (t / thing 
                                                      :name (n / name 
                                                            :op1 "SAM")) 
                                                :mod (d3 / domain-contain)) 
                                          :ARG1 (m2 / mr- 
                                                :mod (m3 / mouse)) 
                                          :op2-of (a2 / and 
                                                :op1 (g / gland 
                                                      :mod (p2 / pineal))))))))))

# ::snt mr-s is evolutionarily conserved from zebrafish through human , organisms through which the mechanism of photoreceptor development is also highly conserved .
# ::tok mr-s is evolutionarily conserved from zebrafish through human , organisms through which the mechanism of photoreceptor development is also highly conserved .
# ::alignments 20-21|0.0.0.0 19-20|0.0.0.0.1 18-19|0.0.0.0.2 16-17|0.0 15-16|0 13-14|0.0.0 9-10|0.0.0.0.0 7-8|0.0.0.0.0.0.3 5-6|0.0.0.0.0.0.1 3-4|0.0.0.0.0.0 2-3|0.0.0.0.0.0.2 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:50.177
(p / photoreceptor 
      :ARG1-of (d / develop-02 
            :mod-of (m / mechanism 
                  :ARG2-of (c / conserve-01 
                        :ARG1 (o / organism 
                              :ARG0-of (c2 / conserve-01 
                                    :ARG1 (m2 / mr-) 
                                    :ARG2 (z / zebrafish) 
                                    :manner (e / evolutionarily) 
                                    :path (h2 / human))) 
                        :degree (h / high) 
                        :mod (a / also)))))

# ::snt Phylogenetic analysis suggests that the SAM domain of mr-s is most closely related to a mouse polyhomeotic ( ph ) ortholog , Mph1/Rae28 , which is known as an epigenetic molecule involved in chromatin modifications .
# ::tok Phylogenetic analysis suggests that the SAM domain of mr-s is most closely related to a mouse polyhomeotic ( ph ) ortholog , Mph1/Rae28 , which is known as an epigenetic molecule involved in chromatin modifications .
# ::alignments 34-35|0.1.1.0.1.0.0 33-34|0.1.1.0.1.0.0.0 31-32|0.1.1.0.1.0 30-31|0.1.1.0.1 26-27|0.1.1.0 22-23|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 20-21|0.1.1 18-19|0.0.0 16-17|0.1.1.1 15-16|0.1.1.1.0 12-13|0.1 11-12|0.1.2 10-11|0.1.2.0 8-9|0.1.0.1 6-7|0.1.0 5-6|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:51.218
(s / suggest-01 
      :ARG0 (a / analyze-01 
            :ARG1 (p2 / ph) 
            :manner (p4 / phylogenetic)) 
      :ARG1 (r / relate-01 
            :ARG1 (d / domain 
                  :mod (t / thing 
                        :name (n2 / name 
                              :op1 "SAM")) 
                  :poss (m5 / mr-)) 
            :ARG2 (o / ortholog 
                  :ARG0-of (k / know-02 
                        :ARG1 (p / person 
                              :name (n / name 
                                    :op1 "Mph1/Rae28")) 
                        :ARG2 (m2 / molecule 
                              :ARG1-of (i / involve-01 
                                    :ARG2 (m / modify-01 
                                          :ARG1 (c / chromatin))))) 
                  :mod (p3 / polyhomeotic 
                        :mod (m3 / mouse))) 
            :manner (c2 / close 
                  :degree (m4 / most))))

# ::snt These findings provide the possibility that mr-s may play a critical role by regulating gene expression in photoreceptor development .
# ::tok These findings provide the possibility that mr-s may play a critical role by regulating gene expression in photoreceptor development .
# ::alignments 18-19|0.0.0 17-18|0.0.0.0 15-16|0 14-15|0.1 13-14|0.0 11-12|0.0.1.1 10-11|0.0.1.1.0 8-9|0.0.1 7-8|0.0.1.3 6-7|0.0.1.0 4-5|0.0.1.2 2-3|0.0.1.2.0 1-2|0.0.1.2.0.0.0+0.0.1.2.0.0 0-1|0.0.1.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:51.367
(e / express-01 
      :ARG1-of (r / regulate-01 
            :ARG2 (d / develop-02 
                  :ARG1 (p / photoreceptor)) 
            :manner-of (p2 / play-01 
                  :ARG0 (m / mr-) 
                  :ARG1 (r2 / role 
                        :ARG1-of (c / critical-02)) 
                  :ARG1-of (p4 / possible-01 
                        :ARG1-of (p5 / provide-01 
                              :ARG0 (t / thing 
                                    :ARG1-of (f / find-01) 
                                    :mod (t2 / this)))) 
                  :ARG1-of (p3 / possible-01))) 
      :mod (g / gene))

# ::snt mr-s is preferentially expressed in the photoreceptors at postnatal day 3 -- 6 ( P3-6 ) , when photoreceptors undergo terminal differentiation , and in the adult pineal gland .
# ::tok mr-s is preferentially expressed in the photoreceptors at postnatal day 3 -- 6 ( P3-6 ) , when photoreceptors undergo terminal differentiation , and in the adult pineal gland .
# ::alignments 28-29|0.4.0.1.1 27-28|0.4.0.1.1.0 26-27|0.4.0.1.1.1 23-24|0.4.0.2 21-22|0.4.0.1 20-21|0.4.0.1.0 19-20|0.4.0 18-19|0.4.0.0 12-13|0.0 10-11|0.4.0.1.1.0.0 9-10|0.4 8-9|0.4.1 6-7|0.2 3-4|0 2-3|0.3 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:52.018
(e / express-01 
      :ARG0 6 
      :ARG1 (m / mr-) 
      :manner (p4 / photoreceptor) 
      :mod (p5 / preferentially) 
      :time (d2 / day 
            :ARG0-of (u / undergo-28 
                  :ARG1 (p2 / photoreceptor) 
                  :ARG2 (d / differentiation 
                        :mod (t / terminal) 
                        :mod-of (g / gland 
                              :mod (p / pineal 
                                    :poss-of 3) 
                              :mod (a / adult))) 
                  :op1-of (a2 / and)) 
            :mod (p3 / postnatal)))

# ::snt Transcription of mr-s is directly regulated by the cone-rod homeodomain protein Crx .
# ::tok Transcription of mr-s is directly regulated by the cone-rod homeodomain protein Crx .
# ::alignments 10-11|0.0.0 9-10|0.1.0 5-6|0.0 4-5|0.0.1 2-3|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:52.103
(t / transcription 
      :ARG1-of (r / regulate-01 
            :ARG0 (p / protein) 
            :ARG1-of (d / direct-02)) 
      :mod (m / mr- 
            :mod-of (h / homeodomain)))

# ::snt Immunoprecipitation assay showed that the mr-s protein self-associates mainly through the SAM domain-containing region as well as ph. The mr-s protein localizes mainly in the nucleus , when mr-s is overexpressed in HEK293T cells .
# ::tok Immunoprecipitation assay showed that the mr-s protein self-associates mainly through the SAM domain-containing region as well as ph. The mr-s protein localizes mainly in the nucleus , when mr-s is overexpressed in HEK293T cells .
# ::alignments 33-34|0.2.0 32-33|0.2.0.0 28-29|0.4 25-26|0.0 22-23|0.2.3 21-22|0.2 20-21|0.2.1 13-14|0.2.2.0 12-13|0.2.2.0.0 11-12|0.2.2.1.0+0.2.2.1+0.2.2 8-9|0.2.0.0.0 6-7|0.1.0 5-6|0.1 2-3|0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:52.394
(s / show-01 
      :ARG0 (n / nucleus) 
      :ARG1 (m4 / mr- 
            :mod-of (p2 / protein)) 
      :ARG2 (l / localize-01 
            :ARG0 (c / cell 
                  :mod (h / HEK293T 
                        :mod-of (m3 / main))) 
            :ARG1 (p / protein) 
            :ARG2 (o / organization 
                  :mod-of (r / region 
                        :mod (d / domain-contain)) 
                  :name (n2 / name 
                        :op1 "SAM")) 
            :mod (m2 / main)) 
      :manner (a / assay) 
      :op1-of (m / mr-))

# ::snt Moreover , in the luciferase assays , we found that mr-s protein fused to GAL4 DNA-binding domain functions as a transcriptional repressor .
# ::tok Moreover , in the luciferase assays , we found that mr-s protein fused to GAL4 DNA-binding domain functions as a transcriptional repressor .
# ::alignments 21-22|0.0.2 17-18|0.0 16-17|0.0.1 15-16|0 12-13|0.0.0.0 11-12|0.0.0 10-11|0.0.0.1 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0 5-6|0.0.0.0.0.1 4-5|0.0.0.0.0.1.0 0-1|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:52.928
(d2 / dna-bind 
      :mod-of (f / function-01 
            :ARG0 (p / protein 
                  :ARG0-of (f2 / fuse-01 
                        :ARG1-of (f3 / find-01 
                              :ARG0 (w / we) 
                              :location (a / assay 
                                    :mod (l / luciferase)))) 
                  :mod (m / mr-)) 
            :ARG1 (d / domain) 
            :ARG2 (r / repressor 
                  :mod-of (m2 / moreover))))

# ::snt We revealed that the repression activity of mr-s is not due to a homophilic interaction through its SAM domain but to the C-terminal region .
# ::tok We revealed that the repression activity of mr-s is not due to a homophilic interaction through its SAM domain but to the C-terminal region .
# ::alignments 23-24|0.0 19-20|0 18-19|0.2.1 17-18|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 14-15|0.2 9-10|0.2.0 7-8|0.1.0.0 5-6|0.1.0 4-5|0.1 1-2|0.3 0-1|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:53.342
(c / contrast-01 
      :ARG0 (r / region) 
      :ARG1-of (r2 / repress-01 
            :ARG1-of (a / activity-06 
                  :ARG0 (m / mr-))) 
      :ARG1-of (i / interact-01 
            :ARG0 - 
            :ARG2 (d / domain 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "SAM")))) 
      :ARG1-of (r3 / reveal-01 
            :ARG0 (w / we)))

# ::snt We identified a novel gene , mr-s , which is predominantly expressed in retinal photoreceptors and pineal gland .
# ::tok We identified a novel gene , mr-s , which is predominantly expressed in retinal photoreceptors and pineal gland .
# ::alignments 17-18|0.0.0.2.0 16-17|0.0.0.2.0.0 15-16|0.0.0.2 14-15|0.0.0.0 13-14|0.0.0.0.0 11-12|0.0.0 10-11|0.0.0.1 6-7|0.1.1 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:53.487
(i / identify-01 
      :ARG0 (w / we 
            :ARG0-of (e / express-01 
                  :ARG2 (p2 / photoreceptor 
                        :mod (r / retinal)) 
                  :mod (p3 / predominant) 
                  :op1-of (a / and 
                        :op2 (g / gland 
                              :mod (p / pineal))))) 
      :ARG1 (g2 / gene 
            :mod (n / novel) 
            :mod (m / mr-)))

# ::snt Based on its expression pattern and biochemical analysis , we predict that mr-s may function as a transcriptional repressor in photoreceptor cells and in pinealocytes of the pineal gland .
# ::tok Based on its expression pattern and biochemical analysis , we predict that mr-s may function as a transcriptional repressor in photoreceptor cells and in pinealocytes of the pineal gland .
# ::alignments 28-29|0.0.0.1.0 27-28|0.0.0.1.0.0 24-25|0.0.0.1.0.1 22-23|0.0.0.0.0.0.1.0.1 21-22|0.0.0.0.0.0.1.0 20-21|0.0.0.0.0.0.1.0.0 18-19|0.0.0.0.0.0.1 14-15|0.0.0.0.0.0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.0.0 10-11|0.0.0.0.0.0.2 9-10|0.0.0.0.0.0.2.0 7-8|0.0.0.1 6-7|0.0.0.1.1 5-6|0.0.0 4-5|0.0 3-4|0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:54.052
(e / express-01 
      :ARG1 (p6 / pattern 
            :op1-of (a3 / and 
                  :ARG2-of (b2 / base-02 
                        :ARG1 (p4 / possible-01 
                              :ARG1 (f / function-01 
                                    :ARG0 (m / mr-) 
                                    :ARG1 (r / repressor 
                                          :location (c / cell 
                                                :mod (p3 / photoreceptor) 
                                                :op1-of (a / and))) 
                                    :ARG1-of (p5 / predict-01 
                                          :ARG0 (w / we))))) 
                  :op2 (a2 / analyze-01 
                        :ARG0 (g / gland 
                              :mod (p / pineal) 
                              :poss-of (p2 / pinealocyt)) 
                        :ARG1 (b / biochemical)))))

# ::snt In the development of the mammalian retina , a diverse range of cell types is generated from a pool of multipotent retinal progenitor cells .
# ::tok In the development of the mammalian retina , a diverse range of cell types is generated from a pool of multipotent retinal progenitor cells .
# ::alignments 23-24|0.0.0 22-23|0.0.0.0 21-22|0.0.0.2 20-21|0.0.0.1 18-19|0.0 15-16|0 13-14|0.1.0 12-13|0.1.0.0 10-11|0.1 9-10|0.1.1 6-7|0.2.0 5-6|0.2.0.0 2-3|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:54.664
(g / generate-01 
      :ARG0 (p2 / pool 
            :mod (c / cell 
                  :mod (p / progenitor) 
                  :mod (m / multipotent) 
                  :mod (r / retinal))) 
      :ARG1 (r2 / range-01 
            :ARG1 (t / type 
                  :mod (c2 / cell)) 
            :mod (d / diverse)) 
      :ARG2 (d2 / develop-02 
            :ARG1 (r3 / retina 
                  :mod (m2 / mammalian))))

# ::snt Among these cell types , photoreceptors account for over 70 % of all cells in the retina .
# ::tok Among these cell types , photoreceptors account for over 70 % of all cells in the retina .
# ::alignments 16-17|0.0.0.0.1 13-14|0.0.0.0 12-13|0.0.0.0.0 10-11|0.0.0 9-10|0.0.0.1 6-7|0.0 5-6|0 3-4|0.0.1 2-3|0.0.1.0 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:54.812
(p2 / photoreceptor 
      :ARG0-of (a2 / account-01 
            :ARG1 (p / percentage-entity 
                  :domain (c / cell 
                        :mod (a / all 
                              :mod-of (t2 / this)) 
                        :part-of (r / retina)) 
                  :value 70) 
            :location (t / type 
                  :mod (c2 / cell))))

# ::snt In vertebrates , there are two classes of photoreceptors , rods and cones .
# ::tok In vertebrates , there are two classes of photoreceptors , rods and cones .
# ::alignments 12-13|0.3 11-12|0 10-11|0.2 8-9|0.1 6-7|0.0 5-6|0.3.1 1-2|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:54.892
(a / and 
      :accompanier-of (c2 / class) 
      :op1 (p / photoreceptor) 
      :op2 (r / rod) 
      :op3 (c / con-01 
            :ARG0 (v / vertebrat) 
            :quant 2))

# ::snt Rods are sensors of dim light , while cones function in bright light and are responsible for color vision .
# ::tok Rods are sensors of dim light , while cones function in bright light and are responsible for color vision .
# ::alignments 18-19|0.0 17-18|0.0.0 15-16|0 13-14|0.1 11-12|0.1.0.0.0.0.0 9-10|0.1.0 8-9|0.1.0.0 5-6|0.1.0.0.0 4-5|0.1.0.0.0.0 2-3|0.1.0.0.0.1 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:55.034
(r / responsible-01 
      :ARG1 (v / vision 
            :mod (c / color)) 
      :op2-of (a / and 
            :op1 (f / function-01 
                  :ARG0 (c2 / con-01 
                        :ARG1 (l / light 
                              :ARG1-of (d / dim-01 
                                    :ARG1-of (b / bright-02)) 
                              :mod-of (s / sensor))) 
                  :ARG1 (r2 / rod))))

# ::snt Phototransduction , a series of signal amplifications detecting a single photon of light , is initiated by the capture of light with 11-cis-retinal , a chromophore bound by the opsin proteins : rhodopsin in rods and cone opsins in cones .
# ::tok Phototransduction , a series of signal amplifications detecting a single photon of light , is initiated by the capture of light with 11-cis-retinal , a chromophore bound by the opsin proteins : rhodopsin in rods and cone opsins in cones .
# ::alignments 39-40|0.0 36-37|0.2 35-36|0 34-35|0.1 32-33|0.0.0 30-31|0.0.1.0.0.1.1 29-30|0.0.1.0.0.1.1.0 26-27|0.0.1.0.0.1 25-26|0.0.1.0.0.1.0 18-19|0.0.1 15-16|0.0.1.0 12-13|0.0.1.0.0.0.0.1 10-11|0.0.1.0.0.0.0 9-10|0.0.1.0.0.0.0.0 7-8|0.0.1.0.0.0 6-7|0.0.1.0.0 5-6|0.0.1.0.0.2 3-4|0.0.1.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:56.179
(a / and 
      :ARG1-of (c / con-01 
            :ARG0 (r2 / rhodopsin) 
            :ARG1-of (c4 / capture-01 
                  :ARG1-of (i / initiate-01 
                        :ARG0 (a2 / amplification 
                              :ARG0-of (d / detect-01 
                                    :ARG1 (p2 / photon 
                                          :ARG1-of (s / single-02) 
                                          :mod (l / light))) 
                              :ARG0-of (b / bind-01 
                                    :ARG1 (c3 / chromophore) 
                                    :ARG3 (p / protein 
                                          :mod (o / opsin))) 
                              :mod (s2 / signal) 
                              :quant (s3 / series))))) 
      :op1 (r / rod) 
      :op2 (c2 / cone))

# ::snt The proteins that carry out phototransduction are located in an elaborate and highly specialized membranous structure , the outer segment .
# ::tok The proteins that carry out phototransduction are located in an elaborate and highly specialized membranous structure , the outer segment .
# ::alignments 19-20|0.2 18-19|0.2.0 15-16|0.1.0 14-15|0.1.0.1 13-14|0.1.0.0 12-13|0.1.0.0.0 11-12|0 10-11|0.1 7-8|0.0 5-6|0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:56.345
(a / and 
      :op1 (l / locate-01 
            :ARG1 (p2 / protein 
                  :ARG0-of (c / carry-01 
                        :ARG1 (p / phototransduction)))) 
      :op2 (e / elaborate-01 
            :mod-of (s2 / structure 
                  :ARG1-of (s3 / specialize-01 
                        :degree (h / high)) 
                  :mod (m / membranou))) 
      :op3 (s / segment 
            :domain-of (o / outer)))

# ::snt The outer segment appears to be relatively fragile , degenerating in response to many environmental and/or genetic perturbations .
# ::tok The outer segment appears to be relatively fragile , degenerating in response to many environmental and/or genetic perturbations .
# ::alignments 17-18|0.0.0.1.0 16-17|0.0.0.0 14-15|0.0.0.1.0.0 13-14|0.0.0.1.0.1 11-12|0.0.0.1 9-10|0.0.0 7-8|0.1 6-7|0.2 3-4|0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:56.752
(a / appear-02 
      :ARG1 (s / segment 
            :ARG0-of (d / degenerate-01 
                  :ARG1 (g / gene) 
                  :ARG2-of (r / respond-01 
                        :ARG1 (p / perturbation 
                              :mod (e / environment) 
                              :quant (m / many)))) 
            :domain-of (o / outer)) 
      :ARG2 (f / fragile) 
      :time (r2 / relative))

# ::snt In the rodent retina , the production of specific cell types during development progresses in a general order [ 1,2 ] .
# ::tok In the rodent retina , the production of specific cell types during development progresses in a general order [ 1,2 ] .
# ::alignments 16-17|0.3.0 13-14|0 12-13|0.2 10-11|0.0 9-10|0.0.0 8-9|0.0.0.0 6-7|0.1 3-4|0.3.1 2-3|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:57.001
(p / progress-01 
      :ARG0 (t / type 
            :mod (c / cell 
                  :ARG1-of (s / specific-02))) 
      :ARG1 (p2 / produce-01) 
      :manner (d / develop-02) 
      :time (r2 / rodent 
            :ARG1-of (g / general-02) 
            :mod-of (r / retina)))

# ::snt Rod photoreceptor generation peaks around the time of birth .
# ::tok Rod photoreceptor generation peaks around the time of birth .
# ::alignments 8-9|0.1.0.0 6-7|0.1.0 4-5|0.1 3-4|0 2-3|0.2 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:57.137
(p / peak-01 
      :ARG0 (p2 / person 
            :name (n / name 
                  :op1 "Rod")) 
      :ARG1 (a / around 
            :op1 (t / time 
                  :time-of (b / birth-01))) 
      :mod (g / generation))

# ::snt Cone photoreceptors , ganglion cells , horizontal cells and amacrine cells are generated earlier , while Mller glia and bipolar cells are generated later .
# ::tok Cone photoreceptors , ganglion cells , horizontal cells and amacrine cells are generated earlier , while Mller glia and bipolar cells are generated later .
# ::alignments 23-24|0.0.1 22-23|0.0 20-21|0.3 19-20|0.3.0 18-19|0 17-18|0.2 16-17|0.1.0.0+0.1.0+0.1 13-14|0.0.0.1 12-13|0.0.0 10-11|0.0.0.0.4 8-9|0.0.0.0 7-8|0.0.0.0.3 6-7|0.0.0.0.3.0 4-5|0.0.0.0.2 3-4|0.0.0.0.2.0 1-2|0.0.0.0.1 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:57.797
(a / and 
      :ARG1-of (g / generate-01 
            :purpose-of (g3 / generate-01 
                  :ARG1 (a2 / and 
                        :op1 (p3 / person 
                              :name (n2 / name 
                                    :op1 "Cone")) 
                        :op2 (p2 / photoreceptor) 
                        :op3 (c4 / cell 
                              :mod (g4 / ganglion)) 
                        :op4 (c3 / cell 
                              :mod (h / horizontal)) 
                        :op5 (c2 / cell)) 
                  :time (e / early)) 
            :time (l / late)) 
      :op1 (p / person 
            :name (n / name 
                  :op1 "Mller")) 
      :op2 (g2 / glia) 
      :op3 (c / cell 
            :mod (b / bipolar)))

# ::snt This production of different cell types at different times appears to derive from differences in the intrinsic properties of progenitor cells involved in the transcription or chromatin modification .
# ::tok This production of different cell types at different times appears to derive from differences in the intrinsic properties of progenitor cells involved in the transcription or chromatin modification .
# ::alignments 27-28|0.0.2.0.0.0.0.2 26-27|0.0.2.0.0.0.0.2.0 25-26|0.0.2.0.0.0.0 24-25|0.0.2.0.0.0.0.1 21-22|0.0.2.0.0.0 20-21|0.0.2.0.0 19-20|0.0.2.0.0.1 17-18|0.0.2.0 16-17|0.0.2.0.1 13-14|0.0.2 11-12|0.0 9-10|0 7-8|0.0.2.0.0.0.0.1.0 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.2.0.0.0.0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:58.152
(a / appear-02 
      :ARG1 (d2 / derive-01 
            :ARG0 (t2 / type 
                  :mod (c3 / cell)) 
            :ARG1 (p3 / produce-01 
                  :mod (t3 / this)) 
            :ARG2 (d / differ-01 
                  :ARG2 (p2 / property 
                        :domain (c2 / cell 
                              :ARG1-of (i / involve-01 
                                    :ARG2 (o / or 
                                          :ARG1-of (d4 / differ-02) 
                                          :op1 (t / transcription 
                                                :op1 (d3 / differ-02)) 
                                          :op2 (m / modify-01 
                                                :ARG1 (c / chromatin)))) 
                              :mod (p / progenitor)) 
                        :mod (i2 / intrinsic)))))

# ::snt Recent studies identified several important transcription factors of photoreceptor development [ 3-7 ] .
# ::tok Recent studies identified several important transcription factors of photoreceptor development [ 3-7 ] .
# ::alignments 9-10|0.0.0 6-7|0.1 5-6|0.1.1 4-5|0.1.0 3-4|0.1.2 2-3|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:58.268
(i2 / identify-01 
      :ARG0 (s2 / study-01 
            :ARG2-of (d / develop-02) 
            :time (r / recent)) 
      :ARG1 (f / factor 
            :mod (i / important) 
            :mod (t / transcription) 
            :quant (s / several)))

# ::snt Two Otx family homeobox genes , Otx2 and Crx , play essential roles in early cell fate determination and terminal differentiation of photoreceptors [ 3,8,9 ] .
# ::tok Two Otx family homeobox genes , Otx2 and Crx , play essential roles in early cell fate determination and terminal differentiation of photoreceptors [ 3,8,9 ] .
# ::alignments 22-23|0.3 20-21|0.2 19-20|0.2.0 18-19|0 17-18|0.1 16-17|0.1.1 15-16|0.1.1.0 14-15|0.1.2 12-13|0.0.1 11-12|0.0.1.0 10-11|0.0 7-8|0.0.0 6-7|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 4-5|0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0.0.0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:59.687
(a / and 
      :location-of (p2 / play-01 
            :ARG0 (a2 / and 
                  :op1 (g / gene 
                        :mod (h / homeobox 
                              :mod (f2 / family))) 
                  :op2 (t2 / thing 
                        :name (n / name 
                              :op1 "Otx2"))) 
            :ARG1 (r / role 
                  :mod (e2 / essential))) 
      :op1 (d2 / determine-01 
            :ARG0 2 
            :ARG1 (f / fate 
                  :mod (c / cell)) 
            :mod (e / early)) 
      :op2 (d / differentiation 
            :mod (t / terminal)) 
      :poss (p / photoreceptor))

# ::snt In the absence of Otx2 function , differentiating photoreceptor cells are converted to amacrine-like neurons [ 9 ] .
# ::tok In the absence of Otx2 function , differentiating photoreceptor cells are converted to amacrine-like neurons [ 9 ] .
# ::alignments 16-17|0.0.0.0.1.0 14-15|0.0.0.0.0 11-12|0.0.0 9-10|0.0 8-9|0 7-8|0.0.1 5-6|0.0.0.0.1 4-5|0.0.0.0.1.1.0.0+0.0.0.0.1.1.0+0.0.0.0.1.1 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:05:59.895
(p / photoreceptor 
      :mod-of (c2 / cell 
            :ARG0-of (c / convert-01 
                  :ARG1 (a / absent-01 
                        :ARG0 (n / neuron) 
                        :ARG1 (f / function-01 
                              :ARG0 9 
                              :ARG1 (t / thing 
                                    :name (n2 / name 
                                          :op1 "Otx2"))))) 
            :ARG1-of (d / differentiate-01)))

# ::snt Crx , a downstream target of Otx2 , controls the transcription of various photoreceptor cell-specific genes and is essential for the formation of outer segments , synaptic terminals , and phototransduction pathways [ 8,10 ] .
# ::tok Crx , a downstream target of Otx2 , controls the transcription of various photoreceptor cell-specific genes and is essential for the formation of outer segments , synaptic terminals , and phototransduction pathways [ 8,10 ] .
# ::alignments 31-32|0.2 30-31|0.2.0 29-30|0 27-28|0.1 26-27|0.1.0 24-25|0.0 23-24|0.0.2 21-22|0.0.1 18-19|0.0.1.0 16-17|0.0.1.0.0 15-16|0.0.1.0.0.0.1.0 13-14|0.0.0 12-13|0.0.1.0.0.0.0.0 10-11|0.0.1.0.0.0.1 8-9|0.0.1.0.0.0 6-7|0.0.1.0.0.0.0.1.0.0+0.0.1.0.0.0.0.1.0+0.0.1.0.0.0.0.1 4-5|0.0.1.0.0.0.0 3-4|0.0.1.0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:00.783
(a / and 
      :op1 (s2 / segment-01 
            :ARG1 (p3 / photoreceptor) 
            :ARG1-of (f / form-01 
                  :purpose-of (e / essential 
                        :op2-of (a2 / and 
                              :op1 (c / control-01 
                                    :ARG0 (t4 / target-01 
                                          :ARG0 (v / various) 
                                          :ARG1 (t3 / thing 
                                                :name (n / name 
                                                      :op1 "Otx2")) 
                                          :mod (d / downstream)) 
                                    :ARG1 (t2 / transcription 
                                          :mod (g / gene)))))) 
            :mod (o / outer)) 
      :op2 (t / terminal 
            :mod (s / synaptic)) 
      :op3 (p / pathway 
            :mod (p2 / phototransduction)))

# ::snt Crx transcripts begin to be expressed in developing photoreceptors at embryonic day 12.5 ( E12 .5 ) in the mouse and a strong upregulation of Crx transcription is apparent across the differentiating photoreceptors at postnatal day 6 ( P6 ) .
# ::tok Crx transcripts begin to be expressed in developing photoreceptors at embryonic day 12.5 ( E12 .5 ) in the mouse and a strong upregulation of Crx transcription is apparent across the differentiating photoreceptors at postnatal day 6 ( P6 ) .
# ::alignments 36-37|0.1.0.0.0 35-36|0.0.0.1.0.0 34-35|0.0.0.1.0 32-33|0.1.1.0 31-32|0.1.1.0.0 29-30|0.1.1 28-29|0.1 26-27|0.1.0.1 23-24|0.1.0 22-23|0.1.0.0 20-21|0 19-20|0.0.0.1.2 11-12|0.0.0.1.3 10-11|0.0.0.1.3.0 8-9|0.0.0.1.1 7-8|0.0.0.1 5-6|0.0.0 2-3|0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:01.858
(a3 / and 
      :op1 (b / begin-01 
            :ARG1 (e2 / express-01 
                  :ARG0 (t2 / transcript 
                        :mod (c / Crx)) 
                  :ARG1 (d4 / develop-02 
                        :ARG0 (p / postnatal 
                              :mod-of (d / day)) 
                        :ARG1 (p3 / photoreceptor) 
                        :location (m / mouse) 
                        :time (d3 / day 
                              :mod (e / embryonic))))) 
      :op2 (a2 / apparent 
            :domain (u / upregulation 
                  :ARG1-of (s / strong-02 
                        :ARG0 6) 
                  :mod (t / transcription)) 
            :location (a / across 
                  :op1 (p2 / photoreceptor 
                        :ARG1-of (d2 / differentiate-01)))))

# ::snt Photoreceptor cells in the Crx knockout ( KO ) mice exhibit a dramatic reduction of many photoreceptor molecules including visual pigments and develop neither photoreceptor outer segments nor a synaptic terminus [ 8,10 ] .
# ::tok Photoreceptor cells in the Crx knockout ( KO ) mice exhibit a dramatic reduction of many photoreceptor molecules including visual pigments and develop neither photoreceptor outer segments nor a synaptic terminus [ 8,10 ] .
# ::alignments 30-31|0.1.0 29-30|0.1.0.0 26-27|0.2.1.1 25-26|0.2.1.1.1 22-23|0.2.1 21-22|0.2 20-21|0.2.1.1.0 19-20|0.2.1.1.0.0 17-18|0.1.1 16-17|0.1.1.0 15-16|0.1.1.1 13-14|0.1 12-13|0.1.2 10-11|0 9-10|0.2.0 7-8|0.0 5-6|0.2.1.0.0 1-2|0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:02.126
(e / exhibit-01 
      :ARG0 (k / ko) 
      :ARG1 (r / reduce-01 
            :ARG0 (t / terminu 
                  :mod (s / synaptic)) 
            :ARG1 (m / molecule 
                  :mod (p2 / photoreceptor) 
                  :quant (m2 / many)) 
            :manner (d2 / dramatic)) 
      :op2-of (a / and 
            :op1 (m3 / mouse) 
            :op3 (d / develop-02 
                  :ARG0 (c / cell 
                        :part-of (k2 / knockout)) 
                  :ARG1 (s2 / segment-01 
                        :ARG1 (p / pigment 
                              :mod (v / visual)) 
                        :mod (o / outer)))))

# ::snt In addition , mutations of human CRX have been demonstrated to be associated with three types of photoreceptor diseases : autosomal dominant cone-rod dystrophy 2 , autosomal dominant-type retinitis pigmentosa , and Leber 's congenital amaurosis ( LCA ) [ 11-14 ] .
# ::tok In addition , mutations of human CRX have been demonstrated to be associated with three types of photoreceptor diseases : autosomal dominant cone-rod dystrophy 2 , autosomal dominant-type retinitis pigmentosa , and Leber 's congenital amaurosis ( LCA ) [ 11-14 ] .
# ::alignments 37-38|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 35-36|0.1 34-35|0.1.0 32-33|0.1.1.0.0+0.1.1.0+0.1.1 31-32|0 29-30|0.0.0.0.2.1 28-29|0.0.0.0.2.1.0 26-27|0.0.0.0.2.1.1 24-25|0.0.0.0.0 23-24|0.0.0.0.0.0 21-22|0.0.0.0.2 20-21|0.0.0.0.2.0 18-19|0.0.0.1.0 17-18|0.0.0.1.0.0 15-16|0.0.0.1 14-15|0.0.0.1.1 12-13|0.0.0 9-10|0.0 6-7|0.0.0.0.1.1.0+0.0.0.0.1.1+0.0.0.0.1 5-6|0.0.0.0.1.0 3-4|0.0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:02.612
(a2 / and 
      :op1 (d4 / demonstrate-01 
            :ARG1 (a5 / associate-01 
                  :ARG1 (m / mutate-01 
                        :ARG0 (2 / 2 
                              :value-of (d / dystrophy)) 
                        :ARG1 (t2 / thing 
                              :mod (h / human) 
                              :name (n3 / name 
                                    :op1 "CRX")) 
                        :purpose-of (d2 / dominate-01 
                              :ARG0 (a4 / autosomal) 
                              :ARG1 (p2 / pigmentosa 
                                    :mod (r / retiniti) 
                                    :mod (a3 / autosomal)))) 
                  :ARG2 (t / type 
                        :mod-of (d3 / disease 
                              :mod (p3 / photoreceptor)) 
                        :quant 3)) 
            :location (a6 / addition)) 
      :op2 (a / amaurosi 
            :mod (c / congenital) 
            :poss (p / person 
                  :name (n2 / name 
                        :op1 "Leber") 
                  :poss-of (o / organization 
                        :name (n / name 
                              :op1 "LCA")))))

# ::snt While Otx2 and Crx control general photoreceptor development , three other transcription factors , TR2 , Nrl , and Nr2e3 regulate the specification of photoreceptor cell types [ 4,5,7 ] .
# ::tok While Otx2 and Crx control general photoreceptor development , three other transcription factors , TR2 , Nrl , and Nr2e3 regulate the specification of photoreceptor cell types [ 4,5,7 ] .
# ::alignments 26-27|0.2.1.2.0 25-26|0.2.1.2 22-23|0.2.0.0 20-21|0.2.0 19-20|0.2.1.0.3.0.0+0.2.1.0.3.0+0.2.1.0.3 18-19|0.2 16-17|0.2.1.0.2 12-13|0 11-12|0.1 10-11|0.0 9-10|0.2.1.1.0 7-8|0.2.1.0.0 6-7|0.2.1.0.0.0 5-6|0.2.1.0.0.1 4-5|0.2.1 2-3|0.2.1.0 1-2|0.2.1.0.1.0.0+0.2.1.0.1.0+0.2.1.0.1 0-1|0.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:03.242
(f / factor 
      :mod (o / other) 
      :mod (t3 / transcription) 
      :op2-of (a / and 
            :ARG0-of (r / regulate-01 
                  :ARG1 (s / specification)) 
            :op1 (c2 / control-01 
                  :ARG0 (a2 / and 
                        :location-of (d / develop-02 
                              :ARG1 (p / photoreceptor) 
                              :ARG1-of (g / general-02)) 
                        :op1 (t4 / thing 
                              :name (n3 / name 
                                    :op1 "Otx2")) 
                        :op2 (n2 / nrl) 
                        :op3 (t2 / thing 
                              :name (n / name 
                                    :op1 "Nr2e3"))) 
                  :ARG0-of (w / while-01 
                        :ARG1 3) 
                  :ARG1 (c / cell 
                        :mod-of (t / type)))))

# ::snt SAM domains ( also known as Pointed , HLH , or SPM domains ) are ~ 70 residues long and have been reported as common protein-protein interaction modules [ 15-17 ] .
# ::tok SAM domains ( also known as Pointed , HLH , or SPM domains ) are ~ 70 residues long and have been reported as common protein-protein interaction modules [ 15-17 ] .
# ::alignments 27-28|0.0.0.0.0.1 26-27|0.0.0.0.0.1.1 24-25|0.0.0.0.0.1.0 22-23|0.0.0.0.0 19-20|0.0.0.0.0.2 18-19|0.0.0.0.0.2.0 17-18|0.0.0.0.0.0 16-17|0.0.0.0.0.0.0 10-11|0.0 6-7|0 4-5|0.0.0 3-4|0.0.0.1 1-2|0.0.0.0 0-1|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:03.416
(p / point-01 
      :op1-of (o / or 
            :time-of (k / know-02 
                  :ARG1 (d / domain 
                        :ARG0-of (r / report-01 
                              :ARG1 (r2 / residu 
                                    :quant 70) 
                              :ARG2 (m / module 
                                    :mod (c / common) 
                                    :mod (i / interact-01)) 
                              :op2-of (a / and 
                                    :op1 (l / long-03))) 
                        :mod (o2 / organization 
                              :name (n / name 
                                    :op1 "SAM"))) 
                  :mod (a2 / also))))

# ::snt This domain is found in a large number of proteins , including Polycomb group ( PcG ) proteins [ 18 ] , serine threonine kinases [ 19 ] , Eph family receptor tyrosine kinases [ 20 ] , the p73 tumor suppressor [ 21 ] , the RNA-binding protein Smaug [ 22 ] , diacylglycerol kinases [ 23,24 ] , yeast mating type signaling proteins [ 19,25 ] and ETS family transcription factors [ 26,27 ] .
# ::tok This domain is found in a large number of proteins , including Polycomb group ( PcG ) proteins [ 18 ] , serine threonine kinases [ 19 ] , Eph family receptor tyrosine kinases [ 20 ] , the p73 tumor suppressor [ 21 ] , the RNA-binding protein Smaug [ 22 ] , diacylglycerol kinases [ 23,24 ] , yeast mating type signaling proteins [ 19,25 ] and ETS family transcription factors [ 26,27 ] .
# ::alignments 72-73|0.0.0.1.2 71-72|0.0.0.1.2.0 70-71|0.0.0.1.2.0.0 69-70|0.0.0.1.2.0.0.0 68-69|0.0.0.1 64-65|0 63-64|0.0 62-63|0.0.0 61-62|0.0.0.0 60-61|0.0.0.0.0 55-56|0.0.0.1.1 51-52|0.0.1 49-50|0.0.0.0.2.0 48-49|0.0.0.0.2.0.0 47-48|0.0.0.0.2 43-44|0.0.2 41-42|0.0.0.0.4.0 40-41|0.0.0.0.4 35-36|0.0.0.0.5 32-33|0.0.0.1.0.2.0.0.0.0 31-32|0.0.0.1.0.2.0.0.0 30-31|0.0.0.1.0.2.0.0 26-27|0.0.0.0.1 24-25|0.0.0.0.3 23-24|0.0.0.0.3.0 22-23|0.0.0.0.3.1 19-20|0.0.0.1.0.0 17-18|0.0.0.1.0.1.1.1 13-14|0.0.0.1.0.1.1 12-13|0.0.0.1.0.1.1.0.0.0+0.0.0.1.0.1.1.0.0+0.0.0.1.0.1.1.0 9-10|0.0.0.1.0.2.1 7-8|0.0.0.1.0.2 6-7|0.0.0.1.0.2.0 3-4|0.0.0.1.0 1-2|0.0.0.1.0.1 0-1|0.0.0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:05.285
(p / protein 
      :ARG1-of (s / signal-01 
            :ARG0 (t2 / type 
                  :mod (m / mate-01 
                        :ARG1 (y / yeast) 
                        :op1-of 19 
                        :op1-of (r / rna-bind 
                              :mod-of (s2 / Smaug 
                                    :mod (p2 / protein))) 
                        :op1-of (k2 / kinas 
                              :mod (t5 / threonine) 
                              :mod (s4 / serine)) 
                        :op1-of (t3 / tumor 
                              :mod-of (s3 / suppressor)) 
                        :op1-of 20) 
                  :op3-of (a / and 
                        :op1 (f4 / find-01 
                              :ARG0 18 
                              :ARG1 (d / domain 
                                    :mod (t7 / this) 
                                    :poss-of (g / group 
                                          :mod (t6 / thing 
                                                :name (n / name 
                                                      :op1 "Polycomb")) 
                                          :mod-of (p3 / protein))) 
                              :location (n2 / number 
                                    :mod (l / large 
                                          :mod-of (f3 / family 
                                                :mod-of (r2 / receptor 
                                                      :mod-of (t4 / tyrosine)))) 
                                    :quant-of (p4 / protein))) 
                        :op2 (k / kinas) 
                        :op4 (f / factor 
                              :mod (t / transcription 
                                    :mod (f2 / family 
                                          :mod (e / et)))))) 
            :ARG2 22 
            :op1-of 21))

# ::snt The PcG proteins are transcriptional repressors that maintain gene silencing during development [ 28-30 ] .
# ::tok The PcG proteins are transcriptional repressors that maintain gene silencing during development [ 28-30 ] .
# ::alignments 11-12|0.0.2 9-10|0.0.1.0 8-9|0.0.1 7-8|0.0 5-6|0.0.0 4-5|0.0.0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:05.373
(p / protein 
      :ARG2-of (m / maintain-01 
            :ARG0 (r / repressor 
                  :mod (t / transcriptional)) 
            :ARG1 (g / gene 
                  :ARG1-of (s / silence-01)) 
            :ARG1-of (d / develop-02)))

# ::snt In mammals , PcG proteins are also implicated in Hox gene regulation .
# ::tok In mammals , PcG proteins are also implicated in Hox gene regulation .
# ::alignments 11-12|0.1 10-11|0.1.0 7-8|0 6-7|0.3 4-5|0.0 3-4|0.0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:05.425
(i / implicate-01 
      :ARG1 (p / protein 
            :mod (p2 / PcG)) 
      :ARG1-of (r / regulate-01 
            :ARG0 (g / gene)) 
      :ARG2 (m / mammal) 
      :mod (a / also))

# ::snt Their biological activity lies in stable silencing of specific sets of genes through chromatin modifications .
# ::tok Their biological activity lies in stable silencing of specific sets of genes through chromatin modifications .
# ::alignments 14-15|0.0 13-14|0 11-12|0.0.0.0.0.1 9-10|0.0.0.0.0 8-9|0.0.0.0.0.0 6-7|0.0.0 5-6|0.0.0.0 3-4|0.0.0.0.1 2-3|0.0.0.0.1.0 1-2|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:05.621
(c / chromatin 
      :ARG1-of (m / modify-01 
            :ARG1-of (s3 / silence-01 
                  :ARG1-of (s4 / stable-03 
                        :ARG2 (s / set 
                              :ARG1-of (s2 / specific-02) 
                              :consist-of (g / gene)) 
                        :ARG2-of (l / lie-07 
                              :ARG1 (a / activity-06 
                                    :mod (b / biology)))))))

# ::snt A member of polycomb repressive complex 1 ( PRC1 ) , ph , contains a SAM domain at the C-terminal , and PRC1 complex is known to form helical , head-to-tail polymers through its SAM domain [ 31 ] .
# ::tok A member of polycomb repressive complex 1 ( PRC1 ) , ph , contains a SAM domain at the C-terminal , and PRC1 complex is known to form helical , head-to-tail polymers through its SAM domain [ 31 ] .
# ::alignments 37-38|0.2.0.1.0 35-36|0.2.0.0.0 31-32|0.2.0.0 28-29|0.2.0.0.1 27-28|0.2.0 25-26|0.2.0.2 23-24|0.2.0.2.1 21-22|0.2 16-17|0.1 15-16|0.1.0.0.0+0.1.0.0+0.1.0 13-14|0 11-12|0.0 6-7|0.2.0.2.0 5-6|0.2.0.1.1.0 4-5|0.2.0.1.1 3-4|0.2.0.1.1.1 1-2|0.2.0.1.2+0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:06.910
(c2 / contain-01 
      :ARG0 (p2 / ph) 
      :ARG1 (d2 / domain 
            :mod (o / organization 
                  :name (n / name 
                        :op1 "SAM"))) 
      :op1-of (a / and 
            :ARG1-of (f / form-01 
                  :ARG0 (p / polymer 
                        :location (d / domain) 
                        :mod (h / helical)) 
                  :ARG2 (h2 / have-org-role-91 
                        :ARG0 31 
                        :ARG1 (r / repress-01 
                              :ARG0 (c3 / complex) 
                              :ARG1 (p3 / polycomb)) 
                        :ARG2 (m / member)) 
                  :ARG2-of (k / know-02 
                        :ARG0 1 
                        :ARG1 (c / complex)))))

# ::snt These polymeric structures mediate the formation of a higher order chromatin structure and possibly stabilize the repressed state of Hox genes .
# ::tok These polymeric structures mediate the formation of a higher order chromatin structure and possibly stabilize the repressed state of Hox genes .
# ::alignments 20-21|0.1.1.1 17-18|0.1.1 16-17|0.1.1.0 14-15|0.1 13-14|0.1.2 12-13|0 11-12|0.1.1.0.0 10-11|0.1.1.0.0.1 8-9|0.1.1.0.0.0 5-6|0.0.1 3-4|0.0 2-3|0.0.0 1-2|0.1.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:07.174
(a / and 
      :op1 (m / mediate-01 
            :ARG0 (s4 / structure 
                  :mod (t / this)) 
            :ARG1 (f / form-01)) 
      :op2 (s2 / stabilize-01 
            :ARG0 (p2 / polymeric) 
            :ARG1 (s / state 
                  :ARG0-of (r / repress-01 
                        :ARG1 (s3 / structure 
                              :ARG1-of (h / high-02) 
                              :mod (c / chromatin))) 
                  :mod (g / gene)) 
            :ARG1-of (p / possible-01)))

# ::snt In this study , we identified a novel gene , mr-s , which encodes a SAM domain-containing protein .
# ::tok In this study , we identified a novel gene , mr-s , which encodes a SAM domain-containing protein .
# ::alignments 17-18|0.1.0.0 16-17|0.1.0.0.0 15-16|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 13-14|0.1.0 10-11|0.1.2 8-9|0.1 7-8|0.1.1 5-6|0 4-5|0.0 2-3|0.2 1-2|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:07.424
(i / identify-01 
      :ARG0 (w / we) 
      :ARG1 (g / gene 
            :ARG0-of (e / encode-01 
                  :ARG1 (p / protein 
                        :mod (d / domain-contain)) 
                  :ARG2 (o / organization 
                        :name (n / name 
                              :op1 "SAM"))) 
            :mod (n2 / novel) 
            :mod (m / mr-)) 
      :time (s / study-01 
            :mod (t / this)))

# ::snt The SAM domain of mr-s is most closely related to that of ph mouse ortholog , MPH1/Rae28 .
# ::tok The SAM domain of mr-s is most closely related to that of ph mouse ortholog , MPH1/Rae28 .
# ::alignments 16-17|0.0.0.0.0.2.0.0+0.0.0.0.0.2.0+0.0.0.0.0.2 14-15|0.0.0 13-14|0.0 12-13|0 10-11|0.0.0.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.3 6-7|0.0.0.0.0.3.0 4-5|0.0.0.0.0.0 2-3|0.0.0.0.0.1 1-2|0.0.0.0.0.1.0.0.0+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:07.608
(p / ph 
      :mod-of (m / mouse 
            :mod-of (o / ortholog 
                  :quant (t / that 
                        :beneficiary-of (r / relate-01 
                              :ARG0 (m3 / mr-) 
                              :ARG1 (d / domain 
                                    :mod (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "SAM"))) 
                              :ARG2 (c / country 
                                    :name (n / name 
                                          :op1 "MPH1/Rae28")) 
                              :manner (c2 / close 
                                    :degree (m2 / most)))))))

# ::snt mr-s is predominantly expressed in retinal photoreceptors when they undergo terminal differentiation , and adult pineal gland .
# ::tok mr-s is predominantly expressed in retinal photoreceptors when they undergo terminal differentiation , and adult pineal gland .
# ::alignments 16-17|0.0.0 15-16|0.0.0.0 14-15|0.0.0.1 13-14|0.0 11-12|0.3.2 10-11|0.3.2.0 9-10|0.3 8-9|0.3.1 6-7|0.1 5-6|0.1.0 3-4|0 2-3|0.2 0-1|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:08.391
(e / express-01 
      :ARG1 (a2 / and 
            :op1 (g / gland 
                  :mod (p / pineal) 
                  :mod (a / adult))) 
      :ARG2 (p2 / photoreceptor 
            :mod (r / retinal)) 
      :mod (p3 / predominant) 
      :time (u / undergo-28 
            :ARG0 (m / mr-) 
            :ARG1 (t2 / they) 
            :ARG2 (d / differentiation 
                  :mod (t / terminal))))

# ::snt The expression of mr-s is directly regulated by Crx .
# ::tok The expression of mr-s is directly regulated by Crx .
# ::alignments 6-7|0.0.0 5-6|0.0.0.0 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:08.409
(m / mr- 
      :ARG1-of (e / express-01 
            :ARG1-of (r / regulate-01 
                  :ARG1-of (d / direct-02))))

# ::snt Moreover , mr-s is localized in the nucleus and can self-associate through its SAM domain-containing region .
# ::tok Moreover , mr-s is localized in the nucleus and can self-associate through its SAM domain-containing region .
# ::alignments 15-16|0.2.0.0 14-15|0.2.0 13-14|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 9-10|0.0 8-9|0 7-8|0.2.1 4-5|0.2 2-3|0.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:08.495
(a / and 
      :ARG1-of (p / possible-01 
            :ARG0 (m / mr-)) 
      :op1 (m2 / moreover) 
      :op2 (l / localize-01 
            :ARG0 (d / domain-contain 
                  :mod-of (r / region 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "SAM")))) 
            :location (n2 / nucleus)))

# ::snt We also found that mr-s protein fused to GAL4 DNA-binding domain functions as a transcriptional repressor .
# ::tok We also found that mr-s protein fused to GAL4 DNA-binding domain functions as a transcriptional repressor .
# ::alignments 15-16|0.0 14-15|0 11-12|0.0.0 10-11|0.0.0.1 9-10|0.0.0.2 6-7|0.0.0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.1 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:08.620
(t / transcriptional 
      :mod-of (r / repressor 
            :ARG2-of (f / function-01 
                  :ARG0 (p / protein 
                        :ARG0-of (f2 / fuse-01 
                              :ARG1-of (f3 / find-01 
                                    :ARG0 (w / we) 
                                    :mod (a / also))) 
                        :mod (m / mr-)) 
                  :ARG1 (d / domain) 
                  :mod (d2 / dna-bind))))

# ::snt These findings suggest that mr-s functions as a member of a transcriptional repressor complex in retinal photoreceptor development .
# ::tok These findings suggest that mr-s functions as a member of a transcriptional repressor complex in retinal photoreceptor development .
# ::alignments 17-18|0.0.1.0.0.1 16-17|0.0.1.0.0.1.0 15-16|0.1 13-14|0.0.1.0.0 12-13|0.0.1.0 8-9|0.0.1.0.0.0.0+0.0.1.0.0.0 5-6|0.0.1 2-3|0 1-2|0.0.0+0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:08.740
(s / suggest-01 
      :ARG0 (t / thing 
            :ARG1-of (f2 / find-01) 
            :ARG1-of (f / function-01 
                  :ARG0 (r2 / repressor 
                        :mod-of (c / complex 
                              :ARG1-of (h / have-org-role-91 
                                    :ARG2 (m / member)) 
                              :topic (d / develop-02 
                                    :ARG1 (p / photoreceptor))))) 
            :mod (t2 / this)) 
      :ARG1 (r / retinal))

# ::snt Cloning of mouse mr-s .
# ::tok Cloning of mouse mr-s .
# ::alignments 3-4|0.1 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:08.771
(c / clone-01 
      :ARG1 (m2 / mouse) 
      :instrument (m / mr-))

# ::snt In order to identify novel mouse genes preferentially expressed in the developing retina , we screened the National Institute for Biotechnology Information ( NCBI ) database , UniGene , using Digital Differential Display ( DDD ) and found EST fragments which are frequently present in mouse retinal cDNA libraries .
# ::tok In order to identify novel mouse genes preferentially expressed in the developing retina , we screened the National Institute for Biotechnology Information ( NCBI ) database , UniGene , using Digital Differential Display ( DDD ) and found EST fragments which are frequently present in mouse retinal cDNA libraries .
# ::alignments 48-49|0.0.0.2.0 47-48|0.0.0.2.0.0 46-47|0.0.0.2 45-46|0.2 43-44|0.0.1.0.1 42-43|0.0.1.0.1.0 39-40|0.0.1.0 38-39|0.0.1.0.0 37-38|0.0.1 36-37|0.0.1.1 34-35|0.0.1.1.0.1.0.1.0.1.0.0+0.0.1.1.0.1.0.1.0.1.0+0.0.1.1.0.1.0.1.0.1 30-33|0.0.0.0.0.2+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 29-30|0.0.0 27-28|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 25-26|0.1 23-24|0.0.1.1.0.0.0.0+0.0.1.1.0.0.0+0.0.1.1.0.0 17-22|0.0.0.3.0.4+0.0.0.3.0.3+0.0.0.3.0.2+0.0.0.3.0.1+0.0.0.3.0.0+0.0.0.3.0+0.0.0.3 15-16|0 14-15|0.0 12-13|0.0.1.1.0.1.0.1 11-12|0.0.1.1.0.1.0.1.0 8-9|0.0.1.1.0.1.0 7-8|0.0.1.1.0.1.0.0 6-7|0.0.1.1.0.1 5-6|0.0.1.1.0.1.1 4-5|0.0.1.1.0.1.0.1.0.0 3-4|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:11.395
(s / screen-01 
      :ARG0 (w / we 
            :ARG0-of (u / use-01 
                  :ARG1 (o2 / organization 
                        :name (n2 / name 
                              :op1 "Digital" 
                              :op2 "Differential" 
                              :op3 "Display")) 
                  :ARG2 (o3 / organization 
                        :name (n3 / name 
                              :op1 "UniGene")) 
                  :op1-of (r / retinal 
                        :mod-of (l / library 
                              :mod (c / cdna))) 
                  :time (o5 / organization 
                        :name (n5 / name 
                              :op1 "National" 
                              :op2 "Institute" 
                              :op3 "for" 
                              :op4 "Biotechnology" 
                              :op5 "Information"))) 
            :ARG0-of (f3 / find-01 
                  :ARG1 (f2 / fragment-01 
                        :ARG1 (e / e) 
                        :mod (p / present 
                              :ARG1-of (f / frequent-02))) 
                  :op1-of (a / and 
                        :time (i / identify-01 
                              :ARG0 (o4 / organization 
                                    :name (n4 / name 
                                          :op1 "NCBI")) 
                              :ARG1 (g / gene 
                                    :ARG1-of (e2 / express-01 
                                          :mod (p2 / preferentially) 
                                          :time (r2 / retina 
                                                :ARG1-of (d2 / develop-02 
                                                      :ARG0 (n6 / novel) 
                                                      :op1-of (o / organization 
                                                            :name (n / name 
                                                                  :op1 "DDD"))))) 
                                    :mod (m2 / mouse)))))) 
      :ARG1 (d / database) 
      :op1-of (m / mouse))

# ::snt We found that one clone in these cDNAs encodes a protein containing a SAM domain related to that of polyhomeotic protein .
# ::tok We found that one clone in these cDNAs encodes a protein containing a SAM domain related to that of polyhomeotic protein .
# ::alignments 20-21|0 15-16|0.0 14-15|0.0.0 13-14|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 11-12|0.0.0.0 10-11|0.0.0.0.0 8-9|0.0.0.0.0.0 7-8|0.0.0.1.1 6-7|0.0.0.1.1.0 4-5|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 0-1|0.0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:11.547
(p / protein 
      :ARG2-of (r / relate-01 
            :ARG1 (d / domain 
                  :ARG1-of (c / contain-01 
                        :ARG0 (p2 / protein 
                              :ARG1-of (e / encode-01 
                                    :ARG0 (c3 / clone) 
                                    :ARG1-of (f / find-01 
                                          :ARG0 (w / we))))) 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "SAM") 
                        :prep-against (c2 / cdna 
                              :mod (t / this))))))

# ::snt A PCR fragment corresponding to this mouse clone was used to screen a mouse P0-P3 retinal cDNA library to obtain a full-length cDNA clone .
# ::tok A PCR fragment corresponding to this mouse clone was used to screen a mouse P0-P3 retinal cDNA library to obtain a full-length cDNA clone .
# ::alignments 23-24|0.0.0.0.0.0 22-23|0.0.0.0.0.0.0 21-22|0.0.0.0.0.0.1 19-20|0.0.0.0.0 17-18|0.0.0.0.0.1 16-17|0.0.0.0.0.1.0 15-16|0.0.1 14-15|0.0.0.0.0.1.1.0.0+0.0.0.0.0.1.1.0+0.0.0.0.0.1.1 13-14|0.0.0.0.1 11-12|0.0.0.0.2.0 9-10|0.0.0.0.2 7-8|0.0 6-7|0 5-6|0.0.2 3-4|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:11.785
(m2 / mouse 
      :mod-of (c4 / clone 
            :ARG2-of (c5 / correspond-01 
                  :ARG1 (f2 / fragment-01 
                        :ARG0-of (o / obtain-01 
                              :ARG1 (c / clone 
                                    :mod (c2 / cdna) 
                                    :mod (f / full-length)) 
                              :purpose-of (l / library 
                                    :mod (c3 / cdna) 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "P0-P3")))) 
                        :ARG1 (m / mouse) 
                        :ARG1-of (u / use-01 
                              :ARG2 (s / screen)))) 
            :domain-of (r / retinal) 
            :mod (t2 / this)))

# ::snt Sequence analysis showed that this cDNA was a novel gene encoding a SAM domain-containing protein .
# ::tok Sequence analysis showed that this cDNA was a novel gene encoding a SAM domain-containing protein .
# ::alignments 14-15|0 13-14|0.1 12-13|0.0.1.0.0+0.0.1.0+0.0.1 10-11|0.0 9-10|0.0.0 8-9|0.0.0.2 5-6|0.0.0.1 4-5|0.0.0.1.0 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:12.024
(p / protein 
      :ARG1-of (e / encode-01 
            :ARG0 (g / gene 
                  :ARG1-of (s / show-01 
                        :ARG0 (a / analyze-01 
                              :manner (s2 / sequence))) 
                  :domain (c / cdna 
                        :mod (t / this)) 
                  :mod (n2 / novel)) 
            :ARG2 (o / organization 
                  :name (n / name 
                        :op1 "SAM"))) 
      :mod (d / domain-contain))

# ::snt We referred to this protein as mr-s ( major retinal SAM domain protein ) .
# ::tok We referred to this protein as mr-s ( major retinal SAM domain protein ) .
# ::alignments 12-13|0 11-12|0.1.0 10-11|0.1.1.0+0.1.1+0.1 9-10|0.2 8-9|0.0 6-7|0.0.0.0.1 4-5|0.0.0.0.0 3-4|0.0.0.0.0.0 1-2|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:12.208
(p / protein 
      :ARG1-of (m / major-02 
            :ARG0 (w / we 
                  :ARG0-of (r2 / refer-01 
                        :ARG1 (p2 / protein 
                              :mod (t / this)) 
                        :mod (m2 / mr-)))) 
      :mod (o / organization 
            :mod-of (d / domain) 
            :name (n / name 
                  :op1 "SAM")) 
      :mod (r / retinal))

# ::snt As shown in Fig. 1A , a translation initiation codon is present in the same open reading frame as the SAM domain .
# ::tok As shown in Fig. 1A , a translation initiation codon is present in the same open reading frame as the SAM domain .
# ::alignments 21-22|0.0 20-21|0 17-18|0.0.0.0.0.0.0.0 16-17|0.0.0.0.0.0.0 15-16|0.0.0.0.0.0.0.0.0 14-15|0.0.0.0.0.0.0.0.1 11-12|0.0.0.0.1 9-10|0.0.0.0 8-9|0.0.0.0.2 7-8|0.0.0.0.0+0.0.0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:12.526
(s / sam 
      :mod-of (d / domain 
            :ARG0-of (s3 / show-01 
                  :ARG1 (c / codon 
                        :ARG1-of (t2 / translate-01 
                              :ARG2 (t / thing 
                                    :ARG0-of (r / read-01 
                                          :mod-of (f / frame 
                                                :ARG1-of (o / open-04) 
                                                :ARG1-of (s2 / same-01))))) 
                        :domain-of (p / present) 
                        :mod (i / initiation)))))

# ::snt This initiation site shows similarity to the consensus sequence proposed by Kozak [ 32 ] including the presence of the highly conserved purine at position -3 .
# ::tok This initiation site shows similarity to the consensus sequence proposed by Kozak [ 32 ] including the presence of the highly conserved purine at position -3 .
# ::alignments 24-25|0.2.0.0.1 22-23|0.3.1 21-22|0.3 20-21|0.3.2 17-18|0.3.1.0 13-14|0.3.0 11-12|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 9-10|0.2.0 8-9|0.2 7-8|0.2.1 4-5|0.1 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:12.705
(s3 / show-01 
      :ARG0 (s4 / site 
            :mod (i / initiation) 
            :mod (t / this)) 
      :ARG1 (s2 / similarity) 
      :ARG2 (s / sequence 
            :ARG1-of (p5 / propose-01 
                  :ARG0 (p4 / person 
                        :name (n / name 
                              :op1 "Kozak") 
                        :poss-of (p / position))) 
            :mod (c2 / consensus)) 
      :purpose (c / conserve-01 
            :ARG0 32 
            :ARG1 (p2 / purine 
                  :poss-of (p3 / presence)) 
            :degree (h / high)))

# ::snt The stop codon of the predicted mr-s protein is also indicated in Fig. 1A .
# ::tok The stop codon of the predicted mr-s protein is also indicated in Fig. 1A .
# ::alignments 12-13|0.1.0.0+0.1.0+0.1 10-11|0 9-10|0.2 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0.1.0.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:12.826
(i / indicate-01 
      :ARG1 (c2 / codon 
            :ARG1-of (s / stop-01) 
            :mod (p / protein 
                  :mod (m / mr- 
                        :ARG1-of (p2 / predict-01)))) 
      :location (c / country 
            :name (n / name 
                  :op1 "Fig.")) 
      :mod (a / also))

# ::snt The amino acid sequence of the SAM domain of mr-s protein ( Fig. 1A , boxed sequence ) exhibits homology with SAM domains of EphB2 , EphA4 , MPH1 , TEL and Smaug ( Fig. 1B ) .
# ::tok The amino acid sequence of the SAM domain of mr-s protein ( Fig. 1A , boxed sequence ) exhibits homology with SAM domains of EphB2 , EphA4 , MPH1 , TEL and Smaug ( Fig. 1B ) .
# ::alignments 31-32|0.2.0 22-23|0.2 19-20|0.3 18-19|0 16-17|0.1.1.0.0 15-16|0.1.1.0 12-13|0.0.0.0+0.0.0+0.0 10-11|0.1.2.1 9-10|0.1.2.1.0 7-8|0.1.2 6-7|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 3-4|0.1 2-3|0.1.0 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:13.170
(e / exhibit-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "Fig.")) 
      :ARG1 (s2 / sequence 
            :mod (a2 / acid) 
            :mod (a3 / amino 
                  :ARG0-of (b / box-01 
                        :ARG1 (s / sequence))) 
            :poss-of (d2 / domain 
                  :mod (o / organization 
                        :name (n2 / name 
                              :op1 "SAM")) 
                  :poss (p / protein 
                        :mod (m / mr-)))) 
      :ARG2 (d / domain 
            :domain (a / and)) 
      :mod (h / homology))

# ::snt By phylogenetic analysis , the SAM domain of mr-s is most closely related to that of Mph1/Rae28 , a mouse homolog of ph ( Fig. 1C ) .
# ::tok By phylogenetic analysis , the SAM domain of mr-s is most closely related to that of Mph1/Rae28 , a mouse homolog of ph ( Fig. 1C ) .
# ::alignments 24-25|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 22-23|0.0.1 20-21|0.0 19-20|0 14-15|0.0.0.1.1 12-13|0.0.0.1 11-12|0.0.0.1.2 10-11|0.0.0.1.2.0 8-9|0.0.0.1.0.1 6-7|0.0.0.1.0 5-6|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 2-3|0.0.0 1-2|0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:13.316
(m / mouse 
      :mod-of (h / homolog 
            :ARG1-of (a / analyze-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Fig.")) 
                  :ARG0-of (r / relate-01 
                        :ARG1 (d / domain 
                              :mod (o / organization 
                                    :name (n2 / name 
                                          :op1 "SAM")) 
                              :poss (m3 / mr-)) 
                        :beneficiary (t / that) 
                        :manner (c2 / close 
                              :degree (m2 / most))) 
                  :manner (p2 / phylogenetic)) 
            :mod (p / ph)))

# ::snt Mouse mr-s protein is conserved in rat , human , chick and zebrafish , which display 91 % , 70 % , 36 % and 26 % identity with mouse mr-s , respectively ( Fig. 1D ) .
# ::tok Mouse mr-s protein is conserved in rat , human , chick and zebrafish , which display 91 % , 70 % , 36 % and 26 % identity with mouse mr-s , respectively ( Fig. 1D ) .
# ::alignments 34-35|0.0.1.0.4.0.0+0.0.1.0.4.0+0.0.1.0.4 32-33|0.0.1.0.0 30-31|0.1 29-30|0 27-28|0.0.1.0.3.0.0.4 26-27|0.0.1.0.3.0.0.4.0 25-26|0.0.1.0.3.0.0.4.0.0 24-25|0.0.1.0.3.0.0 23-24|0.0.1.0.3.0.0.3 22-23|0.0.1.0.3.0.0.3.0 20-21|0.0.1.0.3.0.0.2 19-20|0.0.1.0.3.0.0.2.0 17-18|0.0.1.0.3.0.0.1 16-17|0.0.1.0.3.0.0.1.0 15-16|0.0.1.0.3.0 12-13|0.0.1.0.3 11-12|0.0.1.0 10-11|0.0.1.0.2 8-9|0.0.1.0.1 6-7|0.0.1 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.1.0.3.0.0.0.0.0+0.0.1.0.3.0.0.0.0+0.0.1.0.3.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:14.480
(m2 / mouse 
      :ARG0-of (c3 / conserve-01 
            :ARG1 (p5 / protein 
                  :mod (m3 / mr-)) 
            :location (r2 / rat 
                  :op1-of (a2 / and 
                        :mod (r / respective) 
                        :op2 (h / human) 
                        :op3 (c2 / chick) 
                        :op4 (z / zebrafish 
                              :ARG0-of (d / display-01 
                                    :ARG1 (a / and 
                                          :op1 (p6 / person 
                                                :name (n2 / name 
                                                      :op1 "Mouse")) 
                                          :op2 (p4 / percentage-entity 
                                                :value 91) 
                                          :op3 (p3 / percentage-entity 
                                                :value 70) 
                                          :op4 (p2 / percentage-entity 
                                                :value 36) 
                                          :op5 (i / identity 
                                                :mod (p / percentage-entity 
                                                      :value 26))))) 
                        :op5 (c / country 
                              :name (n / name 
                                    :op1 "Fig."))))) 
      :mod-of (m / mr-))

# ::snt The SAM domains of rat , human , chick and zebrafish mr-s protein are highly conserved and display 96 % , 90 % , 76 % and 72 % identity with the SAM domain of mouse mr-s protein .
# ::tok The SAM domains of rat , human , chick and zebrafish mr-s protein are highly conserved and display 96 % , 90 % , 76 % and 72 % identity with the SAM domain of mouse mr-s protein .
# ::alignments 37-38|0.0.0.0.1.0.0.0.2.0.0 35-36|0.0.0.0.1.0.0.0.2.0.0.0 33-34|0.0.0.0.1.0.0.0.2.0 29-30|0.0.0.0.1.0.0.0.2 28-29|0.0.0.0.1.0.0.1 27-28|0.0.0.0.1.0.0.1.1 26-27|0.0.0.0.1.0.0.0 25-26|0.0.0.0.1.0.0.0.1 24-25|0.0.0.1.2.0+0.0.0.1.2 22-23|0.0.0.0.1.0.0.0.0 21-22|0.0.0.0.1.0.0.0.0.0 19-20|0.0.0.0.1.0.0 18-19|0.0.0.0.1.0.0.1.0 17-18|0.0.0.0.1.0 16-17|0.0.0 15-16|0.0.0.0 14-15|0.0.0.0.2 12-13|0 11-12|0.0 10-11|0.0.0.1.1 9-10|0.0.0.1 8-9|0.0.0.1.0 6-7|0.0.0.0.0 4-5|0.0.0.2 2-3|0.0.0.0.1 1-2|0.0.0.0.1.1.0.0+0.0.0.0.1.1.0+0.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:15.443
(p7 / protein 
      :mod (m2 / mr- 
            :op1-of (a2 / and 
                  :op2 (c / conserve-01 
                        :ARG0 (h2 / human) 
                        :ARG1 (d3 / domain 
                              :ARG0-of (d2 / display-01 
                                    :ARG1 (p6 / percentage-entity 
                                          :op1-of (a / and 
                                                :op2 (p5 / percentage-entity 
                                                      :value 90) 
                                                :op3 (p3 / percentage-entity) 
                                                :op4 (i / identity 
                                                      :poss-of (d / domain 
                                                            :source (p / protein 
                                                                  :mod (m / mouse))))) 
                                          :quant (p2 / percentage-entity 
                                                :value 96 
                                                :value 72))) 
                              :mod (o / organization 
                                    :name (n / name 
                                          :op1 "SAM"))) 
                        :degree (h / high)) 
                  :op3-of (a3 / and 
                        :op1 (c2 / chick) 
                        :op2 (z / zebrafish) 
                        :op4 (p4 / person 
                              :quant 76)) 
                  :poss (r / rat))))

# ::snt The chromosomal localizations of mouse and human mr-s genes were determined by searching the mouse and human genome databases ( NCBI ) , respectively .
# ::tok The chromosomal localizations of mouse and human mr-s genes were determined by searching the mouse and human genome databases ( NCBI ) , respectively .
# ::alignments 23-24|0.1.0 20-21|0.1.2.0.0+0.1.2.0+0.1.2 18-19|0.2.2.0 17-18|0.2.2.0.0 16-17|0.2.2.0.0.0 15-16|0.2.2 14-15|0.2.1 12-13|0.2 10-11|0 8-9|0.2.0 7-8|0.2.0.0 6-7|0.2.0.0.0 5-6|0.1 4-5|0.1.1 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.269
(d2 / determined-02 
      :ARG0 (l / localization 
            :mod (c / chromosomal)) 
      :ARG1 (a2 / and 
            :mod (r / respective) 
            :op1 (m3 / mouse) 
            :op2 (o / organization 
                  :name (n / name 
                        :op1 "NCBI"))) 
      :ARG2 (s / search-01 
            :ARG0 (g2 / gene 
                  :part-of (m2 / mr- 
                        :mod (h2 / human))) 
            :ARG1 (m / mouse) 
            :op1-of (a / and 
                  :op2 (d / database 
                        :mod (g / genome 
                              :mod (h / human))))))

# ::snt Mouse mr-s is mapped to chromosome 4E2 , and human MR-S is mapped to chromosome 1p36 .33 .
# ::tok Mouse mr-s is mapped to chromosome 4E2 , and human MR-S is mapped to chromosome 1p36 .33 .
# ::alignments 15-16|0.2.0.1 14-15|0.2.0.1.0 12-13|0.2.0 10-11|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 9-10|0.1.0 8-9|0.2 5-6|0.1 3-4|0 1-2|0.0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.334
(m2 / map-01 
      :ARG1 (m3 / mr- 
            :mod (p / person 
                  :name (n2 / name 
                        :op1 "Mouse"))) 
      :ARG2 (c2 / chromosome 
            :mod (h / human)) 
      :op1-of (a / and 
            :op2 (m / map-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "MR-S")) 
                  :ARG2 (1 / 1p36 
                        :mod (c / chromosome)))))

# ::snt LCA is the most common cause of inherited childhood blindness .
# ::tok LCA is the most common cause of inherited childhood blindness .
# ::alignments 9-10|0.1 8-9|0.1.0 7-8|0.1.1 5-6|0 4-5|0.2 3-4|0.2.0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.367
(c2 / cause-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "LCA")) 
      :ARG1 (b / blind-02 
            :ARG1 (c / childhood) 
            :ARG1-of (i / inherit-01)) 
      :mod (c3 / common 
            :degree (m / most)))

# ::snt Human MR-S maps in the vicinity region of the LCA9 , recently identified as a new locus for LCA [ 33 ] .
# ::tok Human MR-S maps in the vicinity region of the LCA9 , recently identified as a new locus for LCA [ 33 ] .
# ::alignments 20-21|0.1 18-19|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 16-17|0.2 15-16|0.2.0 12-13|0 11-12|0.3 9-10|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 6-7|0.0.0 5-6|0.0.0.0 2-3|0.0 0-2|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.480
(i / identify-01 
      :ARG0 (m / map 
            :location (r2 / region 
                  :mod (v / vicinity) 
                  :mod-of (o / organization 
                        :name (n / name 
                              :op1 "LCA")) 
                  :poss (t / thing 
                        :name (n3 / name 
                              :op1 "LCA9"))) 
            :mod (t2 / thing 
                  :name (n4 / name 
                        :op1 (h / Human) 
                        :op2 (m2 / MR-S)))) 
      :ARG1 33 
      :ARG2 (l / locu 
            :mod (n2 / new)) 
      :time (r / recent))

# ::snt mr-s nucleotide and amino acid sequences .
# ::tok mr-s nucleotide and amino acid sequences .
# ::alignments 5-6|0.1 4-5|0.1.0 3-4|0.1.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.500
(a3 / and 
      :op1 (n / nucleotide 
            :mod (m / mr-)) 
      :op2 (s / sequence 
            :mod (a / acid) 
            :mod (a2 / amino)))

# ::snt ( A ) mr-s nucleotide and amino acids sequences .
# ::tok ( A ) mr-s nucleotide and amino acids sequences .
# ::alignments 8-9|0.1 7-8|0.1.0 6-7|0.1.1 5-6|0 4-5|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.520
(a3 / and 
      :op1 (n / nucleotide) 
      :op2 (s / sequence 
            :mod (a / acid) 
            :mod (a2 / amino)))

# ::snt Boxed amino acids are the SAM domain sequence and the dashed box indicates a putative nuclear localization signal .
# ::tok Boxed amino acids are the SAM domain sequence and the dashed box indicates a putative nuclear localization signal .
# ::alignments 17-18|0.1.1 16-17|0.1.1.2 15-16|0.1.1.1 14-15|0.1.1.0 12-13|0.1 11-12|0.1.0 10-11|0.1.0.0 8-9|0 7-8|0.0.1 6-7|0.0.1.0.0 5-6|0.0.1.0.1.0+0.0.1.0.1+0.0.1.0 2-3|0.0 1-2|0.0.2 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.691
(a / and 
      :op1 (a2 / acid 
            :ARG1-of (b2 / box-01) 
            :domain-of (s2 / sequence 
                  :mod (o / organization 
                        :mod-of (d2 / domain) 
                        :name (n2 / name 
                              :op1 "SAM"))) 
            :mod (a3 / amino)) 
      :op2 (i / indicate-01 
            :ARG0 (b / box 
                  :ARG1-of (d / dash-01)) 
            :ARG1 (s / signal 
                  :mod (p / putative) 
                  :mod (n / nucleus) 
                  :mod (l / localization))))

# ::snt The underline indicates a putative polyadenylation termination signal .
# ::tok The underline indicates a putative polyadenylation termination signal .
# ::alignments 7-8|0.0.0 6-7|0.0.0.0 4-5|0.0.0.1 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.714
(u / underline-01 
      :ARG0-of (i / indicate-01 
            :ARG1 (s / signal 
                  :mod (t / terminate-01) 
                  :mod (p / putative))))

# ::snt ( B ) Alignment of SAM domain sequences for SAM domain-containing proteins .
# ::tok ( B ) Alignment of SAM domain sequences for SAM domain-containing proteins .
# ::alignments 11-12|0.0 6-7|0.2 5-6|0.2.0.0.0+0.2.0.0+0.2.0 3-4|0 1-2|0.1.1+0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.754
(a / alignment 
      :mod (p / protein) 
      :mod-of (l / location 
            :name (n2 / name 
                  :op1 "B") 
            :wiki -) 
      :quant-of (d / domain 
            :mod (o / organization 
                  :name (n / name 
                        :op1 "SAM"))))

# ::snt The five alpha helices are marked H1-H5 .
# ::tok The five alpha helices are marked H1-H5 .
# ::alignments 6-7|0.0.0.0+0.0.0+0.0 5-6|0 3-4|0.1 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:16.943
(m / mark-01 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 "H1-H5")) 
      :ARG2 (h / helic 
            :mod (a / alpha 
                  :quant 5)))

# ::snt Conserved amino acid residues are shown with a dark shadow and functionally similar residues are shown with a light shadow .
# ::tok Conserved amino acid residues are shown with a dark shadow and functionally similar residues are shown with a light shadow .
# ::alignments 19-20|0 18-19|0.0 15-16|0.1 13-14|0.1.1 12-13|0.1.1.0 11-12|0.1.0.1 10-11|0.1.0 9-10|0.1.0.0.1 8-9|0.1.0.0.1.0 5-6|0.1.0.0 3-4|0.1.0.0.0 2-3|0.1.0.0.0.1 1-2|0.2 0-1|0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:17.400
(s / shadow-02 
      :ARG1 (l / light) 
      :ARG2-of (s2 / show-01 
            :ARG0 (a / and 
                  :ARG0-of (s4 / show-01 
                        :ARG1 (r3 / residu 
                              :ARG1-of (c / conserve-01) 
                              :mod (a2 / acid)) 
                        :ARG2 (s3 / shadow-02 
                              :ARG1-of (d / dark-02))) 
                  :op1 (f / functionally)) 
            :ARG1 (r / residu 
                  :ARG1-of (r2 / resemble-01))) 
      :op1-of (a3 / amino))

# ::snt The sites that were targeted for mutagenesis are indicated by arrows .
# ::tok The sites that were targeted for mutagenesis are indicated by arrows .
# ::alignments 10-11|0.0 8-9|0 6-7|0.1.0.0 4-5|0.1.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:17.421
(i / indicate-01 
      :ARG0 (a / arrow) 
      :ARG1 (s / site 
            :ARG0-of (t / target-01 
                  :ARG1 (m / mutagenesi))))

# ::snt ( C ) Phylogenetic tree of SAM domain-containing proteins .
# ::tok ( C ) Phylogenetic tree of SAM domain-containing proteins .
# ::alignments 8-9|0.1.0 6-7|0.1.1.0+0.1.1+0.1 4-5|0 3-4|0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:17.449
(t / tree 
      :mod (p2 / phylogenetic) 
      :poss (o / organization 
            :mod-of (p / protein 
                  :op1 (c / C)) 
            :name (n / name 
                  :op1 "SAM")))

# ::snt Amino acid sequences were analyzed by the neighbor-joining method in MacVector 7.2 .
# ::tok Amino acid sequences were analyzed by the neighbor-joining method in MacVector 7.2 .
# ::alignments 10-11|0.2 8-9|0.1 7-8|0.1.0 4-5|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:17.492
(a / analyze-01 
      :ARG1 (s / sequence 
            :mod (a2 / acid) 
            :mod (a3 / amino)) 
      :manner (m2 / method 
            :mod (n / neighbor-join)) 
      :time (m / MacVector))

# ::snt Branch lengths reflect the mean number of substitutions per site .
# ::tok Branch lengths reflect the mean number of substitutions per site .
# ::alignments 9-10|0.1.0.0 7-8|0.1.1 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:17.525
(r / reflect-01 
      :ARG1 (l / length 
            :mod (b / branch)) 
      :ARG2 (n / number 
            :ARG1-of (m / mean-01 
                  :location (s / site)) 
            :quant-of (s2 / substitution)))

# ::snt ( D ) Schematic comparison of the amino acid sequences for mouse , rat , human , chick and zebrafish mr-s proteins .
# ::tok ( D ) Schematic comparison of the amino acid sequences for mouse , rat , human , chick and zebrafish mr-s proteins .
# ::alignments 21-22|0.6 19-20|0.5 18-19|0 17-18|0.4 15-16|0.3 13-14|0.2 11-12|0.1 9-10|0.0 8-9|0.0.1 7-8|0.0.2 4-5|0.0.0 3-4|0.0.0.0 1-2|0.7 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:17.607
(a / and 
      :location-of (s / sequence 
            :ARG1-of (c2 / compare-01 
                  :ARG1-of (s2 / schematic)) 
            :mod (a2 / acid) 
            :mod (a3 / amino)) 
      :op1 (m / mouse) 
      :op2 (r / rat) 
      :op3 (h / human) 
      :op4 (c / chick) 
      :op5 (z / zebrafish) 
      :op6 (p / protein) 
      :poss (d / D))

# ::snt The percent similarity of the SAM domains and other regions to the corresponding regions of the mouse protein is shown .
# ::tok The percent similarity of the SAM domains and other regions to the corresponding regions of the mouse protein is shown .
# ::alignments 19-20|0.0 17-18|0 16-17|0.1 13-14|0.0.1.0 12-13|0.0.1 9-10|0.0.0.2 8-9|0.0.0.2.0 7-8|0.0.0 6-7|0.0.0.1 5-6|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:17.869
(p / protein 
      :ARG0-of (s / show-01 
            :ARG1 (a / and 
                  :op1 (s2 / similarity 
                        :mod (p2 / percentage-entity)) 
                  :op2 (d / domain 
                        :mod (o2 / organization 
                              :name (n / name 
                                    :op1 "SAM"))) 
                  :op3 (r2 / region 
                        :mod (o / other))) 
            :ARG2-of (c / correspond-01 
                  :ARG1 (r / region))) 
      :mod (m / mouse))

# ::snt Overall sequence similarity with the mouse protein is shown on the right .
# ::tok Overall sequence similarity with the mouse protein is shown on the right .
# ::alignments 11-12|0.1 8-9|0 6-7|0.1.0 5-6|0.1.0.0 2-3|0.0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:17.946
(s / show-01 
      :ARG1 (s2 / similarity 
            :mod (o / overall) 
            :mod (s3 / sequence)) 
      :ARG2 (r / right-05 
            :ARG0 (p / protein 
                  :mod (m / mouse))))

# ::snt Expression of mr-s in the developing retina and the pineal gland .
# ::tok Expression of mr-s in the developing retina and the pineal gland .
# ::alignments 10-11|0.0.0.1 9-10|0.0.0.1.0 7-8|0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:18.058
(e / expression 
      :mod (m / mr- 
            :op1-of (a / and 
                  :op2 (r / retina 
                        :ARG0-of (d / develop-02)) 
                  :op3 (g / gland 
                        :mod (p / pineal)))))

# ::snt To investigate mr-s expression , we first performed whole mount in situ hybridization in mouse embryos .
# ::tok To investigate mr-s expression , we first performed whole mount in situ hybridization in mouse embryos .
# ::alignments 15-16|0.1.1 14-15|0.1.1.0 12-13|0.1.0 11-12|0.1.0.0 9-10|0.1 8-9|0.1.2 7-8|0 5-6|0.0 3-4|0.2.0 2-3|0.2.0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:18.176
(p / perform-02 
      :ARG0 (w2 / we) 
      :ARG1 (m2 / mount-01 
            :ARG1 (h / hybridization 
                  :mod (s / situ)) 
            :location (e / embryo 
                  :mod (m / mouse)) 
            :mod (w / whole)) 
      :time (i / investigate-01 
            :ARG1 (e2 / express-01 
                  :mod (m3 / mr-))))

# ::snt No hybridization signal was detected at E9 .5 , E10 .5 and E11 .5 with an mr-s probe ( data not shown ) .
# ::tok No hybridization signal was detected at E9 .5 , E10 .5 and E11 .5 with an mr-s probe ( data not shown ) .
# ::alignments 21-22|0 20-21|0.3 19-20|0.1 17-18|0.2 16-17|0.2.0 11-12|0.0 4-5|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:18.284
(s / show-01 
      :ARG0 (a / and 
            :op1 (d2 / detect-01 
                  :ARG1 (s2 / signal 
                        :mod (h / hybridization)) 
                  :polarity -)) 
      :ARG1 (d / data) 
      :ARG1-of (p / probe-01 
            :mod (m / mr-)) 
      :polarity -)

# ::snt We then investigated the expression of the mr-s gene in the developing retina by section in situ hybridization ( Fig. 1A -- G ) .
# ::tok We then investigated the expression of the mr-s gene in the developing retina by section in situ hybridization ( Fig. 1A -- G ) .
# ::alignments 22-23|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 19-20|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 17-18|0.1.4 14-15|0.1.3 12-13|0.1.2.1 11-12|0.1.2 8-9|0.1.1 7-8|0.1.1.0 4-5|0.1 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:18.526
(i / investigate-01 
      :ARG0 (w / we) 
      :ARG1 (e / express-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "G-8") 
                  :wiki "G8") 
            :ARG1 (g / gene 
                  :mod (m / mr-)) 
            :ARG2 (d / develop-02 
                  :ARG0 (c / country 
                        :name (n2 / name 
                              :op1 "Fig.")) 
                  :ARG1 (r / retina)) 
            :location (s / section) 
            :location (h / hybridization)) 
      :time (t / then))

# ::snt No significant signal was detected in the developing retina at E13 ( Fig. 2A ) .
# ::tok No significant signal was detected in the developing retina at E13 ( Fig. 2A ) .
# ::alignments 12-13|0.3.0.0.0.0+0.3.0.0.0+0.3.0.0 10-11|0.1.0.0+0.1.0+0.1 8-9|0.3 7-8|0.3.0 4-5|0 2-3|0.0 1-2|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:18.655
(d2 / detect-01 
      :ARG1 (s / signal 
            :ARG1-of (s2 / significant-02)) 
      :ARG2 (c2 / country 
            :name (n2 / name 
                  :op1 "E13")) 
      :polarity - 
      :time (r / retina 
            :ARG1-of (d / develop-02 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Fig.")))))

# ::snt A weak signal was initially detected in the outer aspect of the neuroblastic layer ( NBL ) , a presumptive photoreceptor layer at E18 ( Fig. 2B , arrow ) .
# ::tok A weak signal was initially detected in the outer aspect of the neuroblastic layer ( NBL ) , a presumptive photoreceptor layer at E18 ( Fig. 2B , arrow ) .
# ::alignments 28-29|0.1.2.0.0 25-26|0.1.1.0.0+0.1.1.0+0.1.1 23-24|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 21-22|0.0.0 20-21|0.0 19-20|0 15-16|0.1.0.0.0+0.1.0.0+0.1.0 13-14|0.1.2.0.1.1 9-10|0.1.2.0.1 8-9|0.1.2.0.1.0 5-6|0.1.2.0 4-5|0.1.2.0.2 2-3|0.1.2 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:18.952
(p2 / presume-01 
      :ARG1 (p / photoreceptor 
            :mod-of (l / layer 
                  :location (c2 / country 
                        :name (n2 / name 
                              :op1 "E18")))) 
      :purpose (w / weak-02 
            :ARG0 (o / organization 
                  :name (n3 / name 
                        :op1 "NBL")) 
            :ARG1 (c / country 
                  :name (n / name 
                        :op1 "Fig.")) 
            :mod-of (s / signal 
                  :ARG1-of (d / detect-01 
                        :ARG0 (a / arrow) 
                        :ARG2 (a2 / aspect 
                              :mod (o2 / outer) 
                              :poss (l2 / layer)) 
                        :time (i / initial)))))

# ::snt At P3 , an mr-s transcript was clearly detected in the developing photoreceptor layer ( Fig. 2E ) .
# ::tok At P3 , an mr-s transcript was clearly detected in the developing photoreceptor layer ( Fig. 2E ) .
# ::alignments 15-16|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 13-14|0.2 12-13|0.2.1 11-12|0.2.0 8-9|0 7-8|0.1 5-6|0.0.0+0.0 4-5|0.0.1 1-2|0.3.0.0+0.3.0+0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:19.127
(d2 / detect-01 
      :ARG1 (t / thing 
            :ARG1-of (t2 / transcribe-01) 
            :mod (m / mr-)) 
      :ARG1-of (c2 / clear-06) 
      :ARG2 (l / layer 
            :ARG1-of (d / develop-02 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Fig."))) 
            :mod (p / photoreceptor)) 
      :ARG4 (c3 / country 
            :name (n2 / name 
                  :op1 "P3")))

# ::snt At P6 , mr-s showed peak expression in the photoreceptor layer ( Fig. 2F ) .
# ::tok At P6 , mr-s showed peak expression in the photoreceptor layer ( Fig. 2F ) .
# ::alignments 12-13|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 10-11|0.2 9-10|0.2.0 6-7|0.1 5-6|0.1.0 4-5|0 3-4|0.0 1-2|0.3.0.0+0.3.0+0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:19.342
(s / show-01 
      :ARG0 (m / mr-) 
      :ARG1 (e / express-01 
            :ARG1-of (p2 / peak-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Fig.")))) 
      :ARG2 (l / layer 
            :mod (p / photoreceptor)) 
      :ARG4 (c2 / country 
            :name (n2 / name 
                  :op1 "P6")))

# ::snt This pattern correlates with the rapid increase in cells expressing rhodopsin and other phototransduction genes between P6-P8 [ 34-37 ] .
# ::tok This pattern correlates with the rapid increase in cells expressing rhodopsin and other phototransduction genes between P6-P8 [ 34-37 ] .
# ::alignments 16-17|0.0.2.1.0.0+0.0.2.1.0+0.0.2.1 14-15|0.0.1 13-14|0.0.1.1 12-13|0.0.1.0 11-12|0 10-11|0.1 9-10|0.0 8-9|0.0.0.0 6-7|0.0.0 5-6|0.0.0.1 2-3|0.0.2 1-2|0.0.2.0 0-1|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:19.620
(a / and 
      :op1 (e / express-01 
            :ARG0 (i / increase-01 
                  :ARG1 (c / cell) 
                  :manner (r2 / rapid)) 
            :ARG1 (g / gene 
                  :mod (o / other) 
                  :mod (p / phototransduction)) 
            :ARG1-of (c2 / correlate-01 
                  :ARG0 (p2 / pattern 
                        :mod (t2 / this)) 
                  :op1-of (t / thing 
                        :name (n / name 
                              :op1 "P6-P8")))) 
      :op2 (r / rhodopsin))

# ::snt At P9 , the intensity of the mr-s signal was significantly reduced but was localized to the outer nuclear layer ( ONL ) ( data not shown ) .
# ::tok At P9 , the intensity of the mr-s signal was significantly reduced but was localized to the outer nuclear layer ( ONL ) ( data not shown ) .
# ::alignments 26-27|0.0.2.0 25-26|0.0.2.0.1 24-25|0.0.2.0.0 21-22|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 19-20|0.1.0 18-19|0.1.0.1 17-18|0.1.0.0 14-15|0.1 12-13|0 11-12|0.0 10-11|0.0.1 8-9|0.0.0.0 7-8|0.0.0.0.0 4-5|0.0.0 1-2|0.0.2.1.0+0.0.2.1+0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:20.013
(c / contrast-01 
      :ARG1 (r / reduce-01 
            :ARG1 (i / intensity 
                  :poss (s3 / signal 
                        :mod (m / mr-))) 
            :ARG2 (s2 / significant-02 
                  :ARG1 (o / organization 
                        :name (n / name 
                              :op1 "ONL"))) 
            :location (c2 / country 
                  :ARG0-of (s / show-01 
                        :ARG1 (d / data) 
                        :polarity -) 
                  :name (n3 / name 
                        :op1 "P9"))) 
      :ARG2 (l2 / localize-01 
            :ARG2 (l / layer 
                  :mod (o2 / outer) 
                  :mod (n2 / nucleus))))

# ::snt Faint expression of mr-s mRNA was observed in mature photoreceptors in the adult retina ( Fig. 2G ) .
# ::tok Faint expression of mr-s mRNA was observed in mature photoreceptors in the adult retina ( Fig. 2G ) .
# ::alignments 15-16|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 13-14|0.1.1 12-13|0.0.2 9-10|0.1 8-9|0.1.0 6-7|0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:20.156
(o / observe-01 
      :ARG1 (e / express-01 
            :ARG1 (m2 / mrna 
                  :mod (m3 / mr-)) 
            :ARG1-of (f / faint-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Fig."))) 
            :ARG2 (a / adult)) 
      :ARG2 (p / photoreceptor 
            :ARG1-of (m / mature-02) 
            :location (r / retina)))

# ::snt mr-s expression in developing mouse retina and pineal gland .
# ::tok mr-s expression in developing mouse retina and pineal gland .
# ::alignments 8-9|0.0.0.1 7-8|0.0.0.1.0 6-7|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 3-4|0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:20.332
(e / express-01 
      :ARG1 (d / develop-02 
            :ARG1 (a / and 
                  :op1 (r / retina 
                        :mod (m / mouse)) 
                  :op2 (g / gland 
                        :mod (p / pineal)))) 
      :mod (m2 / mr-))

# ::snt ( A-G ) mr-s expression during development of the mouse retina .
# ::tok ( A-G ) mr-s expression during development of the mouse retina .
# ::alignments 10-11|0.0.0 9-10|0.0.0.0 6-7|0.0 4-5|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:20.351
(e / express-01 
      :ARG1 (d / develop-02 
            :ARG1 (r / retina 
                  :mod (m / mouse))))

# ::snt The in situ hybridization signal of mr-s was not detected at E13 ( A ) .
# ::tok The in situ hybridization signal of mr-s was not detected at E13 ( A ) .
# ::alignments 9-10|0 8-9|0.1 6-7|0.0.1 4-5|0.0 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:20.421
(d / detect-01 
      :ARG1 (s / signal 
            :mod (h / hybridization) 
            :mod (m / mr-)) 
      :polarity -)

# ::snt The signal ( arrow ) was first detected in the outer aspect of NBL at E18 ( B ) .
# ::tok The signal ( arrow ) was first detected in the outer aspect of NBL at E18 ( B ) .
# ::alignments 17-18|0.0.2+0.0.1.0+0.0.1+0.0 15-16|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 13-14|0.0.0.1.2.0.0+0.0.0.1.2.0+0.0.0.1.2 11-12|0.0.0.1 10-11|0.0.0.1.1 7-8|0.0.0 3-4|0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:20.548
(a2 / arrow 
      :mod-of (l / location 
            :ARG0-of (d / detect-01 
                  :ARG1 (s / signal) 
                  :ARG2 (a / aspect 
                        :location (c / country 
                              :name (n2 / name 
                                    :op1 "E18")) 
                        :mod (o2 / outer) 
                        :poss (o / organization 
                              :name (n3 / name 
                                    :op1 "NBL")))) 
            :name (n / name 
                  :op1 "B") 
            :wiki -))

# ::snt A strong mr-s signal was detected in outer layer of the retina at P3-P6 , and then the signal decreased in the adult retina ( E-G ) .
# ::tok A strong mr-s signal was detected in outer layer of the retina at P3-P6 , and then the signal decreased in the adult retina ( E-G ) .
# ::alignments 23-24|0.0.0.1.1 22-23|0.0.0.1.1.0 19-20|0.0.0.1 18-19|0.0.0.1.0 16-17|0.0.0.1.2 15-16|0 13-14|0.0.2.0.0+0.0.2.0+0.0.2 11-12|0.0.1.1 8-9|0.0.1 7-8|0.0.1.0 5-6|0.0 3-4|0.0.0 2-3|0.0.0.2 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:20.883
(a2 / and 
      :op1 (d2 / detect-01 
            :ARG1 (s2 / signal 
                  :ARG1-of (s3 / strong-02) 
                  :ARG1-of (d / decrease-01 
                        :ARG0 (s / signal) 
                        :ARG2 (r / retina 
                              :mod (a / adult)) 
                        :time (t / then)) 
                  :mod (m / mr-)) 
            :ARG2 (l / layer 
                  :mod (o / outer) 
                  :poss (r2 / retina)) 
            :destination (c / country 
                  :name (n / name 
                        :op1 "P3-P6"))))

# ::snt Control with the sense probe in E18 retina is shown ( C ) .
# ::tok Control with the sense probe in E18 retina is shown ( C ) .
# ::alignments 11-12|0.0.0.0.0 9-10|0.0.0.0 7-8|0.0.0.1 6-7|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 4-5|0.0 3-4|0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:21.008
(s2 / sense-02 
      :ARG1-of (p / probe-01 
            :ARG1-of (c3 / control-01 
                  :ARG1-of (s / show-01 
                        :ARG2 (c / C)) 
                  :ARG2 (r / retina 
                        :mod (c2 / country 
                              :name (n / name 
                                    :op1 "E18"))))))

# ::snt Scale bar , 100 m .
# ::tok Scale bar , 100 m .
# ::alignments 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:21.026
(m / m 
      :ARG1-of (b / bar-01 
            :duration (s / scale)) 
      :quant 100)

# ::snt ( H ) Northern blot analysis of mr-s expression in adult mouse organs .
# ::tok ( H ) Northern blot analysis of mr-s expression in adult mouse organs .
# ::alignments 12-13|0.0.0.1.0 11-12|0.0.0.1 10-11|0.0.0.1.0.0 8-9|0.0.0.0 7-8|0.0.0.0.0 5-6|0.0.0 4-5|0.0 3-4|0.0.0.2 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:21.106
(h / h 
      :ARG0-of (b / blot-01 
            :ARG1 (a2 / analyze-01 
                  :ARG1 (e / express-01 
                        :mod (m2 / mr-)) 
                  :ARG2 (m / mouse 
                        :mod-of (o / organ 
                              :mod (a / adult))) 
                  :mod "Northern_Ireland")))

# ::snt The arrow corresponds to 2.2 kb mr-s transcript .
# ::tok The arrow corresponds to 2.2 kb mr-s transcript .
# ::alignments 7-8|0.1.0+0.1 6-7|0.1.1 5-6|0.1.2 4-5|0.1.3 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:21.131
(c / correspond-01 
      :ARG0 (a / arrow) 
      :ARG2 (t / thing 
            :ARG1-of (t2 / transcribe-01) 
            :mod (m / mr-) 
            :mod (k / kb) 
            :mod 2.2))

# ::snt ( I ) RT-PCR analysis of total RNAs extracted from E13 whole embryo , P0 whole body ( except for the eye ) , P7 retina , P7 pineal gland , P7 brain , P7 liver , adult retina , adult pineal gland , adult brain and adult liver , respectively .
# ::tok ( I ) RT-PCR analysis of total RNAs extracted from E13 whole embryo , P0 whole body ( except for the eye ) , P7 retina , P7 pineal gland , P7 brain , P7 liver , adult retina , adult pineal gland , adult brain and adult liver , respectively .
# ::alignments 50-51|0.1.0.0.0 48-49|0.1.8 47-48|0.1.8.0 46-47|0.1 45-46|0.1.7 44-45|0.1.7.0 42-43|0.1.6 41-42|0.1.6.0 40-41|0.1.6.1 38-39|0.1.5 37-38|0.0.0.0.0 35-36|0.1.4 32-33|0.1.3 29-30|0.1.2 28-29|0.1.2.0 25-26|0.1.1 21-22|0.1.0.0.1 18-19|0.1.0.0 16-17|0.1.0 15-16|0.1.0.1 12-13|0.0.0.0.1.0 11-12|0.0.0.0.1 8-9|0 7-8|0.0.0 6-7|0.0.0.0 4-5|0.0 1-2|0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:21.751
(e4 / extract-01 
      :ARG0 (a6 / analyze-01 
            :ARG1 (r4 / rna 
                  :ARG2-of (t / total-01 
                        :ARG0 (a5 / adult) 
                        :ARG1 (w2 / whole 
                              :mod-of (e3 / embryo))))) 
      :ARG1 (a2 / and 
            :op1 (b3 / body 
                  :ARG2-of (e2 / except-01 
                        :ARG0 (r / respective) 
                        :ARG1 (e / eye)) 
                  :mod (w / whole) 
                  :poss (i / i)) 
            :op2 (r3 / retina) 
            :op3 (g2 / gland 
                  :mod (p2 / pineal)) 
            :op4 (b2 / brain) 
            :op5 (l2 / liver) 
            :op6 (r2 / retina) 
            :op7 (g / gland 
                  :mod (p / pineal) 
                  :mod (a4 / adult)) 
            :op8 (b / brain 
                  :mod (a3 / adult)) 
            :op9 (l / liver 
                  :mod (a / adult))))

# ::snt RPE , retinal pigment epithelium ; NR , neural retina ; NBL , neuroblastic layer ; GCL , ganglion cell layer ; ONL , outer nuclear layer ; INL , inner nuclear layer .
# ::tok RPE , retinal pigment epithelium ; NR , neural retina ; NBL , neuroblastic layer ; GCL , ganglion cell layer ; ONL , outer nuclear layer ; INL , inner nuclear layer .
# ::alignments 32-33|0.0.1.0.0.0.0 31-32|0.0.1.0.0.0.0.0 30-31|0.0.1.0.0.0 26-27|0.0.1.0.0.1.0 25-26|0.0.1.0.0.1.0.0 24-25|0.0.1.0.0.1 22-23|0.0.1.0.0.0.1.1.1.2.0.0+0.0.1.0.0.0.1.1.1.2.0+0.0.1.0.0.0.1.1.1.2 20-21|0.0.0 19-20|0.0 18-19|0 16-17|0.0.1.0.0.0.1.1.1.1.0.0+0.0.1.0.0.0.1.1.1.1.0+0.0.1.0.0.0.1.1.1.1 14-15|0.0.1.0.0.0.0.0.0 11-12|0.0.1.0.0.0.1.1.0.0+0.0.1.0.0.0.1.1.0+0.0.1.0.0.0.1.1 9-10|0.0.1.0.0.0.1.0 8-9|0.0.1.0.0.0.1 5-6|0.0.1.0.0.0.1.1.1 4-5|0.0.1.0 3-4|0.0.1.0.0 2-3|0.0.1 0-1|0.0.1.0.0.0.1.1.1.0.0.0+0.0.1.0.0.0.1.1.1.0.0+0.0.1.0.0.0.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:22.014
(g / ganglion 
      :mod-of (c / cell 
            :mod-of (l3 / layer) 
            :poss-of (r2 / retinal 
                  :mod-of (e / epithelium 
                        :mod (p / pigment 
                              :mod (i / inner 
                                    :mod-of (l / layer 
                                          :mod (n / nucleus 
                                                :poss-of (l4 / layer))) 
                                    :mod-of (n6 / neural 
                                          :mod-of (r / retina) 
                                          :op1 (o4 / organization 
                                                :name (n5 / name 
                                                      :op1 "NBL") 
                                                :op2-of (a / and 
                                                      :op1 (c2 / country 
                                                            :name (n7 / name 
                                                                  :op1 "RPE")) 
                                                      :op3 (o3 / organization 
                                                            :name (n4 / name 
                                                                  :op1 "GCL")) 
                                                      :op4 (o2 / organization 
                                                            :name (n3 / name 
                                                                  :op1 "ONL")))))) 
                              :mod-of (o / outer 
                                    :mod-of (l2 / layer 
                                          :mod (n2 / nucleus))))))))

# ::snt To determine the tissue specificity of mr-s expression , the expression of the mr-s gene in various adult tissues was examined by Northern hybridization ( Fig. 2H ) .
# ::tok To determine the tissue specificity of mr-s expression , the expression of the mr-s gene in various adult tissues was examined by Northern hybridization ( Fig. 2H ) .
# ::alignments 25-26|0.2.0.0.0+0.2.0.0+0.2.0 23-24|0.0 22-23|0.0.1 20-21|0 18-19|0.1.1 17-18|0.0.0.0 16-17|0.1.1.0 14-15|0.1.0 10-11|0.1 7-8|0.0.0 6-7|0.0.0.1 4-5|0.2.1 3-4|0.2.1.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:22.279
(e / examine-01 
      :ARG0 (h / hybridization 
            :ARG1-of (e3 / express-01 
                  :ARG0 (a / adult) 
                  :mod (m / mr-)) 
            :mod "Northern_Ireland") 
      :ARG1 (e2 / express-01 
            :ARG1 (g / gene) 
            :location (t / tissue 
                  :mod (v / various))) 
      :condition (d / determine-01 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "Fig.")) 
            :ARG1 (s / specificity 
                  :mod (t2 / tissue))))

# ::snt As a control , P7 retinal RNA was used .
# ::tok As a control , P7 retinal RNA was used .
# ::alignments 8-9|0 6-7|0.0 5-6|0.0.0 2-3|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:22.293
(u / use-01 
      :ARG1 (r / rna 
            :mod (r2 / retinal)) 
      :ARG2 (c / control-01))

# ::snt Four bands corresponding to 7.2-kb , 4.0-kb , 2.5-kb and 2.2-kb were detected in P7 retina .
# ::tok Four bands corresponding to 7.2-kb , 4.0-kb , 2.5-kb and 2.2-kb were detected in P7 retina .
# ::alignments 15-16|0.0.0 14-15|0.0 12-13|0.0.0.0 9-10|0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:22.340
(a / and 
      :op1 (p / P7 
            :mod-of (r / retina 
                  :ARG0-of (d / detect-01 
                        :ARG1 (b / band 
                              :ARG1-of (c / correspond-01) 
                              :quant 4)))))

# ::snt The 2.2-kb band corresponds to the cDNA characterized in this study .
# ::tok The 2.2-kb band corresponds to the cDNA characterized in this study .
# ::alignments 10-11|0.1.0.0 9-10|0.1.0.0.0 7-8|0.1.0 6-7|0.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:22.364
(c3 / correspond-01 
      :ARG1 (b / band) 
      :ARG2 (c2 / cdna 
            :ARG1-of (c / characterize-01 
                  :ARG2 (s / study-01 
                        :mod (t / this)))))

# ::snt The larger bands , possibly alternative spliced transcripts , have not yet been characterized .
# ::tok The larger bands , possibly alternative spliced transcripts , have not yet been characterized .
# ::alignments 13-14|0.0.0 11-12|0.0.0.2 10-11|0.0.0.1 7-8|0.0.0.0.0 6-7|0.0.0.0 5-6|0.0.0.0.0.0 4-5|0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:22.471
(p / possible-01 
      :ARG0 (b / band 
            :ARG1-of (c / characterize-01 
                  :ARG2-of (s / splice-01 
                        :ARG1 (t / transcript 
                              :mod (a / alternative))) 
                  :polarity - 
                  :time (y / yet)) 
            :mod (l / large)))

# ::snt The mr-s probe did not detect a band in the adult tissues examined , indicating that these tissues do not express mr-s at a level comparable to that of the developing retina .
# ::tok The mr-s probe did not detect a band in the adult tissues examined , indicating that these tissues do not express mr-s at a level comparable to that of the developing retina .
# ::alignments 31-32|0 30-31|0.0 25-26|0.0.0.3.0 24-25|0.0.0.3 21-22|0.0.0.1 20-21|0.0.0 19-20|0.0.0.4 17-18|0.0.0.0 16-17|0.0.0.0.0 14-15|0.0.0.2 12-13|0.0.0.2.0.1.0 11-12|0.0.0.2.0.1.0.0 10-11|0.0.0.2.0.1.0.0.0 7-8|0.0.0.2.0.1 5-6|0.0.0.2.0 4-5|0.0.0.2.0.2 2-3|0.0.0.2.0.0 1-2|0.0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:22.902
(r / retina 
      :ARG1-of (d / develop-02 
            :purpose-of (e / express-01 
                  :ARG0 (t / tissue 
                        :mod (t2 / this)) 
                  :ARG1 (m / mr-) 
                  :ARG1-of (i / indicate-01 
                        :purpose-of (d2 / detect-01 
                              :ARG0 (p / probe-01 
                                    :mod (m2 / mr-)) 
                              :ARG1 (b / band 
                                    :ARG0-of (e2 / examine-01 
                                          :ARG1 (t3 / tissue 
                                                :mod (a / adult)))) 
                              :polarity -)) 
                  :manner (l / level 
                        :ARG1-of (c / comparable-03)) 
                  :polarity -)))

# ::snt Previous reports revealed that many photoreceptor-specific genes are also expressed in the pineal gland [ 38 ] .
# ::tok Previous reports revealed that many photoreceptor-specific genes are also expressed in the pineal gland [ 38 ] .
# ::alignments 15-16|0.0.0 13-14|0.0.3 12-13|0.0.1 9-10|0.1 8-9|0.1.1 6-7|0.1.0 4-5|0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:23.003
(r / reveal-01 
      :ARG0 (r2 / report-01 
            :ARG0 38 
            :ARG1 (p / pineal) 
            :manner (p2 / previou) 
            :mod-of (g / gland)) 
      :ARG1 (e / express-01 
            :ARG1 (g2 / gene 
                  :quant (m / many)) 
            :mod (a / also)))

# ::snt We examined the expression of mr-s transcripts in the whole embryo , whole body , retina , pineal gland , brain , liver and other organs at various stages by RT-PCR ( Fig. 2I and data not shown ) .
# ::tok We examined the expression of mr-s transcripts in the whole embryo , whole body , retina , pineal gland , brain , liver and other organs at various stages by RT-PCR ( Fig. 2I and data not shown ) .
# ::alignments 37-38|0 36-37|0.2 35-36|0.1 34-35|0.0 32-33|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 28-29|0.0.0.0.1.0 27-28|0.0.0.0.1.0.0 25-26|0.0.0.7 24-25|0.0.0.7.0 23-24|0.0.0 22-23|0.0.0.6 20-21|0.0.0.5 18-19|0.0.0.4 17-18|0.0.0.4.0 15-16|0.0.0.3 13-14|0.0.0.2 12-13|0.0.0.2.0 10-11|0.0.0.1 9-10|0.0.0.1.0 6-7|0.0.0.0.1.1 5-6|0.0.0.0.1.1.0 3-4|0.0.0.0.1 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:24.334
(s / show-01 
      :ARG0 (a / and 
            :op1 (a2 / and 
                  :op1 (e3 / examine-01 
                        :ARG0 (w3 / we) 
                        :ARG1 (e2 / express-01 
                              :ARG0 (s2 / stage 
                                    :mod (v / various)) 
                              :ARG1 (t / transcript 
                                    :mod (m / mr-)))) 
                  :op2 (e / embryo 
                        :mod (w2 / whole 
                              :mod-of (c / country 
                                    :name (n / name 
                                          :op1 "Fig.")))) 
                  :op3 (b2 / body 
                        :mod (w / whole)) 
                  :op4 (r / retina) 
                  :op5 (g / gland 
                        :mod (p / pineal)) 
                  :op6 (b / brain) 
                  :op7 (l / liver) 
                  :op8 (o / organ 
                        :mod (o2 / other)))) 
      :ARG1 (d / data) 
      :polarity -)

# ::snt We amplified PCR fragments of 292 bp and 452 bp with primer pairs for genes encoding mouse mr-s and G3PDH , respectively .
# ::tok We amplified PCR fragments of 292 bp and 452 bp with primer pairs for genes encoding mouse mr-s and G3PDH , respectively .
# ::alignments 21-22|0.2.0 18-19|0 17-18|0.1 16-17|0.1.0 15-16|0.0 14-15|0.0.0 12-13|0.3 11-12|0.3.1 7-8|0.2 3-4|0.3.0.0.0 2-3|0.3.0.0.0.0 1-2|0.3.0.0 0-1|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:24.981
(a / and 
      :ARG1-of (e / encode-01 
            :ARG0 (g / gene)) 
      :op1 (m / mr- 
            :mod (m2 / mouse)) 
      :op1-of (a2 / and 
            :mod (r / respective)) 
      :topic-of (p / pair-01 
            :ARG0 (w / we 
                  :ARG0-of (a3 / amplify-01 
                        :ARG1 (f / fragment-01 
                              :ARG1 (p3 / PCR)))) 
            :ARG1 (p2 / primer)))

# ::snt In E13 whole embryo and P0 whole body ( except for the eye ) , no mr-s signal was detected .
# ::tok In E13 whole embryo and P0 whole body ( except for the eye ) , no mr-s signal was detected .
# ::alignments 19-20|0 17-18|0.1 16-17|0.1.0 15-16|0.2 12-13|0.0.1.0.0 9-10|0.0.1.0 7-8|0.0.1 6-7|0.0.1.2 5-6|0.0.1.1 4-5|0.0 3-4|0.0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:25.171
(d / detect-01 
      :ARG0 (a / and 
            :op1 (e3 / embryo 
                  :mod (w2 / whole)) 
            :op2 (b / body 
                  :ARG0-of (e2 / except-01 
                        :ARG1 (e / eye)) 
                  :mod (p / P0) 
                  :mod (w / whole))) 
      :ARG1 (s / signal 
            :mod (m / mr-)) 
      :polarity -)

# ::snt As expected , we observed that mr-s is expressed in the P7 and adult pineal gland .
# ::tok As expected , we observed that mr-s is expressed in the P7 and adult pineal gland .
# ::alignments 15-16|0.0.0.1 14-15|0.0.0.1.0 13-14|0.0.0.1.0.0 12-13|0.0.0 11-12|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 8-9|0.0 6-7|0 4-5|0.0.1 3-4|0.0.1.0 1-2|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:25.302
(m / mr- 
      :ARG1-of (e / express-01 
            :ARG0 (a2 / and 
                  :op1 (c / country 
                        :name (n / name 
                              :op1 "P7")) 
                  :op2 (g / gland 
                        :mod (p / pineal 
                              :mod (a / adult)))) 
            :ARG1-of (o / observe-01 
                  :ARG0 (w / we) 
                  :time (e2 / expect-01))))

# ::snt In the P7 and adult brain , liver and several other organs , the RT-PCR amplified band of mr-s was not detected ( Fig. 2I and data not shown ) .
# ::tok In the P7 and adult brain , liver and several other organs , the RT-PCR amplified band of mr-s was not detected ( Fig. 2I and data not shown ) .
# ::alignments 28-29|0 27-28|0.3 26-27|0.1 25-26|0.0 23-24|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 21-22|0.0.0 20-21|0.0.0.3 18-19|0.0.0.0.0 16-17|0.0.0.0 15-16|0.2 11-12|0.0.0.2.2.0 10-11|0.0.0.2.2.0.0 9-10|0.0.0.2.2 8-9|0.0.0.2.1 7-8|0.0.0.2.1.1 5-6|0.0.0.2.1.0 4-5|0.0.0.2.1.0.0 3-4|0.0.0.2 2-3|0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:26.233
(s / show-01 
      :ARG0 (a / and 
            :ARG1-of (d2 / detect-01 
                  :ARG0 (b / band 
                        :consist-of (m / mr-)) 
                  :ARG2 (c / country 
                        :name (n / name 
                              :op1 "Fig.")) 
                  :ARG3 (a5 / and 
                        :op1 (p / P7) 
                        :op2 (a3 / and 
                              :op1 (b2 / brain 
                                    :mod (a4 / adult)) 
                              :op2 (l / liver)) 
                        :op3 (s2 / several 
                              :quant-of (o / organ 
                                    :mod (o2 / other)))) 
                  :polarity -)) 
      :ARG1 (d / data) 
      :ARG1-of (a2 / amplify-01) 
      :polarity -)

# ::snt Our data showed that mr-s is predominantly expressed in developing photoreceptors and the pineal gland .
# ::tok Our data showed that mr-s is predominantly expressed in developing photoreceptors and the pineal gland .
# ::alignments 14-15|0.1.1.0.1 13-14|0.1.1.0.1.0 11-12|0.1.1.0 10-11|0.1.1.0.0 9-10|0.1.1 7-8|0.1 6-7|0.1.2 4-5|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:26.463
(s / show-01 
      :ARG0 (d2 / data 
            :poss (w / we)) 
      :ARG1 (e / express-01 
            :ARG1 (m / mr-) 
            :ARG2 (d / develop-02 
                  :ARG1 (a / and 
                        :op1 (p2 / photoreceptor) 
                        :op2 (g / gland 
                              :mod (p / pineal)))) 
            :mod (p3 / predominant)))

# ::snt Regulation of mr-s transcription by Crx homeodomain protein .
# ::tok Regulation of mr-s transcription by Crx homeodomain protein .
# ::alignments 7-8|0.0.0 5-6|0.0.1.0+0.0.1+0.0 3-4|0.1 2-3|0.1.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:26.488
(r / regulation 
      :location (p2 / person 
            :mod-of (p / protein) 
            :name (n / name 
                  :op1 "Crx")) 
      :mod (t / transcription 
            :mod (m / mr-)))

# ::snt Transcription factors Otx2 and Crx are known to be key regulators of retinal photoreceptor development [ 3,8,9 ] .
# ::tok Transcription factors Otx2 and Crx are known to be key regulators of retinal photoreceptor development [ 3,8,9 ] .
# ::alignments 14-15|0.1.0.1.0 13-14|0.1.0.1.0.0 12-13|0.0 10-11|0.2 9-10|0.2.0 6-7|0 4-5|0.1.0.0.0+0.1.0.0+0.1.0 3-4|0.1.0.1 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:26.662
(k2 / know-02 
      :ARG0 (r / retinal) 
      :ARG1 (f / factor 
            :mod (p2 / person 
                  :name (n / name 
                        :op1 "Crx") 
                  :op1-of (a / and 
                        :op2 (d / develop-02 
                              :ARG1 (p / photoreceptor)))) 
            :mod (t / transcription)) 
      :ARG2 (r2 / regulator 
            :ARG1-of (k / key-02)))

# ::snt Although both Otx2 and Crx are expressed in developing photoreceptor cells in the embryonic retina , only Crx is highly expressed in the postnatal photoreceptors , suggesting that mr-s may be regulated by Crx .
# ::tok Although both Otx2 and Crx are expressed in developing photoreceptor cells in the embryonic retina , only Crx is highly expressed in the postnatal photoreceptors , suggesting that mr-s may be regulated by Crx .
# ::alignments 31-32|0.2.0.0 29-30|0.2.0 28-29|0.2.0.0.0 26-27|0.2 24-25|0.0 23-24|0.0.0 20-21|0 19-20|0.1 16-17|0.2.0.1 14-15|0.3.1.1 13-14|0.3.1.1.0 10-11|0.3.1.0 9-10|0.3.1.0.0 8-9|0.3.1 6-7|0.3 4-5|0.3.0.1.0.0+0.3.0.1.0+0.3.0.1 3-4|0.3.0 1-2|0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:27.049
(e / express-01 
      :ARG1 (p2 / photoreceptor 
            :mod (p3 / postnatal)) 
      :degree (h / high) 
      :purpose (s / suggest-01 
            :ARG1 (p / possible-01 
                  :ARG1 (r / regulate-01 
                        :ARG1 (m / mr-)) 
                  :mod (o / only))) 
      :time (e3 / express-01 
            :ARG1 (a / and 
                  :mod (b / both) 
                  :op1 (p5 / person 
                        :name (n / name 
                              :op1 "Crx"))) 
            :ARG2 (d / develop-02 
                  :ARG1 (c / cell 
                        :mod (p4 / photoreceptor)) 
                  :location (r2 / retina 
                        :mod (e2 / embryonic)))))

# ::snt To test whether Crx regulates mr-s transcription , we performed in situ hybridization of mr-s mRNA on wild-type and Crx KO P5 retinas ( Fig. 3A , B ) .
# ::tok To test whether Crx regulates mr-s transcription , we performed in situ hybridization of mr-s mRNA on wild-type and Crx KO P5 retinas ( Fig. 3A , B ) .
# ::alignments 27-28|0.2+0.1.0+0.1+0 24-25|0.0.2.0.0.0.2.0.0+0.0.2.0.0.0.2.0+0.0.2.0.0.0.2 22-23|0.0.2.0.0.0.1 19-21|0.0.2.0.0.0.0.0.1+0.0.2.0.0.0.0.0.0+0.0.2.0.0.0.0.0+0.0.2.0.0.0.0 18-19|0.0.2.0.0.0 15-16|0.0.2.0.0.0.3 12-13|0.0.2.0.0.1 9-10|0.0.2.0.0 8-9|0.0.2.0 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:27.475
(l / location 
      :ARG2-of (r2 / regulate-01 
            :ARG0 (p2 / person 
                  :name (n4 / name 
                        :op1 "Crx")) 
            :ARG1 (t / transcription 
                  :mod (m2 / mr-)) 
            :ARG1-of (t2 / test-01 
                  :ARG0 (w / we 
                        :ARG0-of (p / perform-02 
                              :ARG1 (a / and 
                                    :op1 (o / organization 
                                          :name (n3 / name 
                                                :op1 "Crx" 
                                                :op2 "KO")) 
                                    :op2 (r / retina) 
                                    :op3 (c / country 
                                          :name (n2 / name 
                                                :op1 "Fig.")) 
                                    :quant (m / mrna)) 
                              :ARG2 (h / hybridization))))) 
      :name (n / name 
            :op1 "B") 
      :wiki -)

# ::snt In the Crx KO retina , the mr-s transcript was dramatically reduced ( Fig. 3B ) .
# ::tok In the Crx KO retina , the mr-s transcript was dramatically reduced ( Fig. 3B ) .
# ::alignments 11-12|0 10-11|0.2 8-9|0.0.0+0.0 7-8|0.0.1 4-5|0.1 2-4|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:27.529
(r / reduce-01 
      :ARG0 (t / thing 
            :ARG1-of (t2 / transcribe-01) 
            :mod (m / mr-)) 
      :location (r2 / retina 
            :mod (t3 / thing 
                  :name (n / name 
                        :op1 (c / Crx) 
                        :op2 (k / KO)))) 
      :manner (d / dramatic))

# ::snt This indicates that Crx is essential for transactivation of mr-s .
# ::tok This indicates that Crx is essential for transactivation of mr-s .
# ::alignments 9-10|0.2 7-8|0.1.1 5-6|0.1 3-4|0.1.0.0.0+0.1.0.0+0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:27.596
(i / indicate-01 
      :ARG0 (t2 / this) 
      :ARG1 (e / essential 
            :domain (p / person 
                  :name (n / name 
                        :op1 "Crx")) 
            :purpose (t / transactivation)) 
      :op1-of (m / mr-))

# ::snt Moreover , to test whether the transcription of mr-s is also regulated by Crx in the pineal gland , RT-PCR analysis was used to compare transcriptional levels of mr-s in P28 wild-type and Crx KO pineal gland ( Fig. 3C ) .
# ::tok Moreover , to test whether the transcription of mr-s is also regulated by Crx in the pineal gland , RT-PCR analysis was used to compare transcriptional levels of mr-s in P28 wild-type and Crx KO pineal gland ( Fig. 3C ) .
# ::alignments 38-39|0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 36-37|0.0.0.0.1 35-36|0.0.0.0.1.0 33-35|0+0.0.1+0.0+0.0.0 32-33|0.0.0.0 28-29|0.0.0.0.0.2.0.1.0.0 26-27|0.0.0.0.0.2.0.1.0 24-25|0.0.0.0.0.2.0.1 22-23|0.0.0.0.0.2.0 20-21|0.0.0.0.0.2.0.0 17-18|0.0.0.0.0.4 16-17|0.0.0.0.0.4.0 13-14|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 11-12|0.0.0.0.0 10-11|0.0.0.0.0.3 8-9|0.0.0.0.0.1.0 6-7|0.0.0.0.0.1 3-4|0.0.0.0.0.2 0-1|0.0.0.0.0.2.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:28.299
(k / KO 
      :op2-of (n2 / name 
            :name-of (t / thing 
                  :op2-of (a / and 
                        :op1 (r / regulate-01 
                              :ARG0 (p3 / person 
                                    :name (n3 / name 
                                          :op1 "Crx")) 
                              :ARG1 (t2 / transcription 
                                    :mod (m2 / mr-)) 
                              :ARG1-of (t3 / test-01 
                                    :condition-of (u / use-01 
                                          :ARG1 (a2 / analyze-01) 
                                          :ARG2 (c3 / compare-01 
                                                :ARG1 (l / level 
                                                      :mod (m / mr- 
                                                            :mod (m3 / moreover)))))) 
                              :mod (a3 / also) 
                              :prep-in (g2 / gland 
                                    :mod (p2 / pineal))) 
                        :op3 (g / gland 
                              :mod (p / pineal)) 
                        :op4 (c / country 
                              :name (n / name 
                                    :op1 "Fig.")))) 
            :op1 (c2 / Crx)))

# ::snt The results revealed that mr-s transcription was significantly downregulated in the Crx KO pineal gland .
# ::tok The results revealed that mr-s transcription was significantly downregulated in the Crx KO pineal gland .
# ::alignments 14-15|0.0.1.0 13-14|0.0.1 11-13|0.0.1.0.0.0.1+0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 8-9|0.1 7-8|0.1.0 5-6|0.1.1 4-5|0.1.1.0 2-3|0 1-2|0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:28.373
(r / reveal-01 
      :ARG0 (t3 / thing 
            :ARG2-of (r2 / result-01) 
            :mod-of (p / pineal 
                  :mod-of (g / gland 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 (c / Crx) 
                                    :op2 (k / KO)))))) 
      :ARG1 (d / downregulat 
            :ARG1-of (s / significant-02) 
            :domain (t2 / transcription 
                  :mod (m / mr-))))

# ::snt Taken together , these data indicate that mr-s transcription is regulated by Crx in the developing photoreceptors and pineal gland .
# ::tok Taken together , these data indicate that mr-s transcription is regulated by Crx in the developing photoreceptors and pineal gland .
# ::alignments 19-20|0.1.2.2 18-19|0.1.2.1 17-18|0.1.2 16-17|0.1.2.0 15-16|0.1.2.2.0 12-13|0.1.0.0.0+0.1.0.0+0.1.0 10-11|0.1 8-9|0.1.1 7-8|0.1.1.0 5-6|0 4-5|0.0 3-4|0.0.0 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:28.844
(i / indicate-01 
      :ARG0 (d2 / data 
            :mod (t2 / this)) 
      :ARG1 (r / regulate-01 
            :ARG0 (p3 / person 
                  :name (n / name 
                        :op1 "Crx")) 
            :ARG1 (t / transcription 
                  :mod (m / mr-)) 
            :op1-of (a / and 
                  :op2 (p2 / photoreceptor) 
                  :op3 (p / pineal) 
                  :op4 (g / gland 
                        :ARG0-of (d / develop-02)))) 
      :ARG2 (t4 / take-01 
            :mod (t3 / together)))

# ::snt The transcription of mr-s is regulated by Crx .
# ::tok The transcription of mr-s is regulated by Crx .
# ::alignments 7-8|0.0.0.0.0+0.0.0.0+0.0.0 5-6|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:28.862
(t / transcription 
      :ARG1-of (r / regulate-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "Crx"))))

# ::snt ( A , B ) In situ hybridization using a probe for mouse mr-s was performed on the wild-type ( A ) and Crx KO retinas ( B ) at P5 .
# ::tok ( A , B ) In situ hybridization using a probe for mouse mr-s was performed on the wild-type ( A ) and Crx KO retinas ( B ) at P5 .
# ::alignments 27-28|0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 25-26|0.0.0.2.1.0.0 23-25|0.0.0.2.1.0.1.1+0.0.0.2.1.0.1.0+0.0.0.2.1.0.1+0.0.0.2.1.0 22-23|0.0.0.2.1 15-16|0.0.0.2 13-14|0.0 12-13|0 10-11|0.0.0 8-9|0.0.0.1 7-8|0.0.0.1.0 3-4|0.0.0.2.0.1+0.0.0.2.0.0.0+0.0.0.2.0.0+0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:29.265
(m2 / mouse 
      :mod-of (m / mr- 
            :ARG1-of (p2 / probe-01 
                  :ARG0 (l / location 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -) 
                  :ARG1-of (u / use-01 
                        :ARG0 (h / hybridization)) 
                  :ARG3-of (p / perform-02 
                        :ARG1 (l2 / location 
                              :name (n3 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :ARG2 (a / and 
                              :op1 (t / thing 
                                    :mod-of (r / retina) 
                                    :name (n2 / name 
                                          :op1 (c / Crx) 
                                          :op2 (k / KO))))))))

# ::snt mr-s expression was drastically reduced in the Crx KO retina ( B ) .
# ::tok mr-s expression was drastically reduced in the Crx KO retina ( B ) .
# ::alignments 11-12|0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 9-10|0.1 7-9|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 4-5|0 3-4|0.2 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:29.320
(r2 / reduce-01 
      :ARG1 (e / express-01 
            :ARG1 (l / location 
                  :name (n / name 
                        :op1 "B") 
                  :wiki -) 
            :mod (m / mr-)) 
      :location (r / retina 
            :mod (t / thing 
                  :name (n2 / name 
                        :op1 (c / Crx) 
                        :op2 (k / KO)))) 
      :manner (d / drastic))

# ::snt Scale bar , 100 m .
# ::tok Scale bar , 100 m .
# ::alignments 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:29.339
(m / m 
      :ARG1-of (b / bar-01 
            :duration (s / scale)) 
      :quant 100)

# ::snt ( C ) RT-PCR analysis of total RNAs extracted from the pineal glands of P5 wild-type and Crx KO mouse .
# ::tok ( C ) RT-PCR analysis of total RNAs extracted from the pineal glands of P5 wild-type and Crx KO mouse .
# ::alignments 19-20|0.1.0 17-19|0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 16-17|0.1 12-13|0.2 11-12|0.2.0 8-9|0 7-8|0.0.0 6-7|0.1.0.0 4-5|0.0 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:30.018
(e / extract-01 
      :ARG0 (a2 / analyze-01 
            :ARG1 (r / rna)) 
      :ARG1 (a / and 
            :op1 (m / mouse 
                  :ARG1-of (t2 / total-01 
                        :ARG0 (c2 / C)) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 (c / Crx) 
                              :op2 (k / KO))))) 
      :ARG2 (g / gland 
            :mod (p / pineal)))

# ::snt The upper and lower lanes show PCR products amplified by the primer pairs specific for mr-s and G3PDH cDNAs , respectively .
# ::tok The upper and lower lanes show PCR products amplified by the primer pairs specific for mr-s and G3PDH cDNAs , respectively .
# ::alignments 20-21|0.1.0.0.0.0 18-19|0.1.0.0.0.2 16-17|0.1.0.0.0 15-16|0.1.0.0.0.1 13-14|0.1.0.0 12-13|0.1.0.0.1 11-12|0.1.0.0.1.0 8-9|0.1.0 7-8|0.1 5-6|0 4-5|0.1.0.0.1.1 3-4|0.1.0.0.1.1.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:30.272
(s2 / show-01 
      :ARG0 (a3 / and 
            :op1 (u / upper)) 
      :ARG1 (p3 / product 
            :ARG1-of (a2 / amplify-01 
                  :ARG0 (s / specific-02 
                        :ARG1 (a / and 
                              :mod (r / respective) 
                              :op1 (m / mr-) 
                              :op2 (c / cdna)) 
                        :ARG2 (p / pair-01 
                              :ARG1 (p2 / primer) 
                              :ARG2-of (l / lane-01 
                                    :ARG1-of (l2 / low-04)))))))

# ::snt Water was used for control RT-PCR reaction .
# ::tok Water was used for control RT-PCR reaction .
# ::alignments 6-7|0.1 4-5|0.1.0 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:30.297
(u / use-01 
      :ARG1 (w / water) 
      :ARG2 (r / react-01 
            :ARG1-of (c / control-01)))

# ::snt ( D-F ) Crx transactivates mr-s transcription .
# ::tok ( D-F ) Crx transactivates mr-s transcription .
# ::alignments 6-7|0 5-6|0.0 3-4|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:30.311
(t / transcription 
      :mod (m / mr-) 
      :poss (p / person 
            :name (n / name 
                  :op1 "Crx")))

# ::snt Reporter plasmids for the luciferase assay are shown .
# ::tok Reporter plasmids for the luciferase assay are shown .
# ::alignments 7-8|0 5-6|0.0.1 4-5|0.0.1.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:30.353
(s / show-01 
      :ARG1 (p / plasmid 
            :ARG1-of (r / report-01) 
            :prep-for (a / assay 
                  :mod (l / luciferase))))

# ::snt Blue boxes represent Crx binding sites ( D ) .
# ::tok Blue boxes represent Crx binding sites ( D ) .
# ::alignments 7-8|0 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:30.481
(d / D 
      :ARG2-of (r / represent-01 
            :ARG0 (b2 / box 
                  :mod (b3 / blue)) 
            :ARG1 (s / site 
                  :ARG1-of (b / binding-07 
                        :ARG0 (p / person 
                              :name (n / name 
                                    :op1 "Crx"))))))

# ::snt Relative activity of the luciferase is indicated when Pro1 .2 k was co-transfected with Crx , Otx2 , Nrl , and Crx + Nrl , respectively ( E ) .
# ::tok Relative activity of the luciferase is indicated when Pro1 .2 k was co-transfected with Crx , Otx2 , Nrl , and Crx + Nrl , respectively ( E ) .
# ::alignments 27-28|0.0.4 25-26|0.1.1 20-21|0.0 18-19|0.0.3.0.0+0.0.3.0+0.0.3 16-17|0.0.2 14-15|0.0.1.0.0+0.0.1.0+0.0.1 10-11|0.0.0.1 8-9|0.0.0.0.0+0.0.0.0+0.0.0 6-7|0 4-5|0.1.0 1-2|0.1 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:30.844
(i / indicate-01 
      :ARG0 (a / and 
            :op1 (p3 / person 
                  :name (n3 / name 
                        :op1 "Pro1") 
                  :poss-of (k / k)) 
            :op2 (p2 / person 
                  :name (n2 / name 
                        :op1 "Crx")) 
            :op3 (o / Otx2) 
            :op4 (p / person 
                  :name (n / name 
                        :op1 "Nrl")) 
            :op5 (e / E)) 
      :ARG1 (a2 / activity-06 
            :ARG0 (l / luciferase) 
            :ARG1 (r / respective) 
            :mod (r2 / relative)))

# ::snt Fold activation is indicated when Pro1 .2 k , mut1259 , mut198 , mut72 and mut all were co-transfected with the Crx expression vector ( Crx + ) or the empty vector ( Crx - ) into HEK293T cells ( F ) .
# ::tok Fold activation is indicated when Pro1 .2 k , mut1259 , mut198 , mut72 and mut all were co-transfected with the Crx expression vector ( Crx + ) or the empty vector ( Crx - ) into HEK293T cells ( F ) .
# ::alignments 40-41|0.0.1.1.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 38-39|0.0.2.0.0 31-32|0.0.2 30-31|0.0.2.0 28-29|0.0 23-24|0.0.1.0.0.0 22-23|0.0.1.0.0 21-22|0.0.1.0.1.0+0.0.1.0.1+0.0.1.0 16-17|0.1.0.0 14-15|0.0.1 7-8|0.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:31.504
(i / indicate-01 
      :ARG0 (o / or 
            :op1 (k / k) 
            :op2 (a3 / and 
                  :op1 (p / person 
                        :ARG0-of (e2 / express-01 
                              :ARG1 (v2 / vector)) 
                        :name (n2 / name 
                              :op1 "Crx")) 
                  :op2 (a / aircraft-type 
                        :name (n / name 
                              :op1 "F22") 
                        :wiki "Lockheed_Martin_F-22_Raptor")) 
            :op3 (v / vector 
                  :mod (e / empty-02 
                        :ARG1 (c / cell)))) 
      :ARG1 (a4 / activation 
            :ARG1-of (f / fold-01 
                  :ARG0 (a2 / all))))

# ::snt Error bars represent standard error of mean .
# ::tok Error bars represent standard error of mean .
# ::alignments 6-7|0 4-5|0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:31.553
(m / mean-01 
      :ARG0 (b / bar 
            :ARG0-of (r / represent-01 
                  :ARG1 (e / error 
                        :ARG1-of (s / standard-02))) 
            :mod (e2 / error)))

# ::snt To further examine whether Crx regulates mr-s transcription directly or not , we next performed a luciferase assay using the 1.2-kb proximal promoter region of mr-s fused to a luciferase gene as a luciferase reporter ( Fig. 3D , Pro1 .2 k ) and the Crx , Otx2 , Nrl expression vectors , respectively .
# ::tok To further examine whether Crx regulates mr-s transcription directly or not , we next performed a luciferase assay using the 1.2-kb proximal promoter region of mr-s fused to a luciferase gene as a luciferase reporter ( Fig. 3D , Pro1 .2 k ) and the Crx , Otx2 , Nrl expression vectors , respectively .
# ::alignments 53-54|0.1.1 51-52|0.1.5 50-51|0 49-50|0.0 47-48|0.1.4 43-44|0.1 37-38|0.1.2.0.0.0 36-37|0.1.3.0.0+0.1.3.0+0.1.3 34-35|0.1.2 30-31|0.1.2.0.0.1 26-27|0.1.2.0.0 25-26|0.1.2.0 23-24|0.1.0.1 22-23|0.1.0.1.0 21-22|0.1.0.1.1 18-19|0.1.0 17-18|0.1.0.0 14-15|0.1.0.0.0 13-14|0.1.0.0.0.1 12-13|0.1.0.0.0.0 10-11|0.1.0.1.0.0 9-10|0.1.0.0.0.0.0.0.3 8-9|0.1.0.0.0.0.0.0.2 7-8|0.1.0.0.0.0.0.0.1 6-7|0.1.0.0.0.0.0.0.1.0 5-6|0.1.0.0.0.0.0.0 4-5|0.1.0.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0.0 2-3|0.1.0.0.0.0.0 1-2|0.1.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:32.494
(e / express-01 
      :ARG1 (n / nrl) 
      :op4-of (a / and 
            :ARG2-of (u / use-01 
                  :ARG0 (a2 / assay 
                        :ARG1-of (p3 / perform-02 
                              :ARG0 (w / we 
                                    :ARG0-of (e2 / examine-01 
                                          :ARG1 (r4 / regulate-01 
                                                :ARG0 (p4 / person 
                                                      :name (n4 / name 
                                                            :op1 "Crx")) 
                                                :ARG1 (t / transcription 
                                                      :mod (m2 / mr-)) 
                                                :ARG1-of (d / direct-02) 
                                                :op1-of (o2 / or)) 
                                          :degree (f2 / further))) 
                              :manner (n3 / next))) 
                  :ARG1 (r3 / region 
                        :ARG1-of (p / promote-01 
                              :ARG0 -) 
                        :mod (p2 / proximal))) 
            :mod (r / respective) 
            :op1 (r2 / report-01 
                  :ARG1 (m / mr- 
                        :ARG1-of (f / fuse-01 
                              :ARG0 3D 
                              :ARG2 (g / gene)))) 
            :op2 (c / country 
                  :name (n2 / name 
                        :op1 "Fig.")) 
            :op3 (o / Otx2) 
            :op5 (v / vector)))

# ::snt This 1.2-kb region of the mr-s upstream sequence contains three Crx binding consensus sequences .
# ::tok This 1.2-kb region of the mr-s upstream sequence contains three Crx binding consensus sequences .
# ::alignments 13-14|0.1 12-13|0.1.1 11-12|0.1.0 10-11|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 9-10|0.1.0.0.1 8-9|0 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0.1.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:32.823
(c2 / contain-01 
      :ARG0 (r / region 
            :mod (t / this) 
            :mod (s2 / sequence 
                  :mod (u / upstream) 
                  :mod (m / mr-))) 
      :ARG1 (s / sequence 
            :ARG0-of (b / binding-07 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "Crx") 
                        :quant 3)) 
            :mod (c / consensus)))

# ::snt As shown in Fig. 3E , the luciferase activity was significantly upregulated when the Crx or Otx2 expression vector was co-introduced with Pro1 .2 k into HEK293T cells , while the luciferase activity was not altered when the Nrl expression vector was co-introduced .
# ::tok As shown in Fig. 3E , the luciferase activity was significantly upregulated when the Crx or Otx2 expression vector was co-introduced with Pro1 .2 k into HEK293T cells , while the luciferase activity was not altered when the Nrl expression vector was co-introduced .
# ::alignments 40-41|0.0 39-40|0 38-39|0.1 35-36|0.0.0.1 34-35|0.0.0.1.0 32-33|0.0.0 27-28|0.0.0.0 24-25|0.2.2.1 18-19|0.2.2.0 17-18|0.2 15-16|0.2.2 10-11|0.2.0 8-9|0.2.1 3-4|0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 1-2|0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:33.111
(e / express-01 
      :ARG0 (v / vector 
            :ARG1-of (a2 / activity-06 
                  :ARG0 (c / cell) 
                  :ARG1-of (a / alter-01 
                        :polarity -))) 
      :ARG1 (n / nrl) 
      :ARG1-of (e2 / express-01 
            :ARG1-of (s / significant-02) 
            :ARG1-of (a3 / activity-06 
                  :ARG1-of (s2 / show-01 
                        :ARG0 (c2 / country 
                              :name (n2 / name 
                                    :op1 "Fig.")))) 
            :ARG2 (o / or 
                  :op1 (v2 / vector) 
                  :op2 (k / k))))

# ::snt A previous report suggested that the transcriptional activity of Crx is augmented with Nrl when the rhodopsin promoter was used as a reporter gene [ 6 ] .
# ::tok A previous report suggested that the transcriptional activity of Crx is augmented with Nrl when the rhodopsin promoter was used as a reporter gene [ 6 ] .
# ::alignments 25-26|0.1.1.1 23-24|0.1.2.2 22-23|0.1.2.0 19-20|0.1.2 17-18|0.1.2.1 16-17|0.1.2.1.0 13-14|0.1.0.0.0+0.1.0.0+0.1.0 11-12|0.1 9-10|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 7-8|0.1.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:33.387
(s / suggest-01 
      :ARG0 (r3 / report 
            :mod (p4 / previous)) 
      :ARG1 (a / augment-01 
            :ARG0 (p2 / person 
                  :name (n / name 
                        :op1 "Nrl")) 
            :ARG1 (a2 / activity-06 
                  :ARG0 (p3 / person 
                        :name (n2 / name 
                              :op1 "Crx")) 
                  :ARG1 6) 
            :condition (u / use-01 
                  :ARG0 (r / report-01) 
                  :ARG1 (p / promote-01 
                        :mod (r2 / rhodopsin)) 
                  :ARG2 (g / gene))))

# ::snt On the other hand , our present data showed that the luciferase gene expression was not upregulated when both Crx and Nrl expression vectors were co-introduced with Pro1 .2 k compared to the activity when the Crx only expression vector was introduced .
# ::tok On the other hand , our present data showed that the luciferase gene expression was not upregulated when both Crx and Nrl expression vectors were co-introduced with Pro1 .2 k compared to the activity when the Crx only expression vector was introduced .
# ::alignments 41-42|0.1.0 39-40|0.1 38-39|0 37-38|0.2 33-34|0.1.0.1 30-31|0.1.0.1.1 29-30|0.1.0.1.1.0 27-28|0.0.1.0+0.0.1+0.0 23-24|0.1.0.1.0 22-23|0.1.0.1.0.0.2.0 21-22|0.1.0.1.0.0.2.1.0+0.1.0.1.0.0.2.1+0.1.0.1.0.0.2 20-21|0.1.0.1.0.0 19-20|0.1.0.1.0.0.1.0.0+0.1.0.1.0.0.1.0+0.1.0.1.0.0.1 18-19|0.1.0.1.0.0.0 15-16|0.1.0.0 13-14|0.0.0 12-13|0.0.0.1 11-12|0.0.0.1.0 8-9|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0 5-6|0.0.0.0.0.1 3-4|0.0.0.0.1 2-3|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:34.758
(e / express-01 
      :ARG0 (p / person 
            :ARG0-of (e3 / express-01 
                  :ARG1 (s / show-01 
                        :ARG0 (d / data 
                              :mod (p4 / present) 
                              :poss (w / we)) 
                        :ARG1 (h / hand 
                              :mod (o2 / other))) 
                  :mod (g / gene 
                        :mod (l / luciferase))) 
            :name (n / name 
                  :op1 "Pro1")) 
      :ARG1 (v / vector 
            :ARG1-of (i / introduce-02 
                  :ARG0 - 
                  :ARG2 (a / activity-06 
                        :ARG1 (v2 / vector 
                              :op3-of (a2 / and 
                                    :mod (b / both) 
                                    :op1 (p3 / person 
                                          :name (n3 / name 
                                                :op1 "Crx")) 
                                    :op2 (p2 / person 
                                          :ARG0-of (e2 / express-01) 
                                          :name (n2 / name 
                                                :op1 "Nrl")))) 
                        :ARG2-of (c / compare-01 
                              :ARG0 (k / k))))) 
      :mod (o / only))

# ::snt This may be due to cell type differences because a cell type of retinal/pineal origin was not used in our luciferase assay .
# ::tok This may be due to cell type differences because a cell type of retinal/pineal origin was not used in our luciferase assay .
# ::alignments 21-22|0.0.0.1 20-21|0.0.0.1.0 19-20|0.0.0.1.1 17-18|0.0.0 16-17|0.0.0.2 14-15|0.0.0.1.0.0 11-12|0.0.0.1.0.0.0 10-11|0.0.0.1.0.0.0.1 8-9|0.0 7-8|0.0.0.1.0.0.0.0 6-7|0.0.0.1.0.0.0.0.0 5-6|0.0.0.1.0.0.0.0.0.0 1-2|0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:35.071
(p / possible-01 
      :ARG1-of (c2 / cause-01 
            :ARG0 (u / use-01 
                  :ARG1 (t3 / this) 
                  :ARG2 (a / assay 
                        :mod (l / luciferase 
                              :poss (o / originate-01 
                                    :ARG1 (t / type 
                                          :ARG0-of (d / differ-01 
                                                :ARG1 (t2 / type 
                                                      :mod (c3 / cell))) 
                                          :mod (c / cell)))) 
                        :poss (w / we)) 
                  :polarity -)))

# ::snt In addition , our present data showed that Otx2 , which is reported to have the same binding consensus as Crx , also transactivated mr-s expression .
# ::tok In addition , our present data showed that Otx2 , which is reported to have the same binding consensus as Crx , also transactivated mr-s expression .
# ::alignments 25-26|0.0.0 24-25|0.0.0.2 22-23|0.0.0.1 20-21|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 18-19|0.2.0 17-18|0.2 16-17|0.2.0.0 12-13|0.0.2.0 6-7|0 5-6|0.0 4-5|0.0.1 3-4|0.0.2 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:35.356
(s2 / show-01 
      :ARG0 (d / data 
            :ARG1-of (e / express-01 
                  :ARG0 (p / person 
                        :name (n / name 
                              :op1 "Crx")) 
                  :mod (a / also) 
                  :mod (m / mr-)) 
            :mod (p2 / present) 
            :poss (w / we 
                  :ARG0-of (r / report-01))) 
      :ARG1 (a2 / addition) 
      :purpose (b / binding-07 
            :ARG1 (c / consensus 
                  :ARG1-of (s / same-01))))

# ::snt As shown in Fig. 2A -- F , the expression pattern of mr-s correlates with that of Crx .
# ::tok As shown in Fig. 2A -- F , the expression pattern of mr-s correlates with that of Crx .
# ::alignments 15-16|0.0.1 13-14|0.0 12-13|0 10-11|0.0.0 9-10|0.0.0.1 6-7|0.0.0.1.0.1+0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 3-4|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:35.497
(m / mr- 
      :ARG2-of (c / correlate-01 
            :ARG0 (p / pattern 
                  :ARG0-of (s / show-01 
                        :location (c2 / country 
                              :name (n2 / name 
                                    :op1 "Fig."))) 
                  :ARG1-of (e / express-01 
                        :ARG0 (a / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor"))) 
            :ARG1 (t / that)))

# ::snt In contrast , the transcripts of Otx2 are mainly detected in the photoreceptor layer at embryonic stages .
# ::tok In contrast , the transcripts of Otx2 are mainly detected in the photoreceptor layer at embryonic stages .
# ::alignments 16-17|0.0.3 15-16|0.0.3.0 13-14|0.0.1 12-13|0.0.1.0 9-10|0.0 8-9|0.0.2 6-7|0.0.0.0 4-5|0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:35.608
(c / contrast-01 
      :ARG1 (d / detect-01 
            :ARG1 (t / transcript 
                  :mod (o / Otx2)) 
            :location (l / layer 
                  :mod (p / photoreceptor)) 
            :mod (m / main) 
            :time (s / stage 
                  :mod (e / embryonic))))

# ::snt Therefore , we concluded that mr-s transcription is directly regulated mainly by Crx .
# ::tok Therefore , we concluded that mr-s transcription is directly regulated mainly by Crx .
# ::alignments 12-13|0.1.0.0.0+0.1.0.0+0.1.0 10-11|0.1.3 9-10|0.1 8-9|0.1.2 6-7|0.1.1 5-6|0.1.1.0 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:35.659
(c / conclude-01 
      :ARG0 (w / we) 
      :ARG1 (r / regulate-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "Crx")) 
            :ARG1 (t / transcription 
                  :mod (m2 / mr-)) 
            :ARG1-of (d / direct-02) 
            :mod (m / main)))

# ::snt We also constructed reporter vectors in which mutations were introduced at the three Crx binding sites ( Fig. 3D , mut1259 , mut198 , mut72 , mut all ) .
# ::tok We also constructed reporter vectors in which mutations were introduced at the three Crx binding sites ( Fig. 3D , mut1259 , mut198 , mut72 , mut all ) .
# ::alignments 27-28|0.0.1.1.0.0 26-27|0.0.0 24-25|0 18-19|0.0.1.1.0.1.0 17-18|0.0.1.1.0.1.1.0.0+0.0.1.1.0.1.1.0+0.0.1.1.0.1.1 15-16|0.0.1.1 14-15|0.0.1 13-14|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 12-13|0.1 9-10|0.0.1.1.0 7-8|0.0.1.1.0.1 4-5|0.0.1.1.0.2 3-4|0.0 2-3|0.0.1.1.0.2.0 1-2|0.0.1.1.0.2.1 0-1|0.0.1.1.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:36.149
(m2 / mut72 
      :ARG1-of (r / report-01 
            :op1-of (m / mut) 
            :purpose-of (b / binding-07 
                  :ARG0 (t / thing 
                        :name (n2 / name 
                              :op1 "Crx")) 
                  :ARG1 (s / site 
                        :time-of (i / introduce-02 
                              :ARG0 (a / all) 
                              :ARG1 (m3 / mutate-01 
                                    :ARG0 3D 
                                    :ARG1 (c / country 
                                          :name (n / name 
                                                :op1 "Fig."))) 
                              :location (v / vector 
                                    :ARG1-of (c2 / construct-01 
                                          :ARG0 (w / we)) 
                                    :mod (a2 / also)))))) 
      :li 3)

# ::snt Then the Crx expression vector was co-introduced with mut1259 , mut198 , mut72 and mut all , respectively ( Fig. 3F ) .
# ::tok Then the Crx expression vector was co-introduced with mut1259 , mut198 , mut72 and mut all , respectively ( Fig. 3F ) .
# ::alignments 19-20|0.6.0.0+0.6.0+0.6 17-18|0.1 15-16|0.0.1 14-15|0.5 13-14|0 12-13|0.4 10-11|0.3 8-9|0.2 4-5|0.0.3 3-4|0.0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:36.319
(a2 / and 
      :ARG1-of (e / express-01 
            :ARG0 (p / person 
                  :name (n2 / name 
                        :op1 "Crx")) 
            :ARG2 (a / all) 
            :manner (t / then) 
            :mod-of (v / vector)) 
      :mod (r / respective) 
      :op1 (m4 / mut1259) 
      :op2 (m3 / mut198) 
      :op3 (m2 / mut72) 
      :op4 (m / mut) 
      :op5 (c / country 
            :name (n / name 
                  :op1 "Fig.")))

# ::snt The transactivaton activity by Crx was clearly reduced when mut198 or mut72 was co-introduced .
# ::tok The transactivaton activity by Crx was clearly reduced when mut198 or mut72 was co-introduced .
# ::alignments 11-12|0.2 10-11|0 9-10|0.1 7-8|0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.1.0+0.0.1+0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:36.359
(o / or 
      :op1 (p / person 
            :ARG0-of (a / activity-06 
                  :ARG1-of (r / reduce-01 
                        :ARG1-of (c / clear-06))) 
            :name (n / name 
                  :op1 "Crx")) 
      :op2 (m2 / mut198) 
      :op3 (m / mut72))

# ::snt On the other hand , when mut1259 was co-transfected , the transactivation activity by Crx was not altered .
# ::tok On the other hand , when mut1259 was co-transfected , the transactivation activity by Crx was not altered .
# ::alignments 17-18|0 16-17|0.1 14-15|0.0.0.0.0+0.0.0.0+0.0.0 12-13|0.0 8-9|0.0.1 6-7|0.0.1.0 3-4|0.0.0.1 2-3|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:36.407
(a / alter-01 
      :ARG1 (a2 / activity-06 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "Crx") 
                  :part (h / hand 
                        :mod (o / other))) 
            :ARG1 (c / co-transfect 
                  :domain (m / mut1259))) 
      :polarity -)

# ::snt These results suggest that the Crx binding sites 72-bp and 198-bp upstream from the transcription initiation site are crucial for the direct regulation of mr-s transcription by Crx .
# ::tok These results suggest that the Crx binding sites 72-bp and 198-bp upstream from the transcription initiation site are crucial for the direct regulation of mr-s transcription by Crx .
# ::alignments 25-26|0.1.0.0 24-25|0.1.0.0.0 22-23|0.1.0 21-22|0.1.0.1 18-19|0.1 16-17|0.1.0.1.0 15-16|0.1.0.1.0.0 14-15|0.1.0.1.0.1 11-12|0.0.1.0.1.0.0 9-10|0.0.0.0 7-8|0.0.1.0.1 6-7|0.0.1.0.1.0 5-6|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 2-3|0 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:37.072
(s3 / suggest-01 
      :ARG0 (t4 / thing 
            :ARG2-of (r2 / result-01 
                  :ARG1 (a / and)) 
            :mod (t5 / this 
                  :mod-of (t3 / thing 
                        :name (n / name 
                              :op1 "Crx") 
                        :poss-of (s2 / site 
                              :ARG1-of (b / binding-07 
                                    :ARG0 (u / upstream)))))) 
      :ARG1 (c / crucial 
            :prep-for (r / regulate-01 
                  :ARG1 (t / transcription 
                        :mod (m / mr-)) 
                  :ARG1-of (d / direct-02 
                        :ARG0 (s / site 
                              :mod (i / initiation) 
                              :mod (t2 / transcription))))))

# ::snt Self-association of mr-s protein .
# ::tok Self-association of mr-s protein .
# ::alignments 3-4|0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:37.082
(m / mr- 
      :mod-of (p / protein))

# ::snt SAM domains are known to function as protein-protein interaction modules [ 15-17 ] .
# ::tok SAM domains are known to function as protein-protein interaction modules [ 15-17 ] .
# ::alignments 9-10|0.1.0 8-9|0.1.0.0 5-6|0.1 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:37.183
(k / know-02 
      :ARG1 (d / domain 
            :mod (s / sam)) 
      :ARG2 (f / function-01 
            :ARG1 (m / module 
                  :ARG1-of (i / interact-01))))

# ::snt Although SAM domains can bind to various non-SAM domain-containing proteins , many homo-SAM and hetero-SAM domain interactions have been reported .
# ::tok Although SAM domains can bind to various non-SAM domain-containing proteins , many homo-SAM and hetero-SAM domain interactions have been reported .
# ::alignments 19-20|0 16-17|0.0.0 15-16|0.1.2.0 13-14|0.0 11-12|0.0.1 9-10|0.1.1 8-9|0.1.1.0 6-7|0.1.1.1 4-5|0.1 3-4|0.1.2 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:37.322
(r / report-01 
      :ARG1 (a / and 
            :op1 (i / interaction) 
            :quant (m / many)) 
      :concession (b / bind-01 
            :ARG0 (d3 / domain 
                  :mod (s / sam)) 
            :ARG1 (p / protein 
                  :mod (d2 / domain-contain) 
                  :mod (v / various)) 
            :ARG1-of (p2 / possible-01 
                  :ARG0 (d / domain))))

# ::snt To investigate whether the SAM domain of the mr-s protein can also function as a protein-protein interaction module , we performed yeast two-hybrid screening using full-length mr-s protein as the bait .
# ::tok To investigate whether the SAM domain of the mr-s protein can also function as a protein-protein interaction module , we performed yeast two-hybrid screening using full-length mr-s protein as the bait .
# ::alignments 30-31|0.1.0.0.0.0.0.0.0.1 27-28|0.1.0.0.0.0.0.0.0.0 25-26|0.1.0.0.0.0.0.0.0.0.0 24-25|0.1.0.0.0.0.0.0.0 23-24|0.1.0.0.0.0.0.0 21-22|0.1.0.0.0.0.0.0.1 20-21|0.1.0.0.0.0.0 19-20|0.1.0.0.0.0 17-18|0.1.0.1.0+0.1.0.1 16-17|0.1.1 12-13|0.1.0 11-12|0.1.0.2 10-11|0.1.0.0 9-10|0 8-9|0.0 5-6|0.1 4-5|0.1.2 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:37.766
(p4 / protein 
      :mod (m2 / mr-) 
      :poss-of (d / domain 
            :ARG0-of (f2 / function-01 
                  :ARG1-of (p3 / possible-01 
                        :ARG1-of (i2 / investigate-01 
                              :ARG0 (w / we 
                                    :ARG0-of (p2 / perform-02 
                                          :ARG1 (s / screen-01 
                                                :ARG0-of (u / use-01 
                                                      :ARG1 (p / protein 
                                                            :mod (f / full-length)) 
                                                      :ARG2 (b / bait-01)) 
                                                :mod (y / yeast)))))) 
                  :ARG2 (m / module 
                        :wiki -) 
                  :mod (a / also)) 
            :ARG1-of (i / interact-01) 
            :mod (s2 / sam)))

# ::snt Using this bait , we screened the transcriptional activator fusion protein library in which mouse P0-P3 retinal cDNAs were fused to the GAL4 activation domain .
# ::tok Using this bait , we screened the transcriptional activator fusion protein library in which mouse P0-P3 retinal cDNAs were fused to the GAL4 activation domain .
# ::alignments 24-25|0.1.0.1 23-24|0.1.0.1.0 22-23|0.1.0.1.1.0.0+0.1.0.1.1.0+0.1.0.1.1 19-20|0.1.0 17-18|0.1.0.0 16-17|0.1.0.0.1 15-16|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 14-15|0.0.0.0.0 11-12|0.1 10-11|0.1.1 9-10|0.1.1.0 8-9|0.1.1.0.0 7-8|0.1.1.0.0.0 5-6|0 4-5|0.0 2-3|0.0.0.0 1-2|0.0.0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:38.255
(s / screen-01 
      :ARG0 (w / we 
            :ARG0-of (u / use-01 
                  :ARG1 (b / bait-01 
                        :ARG1 (m / mouse) 
                        :mod (t4 / this)))) 
      :ARG1 (l / library 
            :ARG0-of (f / fuse-01 
                  :ARG1 (c / cdna 
                        :mod (t2 / thing 
                              :name (n2 / name 
                                    :op1 "P0-P3")) 
                        :mod (r / retinal)) 
                  :ARG2 (d / domain 
                        :mod (a / activation) 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "GAL4")))) 
            :mod (p / protein 
                  :mod (f2 / fusion 
                        :mod (a2 / activator 
                              :mod (t3 / transcriptional))))))

# ::snt The most frequent positive clones ( 5 out of 28 ) were cDNA fragments containing the SAM domain of mr-s ( Fig. 4A ) .
# ::tok The most frequent positive clones ( 5 out of 28 ) were cDNA fragments containing the SAM domain of mr-s ( Fig. 4A ) .
# ::alignments 21-22|0.3.0.0.0+0.3.0.0+0.3.0 19-20|0.1.0.1 17-18|0.1.0 16-17|0.1.0.0 14-15|0.1 13-14|0 12-13|0.2 9-10|0.0 6-7|0.3.1.0 4-5|0.3 3-4|0.3.2 2-3|0.3.1 1-2|0.3.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:38.543
(f / fragment-01 
      :ARG0 28 
      :ARG0-of (c2 / contain-01 
            :ARG1 (d / domain 
                  :mod (s / sam) 
                  :poss (m / mr-))) 
      :ARG1 (c3 / cdna) 
      :ARG2-of (c4 / clone-01 
            :ARG1 (c / country 
                  :name (n / name 
                        :op1 "Fig.")) 
            :ARG1-of (f2 / frequent-02 
                  :ARG0 5 
                  :degree (m2 / most)) 
            :mod (p / positive)))

# ::snt This result strongly suggests that mr-s protein self-associates through SAM domain-containing regions .
# ::tok This result strongly suggests that mr-s protein self-associates through SAM domain-containing regions .
# ::alignments 11-12|0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0 7-8|0.1 6-7|0.1.0 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:38.596
(s3 / suggest-01 
      :ARG0 (r2 / result-01 
            :ARG1 (s / sam 
                  :mod-of (r / region 
                        :mod (d / domain-contain))) 
            :mod (t / this)) 
      :ARG1 (s2 / self-associat 
            :mod (p / protein)) 
      :ARG1-of (s4 / strong-02))

# ::snt We then directly tested this self-association of mr-s protein in yeast .
# ::tok We then directly tested this self-association of mr-s protein in yeast .
# ::alignments 10-11|0.4.0 8-9|0.4 7-8|0.4.1 4-5|0.1 3-4|0 2-3|0.2 1-2|0.3 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:38.683
(t2 / test-01 
      :ARG0 (w / we) 
      :ARG1 (t / this) 
      :ARG1-of (d / direct-02) 
      :time (t3 / then) 
      :topic-of (p / protein 
            :location (y / yeast) 
            :mod (m / mr-)))

# ::snt We fused full-length or truncated portions of the mr-s protein to the DNA-binding domain of the yeast transcription factor GAL4 to make bait constructs .
# ::tok We fused full-length or truncated portions of the mr-s protein to the DNA-binding domain of the yeast transcription factor GAL4 to make bait constructs .
# ::alignments 23-24|0.1 22-23|0 18-19|0.0.0.0 17-18|0.0.0 16-17|0.0 13-14|0.0.0.0.0 12-13|0.0.0.0.0.0 9-10|0.2.0.2.0 8-9|0.2.0.2.0.0 5-6|0.2.0.2 4-5|0.2 3-4|0.2.0 2-3|0.2.0.1 1-2|0.2.0.0 0-1|0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:38.941
(b / bait-01 
      :ARG0 (y / yeast 
            :mod-of (t / transcription 
                  :mod-of (f / factor 
                        :poss-of (d / domain 
                              :mod (d2 / dna-bind))))) 
      :ARG1 (c / construct) 
      :ARG1-of (t2 / truncate-01 
            :op2-of (o / or 
                  :ARG1-of (f3 / fuse-01 
                        :ARG0 (w / we)) 
                  :op1 (f2 / full-length) 
                  :op3 (p2 / portion 
                        :part-of (p / protein 
                              :mod (m / mr-))))))

# ::snt We fused full-length or truncated portions of the mr-s protein to the GAL4 transcriptional activation domain to make prey constructs ( Fig. 4B ) .
# ::tok We fused full-length or truncated portions of the mr-s protein to the GAL4 transcriptional activation domain to make prey constructs ( Fig. 4B ) .
# ::alignments 21-22|0.0.0.0+0.0.0+0.0 19-20|0.1.0.0.0 18-19|0.1.0.0.0.0 15-16|0.1.0.1.1.0.0.0 14-15|0.1.0.1.1.0.0 13-14|0.1.0.1.1.0 12-13|0.1.0.1.1.1.0+0.1.0.1.1.1+0.1.0.1.1 9-10|0.1.1 8-9|0.1.1.0 5-6|0.1 4-5|0 3-4|0.1.0.1 2-3|0.1.0.1.0 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:39.200
(t3 / truncate-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "Fig.")) 
      :ARG1 (p3 / portion 
            :ARG1-of (f2 / fuse-01 
                  :ARG0 (w / we 
                        :poss-of (c2 / construct 
                              :mod (p / prey))) 
                  :op1-of (o / or 
                        :op2 (f / full-length) 
                        :op3 (t2 / thing 
                              :mod-of (t / transcriptional 
                                    :mod-of (a / activation 
                                          :mod-of (d / domain))) 
                              :name (n2 / name 
                                    :op1 "GAL4")))) 
            :part-of (p2 / protein 
                  :mod (m / mr-))))

# ::snt These constructs were transformed into yeast that contain a transgene with GAL4 binding sites upstream of the lacZ gene .
# ::tok These constructs were transformed into yeast that contain a transgene with GAL4 binding sites upstream of the lacZ gene .
# ::alignments 18-19|0.0.0 17-18|0.0 14-15|0.0.0.0 13-14|0.2.0.1.0 12-13|0.2.0.1 9-10|0.2.0.0 7-8|0.2.0 5-6|0.2 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:39.304
(t2 / transform-01 
      :ARG0 (l / lacZ 
            :mod-of (g / gene 
                  :prep-in-of (u / upstream))) 
      :ARG1 (c2 / construct 
            :mod (t3 / this)) 
      :ARG2 (y / yeast 
            :ARG0-of (c / contain-01 
                  :ARG1 (t / transgene) 
                  :ARG2-of (b / binding-07 
                        :ARG1 (s / site)))))

# ::snt We found that the full-length mr-s bait construct induced lacZ expression with the full-length mr-s prey construct ( Fig. 4B , full  full ) .
# ::tok We found that the full-length mr-s bait construct induced lacZ expression with the full-length mr-s prey construct ( Fig. 4B , full  full ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:39.307
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The N-terminus 400 amino acid ( aa ) stretch of mr-s , which does not contain a SAM domain , does weakly activate transcription of lacZ ( Fig. 4B , full  N ) .
# ::tok The N-terminus 400 amino acid ( aa ) stretch of mr-s , which does not contain a SAM domain , does weakly activate transcription of lacZ ( Fig. 4B , full  N ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:39.316
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt The N-terminus 400 aa stretch of mr-s was able to induce transcription of lacZ weakly with the same N-terminus 400 aa stretch of mr-s ( Fig. 4B , N  N ) .
# ::tok The N-terminus 400 aa stretch of mr-s was able to induce transcription of lacZ weakly with the same N-terminus 400 aa stretch of mr-s ( Fig. 4B , N  N ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:39.321
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Although the N-terminus 400 aa mr-s protein weakly activates lacZ transcription with the same N-terminus portion , a much stronger activation of lacZ expression was observed with a C-terminus portion encoding the 391 -- 542 aa stretch of mr-s ( Fig. 4B , full  C , C  C ) .
# ::tok Although the N-terminus 400 aa mr-s protein weakly activates lacZ transcription with the same N-terminus portion , a much stronger activation of lacZ expression was observed with a C-terminus portion encoding the 391 -- 542 aa stretch of mr-s ( Fig. 4B , full  C , C  C ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:39.335
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Our GAL4 assay indicated that the signal when the full-length mr-s was present in both the bait and prey contexts was weaker than when isolated SAM domains were used .
# ::tok Our GAL4 assay indicated that the signal when the full-length mr-s was present in both the bait and prey contexts was weaker than when isolated SAM domains were used .
# ::alignments 28-29|0.1.0.0.0.0.0.2 26-27|0.1.0.0.0.0.0.2.0 25-26|0.1.0.0.0.0.0.2.0.1 24-25|0.1.0.0.0.0.0.2.0.0 21-22|0.1 19-20|0.1.0.0.0.0.0.1 18-19|0.1.0.0.0.0.0.0 17-18|0.1.0.0.0.0.0 16-17|0.1.0.0 14-15|0.1.0.0.1 12-13|0.1.0.0.0.0 10-11|0.1.0.0.0 9-10|0.1.0.0.0.1 6-7|0.1.0 3-4|0 2-3|0.0 1-2|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:39.822
(i2 / indicate-01 
      :ARG0 (a2 / assay 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "GAL4")) 
            :poss (w2 / we)) 
      :ARG1 (w / weak 
            :domain (s2 / signal 
                  :ARG1-of (b / bait-01 
                        :ARG0 (m / mr- 
                              :domain-of (p2 / present 
                                    :op1-of (a / and 
                                          :op2 (p / prey) 
                                          :op3 (c / context) 
                                          :op4 (u / use-01 
                                                :ARG1 (d / domain 
                                                      :ARG1-of (i / isolate-01) 
                                                      :mod (s / sam))))) 
                              :mod (f / full-length)) 
                        :mod (b2 / both)))))

# ::snt This may simply reflect the tendency for the small fusion proteins to enter the yeast nucleus and occupy GAL4 binding sites .
# ::tok This may simply reflect the tendency for the small fusion proteins to enter the yeast nucleus and occupy GAL4 binding sites .
# ::alignments 20-21|0.0.1.0.1.0 19-20|0.0.1.0.1.0.0 18-19|0.0.1.0.1.0.0.0.0.0+0.0.1.0.1.0.0.0.0+0.0.1.0.1.0.0.0 17-18|0.0.1.0.1 16-17|0.0.1.0 15-16|0.0.1.0.0.1 14-15|0.0.1.0.0.1.0 12-13|0.0.1.0.0 10-11|0.0.1.0.0.0 9-10|0.0.1.0.2 8-9|0.0.1.0.0.0.0 5-6|0.0.1 3-4|0.0 2-3|0.0.2 1-2|0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:40.311
(p2 / possible-01 
      :ARG1 (r / reflect-01 
            :ARG0 (t3 / this) 
            :ARG1 (t2 / tendency 
                  :purpose (a / and 
                        :op1 (e / enter-01 
                              :ARG0 (p / protein 
                                    :mod (s2 / small)) 
                              :ARG1 (n2 / nucleus 
                                    :mod (y / yeast))) 
                        :op2 (o / occupy-01 
                              :ARG1 (s / site 
                                    :ARG1-of (b / binding-07 
                                          :ARG0 (t / thing 
                                                :name (n / name 
                                                      :op1 "GAL4"))))) 
                        :purpose-of (f / fusion))) 
            :manner (s3 / simple)))

# ::snt Alternatively , the SAM domain may be less accessible for interaction in the full-length protein context as previously reported [ 39 ] .
# ::tok Alternatively , the SAM domain may be less accessible for interaction in the full-length protein context as previously reported [ 39 ] .
# ::alignments 20-21|0.0.0 18-19|0.0.2.0.0 17-18|0.0.2.0.0.1 15-16|0.0.2.0 14-15|0.0.2.0.1 13-14|0.0.2.0.2 10-11|0.0.2 8-9|0.0 7-8|0.0.3 5-6|0 4-5|0.0.1 3-4|0.0.1.0 0-1|0.0.2.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:40.447
(p3 / possible-01 
      :ARG1 (a / access-01 
            :ARG0 39 
            :ARG1 (d / domain 
                  :mod (s / sam)) 
            :ARG2 (i / interact-01 
                  :ARG1 (c / context 
                        :ARG0-of (r / report-01 
                              :ARG1 (a2 / alternatively) 
                              :time (p / previous)) 
                        :mod (p2 / protein) 
                        :mod (f / full-length))) 
            :degree (l / less)))

# ::snt Summary of yeast two-hybrid screening and GAL4 assay .
# ::tok Summary of yeast two-hybrid screening and GAL4 assay .
# ::alignments 7-8|0.0.1.0.0 6-7|0.0.1.0.1.0+0.0.1.0.1+0.0.1.0 5-6|0.0.1 4-5|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:40.474
(s2 / summary 
      :source (s / screen-01 
            :ARG1 (y / yeast) 
            :op1-of (a2 / and 
                  :op2 (t / thing 
                        :mod-of (a / assay) 
                        :name (n / name 
                              :op1 "GAL4")))))

# ::snt ( A ) Full-length mr-s as a bait used in the yeast two-hybrid screening and positive clones are indicated .
# ::tok ( A ) Full-length mr-s as a bait used in the yeast two-hybrid screening and positive clones are indicated .
# ::alignments 18-19|0 16-17|0.1.1 15-16|0.1.1.0 14-15|0.1 13-14|0.1.0 11-12|0.1.0.0 8-9|0.1.0.1 7-8|0.1.0.1.0 4-5|0.0 3-4|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:40.607
(i / indicate-01 
      :ARG1 (m / mr- 
            :mod (f / full-length)) 
      :ARG2 (a / and 
            :op1 (s / screen-01 
                  :ARG1 (y / yeast) 
                  :ARG2-of (u / use-01 
                        :ARG1 (b / bait-01))) 
            :op2 (c / clone-01 
                  :mod (p / positive))))

# ::snt Note that all of five mr-s clones identified in the screening contain SAM domains .
# ::tok Note that all of five mr-s clones identified in the screening contain SAM domains .
# ::alignments 13-14|0.0.0.0 12-13|0.0.0 11-12|0.0.0.0.0 10-11|0 7-8|0.0 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0.0.0.0.1.0 2-3|0.0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:40.721
(s2 / screen-01 
      :ARG2-of (i / identify-01 
            :ARG0 (s / sam 
                  :mod-of (d / domain 
                        :ARG1-of (c / contain-01 
                              :ARG0 (a / all) 
                              :ARG1-of (n / note-01 
                                    :op1-of 5)))) 
            :ARG1 (c2 / clone-01 
                  :mod (m / mr-))))

# ::snt ( B ) Schematic diagram of the mr-s fusion proteins used in the yeast GAL4 assay .
# ::tok ( B ) Schematic diagram of the mr-s fusion proteins used in the yeast GAL4 assay .
# ::alignments 15-16|0.1.0.1 14-15|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 13-14|0.2 10-11|0.1.0 9-10|0.1 8-9|0.1.1 7-8|0.1.2 4-5|0 3-4|0.0 1-2|0.1.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:40.945
(d / diagram-01 
      :ARG0 (s / schematic) 
      :ARG1 (p / protein 
            :ARG1-of (u / use-01 
                  :ARG0 (l / location 
                        :name (n2 / name 
                              :op1 "B") 
                        :wiki -) 
                  :ARG2 (a / assay 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "GAL4")))) 
            :mod (f / fusion) 
            :mod (m / mr-)) 
      :location (y / yeast))

# ::snt Black boxes represent the position of SAM domains .
# ::tok Black boxes represent the position of SAM domains .
# ::alignments 7-8|0.1.0 6-7|0.1.0.0 4-5|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:40.987
(r / represent-01 
      :ARG0 (b / box 
            :ARG1-of (b2 / black-05)) 
      :ARG1 (p / position 
            :mod (d / domain 
                  :mod (s / sam))))

# ::snt Relative levels of LacZ expression are shown on the right , respectively .
# ::tok Relative levels of LacZ expression are shown on the right , respectively .
# ::alignments 11-12|0.0.0.0 9-10|0.1 6-7|0 4-5|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:41.046
(s / show-01 
      :ARG1 (l / level 
            :mod (e / express-01 
                  :ARG1 (r / respective)) 
            :mod (r3 / relative)) 
      :ARG2 (r2 / right-05))

# ::snt Note ; + + indicates an intense blue signal visible after 12 hr of incubation at 37 C , + indicates a blue signal visible after 24 hr of incubation .
# ::tok Note ; + + indicates an intense blue signal visible after 12 hr of incubation at 37 C , + indicates a blue signal visible after 24 hr of incubation .
# ::alignments 29-30|0.2.1.0.0 26-27|0.1.0.0 25-26|0.2.1.0 24-25|0.2.1 23-24|0.2 22-23|0.2.0 20-21|0 17-18|0.1.0.1.1.0 16-17|0.1.0.1.1.0.0 14-15|0.0.0.1 12-13|0.0 11-12|0.0.0.0 10-11|0.0.0 9-10|0.1.0.1.2 8-9|0.1.0.1 7-8|0.1.0.1.0 6-7|0.1.0.1.1 4-5|0.1.0 1-2|0.1.1 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:42.127
(i2 / indicate-01 
      :ARG0 (h / hr 
            :op2-of (a2 / after 
                  :op1 12 
                  :op3 (i3 / incubation))) 
      :ARG1 (n / note-01 
            :ARG1 (i5 / indicate-01 
                  :ARG0 24 
                  :ARG1 (s2 / signal 
                        :mod (b2 / blue) 
                        :mod (i4 / intense-02 
                              :ARG1 (c / C 
                                    :era-of 37)) 
                        :mod (v2 / visible))) 
            :op1-of (a3 / and)) 
      :ARG2 (s / signal 
            :mod (b / blue) 
            :mod (v / visible 
                  :time (a / after 
                        :op1 (i / incubation)))))

# ::snt BD , binding domain ; AD , activation domain ; full , full-length mr-s ; N , N-terminal portion of mr-s ( amino acids 1 to 400 ) ; C , C-terminal portion of mr-s ( amino acids 391 to 542 ) .
# ::tok BD , binding domain ; AD , activation domain ; full , full-length mr-s ; N , N-terminal portion of mr-s ( amino acids 1 to 400 ) ; C , C-terminal portion of mr-s ( amino acids 391 to 542 ) .
# ::alignments 37-38|0.1.0.4.0 36-37|0.1.0.4 34-35|0.1.0.6 32-33|0.1.0.6.2 29-30|0.1.0.0 26-27|0.1.0.5 24-25|0.1.0.3 23-24|0.1 22-23|0 20-21|0.1.0.2 18-19|0.1.0.2.0 15-16|0.1.0.6.1.2 13-14|0.1.0.6.1.1 12-13|0.1.0.6.1.1.1 10-11|0.1.0.6.1.1.0 8-9|0.1.0.6.0.0 7-8|0.1.0.6.0 5-6|0.1.0.6.1.0 4-5|0.1.0.6.1 3-4|0.1.0.1 2-3|0.1.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:42.415
(a4 / amino 
      :mod (b2 / bd) 
      :mod-of (a3 / acid 
            :op1 (b / binding-07 
                  :ARG0 (c / C) 
                  :ARG1 (d2 / domain) 
                  :op1-of (m2 / mr- 
                        :quant (p2 / portion)) 
                  :op1-of 1 
                  :op1-of (a2 / amino 
                        :mod-of (a / acid)) 
                  :op1-of 400 
                  :op1-of (m / mr- 
                        :mod (a5 / activation 
                              :mod-of (d / domain)) 
                        :op4-of (a6 / and 
                              :op1 "AD" 
                              :op2 (m3 / mr- 
                                    :mod (f2 / full) 
                                    :mod (f / full-length)) 
                              :op3 (n / N)) 
                        :quant (p / portion)))))

# ::snt To confirm self-association of the mr-s protein in mammalian cells , we next performed co-immunoprecipitation studies in HEK293T cells by co-transfection of HA-tagged full-length/truncated mr-s and Flag-tagged full-length/truncated mr-s ( Fig. 5A ) .
# ::tok To confirm self-association of the mr-s protein in mammalian cells , we next performed co-immunoprecipitation studies in HEK293T cells by co-transfection of HA-tagged full-length/truncated mr-s and Flag-tagged full-length/truncated mr-s ( Fig. 5A ) .
# ::alignments 30-31|0.0.0.0.0.0.3.0.0+0.0.0.0.0.0.3.0+0.0.0.0.0.0.3 28-29|0.0.0.0.0.0.2 26-27|0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1 25-26|0.0.0.0.0.0 24-25|0.0.0.0.0.0.0 23-24|0.0.0.0.0.0.0.0 22-23|0.0.1.0.0+0.0.1.0+0.0.1 18-19|0.0.0.0.0.1 17-18|0.0.0.0.0.1.0 15-16|0.0.0.0.0 13-14|0.0.0.0 12-13|0.0.0.0.1 11-12|0.0.0 9-10|0.1 8-9|0.1.0 6-7|0 5-6|0.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:43.039
(p2 / protein 
      :ARG0-of (c4 / confirm-01 
            :ARG1 (w / we 
                  :ARG0-of (p / perform-02 
                        :ARG1 (s / study-01 
                              :ARG1 (a / and 
                                    :op1 (m2 / mr- 
                                          :mod (f / full-length/truncat)) 
                                    :op2 (t / thing 
                                          :name (n2 / name 
                                                :op1 "Flag-tagged")) 
                                    :op3 (m / mr-) 
                                    :op4 (c / country 
                                          :name (n / name 
                                                :op1 "Fig."))) 
                              :location (c2 / cell 
                                    :mod (h / HEK293T))) 
                        :manner (n4 / next))) 
            :ARG2 (t2 / thing 
                  :name (n3 / name 
                        :op1 "HA-tagged"))) 
      :location (c3 / cell 
            :mod (m3 / mammalian)) 
      :mod (m4 / mr-))

# ::snt As a negative control , we constructed Flag-tagged Sonic hedgehog ( Shh ) ( lane 2 and 7 ) .
# ::tok As a negative control , we constructed Flag-tagged Sonic hedgehog ( Shh ) ( lane 2 and 7 ) .
# ::alignments 17-18|0.0.0.0.1.0 16-17|0 15-16|0.0.0.0.1.1 14-15|0.0.0.0.1 9-10|0.0.0.0.0 8-9|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 7-8|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0 3-4|0.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:43.453
(a / and 
      :op1 (c2 / control-01 
            :ARG0 (w / we 
                  :ARG0-of (c / construct-01 
                        :ARG1 (h / hedgehog 
                              :mod (o / organization 
                                    :name (n / name 
                                          :op1 "Sonic")) 
                              :quant (t / thing 
                                    :name (n2 / name 
                                          :op1 "Flag-tagged"))) 
                        :ARG2-of (l / lane-01 
                              :ARG0 7 
                              :ARG1 2))) 
            :mod (n3 / negative)))

# ::snt In accordance with the result of the yeast two-hybrid GAL4 assay , HA-tagged full-length mr-s ( full-HA ) was co-immunoprecipitated with Flag-tagged full-length mr-s ( Flag-mrs ) and the Flag-tagged C-terminus portion containing the SAM domain ( Flag-SAM ) , respectively ( Fig 5B , lane3 and lane5 ) .
# ::tok In accordance with the result of the yeast two-hybrid GAL4 assay , HA-tagged full-length mr-s ( full-HA ) was co-immunoprecipitated with Flag-tagged full-length mr-s ( Flag-mrs ) and the Flag-tagged C-terminus portion containing the SAM domain ( Flag-SAM ) , respectively ( Fig 5B , lane3 and lane5 ) .
# ::alignments 46-47|0 42-43|0.1.0.0+0.1.0+0.1 40-41|0.2.0 37-38|0.2.4.0.0+0.2.4.0+0.2.4 35-36|0.2.3.0.0 34-35|0.2.3.0.0.0 32-33|0.2.3.0 31-32|0.2.3 30-31|0.2.3.1 27-28|0.2 25-26|0.2.2.0.1.0 23-24|0.2.2 21-22|0.2.1.0.0+0.2.1.0+0.2.1 14-15|0.2.2.0.0 13-14|0.2.2.0.0.0 12-13|0.0.0.0+0.0.0+0.0 10-11|0.2.2.0.1.1 9-10|0.2.2.0.1.1.0.0.0+0.2.2.0.1.1.0.0+0.2.2.0.1.1.0 7-8|0.2.3.0.1 4-5|0.2.2.0.1 1-2|0.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:44.251
(a / and 
      :op1 (t2 / thing 
            :name (n4 / name 
                  :op1 "HA-tagged")) 
      :op2 (c / country 
            :name (n / name 
                  :op1 "Fig")) 
      :op5-of (a2 / and 
            :mod (r / respective) 
            :op1 (t / thing 
                  :name (n3 / name 
                        :op1 "Flag-tagged")) 
            :op2 (m / mr- 
                  :ARG2-of (a4 / accord-02 
                        :ARG1 (m2 / mr- 
                              :mod (f2 / full-length)) 
                        :ARG2-of (r2 / result-01 
                              :ARG0 (f / flag-mr) 
                              :ARG1 (a3 / assay 
                                    :mod (t3 / thing 
                                          :name (n5 / name 
                                                :op1 "GAL4")))))) 
            :op3 (p / portion 
                  :ARG0-of (c2 / contain-01 
                        :ARG1 (d / domain 
                              :mod (s / sam)) 
                        :ARG2 (y / yeast)) 
                  :mod (c3 / c-terminu)) 
            :op4 (o / organization 
                  :name (n2 / name 
                        :op1 "Flag-SAM"))))

# ::snt We also found a weak co-immunoprecipitation band in co-transfection of full-HA and Flag-tagged N-terminus portion of mr-s ( Flag-SAM , Fig. 5B , lane 4 ) .
# ::tok We also found a weak co-immunoprecipitation band in co-transfection of full-HA and Flag-tagged N-terminus portion of mr-s ( Flag-SAM , Fig. 5B , lane 4 ) .
# ::alignments 24-25|0.1.4 23-24|0 20-21|0.0.0.0+0.0.0+0.0 18-19|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 16-17|0.1.3.1.1 14-15|0.1.3.1 13-14|0.1.3.1.0.0.0+0.1.3.1.0.0+0.1.3.1.0 12-13|0.1.3.0.0.0+0.1.3.0.0+0.1.3.0 11-12|0.1.3 6-7|0.1.1 4-5|0.1.1.0 2-3|0.1 1-2|0.1.2 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:44.585
(l / lane-01 
      :ARG1 (c / country 
            :name (n / name 
                  :op1 "Fig.")) 
      :ARG2 (f / find-01 
            :ARG0 (w2 / we) 
            :ARG1 (b / band 
                  :ARG1-of (w / weak-02 
                        :ARG0 (o / organization 
                              :name (n2 / name 
                                    :op1 "Flag-SAM")))) 
            :mod (a2 / also) 
            :op1-of (a / and 
                  :op2 (t2 / thing 
                        :name (n4 / name 
                              :op1 "Flag-tagged")) 
                  :op3 (p / portion 
                        :mod (t / thing 
                              :name (n3 / name 
                                    :op1 "N-terminus")) 
                        :quant-of (m / mr-))) 
            :op1-of 4))

# ::snt When SAM-HA and Flag-tagged deletion mutants were co-transfected , SAM-HA was co-immunoprecipitated with Flag-mrs and Flag-SAM ( Fig. 5B , lane 8 and lane 9 ) , while SAM-HA was not co-immunoprecipitated with Flag-SAM ( Fig. 5B , lane 10 ) .
# ::tok When SAM-HA and Flag-tagged deletion mutants were co-transfected , SAM-HA was co-immunoprecipitated with Flag-mrs and Flag-SAM ( Fig. 5B , lane 8 and lane 9 ) , while SAM-HA was not co-immunoprecipitated with Flag-SAM ( Fig. 5B , lane 10 ) .
# ::alignments 39-40|0.1.0 38-39|0.0.1.3.0 30-31|0.1.1 24-25|0.0.1.3.0.0 23-24|0.1 22-23|0 21-22|0.0.1.3.0.1 20-21|0.0.1.3 17-18|0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 15-16|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 14-15|0.0.1 13-14|0.0.1.0 7-8|0.0.3.0 5-6|0.0.3 4-5|0.0.3.1 3-4|0.0.2.0.0+0.0.2.0+0.0.2 2-3|0.0 1-2|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:44.985
(a / and 
      :op1 (a3 / and 
            :op1 (o2 / organization 
                  :name (n4 / name 
                        :op1 "SAM-HA")) 
            :op1-of (a2 / and 
                  :op2 (f / flag-mr) 
                  :op3 (o / organization 
                        :name (n2 / name 
                              :op1 "Flag-SAM")) 
                  :op4 (c / country 
                        :name (n / name 
                              :op1 "Fig.")) 
                  :op5 (l3 / lane-01 
                        :ARG1 (l / lane-01 
                              :ARG0 9 
                              :ARG1 8))) 
            :op2 (t / thing 
                  :name (n3 / name 
                        :op1 "Flag-tagged")) 
            :op3 (m / mutant 
                  :domain-of (c2 / co-transfect) 
                  :mod (d / deletion))) 
      :op2 (l2 / lane-01 
            :ARG0 10 
            :ARG1 -))

# ::snt The mr-s protein can self-associate in mammalian cells .
# ::tok The mr-s protein can self-associate in mammalian cells .
# ::alignments 7-8|0.0 6-7|0.0.1 3-4|0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:44.999
(p / possible-01 
      :ARG1 (c / cell 
            :location-of (p2 / protein) 
            :mod (m / mammalian)))

# ::snt ( A ) Schematic drawing of the constructs used for immunoprecipitation assay .
# ::tok ( A ) Schematic drawing of the constructs used for immunoprecipitation assay .
# ::alignments 11-12|0.0.0.0 10-11|0.0.0.0.0 8-9|0.0.0 7-8|0.0 4-5|0 3-4|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:45.028
(d / draw-01 
      :ARG1 (c / construct 
            :ARG1-of (u / use-01 
                  :ARG2 (a / assay 
                        :mod (i / immunoprecipitation)))) 
      :mod (s / schematic))

# ::snt HA-tagged or Flag-tagged full-length ( amino acids 1 to 542 ) , SAM ( amino acids 1 to 400 ) and SAM ( amino acids 401 to 542 ) regions were inserted into pcDNA3 vector , respectively .
# ::tok HA-tagged or Flag-tagged full-length ( amino acids 1 to 542 ) , SAM ( amino acids 1 to 400 ) and SAM ( amino acids 401 to 542 ) regions were inserted into pcDNA3 vector , respectively .
# ::alignments 36-37|0.0.0.3 34-35|0.0.0.2 31-32|0.0.0 29-30|0.0.0.0 24-25|0.0 23-24|0 20-21|0.0.0.1 18-19|0.0.0.1.2.3 16-17|0.0.0.4 15-16|0.0.0.5 14-15|0.0.0.5.0 12-13|0.0.0.1.1 7-8|0.0.0.0.0 6-7|0.0.0.1.0 5-6|0.0.0.1.0.0 3-4|0.0.0.1.2.2 2-3|0.0.0.1.2.1.0.0+0.0.0.1.2.1.0+0.0.0.1.2.1 1-2|0.0.0.1.2 0-1|0.0.0.1.2.0.0.0+0.0.0.1.2.0.0+0.0.0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:45.606
(a2 / amino 
      :mod-of (a / acid 
            :ARG2-of (i / insert-01 
                  :ARG0 (r2 / region 
                        :mod 1) 
                  :ARG1 (a3 / and 
                        :op1 (a6 / acid 
                              :mod (a7 / amino)) 
                        :op2 (s / sam) 
                        :op4-of (o / or 
                              :op1 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "HA-tagged")) 
                              :op2 (t / thing 
                                    :name (n / name 
                                          :op1 "Flag-tagged")) 
                              :op3 (f / full-length) 
                              :poss-of 400)) 
                  :ARG3 (v / vector) 
                  :mod (r / respective) 
                  :op1-of 1 
                  :time (a4 / acid 
                        :mod (a5 / amino)))))

# ::snt ( B ) The constructs indicated above were transfected into HEK293T cells .
# ::tok ( B ) The constructs indicated above were transfected into HEK293T cells .
# ::alignments 11-12|0.0.0 10-11|0.0.0.0 6-7|0.0.2 5-6|0.0 4-5|0 1-2|0.0.1.1+0.0.1.0.0+0.0.1.0+0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:45.787
(c2 / construct 
      :ARG0-of (i / indicate-01 
            :ARG1 (c / cell 
                  :mod (h / HEK293T)) 
            :ARG2 (l / location 
                  :name (n / name 
                        :op1 "B") 
                  :wiki -) 
            :path (a / above)))

# ::snt Each lane was co-immunoprecipitated by anti-Flag antibody and detected by anti-HA antibody .
# ::tok Each lane was co-immunoprecipitated by anti-Flag antibody and detected by anti-HA antibody .
# ::alignments 11-12|0.1.0 8-9|0.1 7-8|0 6-7|0.0 3-4|0.1.1.0 1-2|0.1.1 0-1|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:45.818
(a2 / and 
      :op1 (a3 / antibody) 
      :op2 (d / detect-01 
            :ARG0 (a / antibody) 
            :ARG1 (l / lane-01 
                  :domain-of (c / co-immunoprecipitat) 
                  :mod (e / each))))

# ::snt Input protein lysates are shown in the lower panels .
# ::tok Input protein lysates are shown in the lower panels .
# ::alignments 8-9|0.1 7-8|0.1.0 4-5|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:45.858
(s / show-01 
      :ARG1 (l2 / lysat 
            :mod (p2 / protein) 
            :mod (i / input)) 
      :time (p / panel-01 
            :ARG1-of (l / low-04)))

# ::snt ( C ) Flag-tagged two site-directed mr-s mutants , Flag-W404A and Flag-G453A were generated and co-transfected with full-HA .
# ::tok ( C ) Flag-tagged two site-directed mr-s mutants , Flag-W404A and Flag-G453A were generated and co-transfected with full-HA .
# ::alignments 14-15|0.0.1 13-14|0.0 11-12|0.3.0.0+0.3.0+0.3 10-11|0 9-10|0.2.0.0+0.2.0+0.2 7-8|0.1 6-7|0.1.0 5-6|0.1.1 4-5|0.1.2 3-4|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:46.068
(a2 / and 
      :ARG0-of (g / generate-01 
            :ARG1 (c / C 
                  :mod (f / flag-tagg)) 
            :op1-of (a / and)) 
      :op1 (m / mutant 
            :mod (m2 / mr-) 
            :mod (s / site-direct) 
            :quant 2) 
      :op2 (o2 / organization 
            :name (n2 / name 
                  :op1 "Flag-W404A")) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "Flag-G453A")))

# ::snt Each lane was co-immunoprecipitated by anti-HA antibody and detected by anti-Flag antibody .
# ::tok Each lane was co-immunoprecipitated by anti-HA antibody and detected by anti-Flag antibody .
# ::alignments 11-12|0.1.0 8-9|0.1 7-8|0 6-7|0.0 3-4|0.1.1.0 1-2|0.1.1 0-1|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:46.100
(a2 / and 
      :op1 (a3 / antibody) 
      :op2 (d / detect-01 
            :ARG0 (a / antibody) 
            :ARG1 (l / lane-01 
                  :domain-of (c / co-immunoprecipitat) 
                  :mod (e / each))))

# ::snt To investigate whether the mr-s protein self-associates mainly through the SAM domain , two site-directed mutations were generated in the SAM domain of mr-s ( Fig. 1B , arrows ) .
# ::tok To investigate whether the mr-s protein self-associates mainly through the SAM domain , two site-directed mutations were generated in the SAM domain of mr-s ( Fig. 1B , arrows ) .
# ::alignments 28-29|0.0.2.1 25-26|0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 23-24|0.0.1.0 21-22|0.0.1 17-18|0.0 15-16|0.0.0 14-15|0.0.0.2 13-14|0.0.0.3 11-12|0.0.0.1.0 10-11|0.0.0.1 7-8|0.0.0.0 5-6|0 4-5|0.1 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:46.361
(p / protein 
      :ARG0-of (g / generate-01 
            :ARG1 (m2 / mutate-01 
                  :ARG0 (m3 / main) 
                  :ARG1 (s2 / sam 
                        :mod-of (d2 / domain)) 
                  :mod (s / site-direct) 
                  :quant 2) 
            :location (d / domain 
                  :poss (m / mr-)) 
            :time (i / investigate-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Fig.")) 
                  :ARG1 (a / arrow))) 
      :mod (m4 / mr-))

# ::snt These mutations alter residues that are conserved in the SAM domain of ph and previous report indicates that these mutations of ph-SAM cause significant reduction in binding activity to the other SAM domain-containing protein , Sex comb on midleg ( Scm ) ( 41 ) .
# ::tok These mutations alter residues that are conserved in the SAM domain of ph and previous report indicates that these mutations of ph-SAM cause significant reduction in binding activity to the other SAM domain-containing protein , Sex comb on midleg ( Scm ) ( 41 ) .
# ::alignments 43-44|0.0.1.0.1.0 38-39|0.0.2.1.0.1.0 36-37|0.0.2.1.0.1 35-36|0.0.2.1.0.1.1 33-34|0 32-33|0.1 30-31|0.0.2.1.0.0.0.0.0 27-28|0.0.1.0 26-27|0.0.1.0.1 24-25|0.0.1 23-24|0.0.1.1 22-23|0.0 19-20|0.0.0 18-19|0.0.0.0 16-17|0.0.2 15-16|0.0.2.0 14-15|0.0.2.0.0 13-14|0.0.2.1 12-13|0.0.1.0.0.1 10-11|0.0.1.0.0 9-10|0.0.1.0.0.0 6-7|0.0.2.1.0.0.0.0 3-4|0.0.2.1.0.0.0 2-3|0.0.2.1.0.0 1-2|0.0.2.1.0 0-1|0.0.2.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:47.940
(p / protein 
      :ARG2-of (c2 / cause-01 
            :ARG0 (m2 / mutate-01 
                  :mod (t / this)) 
            :ARG1 (r / reduce-01 
                  :ARG1 (a / activity-06 
                        :ARG1 (d2 / domain 
                              :mod (s3 / sam) 
                              :poss (p3 / ph)) 
                        :ARG1-of (b / binding-07 
                              :ARG0 41)) 
                  :ARG1-of (s2 / significant-02)) 
            :ARG1-of (i / indicate-01 
                  :ARG0 (r2 / report 
                        :mod (p2 / previous)) 
                  :op2-of (a2 / and 
                        :op1 (m3 / mutate-01 
                              :ARG0-of (a3 / alter-01 
                                    :ARG1 (r3 / residu 
                                          :ARG1-of (c3 / conserve-01 
                                                :ARG0 (o / other)))) 
                              :ARG1 (c / comb-01 
                                    :ARG1 (m / midleg) 
                                    :mod (s / sex)) 
                              :mod (t2 / this))))) 
      :mod (d / domain-contain))

# ::snt Based on this result , we introduced two types of site-directed mutations , which correspond to the mutations introduced in ph protein , into Flag-tagged full-length mr-s ( Flag-W404A and Flag-G453A ) .
# ::tok Based on this result , we introduced two types of site-directed mutations , which correspond to the mutations introduced in ph protein , into Flag-tagged full-length mr-s ( Flag-W404A and Flag-G453A ) .
# ::alignments 30-31|0.0.0.0.0.2.0.0+0.0.0.0.0.2.0+0.0.0.0.0.2 29-30|0.0.0.0.0 28-29|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 26-27|0.0.0.0.0.0 25-26|0.0.0.0.0.0.0 24-25|0.0.0.0.1.0.0.0.0.0.0.0+0.0.0.0.1.0.0.0.0.0.0+0.0.0.0.1.0.0.0.0.0 21-22|0 20-21|0.1 18-19|0.0 17-18|0.0.0 14-15|0.0.0.0 11-12|0.0.0.0.1 10-11|0.0.0.0.1.2 8-9|0.0.0.0.1.1 7-8|0.0.0.0.1.1.0 6-7|0.0.0.0.1.0 5-6|0.0.0.0.1.0.0 3-4|0.0.0.0.1.0.0.0.0 2-3|0.0.0.0.1.0.0.0.0.1 0-1|0.0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:48.278
(p / protein 
      :ARG2-of (i / introduce-02 
            :ARG1 (m2 / mutate-01 
                  :ARG2-of (c / correspond-02 
                        :ARG0 (a / and 
                              :op1 (m / mr- 
                                    :mod (f / full-length)) 
                              :op2 (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "Flag-W404A")) 
                              :op3 (o / organization 
                                    :name (n / name 
                                          :op1 "Flag-G453A"))) 
                        :ARG1 (m3 / mutate-01 
                              :ARG1-of (i2 / introduce-02 
                                    :ARG0 (w / we 
                                          :ARG0-of (b / base-02 
                                                :ARG2 (r / result-01 
                                                      :ARG1 (t / thing 
                                                            :name (n3 / name 
                                                                  :op1 "Flag-tagged")) 
                                                      :mod (t3 / this))))) 
                              :mod (t2 / type 
                                    :quant 2) 
                              :mod (s / site-direct))))) 
      :mod (p2 / ph))

# ::snt We found that Flag-W404A binding activity was significantly reduced and Flag-G453A binding activity was also slightly reduced compared to Flag-mrs ( Fig. 5C ) .
# ::tok We found that Flag-W404A binding activity was significantly reduced and Flag-G453A binding activity was also slightly reduced compared to Flag-mrs ( Fig. 5C ) .
# ::alignments 21-22|0.0.0.0.3.0.0+0.0.0.0.3.0+0.0.0.0.3 19-20|0 17-18|0.0 16-17|0.0.0 15-16|0.0.0.2 14-15|0.0.0.3 12-13|0.0.0.1 11-12|0.0.0.1.1 10-11|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 9-10|0.0.0.4 8-9|0.0.0.0.1 7-8|0.0.0.0.1.1 5-6|0.0.0.0 4-5|0.0.0.0.2 3-4|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 1-2|0.0.0.0.1.0.0 0-1|0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:48.874
(f / flag-mr 
      :ARG2-of (c2 / compare-01 
            :time-of (r / reduce-01 
                  :ARG0 (a4 / activity-06 
                        :ARG0 (o2 / organization 
                              :name (n3 / name 
                                    :op1 "Flag-W404A")) 
                        :ARG1-of (r2 / reduce-01 
                              :ARG0 (w / we 
                                    :ARG0-of (f2 / find-01)) 
                              :ARG1-of (s2 / significant-02)) 
                        :ARG1-of (b2 / binding-07) 
                        :location (c / country 
                              :name (n / name 
                                    :op1 "Fig."))) 
                  :ARG1 (a2 / activity-06 
                        :ARG0 (o / organization 
                              :name (n2 / name 
                                    :op1 "Flag-G453A")) 
                        :ARG1-of (b / binding-07)) 
                  :manner (s / slight) 
                  :mod (a / also) 
                  :op1-of (a3 / and))))

# ::snt These results , together with yeast two-hybrid GAL4 assay , indicate that the mr-s protein self-associates strongly through its SAM domain and weakly through the N-terminus portion lacking SAM domain .
# ::tok These results , together with yeast two-hybrid GAL4 assay , indicate that the mr-s protein self-associates strongly through its SAM domain and weakly through the N-terminus portion lacking SAM domain .
# ::alignments 29-30|0.1.2.1 27-28|0.1.2 26-27|0.1.1.0 25-26|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 22-23|0.1.1 21-22|0.1 20-21|0.1.2.0.1.0 19-20|0.1.2.0.1 16-17|0.1.0 14-15|0.1.2.0 13-14|0.1.2.0.0 10-11|0 8-9|0.0.0.0.0.0 7-8|0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 5-6|0.0.0.0 3-4|0.1.2.2 1-2|0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:49.967
(i / indicate-01 
      :ARG0 (t4 / thing 
            :ARG2-of (r / result-01 
                  :ARG0 (y / yeast 
                        :mod-of (t2 / thing 
                              :mod-of (a2 / assay) 
                              :name (n2 / name 
                                    :op1 "GAL4")))) 
            :mod (t5 / this)) 
      :ARG1 (a / and 
            :ARG1-of (s2 / strong-02) 
            :op1 (w / weakly 
                  :path (p / portion 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "N-terminus")))) 
            :op2 (l / lack-01 
                  :ARG0 (p2 / protein 
                        :mod (m / mr-) 
                        :poss-of (s / sam 
                              :mod-of (d2 / domain))) 
                  :ARG1 (d / domain) 
                  :ARG2 (t3 / together))))

# ::snt The subcellular localization of mr-s protein in mammalian cells .
# ::tok The subcellular localization of mr-s protein in mammalian cells .
# ::alignments 8-9|0.0 7-8|0.0.0 5-6|0.1 4-5|0.1.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:49.990
(l / localization 
      :location (c / cell 
            :mod (m / mammalian)) 
      :mod (p / protein 
            :mod (m2 / mr-)))

# ::snt The putative nuclear localization signal at the N-terminus of the mr-s protein ( Fig. 1A , dashed box ) suggests that the mr-s protein localizes in the nucleus .
# ::tok The putative nuclear localization signal at the N-terminus of the mr-s protein ( Fig. 1A , dashed box ) suggests that the mr-s protein localizes in the nucleus .
# ::alignments 27-28|0.1.1 24-25|0.1 23-24|0.1.0 19-20|0 17-18|0.1.3.1 16-17|0.1.3 13-14|0.1.2.0.0+0.1.2.0+0.1.2 11-12|0.1.3.0.0 10-11|0.1.3.0 7-8|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0 3-4|0.0.3 2-3|0.0.2 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:50.436
(s / suggest-01 
      :ARG0 (s2 / signal 
            :location (t / thing 
                  :name (n3 / name 
                        :op1 "N-terminus")) 
            :mod (p3 / putative) 
            :mod (n4 / nucleus) 
            :mod (l2 / localization)) 
      :ARG1 (l / localize-01 
            :ARG0 (p / protein) 
            :ARG1 (n / nucleus) 
            :ARG2 (c / country 
                  :name (n2 / name 
                        :op1 "Fig.")) 
            :purpose-of (d / dash-01 
                  :ARG0 (m / mr- 
                        :mod-of (p2 / protein)) 
                  :ARG1 (b / box))))

# ::snt To determine the subcellular localization of mr-s in mammalian cells , we introduced an HA-tagged full-length mr-s plasmid into HEK293T cells .
# ::tok To determine the subcellular localization of mr-s in mammalian cells , we introduced an HA-tagged full-length mr-s plasmid into HEK293T cells .
# ::alignments 20-21|0.2.1.0 19-20|0.2.1 16-17|0.1 15-16|0.1.0 14-15|0.1.1.0.0+0.1.1.0+0.1.1 12-13|0 11-12|0.0 9-10|0.2.0.0.0 8-9|0.2.0.0.0.0 6-7|0.2.0.0 4-5|0.2.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:50.589
(i / introduce-02 
      :ARG0 (w / we) 
      :ARG1 (m / mr- 
            :mod (f / full-length) 
            :quant (t / thing 
                  :name (n / name 
                        :op1 "HA-tagged"))) 
      :time (d / determine-01 
            :ARG1 (l / localization 
                  :mod (m3 / mr- 
                        :location (c2 / cell 
                              :mod (m2 / mammalian)))) 
            :ARG2 (h / HEK293T 
                  :mod-of (c / cell))))

# ::snt Confocal microscopy showed that the mr-s protein localized mainly in the nucleus of HEK293T cells ( Fig. 6A , B ) .
# ::tok Confocal microscopy showed that the mr-s protein localized mainly in the nucleus of HEK293T cells ( Fig. 6A , B ) .
# ::alignments 19-20|0.1.1.1.0.1+0.1.1.1.0.0.0+0.1.1.1.0.0+0.1.1.1.0 16-17|0.1.2.0.0+0.1.2.0+0.1.2 14-15|0.1.1 13-14|0.1.1.1 11-12|0.1.1.0 8-9|0.1.3 7-8|0.1 6-7|0.1.0 5-6|0.1.0.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:50.742
(s / show-01 
      :ARG0 (m3 / microscopy) 
      :ARG1 (l2 / localize-01 
            :ARG0 (p / protein 
                  :mod (m2 / mr-)) 
            :ARG1 (c2 / cell 
                  :domain-of (n3 / nucleus) 
                  :mod (h / HEK293T 
                        :op1 (l / location 
                              :name (n / name 
                                    :op1 "B") 
                              :wiki -))) 
            :ARG2 (c / country 
                  :name (n2 / name 
                        :op1 "Fig.")) 
            :mod (m / main)))

# ::snt To confirm the precise localization of the mr-s protein , full-length mr-s was co-immunostained with DAPI ( Fig. 6C -- E ) .
# ::tok To confirm the precise localization of the mr-s protein , full-length mr-s was co-immunostained with DAPI ( Fig. 6C -- E ) .
# ::alignments 20-21|0.1.0.1 17-18|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 15-16|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 11-12|0.2 10-11|0.2.0 8-9|0 7-8|0.0 4-5|0.1 3-4|0.1.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:50.988
(p2 / protein 
      :mod (m2 / mr-) 
      :poss-of (l / localization 
            :ARG1-of (c2 / confirm-01 
                  :ARG2 (p / person 
                        :name (n2 / name 
                              :op1 "DAPI")) 
                  :op1-of (e / E)) 
            :manner (p3 / precise 
                  :mod (c / country 
                        :name (n / name 
                              :op1 "Fig.")))) 
      :poss-of (m / mr- 
            :mod (f / full-length)))

# ::snt These data showed that the mr-s protein localizes preferentially to the nucleus in mammalian cells , supporting the idea that the mr-s protein is involved in transcriptional regulation as are ph and/or TEL. .
# ::tok These data showed that the mr-s protein localizes preferentially to the nucleus in mammalian cells , supporting the idea that the mr-s protein is involved in transcriptional regulation as are ph and/or TEL. .
# ::alignments 30-31|0.1.1.1.0 27-28|0.1.1.1 24-25|0.1.1 22-23|0.1.1.0 18-19|0.1.0.0.0 16-17|0.1.0.0 14-15|0.1.2.0 13-14|0.1.2.0.0 11-12|0.1.2 8-9|0.1.3 7-8|0.1 6-7|0.1.0 5-6|0.1.0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.173
(s2 / show-01 
      :ARG0 (d / data 
            :mod (t / this)) 
      :ARG1 (l / localize-01 
            :ARG0 (p4 / protein 
                  :ARG0-of (s / support-01 
                        :ARG1 (i2 / idea)) 
                  :mod (m2 / mr-)) 
            :ARG1 (i / involve-01 
                  :ARG1 (p2 / protein) 
                  :ARG2 (r / regulate-01 
                        :ARG1 (p / ph))) 
            :ARG4 (n / nucleus 
                  :location (c / cell 
                        :mod (m / mammalian))) 
            :manner (p3 / preferentially)))

# ::snt Subcellular localization of mr-s in mammalian cells .
# ::tok Subcellular localization of mr-s in mammalian cells .
# ::alignments 6-7|0.0.0 5-6|0.0.0.0 3-4|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.191
(l / localization 
      :mod (m2 / mr- 
            :location (c / cell 
                  :mod (m / mammalian))))

# ::snt ( A , B ) HA-tagged full-length mr-s was transfected into HEK293T ( B ) and detected by anti-HA antibody ( A ) .
# ::tok ( A , B ) HA-tagged full-length mr-s was transfected into HEK293T ( B ) and detected by anti-HA antibody ( A ) .
# ::alignments 19-20|0.0.0 16-17|0.0 15-16|0 13-14|0.0.2.0.1+0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 7-8|0.0.1.1 6-7|0.0.1 5-6|0.0.1.0 3-4|0.0.2.2+0.0.2.1.0+0.0.2.1+0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.373
(a2 / and 
      :op1 (d / detect-01 
            :ARG0 (a / antibody) 
            :ARG1 (f / full-length 
                  :mod (h / ha-tagg) 
                  :mod (m / mr-)) 
            :ARG2 (l2 / location 
                  :mod-of (l / location 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -) 
                  :name (n2 / name 
                        :op1 "B") 
                  :wiki -)))

# ::snt Scale bar , 20 m .
# ::tok Scale bar , 20 m .
# ::alignments 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.389
(m / m 
      :ARG1-of (b / bar-01 
            :duration (s / scale)) 
      :quant 20)

# ::snt ( C-E ) HEK293T cells immunostained with anti-HA antibody ( C ) , DAPI ( D ) , and merged image ( E ) .
# ::tok ( C-E ) HEK293T cells immunostained with anti-HA antibody ( C ) , DAPI ( D ) , and merged image ( E ) .
# ::alignments 22-23|0.0.2.0.1.0 20-21|0.0.2 19-20|0.0.2.0 18-19|0.0 15-16|0 13-14|0.0.1.0.0+0.0.1.0+0.0.1 10-11|0.0.2.0.0 8-9|0.0.0 4-5|0.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.526
(d / D 
      :op3-of (a / and 
            :op1 (a2 / antibody) 
            :op2 (p / person 
                  :name (n / name 
                        :op1 "DAPI")) 
            :op4 (i / image 
                  :ARG1-of (m / merge-01 
                        :ARG0 (c / C) 
                        :ARG2 (c2 / cell 
                              :poss (e / E))))))

# ::snt Scale bar , 50 m .
# ::tok Scale bar , 50 m .
# ::alignments 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.541
(m / m 
      :ARG1-of (b / bar-01 
            :duration (s / scale)) 
      :quant 50)

# ::snt The GAL4-mr-s fusion protein functions as transcriptional repressor .
# ::tok The GAL4-mr-s fusion protein functions as transcriptional repressor .
# ::alignments 7-8|0.1 4-5|0 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.573
(f / function-01 
      :ARG1 (p / protein 
            :mod (f2 / fusion)) 
      :ARG3 (r / repressor))

# ::snt A member of PcG proteins , ph , does not contain an obvious sequence-specific DNA binding motif ( 16 ) .
# ::tok A member of PcG proteins , ph , does not contain an obvious sequence-specific DNA binding motif ( 16 ) .
# ::alignments 18-19|0.0.0.0 16-17|0.1 15-16|0.1.1 14-15|0.1.1.0 12-13|0.1.0 10-11|0 9-10|0.3 6-7|0.2 4-5|0.0.0.1 1-2|0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.831
(c / contain-01 
      :ARG0 (m2 / member 
            :ARG2-of (h / have-org-role-91 
                  :ARG0 16 
                  :ARG1 (p2 / protein))) 
      :ARG1 (m / motif 
            :ARG1-of (o / obvious-01) 
            :ARG1-of (b / binding-07 
                  :ARG0 (d / DNA))) 
      :ARG2 (p / ph) 
      :polarity -)

# ::snt Ph functions as a transcriptional repressor through its polymerization and protein-protein interaction with other sequence-specific transcriptional repressors , which can form a higher order chromatin structure .
# ::tok Ph functions as a transcriptional repressor through its polymerization and protein-protein interaction with other sequence-specific transcriptional repressors , which can form a higher order chromatin structure .
# ::alignments 25-26|0.2 24-25|0.2.2 22-23|0.2.1 20-21|0.2.0 19-20|0.2.0.0 16-17|0.1.1 13-14|0.1.1.0 11-12|0.1 9-10|0 8-9|0.0 5-6|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.949
(a / and 
      :op1 (p2 / polymerization) 
      :op2 (i / interact-01 
            :ARG0 (r2 / repressor 
                  :ARG1-of (f2 / function-01)) 
            :ARG1 (r / repressor 
                  :mod (o / other))) 
      :op3 (s / structure 
            :ARG1-of (f / form-01 
                  :ARG1-of (p / possible-01)) 
            :ARG1-of (h / high-02) 
            :mod (c / chromatin)))

# ::snt The mr-s protein also does not have an obvious DNA-binding domain .
# ::tok The mr-s protein also does not have an obvious DNA-binding domain .
# ::alignments 10-11|0.0.0 9-10|0.0.0.0 8-9|0.0 5-6|0.0.1 3-4|0.2 2-3|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:51.976
(p / protein 
      :ARG0-of (o / obvious-01 
            :ARG1 (d / domain 
                  :mod (d2 / dna-bind)) 
            :polarity -) 
      :mod (m / mr-) 
      :mod (a / also))

# ::snt To characterize the biochemical activity of mr-s , we next performed a luciferase assay .
# ::tok To characterize the biochemical activity of mr-s , we next performed a luciferase assay .
# ::alignments 13-14|0.0.0.0.0.0 12-13|0.0.0.0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.0.1 8-9|0.0.0.0 6-7|0 4-5|0.0 3-4|0.0.1 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:52.064
(m / mr- 
      :ARG1-of (a2 / activity-06 
            :ARG1-of (c / characterize-01 
                  :ARG0 (w / we 
                        :ARG0-of (p / perform-02 
                              :ARG1 (a / assay 
                                    :mod (l / luciferase)) 
                              :manner (n / next)))) 
            :mod (b / biochemical)))

# ::snt We generated effector plasmids , which express various deletion constructs of mr-s fused to the GAL4 DNA-binding domain ( Fig. 7A ) .
# ::tok We generated effector plasmids , which express various deletion constructs of mr-s fused to the GAL4 DNA-binding domain ( Fig. 7A ) .
# ::alignments 19-21|0.0.1+0+0.0+0.0.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.1 15-16|0.0.0.0.0.0.1.0.0.0.0+0.0.0.0.0.0.1.0.0.0+0.0.0.0.0.0.1.0.0 12-13|0.0.0.0 11-12|0.0.0.0.1 9-10|0.0.0.0.0.0.1 8-9|0.0.0.0.0.0.1.0 7-8|0.0.0.0.0.0.1.1 6-7|0.0.0.0.0.0 3-4|0.0.0.0.0.0.0 2-3|0.0.0.0.0.0.0.1 1-2|0.0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:52.417
(f / Fig. 
      :op1-of (n / name 
            :name-of (t / thing 
                  :ARG0-of (f2 / fuse-01 
                        :ARG1 (d / domain 
                              :ARG2-of (e / express-01 
                                    :ARG0 (p / plasmid 
                                          :ARG1-of (g / generate-01 
                                                :ARG0 (w / we)) 
                                          :mod (e2 / effector)) 
                                    :ARG1 (c / construct 
                                          :mod (d3 / deletion 
                                                :part (t2 / thing 
                                                      :name (n2 / name 
                                                            :op1 "GAL4"))) 
                                          :mod (v / various))) 
                              :mod (d2 / dna-bind)) 
                        :mod (m / mr-))) 
            :op2 7A))

# ::snt We first confirmed that full-length mr-s fused to GAL4 DNA binding domain ( DBD-mrs ) had no effect on the pGL3 promoter plasmid lacking GAL4 binding sites ( data not shown ) .
# ::tok We first confirmed that full-length mr-s fused to GAL4 DNA binding domain ( DBD-mrs ) had no effect on the pGL3 promoter plasmid lacking GAL4 binding sites ( data not shown ) .
# ::alignments 30-31|0 29-30|0.2 28-29|0.1 26-27|0.1.0.0.0 25-26|0.1.0.0.0.0 23-24|0.1.0.0 21-22|0.1.0 17-18|0.1.0.1 16-17|0.1.0.1.1 13-14|0.0 11-12|0.1.0.1.0.0.0.0.0 10-11|0.1.0.1.0.0.0.0.0.0 9-10|0.1.0.1.0.0.0.0.0.0.0 8-9|0.1.0.1.0.0.0.0.0.1.0.0+0.1.0.1.0.0.0.0.0.1.0+0.1.0.1.0.0.0.0.0.1 6-7|0.1.0.1.0.0.0.0 5-6|0.1.0.1.0.0.0 4-5|0.1.0.1.0.0.0.1 2-3|0.1.0.1.0.0 0-1|0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:52.821
(s / show-01 
      :ARG0 (d2 / dbd-mr) 
      :ARG1 (d / data 
            :ARG0-of (p / promote-01 
                  :ARG1 (l / lack-01 
                        :ARG1 (s2 / site 
                              :ARG1-of (b / binding-07))) 
                  :ARG1-of (e / effect-03 
                        :ARG0 (w / we 
                              :ARG0-of (c / confirm-01 
                                    :ARG1 (m / mr- 
                                          :ARG1-of (f / fuse-01 
                                                :ARG2 (d3 / domain 
                                                      :ARG0-of (b2 / binding-07 
                                                            :ARG1 (d4 / DNA)) 
                                                      :mod (t / thing 
                                                            :name (n / name 
                                                                  :op1 "GAL4")))) 
                                          :mod (f2 / full-length)))) 
                        :polarity -))) 
      :polarity -)

# ::snt When the 5xGAL4-pGL3 reporter plasmid was co-transfected , DBD-mrs repressed luciferase activity by about 90 % in a dose-dependent manner ( Fig. 7B ) .
# ::tok When the 5xGAL4-pGL3 reporter plasmid was co-transfected , DBD-mrs repressed luciferase activity by about 90 % in a dose-dependent manner ( Fig. 7B ) .
# ::alignments 21-23|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 19-20|0.0.0.3 15-16|0.0.0.2.0 14-15|0.0.0.2.0.0 13-14|0.0.0.2 11-12|0.0.0.0 9-10|0.0.0 8-9|0.0 6-7|0.0.0.1 4-5|0.0.0.1.0 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:52.936
(r2 / report-01 
      :ARG1 (d / dbd-mr 
            :ARG0-of (r / repress-01 
                  :ARG1 (a2 / activity-06 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 (f / Fig.) 
                                    :op2 7B))) 
                  :ARG2 (c / co-transfect 
                        :domain (p2 / plasmid)) 
                  :duration (a / about 
                        :op1 (p / percentage-entity 
                              :value 90)) 
                  :location (m / manner))))

# ::snt As a control , GAL4 DNA-binding domain ( DBD ) had no significant effect on the 5xGAL4-pGL3 reporter plasmid .
# ::tok As a control , GAL4 DNA-binding domain ( DBD ) had no significant effect on the 5xGAL4-pGL3 reporter plasmid .
# ::alignments 17-18|0.0.0 13-14|0.0 12-13|0.0.2 11-12|0.0.1.0 8-9|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 6-7|0 5-6|0.2 4-5|0.1.0.0+0.1.0+0.1 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:53.040
(d / domain 
      :ARG0-of (e / effect-03 
            :ARG1 (r / report-01 
                  :ARG0 (o / organization 
                        :name (n / name 
                              :op1 "DBD"))) 
            :ARG1-of (c / control-01 
                  :ARG0 -) 
            :ARG1-of (s / significant-02)) 
      :mod (t / thing 
            :name (n2 / name 
                  :op1 "GAL4")) 
      :mod (d2 / dna-bind))

# ::snt In addition , we confirmed that full-length mr-s without GAL4 DBD had no effect on the same reporter plasmid ( data not shown ) .
# ::tok In addition , we confirmed that full-length mr-s without GAL4 DBD had no effect on the same reporter plasmid ( data not shown ) .
# ::alignments 22-23|0 21-22|0.1 20-21|0.0 18-19|0.0.0.2.0 17-18|0.0.0 16-17|0.0.0.2 13-14|0.0.0.1 12-13|0.0.0.1.2 9-11|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 7-8|0.0.0.1.0 6-7|0.0.0.1.0.0 4-5|0.0.0.1.1 3-4|0.0.0.1.1.0 1-2|0.0.0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:53.318
(s / show-01 
      :ARG1 (d / data 
            :ARG0-of (r / report-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (g / GAL4) 
                              :op2 (d2 / DBD))) 
                  :ARG1-of (e / effect-03 
                        :ARG0 (m / mr- 
                              :mod (f / full-length)) 
                        :ARG1-of (c / confirm-01 
                              :ARG0 (w / we) 
                              :prep-in (a / addition)) 
                        :polarity -) 
                  :ARG1-of (s2 / same-01 
                        :ARG0 (p / plasmid)))) 
      :polarity -)

# ::snt We next analyzed deletion constructs in which the N-terminus 400 aa stretch of mr-s ( amino acids 1 to 400 ) or the C-terminus portion ( amino acids 391 to 542 ) were fused to the GAL4 DBD ( Fig. 7A , DBD-N , DBD-C ) .
# ::tok We next analyzed deletion constructs in which the N-terminus 400 aa stretch of mr-s ( amino acids 1 to 400 ) or the C-terminus portion ( amino acids 391 to 542 ) were fused to the GAL4 DBD ( Fig. 7A , DBD-N , DBD-C ) .
# ::alignments 40-41|0.1.0.0.2.1 39-40|0.1.0.0.2.2.0+0.1.0.0.2.2+0.1.0.0.2 36-38|0.1.2.0.1+0.1.2.0.0+0.1.2.0+0.1.2 33-34|0.1 27-28|0.0 26-27|0.0.0 24-25|0.4 23-24|0.4.0 21-22|0 19-20|0.1.3 17-18|0.1.4 16-17|0.3 15-16|0.3.0 13-14|0.2 11-12|0.1.1.0+0.1.1 10-11|0.1.1.0.0 9-10|0.1.0.0.2.0 8-9|0.1.1.0.1.0.0+0.1.1.0.1.0+0.1.1.0.1 4-5|0.1.0.0.0 3-4|0.1.0.0.0.0 2-3|0.1.0.0 1-2|0.1.0.0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:55.162
(o / or 
      :domain (a / acid 
            :mod (a2 / amino)) 
      :example-of (f / fuse-01 
            :ARG0 (w / we 
                  :ARG0-of (a6 / analyze-01 
                        :ARG1 (c3 / construct 
                              :mod (d2 / deletion)) 
                        :manner (n4 / next) 
                        :op1-of (c / country 
                              :mod-of 400 
                              :mod-of 7A 
                              :name (n / name 
                                    :op1 "Fig.")))) 
            :ARG1 (t2 / thing 
                  :ARG1-of (s / stretch-01 
                        :ARG0 (a5 / aa) 
                        :ARG2 (t3 / thing 
                              :name (n3 / name 
                                    :op1 "N-terminus")))) 
            :ARG2 (t / thing 
                  :name (n2 / name 
                        :op1 (g / GAL4) 
                        :op2 (d / DBD))) 
            :op1-of 400 
            :op1-of 1) 
      :op1 (m / mr-) 
      :op2 (a3 / acid 
            :mod (a4 / amino)) 
      :op3 (p / portion 
            :mod (c2 / c-terminu)))

# ::snt While DBD-N had no repressive effect on this reporter activity , DBD-C repressed luciferase gene expression by about 65 % .
# ::tok While DBD-N had no repressive effect on this reporter activity , DBD-C repressed luciferase gene expression by about 65 % .
# ::alignments 19-20|0.0.2.0 18-19|0.0.2.0.0 17-18|0.0.2 15-16|0 14-15|0.1 12-13|0.0 9-10|0.1.0.0 8-9|0.1.0 7-8|0.1.0.0.1 5-6|0.1.0.0.0 4-5|0.1.0.0.0.0 3-4|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:55.266
(e / express-01 
      :ARG1-of (r / repress-01 
            :ARG0 - 
            :ARG1-of (w / while-01) 
            :duration (a / about 
                  :op1 (p / percentage-entity 
                        :value 65))) 
      :mod (g / gene 
            :ARG0-of (r2 / report-01 
                  :ARG0-of (a2 / activity-06 
                        :ARG1-of (e2 / effect-03 
                              :ARG0-of (r3 / repress-01)) 
                        :mod (t / this)))))

# ::snt This result suggested to us the possibility that DBD-mrs exerts transcriptional repressive activity via self-association through its SAM domain .
# ::tok This result suggested to us the possibility that DBD-mrs exerts transcriptional repressive activity via self-association through its SAM domain .
# ::alignments 18-19|0.0.0.2 17-18|0.0.0.2.0 12-13|0.0.0.1 11-12|0.0.0.1.0 9-10|0.0.0 8-9|0.0.0.0 6-7|0.0 2-3|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:55.332
(s2 / suggest-01 
      :ARG1 (p / possible-01 
            :ARG1 (e / exert-01 
                  :ARG0 (d2 / dbd-mr) 
                  :ARG1 (a / activity-06 
                        :ARG0-of (r / repress-01)) 
                  :ARG2 (d / domain 
                        :mod (s / sam)))) 
      :ARG2-of (r2 / result-01 
            :mod (t / this)))

# ::snt To investigate whether the homophilic association of mr-s is required for transcriptional repression , two site-directed mutants , DBD-W404A and DBD-G453A , either of which may reduce self-binding ability , were analyzed ( Fig. 7C ) .
# ::tok To investigate whether the homophilic association of mr-s is required for transcriptional repression , two site-directed mutants , DBD-W404A and DBD-G453A , either of which may reduce self-binding ability , were analyzed ( Fig. 7C ) .
# ::alignments 31-32|0.0.0.0.0 28-29|0.0 27-28|0 26-27|0.0.0 25-26|0.0.0.1 22-23|0.0.0.0.2.0.0.0 20-21|0.0.0.0.2.1.0.0+0.0.0.0.2.1.0+0.0.0.0.2.1 19-20|0.0.0.0.2 18-19|0.0.0.0.2.0.1.0+0.0.0.0.2.0.1+0.0.0.0.2.0 16-17|0.0.0.0 15-16|0.0.0.0.1 14-15|0.0.0.0.3 12-13|0.0.0.0.2.0.0.2.0 11-12|0.0.0.0.2.0.0.2.0.0 9-10|0.0.0.0.2.0.0.2 7-8|0.0.0.0.2.0.0.1 5-6|0.0.0.0.2.0.0 1-2|0.0.0.0.2.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:56.113
(s / self-bind 
      :mod-of (a2 / ability 
            :ARG1-of (r / reduce-01 
                  :ARG0 (m / mutant 
                        :ARG1-of (a / analyze-01) 
                        :mod (s2 / site-direct) 
                        :op1-of (a3 / and 
                              :op2 (o2 / organization 
                                    :ARG2-of (a4 / associate-01 
                                          :ARG0 (e / either) 
                                          :ARG1 (m2 / mr-) 
                                          :ARG2-of (r3 / require-01 
                                                :ARG1 (r2 / repress-01 
                                                      :ARG1 (t / transcriptional)) 
                                                :ARG1-of (i / investigate-01))) 
                                    :name (n2 / name 
                                          :op1 "DBD-W404A")) 
                              :op3 (o / organization 
                                    :name (n / name 
                                          :op1 "DBD-G453A"))) 
                        :quant 2) 
                  :ARG1-of (p / possible-01))))

# ::snt Compared to DBD-mrs , DBD-W404A and DBD-G453A had repression activity of 72 % and 87 % , respectively .
# ::tok Compared to DBD-mrs , DBD-W404A and DBD-G453A had repression activity of 72 % and 87 % , respectively .
# ::alignments 17-18|0.0.1.0.1.0 15-16|0.0.1.0.1.3 14-15|0.0.1.0.1.3.0 13-14|0.0.1 12-13|0.0.1.1 11-12|0.0.0 9-10|0.0.1.0 8-9|0.0.1.0.0 6-7|0.0.1.0.1.2.0.0+0.0.1.0.1.2.0+0.0.1.0.1.2 5-6|0.0.1.0.1 4-5|0.0.1.0.1.1.0.0+0.0.1.0.1.1.0+0.0.1.0.1.1 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:56.650
(d / dbd-mr 
      :ARG4-of (c / compare-01 
            :ARG0 72 
            :ARG1 (a / and 
                  :op1 (a2 / activity-06 
                        :ARG0 (r2 / repress-01) 
                        :ARG1 (a3 / and 
                              :mod (r / respective) 
                              :op1 (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "DBD-W404A")) 
                              :op2 (o / organization 
                                    :name (n / name 
                                          :op1 "DBD-G453A")) 
                              :op3 (p / percentage-entity 
                                    :value 87))) 
                  :op2 (p2 / percentage-entity))))

# ::snt While the ability of mr-s self-association partially correlates with transcriptional repressive activity , these mutants do not compromise the ability to repress transcription critically .
# ::tok While the ability of mr-s self-association partially correlates with transcriptional repressive activity , these mutants do not compromise the ability to repress transcription critically .
# ::alignments 23-24|0.0.1 22-23|0 21-22|0.0 19-20|0.0.0.0.0 17-18|0.0.0.0 16-17|0.0.0.0.2 14-15|0.0.0 13-14|0.0.0.1 11-12|0.0.0.0.3.1 10-11|0.0.0.0.3.1.0 7-8|0.0.0.0.3 6-7|0.0.0.0.3.2 4-5|0.0.0.0.3.1.1 2-3|0.0.0.0.3.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:57.032
(t / transcription 
      :ARG1-of (r / repress-01 
            :ARG0 (m / mutant 
                  :ARG0-of (c2 / compromise-01 
                        :ARG1 (a / ability) 
                        :ARG1-of (w / while-01) 
                        :polarity - 
                        :purpose (c3 / correlate-01 
                              :ARG0 (a3 / ability) 
                              :ARG1 (a2 / activity-06 
                                    :ARG0-of (r2 / repress-01) 
                                    :ARG1 (m2 / mr-)) 
                              :manner (p / partial))) 
                  :mod (t2 / this)) 
            :ARG2 (c / critical)))

# ::snt To determine the regions of mr-s involved in transcriptional repression more precisely , the C-terminus portion was divided into two regions and each was fused to the GAL4 DBD ( Fig. 7A , DBD-tail , DBD-SAM ) .
# ::tok To determine the regions of mr-s involved in transcriptional repression more precisely , the C-terminus portion was divided into two regions and each was fused to the GAL4 DBD ( Fig. 7A , DBD-tail , DBD-SAM ) .
# ::alignments 31-32|0.0.0.0.0.0 30-31|0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 27-29|0.1.0.0.1.0.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 24-25|0.1.0.0 22-23|0.1.0.0.0 21-22|0 20-21|0.1.1 19-20|0.1.1.0 17-18|0.1 15-16|0.1.0 14-15|0.1.0.1 11-12|0.0.1.0 10-11|0.0.1 9-10|0.0.0.0 6-7|0.0.0.0.1 5-6|0.0.0.0.1.0 3-4|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:58.217
(a / and 
      :condition (d3 / determine-01 
            :ARG1 (r3 / region 
                  :ARG0-of (r2 / repress-01 
                        :ARG1 (c / country 
                              :mod-of 7A 
                              :name (n / name 
                                    :op1 "Fig.")) 
                        :ARG2-of (i / involve-01 
                              :ARG1 (m2 / mr-)))) 
            :ARG2 (m / more 
                  :degree-of (p2 / precise))) 
      :op1 (d2 / divide-02 
            :ARG1 (p / portion 
                  :ARG0-of (f / fuse-01 
                        :ARG1 (e / each) 
                        :ARG2 (t / thing 
                              :name (n2 / name 
                                    :op1 (g / GAL4) 
                                    :op2 (d / DBD)))) 
                  :mod (c2 / c-terminu)) 
            :ARG2 (r / region 
                  :quant 2)))

# ::snt As a consequence , DBD-SAM ( amino acids 384 to 462 ) did not have a repressive effect on the 5xGAL4-pGL3 reporter plasmid .
# ::tok As a consequence , DBD-SAM ( amino acids 384 to 462 ) did not have a repressive effect on the 5xGAL4-pGL3 reporter plasmid .
# ::alignments 21-22|0.0.0.1 17-18|0.0.0 16-17|0.0 13-14|0.0.0.1.1 7-8|0.1 6-7|0 4-5|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 2-3|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:58.325
(a2 / amino 
      :ARG1-of (r2 / repress-01 
            :ARG0 (e / effect-03 
                  :ARG0 (p / person 
                        :name (n / name 
                              :op1 "DBD-SAM")) 
                  :ARG1 (r / report-01 
                        :ARG1 (c / consequence) 
                        :time -))) 
      :mod-of (a / acid))

# ::snt On the other hand , luciferase activity was repressed by 55 % when DBD-tail ( amino acids 459 to 542 ) was co-transfected with this reporter plasmid ( Fig. 7D ) .
# ::tok On the other hand , luciferase activity was repressed by 55 % when DBD-tail ( amino acids 459 to 542 ) was co-transfected with this reporter plasmid ( Fig. 7D ) .
# ::alignments 28-29|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 26-27|0.0 25-26|0 24-25|0.0.0 22-23|0.2.3 16-17|0.1.0 15-16|0.1 11-12|0.2.0 10-11|0.2.0.0 8-9|0.2 6-7|0.2.1 5-6|0.2.1.1 3-4|0.2.2 2-3|0.2.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:58.648
(r / report-01 
      :ARG0 (p / plasmid 
            :mod (t / this)) 
      :ARG1 (a2 / amino 
            :mod-of (a / acid)) 
      :ARG2 (r2 / repress-01 
            :ARG0 (p2 / percentage-entity 
                  :value 55) 
            :ARG1 (a3 / activity-06 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Fig.")) 
                  :ARG1 (l / luciferase)) 
            :time (h / hand 
                  :mod (o / other)) 
            :time-of (c2 / co-transfect)))

# ::snt To assess the transcriptional repressive activity of mr-s in cells of retinal origin , we performed similar experiments using human Y79 retinoblastoma cells .
# ::tok To assess the transcriptional repressive activity of mr-s in cells of retinal origin , we performed similar experiments using human Y79 retinoblastoma cells .
# ::alignments 22-23|0.1.1.0 21-22|0.1.1.0.0 20-21|0.1.1.0.0.0.0 19-20|0.1.1.0.0.0 18-19|0.1.1 17-18|0 16-17|0.0 15-16|0.1 14-15|0.1.0 12-13|0.1.2.0.2.0 11-12|0.1.2.0.2.0.0 9-10|0.1.2.0.2 7-8|0.1.2.0.1 5-6|0.1.2.0 4-5|0.1.2.0.0 1-2|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:58.918
(e / experiment-01 
      :ARG1-of (r2 / resemble-01) 
      :ARG1-of (p / perform-02 
            :ARG0 (w / we) 
            :ARG2 (u / use-01 
                  :ARG1 (c / cell 
                        :mod (r / retinoblastoma 
                              :mod (h / human 
                                    :mod-of (y / Y79))))) 
            :condition (a2 / assess-01 
                  :ARG1 (a / activity-06 
                        :ARG0-of (r4 / repress-01) 
                        :ARG1 (m / mr-) 
                        :location (c2 / cell 
                              :ARG1-of (o / originate-01 
                                    :ARG2 (r3 / retinal)))))))

# ::snt The results indicated that DBD-mrs also reduced luciferase activity significantly in Y79 retinoblastoma cells ( Fig. 7E ) .
# ::tok The results indicated that DBD-mrs also reduced luciferase activity significantly in Y79 retinoblastoma cells ( Fig. 7E ) .
# ::alignments 15-16|0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 13-14|0.0.0.0.2.0 12-13|0.0.0.0.2.0.0 11-12|0.0.0.0.2.0.0.0 9-10|0.0.0.0.2 8-9|0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0.0.3 4-5|0.0.0.0.0 2-3|0 1-2|0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:58.995
(i / indicate-01 
      :ARG0 (t / thing 
            :ARG2-of (r3 / result-01 
                  :ARG1 (r2 / reduce-01 
                        :ARG0 (d / dbd-mr) 
                        :ARG1 (a / activity-06 
                              :ARG0 (c / country 
                                    :name (n / name 
                                          :op1 "Fig."))) 
                        :ARG1-of (s / significant-02 
                              :ARG2 (c2 / cell 
                                    :mod (r / retinoblastoma 
                                          :mod (y / Y79)))) 
                        :mod (a2 / also)))))

# ::snt However , luciferase activity was repressed by about 30 % in Y79 cells , while it was repressed by 90 % in HEK293T cells .
# ::tok However , luciferase activity was repressed by about 30 % in Y79 cells , while it was repressed by 90 % in HEK293T cells .
# ::alignments 23-24|0.0 22-23|0 20-21|0.0.0 19-20|0.0.0.1 17-18|0.0.0.0 12-13|0.0.0.0.0 11-12|0.0.0.0.0.1 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0.0.2 7-8|0.0.0.0.0.0.1 5-6|0.0.0.0.0.0.0 3-4|0.0.0.0.0.0.0.0 2-3|0.0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:59.098
(h / HEK293T 
      :mod-of (c / cell 
            :location-of (p / percentage-entity 
                  :ARG0-of (r / repress-01 
                        :ARG1 (c2 / cell 
                              :location-of (p2 / percentage-entity 
                                    :ARG0-of (r2 / repress-01 
                                          :ARG1 (a2 / activity-06 
                                                :ARG1 (l / luciferase))) 
                                    :op1-of (a / about) 
                                    :value 30) 
                              :mod (y / Y79))) 
                  :value 90)))

# ::snt This might be due to the difference in transfection efficiency between these cell lines .
# ::tok This might be due to the difference in transfection efficiency between these cell lines .
# ::alignments 13-14|0.0.0 12-13|0.0.0.0 11-12|0.0.0.1 9-10|0.0.1 6-7|0.0 1-2|0 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:59.134
(p / possible-01 
      :ARG1 (d / differ-02 
            :ARG1 (l / line 
                  :mod (c / cell) 
                  :mod (t / this)) 
            :prep-in (e / efficient-01 
                  :ARG1 (t2 / this))))

# ::snt Another possibility is that intracellular environment in Y79 cells , a retinoblastoma cell line , is insufficient for recapitulating developing photoreceptors .
# ::tok Another possibility is that intracellular environment in Y79 cells , a retinoblastoma cell line , is insufficient for recapitulating developing photoreceptors .
# ::alignments 20-21|0.0 19-20|0.0.0 18-19|0 16-17|0.1.1+0.1 13-14|0.1.0.1.0 12-13|0.1.0.1 11-12|0.1.0.1.0.0 8-9|0.1.0.0 7-8|0.1.0.0.1 5-6|0.1.0.0.0 4-5|0.1.0.0.0.0 1-2|0.1.0 0-1|0.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:06:59.396
(r / recapitulate-01 
      :ARG1 (p / photoreceptor 
            :ARG1-of (d / develop-02)) 
      :ARG2-of (s / suffice-01 
            :ARG1 (p2 / possible-01 
                  :ARG0 (c2 / cell 
                        :location-of (e / environment 
                              :mod (i / intracellular)) 
                        :mod (y / Y79)) 
                  :ARG1 (c / cell 
                        :mod-of (l / line 
                              :mod (r2 / retinoblastoma))) 
                  :mod (a / another)) 
            :polarity -))

# ::snt In this study , we did not address the question whether or not our in vitro data reflect native mr-s transcriptional repression in vivo .
# ::tok In this study , we did not address the question whether or not our in vitro data reflect native mr-s transcriptional repression in vivo .
# ::alignments 23-24|0.1.0.0 21-22|0.1.0 19-20|0.1.0.1.0.0 18-19|0.1.0.1 17-18|0.1.1 16-17|0.1.1.0 15-16|0.0.1.0 13-14|0.1.1.0.0 12-13|0.1.0.1.0 11-12|0.1 9-10|0.0.0 7-8|0 6-7|0.2 4-5|0.0 2-3|0.0.1 1-2|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:00.570
(a / address-02 
      :ARG0 (w2 / we 
            :ARG0-of (q / question-01) 
            :ARG0-of (s / study-01 
                  :ARG1 (v2 / vitro) 
                  :mod (t / this))) 
      :ARG1 (o / or 
            :ARG1-of (r / repress-01 
                  :location (v / vivo) 
                  :mod (n / native 
                        :polarity (- / - 
                              :polarity-of (m / mr-)))) 
            :ARG2-of (r2 / reflect-01 
                  :ARG1 (d / data 
                        :poss (w / we)))) 
      :polarity -)

# ::snt However , these in vitro experiments using HEK293T and Y79 cells strongly support our hypothesis that mr-s functions as a transcriptional repressor in developing photoreceptors .
# ::tok However , these in vitro experiments using HEK293T and Y79 cells strongly support our hypothesis that mr-s functions as a transcriptional repressor in developing photoreceptors .
# ::alignments 24-25|0.0.1.0.0.0.0 23-24|0.0.1.0.0.0 21-22|0.0.1.0.0.0.0.0 17-18|0.0.1.0.0 14-15|0.0.1.0 13-14|0.0.1.0.2 12-13|0.0.1.0.1 11-12|0.0.1.0.1.0 10-11|0.0.1 8-9|0 6-7|0.0 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:00.816
(a / and 
      :op1 (u / use-01 
            :ARG0 (e / experiment-01 
                  :ARG0 (v / vitro) 
                  :mod (t / this)) 
            :ARG1 (c / cell 
                  :poss-of (h / hypothesi 
                        :ARG1-of (f / function-01 
                              :ARG0-of (d / develop-02 
                                    :ARG1 (p / photoreceptor 
                                          :location-of (r / repressor)))) 
                        :ARG1-of (s / support-01 
                              :ARG1-of (s2 / strong-02)) 
                        :poss (w / we)))))

# ::snt Our results suggested that the C-terminal region of mr-s ( amino acids 463 to 542 ) is required for transcriptional repression of mr-s and the SAM domain appears to be dispensable for this repressive activity .
# ::tok Our results suggested that the C-terminal region of mr-s ( amino acids 463 to 542 ) is required for transcriptional repression of mr-s and the SAM domain appears to be dispensable for this repressive activity .
# ::alignments 34-35|0.1.1.0.1 33-34|0.1.1.0.1.0 32-33|0.1.1.0.1.1 30-31|0.1.1.0 27-28|0.1.1 26-27|0.1.1.0.0 25-26|0.1.1.0.0.0 23-24|0.1 22-23|0.1.0.0.0 20-21|0.1.0.0 17-18|0.1.0 11-12|0.1.1.0.1.0.0 10-11|0.1.1.0.1.0.0.0 8-9|0.1.0.1.0 6-7|0.1.0.1 2-3|0 1-2|0.0.0+0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:01.196
(s2 / suggest-01 
      :ARG0 (t2 / thing 
            :ARG2-of (r5 / result-01 
                  :ARG1 (w / we))) 
      :ARG1 (a3 / and 
            :op1 (r3 / require-01 
                  :ARG1 (r2 / repress-01 
                        :ARG1 (m / mr-)) 
                  :ARG2 (r4 / region 
                        :mod (m2 / mr-))) 
            :op2 (a2 / appear-02 
                  :ARG1 (d / dispensable 
                        :domain (d2 / domain 
                              :mod (s / sam)) 
                        :domain (a / activity-06 
                              :ARG0-of (r / repress-01 
                                    :ARG1 (a4 / acid 
                                          :op1-of (a5 / amino))) 
                              :mod (t / this))))))

# ::snt This C-terminal region of mouse mr-s is highly conserved among species ( Fig. 7F ) .
# ::tok This C-terminal region of mouse mr-s is highly conserved among species ( Fig. 7F ) .
# ::alignments 12-13|0.0.0.0+0.0.0+0.0 10-11|0.2 8-9|0 7-8|0.3 5-6|0.1.1 4-5|0.1.1.0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:01.269
(c2 / conserve-01 
      :ARG0 (c / country 
            :name (n / name 
                  :op1 "Fig.")) 
      :ARG1 (r / region 
            :mod (t / this) 
            :mod (m / mr- 
                  :mod (m2 / mouse))) 
      :ARG2 (s / species) 
      :degree (h / high))

# ::snt The sequence identity of the region was 93 % , 73 % , 41 % and 40 % for rat , human , chick and zebrafish , respectively ( Fig. 1D ) .
# ::tok The sequence identity of the region was 93 % , 73 % , 41 % and 40 % for rat , human , chick and zebrafish , respectively ( Fig. 1D ) .
# ::alignments 29-30|0.7.0.0+0.7.0+0.7 27-28|0.1 25-26|0.6 24-25|0 23-24|0.5 21-22|0.4 19-20|0.3 17-18|0.0 16-17|0.0.0 15-16|0.2 14-15|0.2.3 13-14|0.2.3.0 11-12|0.2.2 10-11|0.2.2.0 8-9|0.2.1 7-8|0.2.1.0 5-6|0.2.0.1 2-3|0.2.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:01.446
(a / and 
      :domain-of (p / percentage-entity 
            :value 40) 
      :mod (r / respective) 
      :op1 (a2 / and 
            :op1 (i / identity 
                  :mod (s / sequence) 
                  :poss (r3 / region)) 
            :op2 (p4 / percentage-entity 
                  :value 93) 
            :op3 (p3 / percentage-entity 
                  :value 73) 
            :op4 (p2 / percentage-entity 
                  :value 41)) 
      :op2 (r2 / rat) 
      :op3 (h / human) 
      :op4 (c2 / chick) 
      :op5 (z / zebrafish) 
      :op6 (c / country 
            :name (n / name 
                  :op1 "Fig.")))

# ::snt This strongly suggests that the C-terminal region of mouse mr-s functions as a transcriptional repressive domain in photoreceptor development .
# ::tok This strongly suggests that the C-terminal region of mouse mr-s functions as a transcriptional repressive domain in photoreceptor development .
# ::alignments 18-19|0.1 17-18|0.1.0 15-16|0.1.1 14-15|0.1.1.0 10-11|0.1.1.0.0.0 8-9|0.1.1.0.0 6-7|0.1.1.0.0.1 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:01.504
(s / suggest-01 
      :ARG0 (t / this) 
      :ARG1 (d / develop-02 
            :ARG1 (p / photoreceptor) 
            :topic-of (d2 / domain 
                  :ARG0-of (r / repress-01 
                        :op1-of (m / mouse 
                              :ARG1-of (f / function-01) 
                              :mod-of (r2 / region))))) 
      :ARG1-of (s2 / strong-02))

# ::snt However , this region does not contain characteristic amino acid motifs and the mechanism through which the region achieves and/or maintains gene repression remains to be clarified in the future .
# ::tok However , this region does not contain characteristic amino acid motifs and the mechanism through which the region achieves and/or maintains gene repression remains to be clarified in the future .
# ::alignments 29-30|0.0.0.0.0.1 26-27|0.0.0.0.0 23-24|0.0.0.0 22-23|0.0.0.0.0.0 21-22|0.0.0.0.0.0.1 20-21|0.0.0 18-19|0.1.2.1 17-18|0.1.2.1.0 13-14|0.1.2 11-12|0.1 10-11|0.1.1 9-10|0.1.0 8-9|0.0.0.0.0.0.0 7-8|0.1.2.0 6-7|0 5-6|0.2 3-4|0.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:02.129
(c3 / contain-01 
      :ARG0 (r4 / region 
            :ARG0-of (m / maintain-01 
                  :ARG1 (r / remain-01 
                        :ARG1 (c / clarify-01 
                              :ARG1 (r2 / repress-01 
                                    :ARG0 (a4 / amino) 
                                    :ARG1 (g / gene)) 
                              :time (f / future)))) 
            :mod (t / this)) 
      :ARG1 (a2 / and 
            :mod (a3 / acid) 
            :op1 (m3 / motif) 
            :op2 (m2 / mechanism 
                  :ARG1-of (c2 / characteristic-02) 
                  :ARG1-of (a / achieve-01 
                        :ARG0 (r3 / region)))) 
      :polarity -)

# ::snt mr-s fused to GAL4 DNA binding domain functions as a transcriptional repressor in HEK293T cells .
# ::tok mr-s fused to GAL4 DNA binding domain functions as a transcriptional repressor in HEK293T cells .
# ::alignments 14-15|0.1.0.1.0 11-12|0.1.0.1 7-8|0.1.0 6-7|0.1 5-6|0.1.0.0 4-5|0.2 3-4|0.2.0.0.0+0.2.0.0+0.2.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:02.309
(f2 / fuse-01 
      :ARG0 (m / mr-) 
      :ARG1 (d / domain 
            :ARG1-of (f / function-01 
                  :ARG0-of (b / binding-07) 
                  :ARG3 (r / repressor 
                        :location (c / cell)))) 
      :ARG2 (d2 / DNA 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "GAL4"))))

# ::snt ( A ) Schematic drawing of the constructs used for the luciferase assay .
# ::tok ( A ) Schematic drawing of the constructs used for the luciferase assay .
# ::alignments 12-13|0 8-9|0.0 7-8|0.0.0 4-5|0.0.1 3-4|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:02.375
(a / assay 
      :ARG2-of (u / use-01 
            :ARG1 (c / construct) 
            :manner-of (d / draw-01 
                  :ARG1 (s / schematic))))

# ::snt 5xGAL4-pGL3 reporter plasmid was co-transfected into HEK293T cells with effector plasmids expressing various deletion mutants fused to GAL4-DBD .
# ::tok 5xGAL4-pGL3 reporter plasmid was co-transfected into HEK293T cells with effector plasmids expressing various deletion mutants fused to GAL4-DBD .
# ::alignments 17-18|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 15-16|0.1.0 14-15|0.1 13-14|0.1.1 12-13|0.1.2 11-12|0 10-11|0.1.0.0 9-10|0.1.0.0.0 7-8|0.1.1.0.0.0 6-7|0.1.1.0.0 2-3|0.0 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:02.913
(e / express-01 
      :ARG0 (p2 / plasmid) 
      :ARG1 (m / mutant 
            :ARG0-of (f / fuse-01 
                  :ARG1 (p / plasmid 
                        :mod (e2 / effector)) 
                  :ARG2 (o / organization 
                        :name (n / name 
                              :op1 "GAL4-DBD"))) 
            :mod (d / deletion 
                  :ARG0-of (r / report-01 
                        :ARG1 (h / HEK293T 
                              :mod-of (c / cell)))) 
            :mod (v / various)))

# ::snt ( B ) Various amounts of DBD , DBD-mrs , DBD-N or DBD-C plasmids were transfected with 0.1 g of 5xGAL4-pGL3 reporter plasmid .
# ::tok ( B ) Various amounts of DBD , DBD-mrs , DBD-N or DBD-C plasmids were transfected with 0.1 g of 5xGAL4-pGL3 reporter plasmid .
# ::alignments 22-23|0.3 21-22|0.2 18-19|0.3.0 17-18|0.3.0.0 11-12|0 8-9|0.1 6-7|0.0.0.0+0.0.0+0.0 4-5|0.0.1 3-4|0.0.1.0 1-2|0.2.0.1+0.2.0.0.0+0.2.0.0+0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:02.991
(o / or 
      :op1 (o2 / organization 
            :name (n / name 
                  :op1 "DBD") 
            :quant (a / amount 
                  :mod (v / variou))) 
      :op2 (d / dbd-mr) 
      :op3 (r / report-01 
            :ARG1 (l / location 
                  :name (n2 / name 
                        :op1 "B") 
                  :wiki -)) 
      :op4 (p / plasmid 
            :mod-of (g / g 
                  :quant 0.1)))

# ::snt The reporter activity in the presence of the pcDNA3 vector ( pcDNA3 ) was designated as 1 .
# ::tok The reporter activity in the presence of the pcDNA3 vector ( pcDNA3 ) was designated as 1 .
# ::alignments 16-17|0.0.0.0.1 14-15|0.0.0.0.2 9-10|0.0 8-9|0 5-6|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.045
(p / pcDNA3 
      :mod-of (v / vector 
            :poss-of (p2 / presence 
                  :location-of (a / activity-06 
                        :ARG0 (r / report-01) 
                        :ARG1 1 
                        :ARG1-of (d / designate-01)))))

# ::snt Error bars represent standard error of mean .
# ::tok Error bars represent standard error of mean .
# ::alignments 6-7|0 4-5|0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.095
(m / mean-01 
      :ARG0 (b / bar 
            :ARG0-of (r / represent-01 
                  :ARG1 (e / error 
                        :ARG1-of (s / standard-02))) 
            :mod (e2 / error)))

# ::snt ( C ) DBD-W404A and DBD-G453A were co-transfected into HEK293T cells with 5xGAL4-pGL3 reporter plasmid .
# ::tok ( C ) DBD-W404A and DBD-G453A were co-transfected into HEK293T cells with 5xGAL4-pGL3 reporter plasmid .
# ::alignments 14-15|0.3 13-14|0.2 10-11|0.3.0 5-6|0.1.0.0+0.1.0+0.1 4-5|0 3-4|0.0.1.0+0.0.1+0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.142
(a / and 
      :op1 (o2 / organization 
            :mod-of (c2 / C) 
            :name (n2 / name 
                  :op1 "DBD-W404A")) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "DBD-G453A")) 
      :op3 (r / report-01) 
      :op4 (p / plasmid 
            :topic (c / cell)))

# ::snt Fold repression was calculated as the fold decrease in luciferase activity compared with DBD-mrs .
# ::tok Fold repression was calculated as the fold decrease in luciferase activity compared with DBD-mrs .
# ::alignments 13-14|0 11-12|0.0 10-11|0.0.0 7-8|0.0.0.0 6-7|0.0.0.0.1 3-4|0.0.0.0.0 1-2|0.0.0.0.0.0 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.191
(d / dbd-mr 
      :ARG2-of (c / compare-01 
            :ARG1 (a / activity-06 
                  :ARG1-of (d2 / decrease-01 
                        :ARG2-of (c2 / calculate-01 
                              :ARG1 (r / repress-01 
                                    :ARG1 (f2 / fold-01))) 
                        :mod (f / fold)))))

# ::snt Error bars represent standard deviation .
# ::tok Error bars represent standard deviation .
# ::alignments 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.232
(r / represent-01 
      :ARG0 (b / bar 
            :mod (e / error)) 
      :ARG1 (d / deviation 
            :ARG1-of (s / standard-02)))

# ::snt ( D ) Various amounts of DBD-tail or DBD-SAM were transfected with 5xGAL4-pGL3 reporter plasmid .
# ::tok ( D ) Various amounts of DBD-tail or DBD-SAM were transfected with 5xGAL4-pGL3 reporter plasmid .
# ::alignments 14-15|0.1.0.0 13-14|0.1.0 8-9|0.1.1.0.0+0.1.1.0+0.1.1 7-8|0.1 4-5|0 3-4|0.0 1-2|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.380
(a / amount 
      :mod (v / variou) 
      :op1-of (o / or 
            :ARG1-of (r / report-01 
                  :ARG0 (p / plasmid) 
                  :ARG2 (d / D)) 
            :op2 (p2 / person 
                  :name (n / name 
                        :op1 "DBD-SAM"))))

# ::snt Error bars represent standard error of mean .
# ::tok Error bars represent standard error of mean .
# ::alignments 6-7|0 4-5|0.0.0.0 3-4|0.0.0.0.0 2-3|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.432
(m / mean-01 
      :ARG0 (b / bar 
            :ARG0-of (r / represent-01 
                  :ARG1 (e / error 
                        :ARG1-of (s / standard-02))) 
            :mod (e2 / error)))

# ::snt ( E ) pcDNA3 or DBD-mrs ( 5 g ) was co-transfected into Y79 retinoblastoma cells with 0.5 g of 5xGAL4-pGL3 reporter plasmid .
# ::tok ( E ) pcDNA3 or DBD-mrs ( 5 g ) was co-transfected into Y79 retinoblastoma cells with 0.5 g of 5xGAL4-pGL3 reporter plasmid .
# ::alignments 22-23|0.0.0.0.0.0 21-22|0.0.0 17-18|0.0.2.0 15-16|0.0.0.0 14-15|0.0.0.0.0 8-9|0 7-8|0.0.0.1 5-6|0.0.3 4-5|0.0 3-4|0.0.2 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.567
(g / g 
      :op4-of (o / or 
            :ARG1-of (r / report-01 
                  :ARG0 (c / cell 
                        :mod (r2 / retinoblastoma 
                              :name-of (p / plasmid))) 
                  :op1-of 5) 
            :op1 (e / E) 
            :op2 (p2 / pcDNA3 
                  :mod 0.5) 
            :op3 (d / dbd-mr)))

# ::snt The reporter activity in the presence of pcDNA3 was designated as 1 .
# ::tok The reporter activity in the presence of pcDNA3 was designated as 1 .
# ::alignments 11-12|0.0.2 9-10|0 7-8|0.0.1.0 5-6|0.0.1 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.646
(d / designate-01 
      :ARG1 (a / activity-06 
            :ARG0 (r / report-01) 
            :location (p2 / presence 
                  :mod (p / pcDNA3)) 
            :time 1))

# ::snt Error bars represent standard deviation .
# ::tok Error bars represent standard deviation .
# ::alignments 4-5|0.1 3-4|0.1.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.687
(r / represent-01 
      :ARG0 (b / bar 
            :mod (e / error)) 
      :ARG1 (d / deviation 
            :ARG1-of (s / standard-02)))

# ::snt Asterisk marks statistically significant difference ( Student 's t test : p < 0.03 ) .
# ::tok Asterisk marks statistically significant difference ( Student 's t test : p < 0.03 ) .
# ::alignments 11-12|0.0.2.0 9-10|0.0.1 8-9|0.0.1.1 6-7|0.0.1.0.0+0.0.1.0 4-5|0.0 3-4|0.0.2 2-3|0.0.2.1 1-2|0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.894
(m / mark-01 
      :ARG1 (d / differ-02 
            :ARG0 (a / asterisk) 
            :ARG1 (t / test-01 
                  :ARG0 (p2 / person 
                        :ARG0-of (s / study-01)) 
                  :ARG1 (t2 / t)) 
            :ARG1-of (s2 / significant-02 
                  :ARG0 (p / p) 
                  :mod (s3 / statistics))))

# ::snt ( F ) Alignment of the C-terminal regions for mouse , rat , human , chick and zebrafish mr-s proteins .
# ::tok ( F ) Alignment of the C-terminal regions for mouse , rat , human , chick and zebrafish mr-s proteins .
# ::alignments 19-20|0 17-18|0.0.5 16-17|0.0 15-16|0.0.4 13-14|0.0.3 11-12|0.0.2 9-10|0.0.1 7-8|0.0.0 3-4|0.0.0.0 1-2|0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:03.984
(p / protein 
      :op6-of (a / and 
            :example-of (r2 / region 
                  :location-of (a2 / alignment 
                        :mod-of (a3 / aircraft-type 
                              :name (n / name 
                                    :op1 "F22") 
                              :wiki "Lockheed_Martin_F-22_Raptor"))) 
            :op1 (m / mouse) 
            :op2 (r / rat) 
            :op3 (h / human) 
            :op4 (c / chick) 
            :op5 (z / zebrafish)))

# ::snt Conserved amino acid residues are shown with a dark shadow .
# ::tok Conserved amino acid residues are shown with a dark shadow .
# ::alignments 9-10|0 8-9|0.0 5-6|0.1 3-4|0.1.0 2-3|0.1.0.1 1-2|0.1.0.2 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:04.052
(s / shadow-02 
      :ARG1-of (d / dark-02) 
      :ARG2-of (s2 / show-01 
            :ARG1 (r / residu 
                  :ARG1-of (c / conserve-01) 
                  :mod (a / acid) 
                  :mod (a2 / amino))))

# ::snt Taken together , our findings suggest that DBD-mrs functions as a transcriptional repressor and that the repression activity of mr-s is not due to a homophilic interaction through its SAM domain but to the C-terminal region ( amino acids 463 to 542 ) .
# ::tok Taken together , our findings suggest that DBD-mrs functions as a transcriptional repressor and that the repression activity of mr-s is not due to a homophilic interaction through its SAM domain but to the C-terminal region ( amino acids 463 to 542 ) .
# ::alignments 38-39|0.2.0.1.1.0.0 37-38|0.2.0.1.1.0 35-36|0.0 31-32|0 30-31|0.1.0 29-30|0.1.0.0 26-27|0.1 21-22|0.2.0.2.0 19-20|0.2.0.1.1.1.0 17-18|0.2.0.1.1.1 16-17|0.2.0.1.1 13-14|0.2 12-13|0.2.0.0.0.0.0 8-9|0.2.0.1 7-8|0.2.0.1.0 5-6|0.2.0 4-5|0.2.0.0.0+0.2.0.0 3-4|0.2.0.0.0.0 1-2|0.2.0.2.1 0-1|0.2.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:04.588
(c / contrast-01 
      :ARG1 (r / region) 
      :ARG1-of (i / interact-01 
            :ARG0 (d / domain 
                  :mod (s / sam))) 
      :ARG2 (a4 / and 
            :ARG1-of (s2 / suggest-01 
                  :ARG0 (t / thing 
                        :ARG1-of (f2 / find-01 
                              :ARG0 (w / we 
                                    :poss-of (r3 / repressor)))) 
                  :ARG2 (f / function-01 
                        :ARG1 (d2 / dbd-mr) 
                        :ARG1-of (r2 / repress-01 
                              :ARG0 (a2 / amino 
                                    :mod-of (a / acid)) 
                              :ARG1-of (a3 / activity-06 
                                    :ARG0 (m / mr-)))) 
                  :purpose (t3 / take-01 
                        :ARG1 - 
                        :mod (t2 / together)))))

# ::snt In the present study , we identified a novel gene , mr-s , which is predominantly expressed in retinal photoreceptors and the pineal gland .
# ::tok In the present study , we identified a novel gene , mr-s , which is predominantly expressed in retinal photoreceptors and the pineal gland .
# ::alignments 23-24|0.1.0.2.0 22-23|0.1.0.2.0.0 20-21|0.1.0.2 19-20|0.1.0.0 18-19|0.1.0.0.0 16-17|0.1.0 15-16|0.1.0.1 11-12|0.1.2 9-10|0.1 8-9|0.1.1 6-7|0 5-6|0.0 3-4|0.2 2-3|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:04.736
(i / identify-01 
      :ARG0 (w / we) 
      :ARG1 (g2 / gene 
            :ARG1-of (e / express-01 
                  :ARG2 (p2 / photoreceptor 
                        :mod (r / retinal)) 
                  :mod (p3 / predominant) 
                  :op1-of (a / and 
                        :op2 (g / gland 
                              :mod (p / pineal)))) 
            :mod (n / novel) 
            :mod (m / mr-)) 
      :time (s / study-01 
            :time (p4 / present)))

# ::snt The peak of mr-s expression in the developing retina is around P6 .
# ::tok The peak of mr-s expression in the developing retina is around P6 .
# ::alignments 11-12|0.1.1+0.1+0 10-11|0.0 8-9|0.1.0.1 7-8|0.1.0.1.0 4-5|0.1.0.0 3-4|0.1.0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:04.866
(t / thing 
      :degree (a / around) 
      :name (n / name 
            :domain (p / peak-01 
                  :ARG1 (e / express-01 
                        :mod (m / mr-)) 
                  :ARG2 (r / retina 
                        :ARG1-of (d / develop-02))) 
            :op1 "P6"))

# ::snt This expression pattern correlates with the rapid increase of Crx , rhodopsin and other photoreceptor genes around P6-P8 .
# ::tok This expression pattern correlates with the rapid increase of Crx , rhodopsin and other photoreceptor genes around P6-P8 .
# ::alignments 17-18|0.1.1.0.0.0.0.0+0.1.1.0.0.0.0+0.1.1.0.0.0 16-17|0.1.1.0.0 15-16|0.1.1.0 14-15|0.1.1.0.1 13-14|0.0.0.0 12-13|0.1.0 11-12|0.1.0.0 9-10|0.1.1.1.0+0.1.1.1+0.1.1 7-8|0.1 6-7|0.1.2 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:05.275
(c / correlate-01 
      :ARG0 (p2 / pattern 
            :ARG1-of (e / express-01 
                  :ARG0 (o / other)) 
            :mod (t3 / this)) 
      :ARG1 (i / increase-01 
            :ARG0 (a2 / and 
                  :op1 (r / rhodopsin)) 
            :ARG1 (t2 / thing 
                  :mod-of (g / gene 
                        :location (a / around 
                              :op1 (t / thing 
                                    :name (n / name 
                                          :op1 "P6-P8"))) 
                        :mod (p / photoreceptor)) 
                  :name (n2 / name 
                        :op1 "Crx")) 
            :manner (r2 / rapid)))

# ::snt Around P6 , the outer plexiform layer becomes visible and the outer layer of retina separates into two layers , ONL and INL .
# ::tok Around P6 , the outer plexiform layer becomes visible and the outer layer of retina separates into two layers , ONL and INL .
# ::alignments 22-23|0.0.0.0.2.1.0.0+0.0.0.0.2.1.0+0.0.0.0.2.1 21-22|0.0.0.0.2 20-21|0.0.0.0.2.0.0.0+0.0.0.0.2.0.0+0.0.0.0.2.0 18-19|0.0.0.0.1 17-18|0.0.0.0.1.0 15-16|0.0.0.0 14-15|0.0.0.0.0.1 12-13|0.0.0.0.0 11-12|0.0.0.0.0.0 9-10|0 8-9|0.0.1 7-8|0.0 6-7|0.0.0 5-6|0.0.0.2 4-5|0.0.0.1 1-2|0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:06.046
(a2 / and 
      :op1 (b / become-01 
            :ARG1 (l3 / layer 
                  :ARG0-of (s / separate-01 
                        :ARG1 (l2 / layer 
                              :mod (o3 / outer) 
                              :mod (r / retina)) 
                        :ARG2 (l / layer 
                              :quant 2) 
                        :destination (a / and 
                              :op1 (o2 / organization 
                                    :name (n2 / name 
                                          :op1 "ONL")) 
                              :op2 (o / organization 
                                    :name (n / name 
                                          :op1 "INL")))) 
                  :mod (o4 / outer) 
                  :mod (p / plexiform)) 
            :ARG2 (v / visible) 
            :time (a3 / around 
                  :op1 (t / thing 
                        :name (n3 / name 
                              :op1 "P6")))))

# ::snt At the same time , photoreceptors begin to undergo terminal differentiation , forming the outer segment .
# ::tok At the same time , photoreceptors begin to undergo terminal differentiation , forming the outer segment .
# ::alignments 15-16|0.0.0.0.0 14-15|0.0.0.0.0.0 12-13|0.0.0.0 10-11|0.0.1 9-10|0.0.1.0 8-9|0.0 6-7|0 5-6|0.0.0 3-4|0.1 2-3|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:06.114
(b / begin-01 
      :ARG1 (u / undergo-28 
            :ARG0 (p / photoreceptor 
                  :ARG0-of (f / form-01 
                        :ARG1 (s / segment 
                              :domain-of (o / outer)))) 
            :ARG2 (d / differentiation 
                  :mod (t / terminal))) 
      :time (t2 / time 
            :ARG1-of (s2 / same-01)))

# ::snt We therefore hypothesized that mr-s is a key molecule in the late development of photoreceptors .
# ::tok We therefore hypothesized that mr-s is a key molecule in the late development of photoreceptors .
# ::alignments 14-15|0.0.0.1.0 12-13|0.0.0.1 11-12|0.0.0.1.1 8-9|0.0.0 7-8|0.0 4-5|0 2-3|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:06.207
(m2 / mr- 
      :ARG0-of (k / key-02 
            :ARG1 (m / molecule 
                  :ARG1-of (h / hypothesize-01 
                        :ARG0 (w / we)) 
                  :topic (d / develop-02 
                        :ARG1 (p / photoreceptor) 
                        :time (l / late)))))

# ::snt We previously reported that Otx2 and Crx have a critical role in photoreceptor development and that Otx2 directly regulates Crx transcription [ 3,9 ] .
# ::tok We previously reported that Otx2 and Crx have a critical role in photoreceptor development and that Otx2 directly regulates Crx transcription [ 3,9 ] .
# ::alignments 20-21|0.1.2.1 18-19|0.1.2 17-18|0.1.2.2 14-15|0.1 13-14|0.1.1.1 12-13|0.1.1.1.0 10-11|0.1.1 9-10|0.1.1.0 6-7|0.1.0.0.0+0.1.0.0+0.1.0 5-6|0.1.2.3 4-5|0.1.2.0.0.0+0.1.2.0.0+0.1.2.0 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:06.526
(r3 / report-01 
      :ARG0 (w / we) 
      :ARG1 (a / and 
            :op1 (t2 / thing 
                  :name (n / name 
                        :op1 "Crx")) 
            :op2 (r2 / role 
                  :ARG1-of (c / critical-02) 
                  :mod (d2 / develop-02 
                        :ARG1 (p / photoreceptor))) 
            :op3 (r / regulate-01 
                  :ARG0 (t3 / thing 
                        :name (n2 / name 
                              :op1 "Otx2")) 
                  :ARG1 (t / transcription) 
                  :ARG1-of (d / direct-02) 
                  :op1-of (a2 / and))) 
      :time (p2 / previous))

# ::snt In situ hybridization and RT-PCR showed significant reduction of mr-s signal in the Crx KO retina and pineal gland .
# ::tok In situ hybridization and RT-PCR showed significant reduction of mr-s signal in the Crx KO retina and pineal gland .
# ::alignments 18-19|0.1.0.0.1 17-18|0.1.0.0.1.0 16-17|0.1.0.0 15-16|0.1.0.0.0 13-15|0.1.0.0.0.0.0.1+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 10-11|0.1.0 9-10|0.1.0.1 7-8|0.1 6-7|0.1.1 5-6|0 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:06.678
(s3 / show-01 
      :ARG0 (a2 / and 
            :op1 (h / hybridization)) 
      :ARG1 (r2 / reduce-01 
            :ARG1 (s / signal 
                  :location (a / and 
                        :op1 (r / retina 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "Crx" 
                                          :op2 "KO"))) 
                        :op2 (g / gland 
                              :mod (p / pineal))) 
                  :mod (m / mr-)) 
            :ARG1-of (s2 / significant-02)))

# ::snt Furthermore , the luciferase assay demonstrated that Otx2 and Crx may directly upregulate the transcription of mr-s in mammalian cells .
# ::tok Furthermore , the luciferase assay demonstrated that Otx2 and Crx may directly upregulate the transcription of mr-s in mammalian cells .
# ::alignments 19-20|0.1.0.0.0 18-19|0.1.0.0.0.0 16-17|0.1.0.0 14-15|0.1.0 11-12|0.1.1.0 10-11|0.1 9-10|0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 8-9|0.1.1 7-8|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 5-6|0 4-5|0.0 3-4|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:06.780
(d2 / demonstrate-01 
      :ARG0 (a2 / assay 
            :mod (l / luciferase)) 
      :ARG1 (p / possible-01 
            :ARG1 (t / transcription 
                  :mod (m2 / mr- 
                        :location (c / cell 
                              :mod (m / mammalian)))) 
            :op3-of (a / and 
                  :ARG0-of (d / direct-02) 
                  :op1 (t3 / thing 
                        :name (n2 / name 
                              :op1 "Otx2")) 
                  :op2 (t2 / thing 
                        :name (n / name 
                              :op1 "Crx")))) 
      :time (f / furthermore))

# ::snt In retinal photoreceptor cells , the Otx2 transcripts are not highly expressed at P6-P9 , while the Crx transcripts are strongly detected around P6 .
# ::tok In retinal photoreceptor cells , the Otx2 transcripts are not highly expressed at P6-P9 , while the Crx transcripts are strongly detected around P6 .
# ::alignments 23-24|0.5.2.0.0.0+0.5.2.0.0+0.5.2.0 22-23|0.5.2 21-22|0.5 20-21|0.5.1 18-19|0.5.0 17-18|0.5.0.0.0.0+0.5.0.0.0+0.5.0.0 13-14|0.1.0.0+0.1.0+0.1 11-12|0 10-11|0.2 9-10|0.4 7-8|0.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 3-4|0.3 2-3|0.3.0 1-2|0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:07.201
(e / express-01 
      :ARG1 (t4 / transcript 
            :mod (t5 / thing 
                  :name (n4 / name 
                        :op1 "Otx2"))) 
      :ARG2 (c / country 
            :name (n3 / name 
                  :op1 "P6-P9")) 
      :degree (h / high) 
      :manner (c2 / cell 
            :mod (p / photoreceptor) 
            :mod (r / retinal)) 
      :polarity - 
      :time (d / detect-01 
            :ARG1 (t2 / transcript 
                  :mod (t3 / thing 
                        :name (n2 / name 
                              :op1 "Crx"))) 
            :ARG1-of (s / strong-02) 
            :location (a / around 
                  :op1 (t / thing 
                        :name (n / name 
                              :op1 "P6")))))

# ::snt Therefore , our results strongly suggest that mr-s transcription is directly regulated by Crx .
# ::tok Therefore , our results strongly suggest that mr-s transcription is directly regulated by Crx .
# ::alignments 13-14|0.1.0.0.0+0.1.0.0+0.1.0 11-12|0.1 10-11|0.1.2 8-9|0.1.1 7-8|0.1.1.0 5-6|0 4-5|0.2 3-4|0.0.0+0.0 2-3|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:07.264
(s / suggest-01 
      :ARG0 (t3 / thing 
            :ARG2-of (r2 / result-01 
                  :ARG1 (w / we))) 
      :ARG1 (r / regulate-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "Crx")) 
            :ARG1 (t2 / transcription 
                  :mod (m / mr-)) 
            :ARG1-of (d / direct-02)) 
      :ARG1-of (s2 / strong-02))

# ::snt In the present study , Nrl , a photoreceptor-specific transcription factor that is highly expressed in photoreceptors at the postnatal stage , did not affect the transcription of mr-s .
# ::tok In the present study , Nrl , a photoreceptor-specific transcription factor that is highly expressed in photoreceptors at the postnatal stage , did not affect the transcription of mr-s .
# ::alignments 28-29|0.0.0 26-27|0.0 24-25|0 23-24|0.2 20-21|0.1.0.0.3 19-20|0.1.0.0.3.0 16-17|0.1.0.0.2 14-15|0.1.0.0 13-14|0.1.0.0.1 10-11|0.1.0.0.0 9-10|0.1.0.0.0.0 5-6|0.1.0.1.0+0.1.0.1+0.1.0 3-4|0.1 2-3|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:07.606
(a / affect-01 
      :ARG1 (t / transcription 
            :mod (m / mr-)) 
      :ARG2 (s2 / study-01 
            :ARG0 (p3 / person 
                  :ARG0-of (e / express-01 
                        :ARG1 (f / factor 
                              :mod (t2 / transcription)) 
                        :degree (h / high) 
                        :manner (p2 / photoreceptor) 
                        :time (s / stage 
                              :mod (p / postnatal))) 
                  :name (n / name 
                        :op1 "Nrl")) 
            :time (p4 / present)) 
      :polarity -)

# ::snt This finding is actually consistent with the analysis of the Nrl KO mouse which was recently reported [ 40 ] .
# ::tok This finding is actually consistent with the analysis of the Nrl KO mouse which was recently reported [ 40 ] .
# ::alignments 18-19|0.0.0 16-17|0.1.0.0 15-16|0.1.0.0.0 12-13|0.1.0 10-12|0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 7-8|0.1 4-5|0 3-4|0.2 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:07.697
(c / consistent-01 
      :ARG1 (f / find-01 
            :ARG1 40 
            :mod (t2 / this)) 
      :ARG2 (a / analyze-01 
            :ARG1 (m / mouse 
                  :ARG0-of (r / report-01 
                        :time (r2 / recent)) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 (n2 / Nrl) 
                              :op2 (k / KO))))) 
      :mod (a2 / actual))

# ::snt The expression profiles of wild-type and Nrl KO retinas at P2 , P10 and 2 months were analyzed and mr-s was not included in 161 differentially expressed genes in the Nrl KO retina .
# ::tok The expression profiles of wild-type and Nrl KO retinas at P2 , P10 and 2 months were analyzed and mr-s was not included in 161 differentially expressed genes in the Nrl KO retina .
# ::alignments 32-33|0.1 30-32|0.1.0.1.1+0.1.0.1.0+0.1.0.1+0.1.0 27-28|0.0 26-27|0 25-26|0.2 22-23|0.1.0.0 21-22|0.1.0.0.3 19-20|0.1.0.0.1 18-19|0.1.0.0.2 17-18|0.1.0.0.2.1 15-16|0.1.0.0.2.1.0.1+0.1.0.0.2.1.0 14-15|0.1.0.0.2.1.0.0 13-14|0.1.0.0.0.0 8-9|0.1.0.0.0 6-8|0.1.0.0.0.1.0.1+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 5-6|0.1.0.0.0.2 2-3|0.1.0.0.2.0 1-2|0.1.0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:08.616
(e / express-01 
      :ARG1 (g / gene) 
      :manner (r / retina 
            :mod (t / thing 
                  :ARG2-of (i / include-01 
                        :ARG0 (r2 / retina 
                              :location (a3 / and) 
                              :mod (t3 / thing 
                                    :name (n2 / name 
                                          :op1 (n3 / Nrl) 
                                          :op2 (k / KO))) 
                              :op1-of (a4 / and)) 
                        :ARG1 (m / mr-) 
                        :op2-of (a / and 
                              :ARG0-of (p / profile-01 
                                    :ARG1 (e2 / express-01)) 
                              :op1 (a2 / analyze-01 
                                    :ARG1 (t2 / temporal-quantity 
                                          :quant 2 
                                          :unit (m2 / month)))) 
                        :polarity -) 
                  :name (n / name 
                        :op1 "Nrl" 
                        :op2 "KO"))) 
      :mod (d / differentially))

# ::snt Previous reports suggested that the SAM domain is a protein-protein interaction module .
# ::tok Previous reports suggested that the SAM domain is a protein-protein interaction module .
# ::alignments 11-12|0.1.2+0.1 10-11|0.1.1 6-7|0.1.0 5-6|0.1.0.0 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:08.648
(s2 / suggest-01 
      :ARG0 (r / report-01 
            :ARG0 (p / previou)) 
      :ARG1 (m / module 
            :domain (d / domain 
                  :mod (s / sam)) 
            :mod (i / interact-01) 
            :wiki -))

# ::snt The SAM domain of the mr-s protein is closely related to that of ph and TEL , whose SAM domains can form a helical , head-to-tail polymeric structure and mediate the formation of a higher order chromatin structure .
# ::tok The SAM domain of the mr-s protein is closely related to that of ph and TEL , whose SAM domains can form a helical , head-to-tail polymeric structure and mediate the formation of a higher order chromatin structure .
# ::alignments 37-38|0.1.1.0.2.0 36-37|0.1.1.0.2.0.0 34-35|0.1.1.0.2 31-32|0.1.1 29-30|0.1 28-29|0 27-28|0.0.1 26-27|0.0.1.0 23-24|0.0.1.1 21-22|0.0 20-21|0.0.2 19-20|0.0.0 15-16|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 14-15|0.1.0.0 13-14|0.1.0 11-12|0.1.1.0.0 9-10|0.1.1.0 8-9|0.1.1.0.3 6-7|0.1.1.0.1.1 5-6|0.1.1.0.1.1.0 2-3|0.1.1.0.1 1-2|0.1.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:09.740
(a / and 
      :op1 (f2 / form-01 
            :ARG0 (d / domain) 
            :ARG1 (s2 / structure 
                  :mod (p / polymeric) 
                  :mod (h2 / helical)) 
            :ARG1-of (p2 / possible-01)) 
      :op2 (m / mediate-01 
            :ARG0 (p3 / ph 
                  :op1-of (a2 / and 
                        :op2 (o / organization 
                              :name (n / name 
                                    :op1 "TEL")))) 
            :ARG1 (f / form-01 
                  :ARG1 (r / relate-01 
                        :ARG0 (t / that) 
                        :ARG1 (d2 / domain 
                              :mod (s3 / sam) 
                              :poss (p4 / protein 
                                    :mod (m2 / mr-))) 
                        :ARG2-of (h / high-02 
                              :ARG1 (s / structure 
                                    :mod (c / chromatin))) 
                        :manner (c2 / close)))))

# ::snt To characterize the biochemical function of mr-s , we performed yeast two-hybrid screening using full-length mr-s as the bait .
# ::tok To characterize the biochemical function of mr-s , we performed yeast two-hybrid screening using full-length mr-s as the bait .
# ::alignments 18-19|0.0.1 15-16|0.0.0 14-15|0.0.0.0 13-14|0.0 12-13|0 10-11|0.1 9-10|0.2 8-9|0.2.0 6-7|0.0.1.0 4-5|0.2.0.0.0 3-4|0.2.0.0.0.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:09.923
(s / screen-01 
      :ARG0-of (u / use-01 
            :ARG1 (m / mr- 
                  :mod (f / full-length)) 
            :ARG2 (b / bait-01 
                  :ARG1 (m2 / mr-))) 
      :ARG1 (y / yeast) 
      :ARG1-of (p / perform-02 
            :ARG0 (w / we 
                  :ARG0-of (c / characterize-01 
                        :ARG1 (f2 / function-01 
                              :ARG1 (b2 / biochemical))))))

# ::snt As a result , the most frequent positive clones ( 5/28 ) in the screening were the cDNA fragments containing the SAM domain of mr-s .
# ::tok As a result , the most frequent positive clones ( 5/28 ) in the screening were the cDNA fragments containing the SAM domain of mr-s .
# ::alignments 24-25|0.0.0.0.1 22-23|0.0.0.0 21-22|0.0.0.0.0 19-20|0.0.0 18-19|0.0 17-18|0.0.1 14-15|0 8-9|0.0.2.0.0 7-8|0.0.2.0.0.0 6-7|0.0.2.0 5-6|0.0.2.0.1 2-3|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:10.110
(s2 / screen-01 
      :manner-of (f / fragment-01 
            :ARG0-of (c / contain-01 
                  :ARG1 (d / domain 
                        :mod (s / sam) 
                        :poss (m / mr-))) 
            :ARG1 (c2 / cdna) 
            :ARG2-of (r / result-01 
                  :topic-of (f2 / frequent-02 
                        :ARG1 (c3 / clone-01 
                              :mod (p / positive)) 
                        :degree (m2 / most)))))

# ::snt This strongly suggests that mr-s self-associates through its SAM domain .
# ::tok This strongly suggests that mr-s self-associates through its SAM domain .
# ::alignments 9-10|0.3.0 8-9|0.3 5-6|0.3.0.0 3-4|0.1 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:10.183
(s3 / suggest-01 
      :ARG0 (t2 / this) 
      :ARG1 (t / that) 
      :ARG1-of (s4 / strong-02) 
      :ARG2 (s / sam 
            :mod-of (d / domain 
                  :location-of (s2 / self-associat))))

# ::snt An immunoprecipitation assay , using two site-directed mutants of the SAM domain of mr-s , demonstrated that the mr-s protein can self-associate through its SAM domain in mammalian cells .
# ::tok An immunoprecipitation assay , using two site-directed mutants of the SAM domain of mr-s , demonstrated that the mr-s protein can self-associate through its SAM domain in mammalian cells .
# ::alignments 28-29|0.1.0 27-28|0.1.0.0 25-26|0.0.0.1 24-25|0.0.0.1.0 20-21|0.1 19-20|0.0.0.0.1 15-16|0 13-14|0.0.0.0.2.1 11-12|0.0.0.0.2 10-11|0.0.0.0.2.0 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.3 4-5|0.0.0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:10.377
(d2 / demonstrate-01 
      :ARG0 (a / assay 
            :ARG0-of (u / use-01 
                  :ARG1 (m3 / mutant 
                        :mod (s3 / site-direct) 
                        :mod (p2 / protein) 
                        :poss-of (d3 / domain 
                              :mod (s2 / sam) 
                              :poss (m2 / mr-)) 
                        :quant 2) 
                  :ARG2 (d / domain 
                        :mod (s / sam)))) 
      :ARG1 (p / possible-01 
            :ARG1 (c / cell 
                  :mod (m / mammalian))))

# ::snt While we did not address the question whether the SAM domain of mr-s forms a polymeric structure in the present study , the phylogenetic analysis of SAM domain of mr-s and other SAM domain-containing molecules suggests that mr-s can form head-to-tail polymer and mediate gene silencing by spreading repressive complexes along the chromatin similar to ph and/or TEL. .
# ::tok While we did not address the question whether the SAM domain of mr-s forms a polymeric structure in the present study , the phylogenetic analysis of SAM domain of mr-s and other SAM domain-containing molecules suggests that mr-s can form head-to-tail polymer and mediate gene silencing by spreading repressive complexes along the chromatin similar to ph and/or TEL. .
# ::alignments 57-58|0.1.1.2.0.1.0.0.1.0.0+0.1.1.2.0.1.0.0.1.0+0.1.1.2.0.1.0.0.1 55-56|0.1.1.2.0.0.0 53-54|0.1.1.2.0.1.0.0 52-53|0.1.1.2.0.1.0 50-51|0.1.1.2.0.1 49-50|0.1.1.2.0 48-49|0.1.1.2.0.0 47-48|0.1.1.2 45-46|0.1.1.1 44-45|0.1.1.1.0 43-44|0.1.1 42-43|0.1 41-42|0.1.0.1 39-40|0.1.0 38-39|0.1.0.2 37-38|0.1.1.0 35-36|0 34-35|0.1.0.2.0 33-34|0.1.0.2.0.0 31-32|0.1.1.2.0.1.0.0.0 30-31|0.1.0.0.0.1.0.0.0 29-30|0.1.0.0.0.1.0.0.0.0 27-28|0.1.0.0.0.1.0.0 24-25|0.1.0.0.0.1.0 23-24|0.1.0.0.0.1.0.1 20-21|0.1.0.0.0.0.2 19-20|0.1.0.0.0.0.2.0 16-17|0.1.0.0.0.0.1 15-16|0.1.0.0.0.0.1.0 13-14|0.1.0.0.0.0 12-13|0.0 10-11|0.1.0.0.0.0.0 9-10|0.1.0.0.0.0.0.0 6-7|0.1.0.0.0 4-5|0.1.0.0.0.1 3-4|0.1.0.0.0.1.2 1-2|0.1.0.0 0-1|0.1.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:12.213
(s3 / suggest-01 
      :ARG0 (m5 / mr-) 
      :ARG1 (a2 / and 
            :op1 (f / form-01 
                  :ARG0 (w / we 
                        :ARG0-of (q / question-01 
                              :ARG1 (f2 / form-02 
                                    :ARG0 (d3 / domain 
                                          :mod (s6 / sam)) 
                                    :ARG1 (s5 / structure 
                                          :mod (p6 / polymeric)) 
                                    :ARG2 (s4 / study-01 
                                          :time (p5 / present))) 
                              :ARG1-of (a5 / address-02 
                                    :ARG0 (a4 / analyze-01 
                                          :ARG1 (d2 / domain 
                                                :op1-of (a3 / and 
                                                      :op2 (m4 / mr-))) 
                                          :manner (p4 / phylogenetic)) 
                                    :ARG0-of (w2 / while-01) 
                                    :polarity -))) 
                  :ARG1 (p2 / polym) 
                  :ARG1-of (p3 / possible-01 
                        :ARG0 (m3 / molecule 
                              :mod (d / domain-contain)))) 
            :op2 (m / mediate-01 
                  :ARG0 (m2 / mr-) 
                  :ARG1 (s2 / silence-01 
                        :ARG1 (g / gene)) 
                  :ARG2 (s / spread-03 
                        :ARG1 (c2 / complex 
                              :ARG0-of (r2 / repress-01 
                                    :ARG1 (p / ph)) 
                              :location (a / along 
                                    :op1 (c / chromatin 
                                          :ARG1-of (r / resemble-01 
                                                :ARG0 (o2 / other) 
                                                :ARG2 (o / organization 
                                                      :name (n / name 
                                                            :op1 "TEL."))))))))))

# ::snt Although our results in the immunoprecipitation assay demonstrated that the N-terminal constructs lacking a SAM domain still interact with each other , these results do not fit into the head-to-tail polymer model .
# ::tok Although our results in the immunoprecipitation assay demonstrated that the N-terminal constructs lacking a SAM domain still interact with each other , these results do not fit into the head-to-tail polymer model .
# ::alignments 31-32|0.0.0.0.0.0.1.2 30-31|0.0.0.0.0.0.1.2.0 26-27|0.0.0.0.0.0.1 25-26|0.0.0.0.0.0.1.3 23-24|0.0.0.0.0.0.1.1.0+0.0.0.0.0.0.1.1 22-23|0.0.0.0.0.0.1.1.1 20-21|0.0.0.0.0.0.1.0.0 19-20|0.0.0.0.0.0.1.0 17-18|0.0.0.0.0 16-17|0.0.0.0.0.1 15-16|0.0 14-15|0 12-13|0.0.0 11-12|0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.1 5-6|0.0.0.1.0 2-3|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:13.084
(s2 / sam 
      :mod-of (d / domain 
            :ARG1-of (l / lack-01 
                  :ARG0 (c / construct 
                        :ARG0-of (i / interact-01 
                              :ARG1-of (d2 / demonstrate-01 
                                    :ARG0 (t3 / thing 
                                          :ARG2-of (r2 / result-01 
                                                :ARG1 (w / we))) 
                                    :purpose-of (f / fit-06 
                                          :ARG0 (e / each 
                                                :mod-of (o / other)) 
                                          :ARG1 (t / thing 
                                                :ARG2-of (r / result-01) 
                                                :mod (t2 / this)) 
                                          :ARG2 (m / model 
                                                :mod (p / polym)) 
                                          :polarity -)) 
                              :mod (s / still))) 
                  :ARG2 (a / assay 
                        :mod (i2 / immunoprecipitation)))))

# ::snt We can not exclude the possibility that the resulting protein-protein interaction of mr-s is an artifact of the overexpression conditions .
# ::tok We can not exclude the possibility that the resulting protein-protein interaction of mr-s is an artifact of the overexpression conditions .
# ::alignments 19-20|0.0.0 18-19|0.0 15-16|0.1.2 12-13|0.1.0 10-11|0.1 8-9|0 5-6|0.1.1 3-4|0.1.1.0 2-3|0.1.1.0.1.0 1-2|0.1.1.0.1 0-1|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:13.204
(r / result-01 
      :ARG0 (o / overexpression 
            :mod-of (c / condition)) 
      :ARG1 (i / interact-01 
            :ARG1 (m / mr-) 
            :ARG1-of (p / possible-01 
                  :ARG1-of (e / exclude-01 
                        :ARG0 (w / we) 
                        :ARG1-of (p2 / possible-01 
                              :polarity -))) 
            :domain-of (a / artifact)))

# ::snt The issue of whether or not mr-s forms a polymer awaits future analysis .
# ::tok The issue of whether or not mr-s forms a polymer awaits future analysis .
# ::alignments 12-13|0.2 11-12|0.2.1 10-11|0 9-10|0.0 7-8|0.2.0 6-7|0.2.0.0 5-6|0.2.0.1 4-5|0.1.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:13.250
(a2 / await-01 
      :ARG0 (p / polym) 
      :ARG1 (i / issue-02 
            :ARG1 (o / or)) 
      :ARG2 (a / analyze-01 
            :ARG1 (f2 / form 
                  :mod (m / mr-) 
                  :polarity -) 
            :manner (f / future)))

# ::snt A previous report indicated that TEL contains a sequence-specific DNA binding domain , namely the ETS domain , and binds to specific sites via its ETS domain [ 41 ] .
# ::tok A previous report indicated that TEL contains a sequence-specific DNA binding domain , namely the ETS domain , and binds to specific sites via its ETS domain [ 41 ] .
# ::alignments 28-29|0.1.2 26-27|0.1.0.0.3 22-23|0.1.0.0.1 21-22|0.1.0.0.1.0 19-20|0.1.0.0 18-19|0.1.0.0.2 16-17|0.1.0.0.2.0 15-16|0.1.0.0.2.0.0.0.0+0.1.0.0.2.0.0.0+0.1.0.0.2.0.0 13-14|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0 11-12|0.1.1 10-11|0.1.1.0 9-10|0.1.1.0.0 6-7|0.1 5-6|0.1.0.1.0+0.1.0.1+0.1.0 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:13.715
(i / indicate-01 
      :ARG0 (r / report 
            :mod (p / previous)) 
      :ARG1 (c2 / contain-01 
            :ARG0 (o2 / organization 
                  :ARG0-of (b / bind-01 
                        :ARG1 (c / country 
                              :name (n2 / name) 
                              :wiki "United_Kingdom") 
                        :ARG4 (s / site 
                              :ARG1-of (s2 / specific-02)) 
                        :op2-of (a / and 
                              :op1 (d2 / domain 
                                    :mod (o / organization 
                                          :name (n / name 
                                                :op1 "ETS")))) 
                        :prep-as (d / domain)) 
                  :name (n3 / name 
                        :op1 "TEL")) 
            :ARG1 (d3 / domain 
                  :ARG1-of (b2 / binding-07 
                        :ARG0 (d4 / DNA))) 
            :ARG2 41))

# ::snt TEL could serve to nucleate a polymer , which would spread by oligomerization of the SAM domain .
# ::tok TEL could serve to nucleate a polymer , which would spread by oligomerization of the SAM domain .
# ::alignments 16-17|0.0.1.0.0.0 15-16|0.0.1.0.0.0.0 12-13|0.0.1.0.0 10-11|0.0.1.0 6-7|0.0.1 2-3|0.0 1-2|0 0-1|0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:13.809
(p2 / possible-01 
      :ARG1 (s3 / serve-01 
            :ARG0 (o2 / organization 
                  :name (n / name 
                        :op1 "TEL")) 
            :ARG1 (p / polym 
                  :ARG1-of (s2 / spread-02 
                        :ARG0 (o / oligomerization 
                              :poss-of (d / domain 
                                    :mod (s / sam)))))))

# ::snt In contrast to TEL , ph does not contain an obvious sequence-specific DNA binding motif ( 16 ) .
# ::tok In contrast to TEL , ph does not contain an obvious sequence-specific DNA binding motif ( 16 ) .
# ::alignments 16-17|0.2.0 14-15|0.1 13-14|0.1.1 12-13|0.1.1.0 10-11|0.1.0 8-9|0 7-8|0.3 5-6|0.0 3-4|0.2.1.0.0+0.2.1.0+0.2.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:13.921
(c / contain-01 
      :ARG0 (p / ph) 
      :ARG1 (m / motif 
            :ARG1-of (o / obvious-01) 
            :ARG1-of (b / binding-07 
                  :ARG0 (d / DNA))) 
      :ARG1-of (c2 / contrast-01 
            :ARG0 16 
            :ARG2 (o2 / organization 
                  :name (n / name 
                        :op1 "TEL"))) 
      :polarity -)

# ::snt Therefore , its initial binding to the template may require protein-protein interactions with other sequence-specific transcriptional repressors .
# ::tok Therefore , its initial binding to the template may require protein-protein interactions with other sequence-specific transcriptional repressors .
# ::alignments 16-17|0.0.1.0 13-14|0.0.1.0.0 11-12|0.0.1 9-10|0.0 8-9|0 7-8|0.0.0.0 4-5|0.0.0 3-4|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:14.008
(p / possible-01 
      :ARG1 (r2 / require-01 
            :ARG0 (b / binding-07 
                  :ARG1 (t / template) 
                  :time (i2 / initial)) 
            :ARG1 (i / interaction 
                  :prep-with (r / repressor 
                        :mod (o / other)))))

# ::snt The segmentation gene-encoding transcriptional repressors such as Hunchback have a role in recruiting SAM domain-containing PcG proteins , which can spread along the template via polymerization [ 42 ] .
# ::tok The segmentation gene-encoding transcriptional repressors such as Hunchback have a role in recruiting SAM domain-containing PcG proteins , which can spread along the template via polymerization [ 42 ] .
# ::alignments 27-28|0.0.0.0.1 25-26|0.0.0.0.2 23-24|0.0.1 21-22|0.0.2 20-21|0.0 19-20|0 16-17|0.0.0 15-16|0.0.0.1 14-15|0.0.0.2 13-14|0.0.0.3 12-13|0.0.0.0 10-11|0.0.0.0.3 7-8|0.0.0.0.0 5-6|0.1 4-5|0.0.0.0.0.0 2-3|0.0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:14.545
(p2 / possible-01 
      :ARG1 (s / spread-02 
            :ARG0 (p3 / protein 
                  :ARG1-of (r / recruit-01 
                        :ARG0 (h / hunchback 
                              :example-of (r3 / repressor 
                                    :mod (g / gene-encod) 
                                    :mod (s4 / segmentation))) 
                        :op1-of 42 
                        :op1-of (p / polymerization) 
                        :purpose-of (r2 / role)) 
                  :mod (p4 / PcG) 
                  :mod (d / domain-contain) 
                  :mod (s2 / sam)) 
            :ARG1 (t / template) 
            :manner (a / along)) 
      :op1-of (s3 / such))

# ::snt Since mr-s does not contain obvious DNA binding motifs , we suppose that there is a sequence-specific transcription factor ( s ) which interacts with mr-s .
# ::tok Since mr-s does not contain obvious DNA binding motifs , we suppose that there is a sequence-specific transcription factor ( s ) which interacts with mr-s .
# ::alignments 25-26|0.0.0.1 23-24|0.0.0 18-19|0.0.0.0 17-18|0.0.0.0.0 11-12|0 10-11|0.0 8-9|0.1.0.1 7-8|0.1.0.1.0 6-7|0.1.0.1.0.0 5-6|0.1.0.1.1 4-5|0.1.0 3-4|0.1.0.2 1-2|0.1.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:14.740
(s / suppose-01 
      :ARG0 (w / we 
            :ARG0-of (i / interact-01 
                  :ARG1 (f / factor 
                        :mod (t / transcription)) 
                  :ARG2 (m / mr-))) 
      :time (s2 / since 
            :op1 (c / contain-01 
                  :ARG0 (m3 / mr-) 
                  :ARG1 (m2 / motif 
                        :ARG0-of (b / binding-07 
                              :ARG1 (d / DNA)) 
                        :ARG1-of (o / obvious-01)) 
                  :polarity -)))

# ::snt However , we did not find any transcription factors in the present yeast two-hybrid screening .
# ::tok However , we did not find any transcription factors in the present yeast two-hybrid screening .
# ::alignments 14-15|0 12-13|0.1 11-12|0.0 8-9|0.2.1 7-8|0.2.1.0 6-7|0.2.1.1 5-6|0.2 4-5|0.2.2 2-3|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:14.841
(s / screen-01 
      :ARG1 (p / present) 
      :mod (y / yeast) 
      :purpose-of (f2 / find-01 
            :ARG0 (w / we) 
            :ARG1 (f / factor 
                  :mod (t / transcription) 
                  :mod (a / any)) 
            :polarity -))

# ::snt We also found that full-length mr-s fused to the GAL4 DNA binding domain ( DBD-mrs ) functions as a transcriptional repressor .
# ::tok We also found that full-length mr-s fused to the GAL4 DNA binding domain ( DBD-mrs ) functions as a transcriptional repressor .
# ::alignments 20-21|0.0.0.0 16-17|0.0.0 14-15|0.1.0.0.0 12-13|0.1.1 11-12|0.1.0.0 10-11|0.1.2 6-7|0.1 5-6|0.1.0 4-5|0.1.0.1 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:14.971
(f4 / find-01 
      :ARG0 (w / we 
            :ARG0-of (f / function-01 
                  :ARG2 (r / repressor))) 
      :ARG1 (f2 / fuse-01 
            :ARG0 (m / mr- 
                  :ARG0-of (b / binding-07 
                        :ARG1 (d / dbd-mr)) 
                  :mod (f3 / full-length)) 
            :ARG1 (d2 / domain) 
            :ARG2 (d3 / DNA)) 
      :mod (a / also))

# ::snt This may support the idea that mr-s is involved in repressive complexes similar to other SAM domain-containing proteins .
# ::tok This may support the idea that mr-s is involved in repressive complexes similar to other SAM domain-containing proteins .
# ::alignments 17-18|0 16-17|0.1 15-16|0.0.0.1.1 14-15|0.0.0.0.0 12-13|0.0 11-12|0.0.0 10-11|0.0.0.0 8-9|0.0.0.1 6-7|0.0.0.1.0 4-5|0.0.0.1.2 2-3|0.0.0.1.2.0 1-2|0.0.0.1.2.0.1 0-1|0.0.0.1.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:15.279
(p / protein 
      :ARG2-of (r / resemble-01 
            :ARG1 (c / complex 
                  :ARG0-of (r2 / repress-01 
                        :ARG1 (o / other)) 
                  :ARG2-of (i / involve-01 
                        :ARG1 (m / mr-) 
                        :ARG3 (s / sam) 
                        :topic-of (i2 / idea 
                              :ARG1-of (s2 / support-01 
                                    :ARG0 (t / this) 
                                    :ARG1-of (p2 / possible-01)))))) 
      :mod (d / domain-contain))

# ::snt Our results , however , showed that the self-association of mr-s through its SAM domain is not essential for the transcriptional repressive activity .
# ::tok Our results , however , showed that the self-association of mr-s through its SAM domain is not essential for the transcriptional repressive activity .
# ::alignments 22-23|0.1.1 21-22|0.1.1.0 17-18|0.1 16-17|0.1.0 14-15|0.1.1.0.0.0.0 13-14|0.1.1.0.0.0 10-11|0.1.1.0.0 5-6|0 1-2|0.0.0+0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:15.364
(s2 / show-01 
      :ARG0 (t / thing 
            :ARG2-of (r2 / result-01 
                  :ARG1 (w / we))) 
      :ARG1 (e / essential 
            :polarity - 
            :purpose (a / activity-06 
                  :ARG0-of (r / repress-01 
                        :ARG1 (m / mr- 
                              :poss-of (s / sam 
                                    :mod-of (d / domain)))))))

# ::snt Polymerization of the SAM domain has been previously reported to be essential for the repressive functions of ph and TEL [ 43,44 ] .
# ::tok Polymerization of the SAM domain has been previously reported to be essential for the repressive functions of ph and TEL [ 43,44 ] .
# ::alignments 19-20|0.1.0.0+0.1.0+0.1 18-19|0 17-18|0.0.1 15-16|0.0 14-15|0.0.0 11-12|0.0.2 8-9|0.0.2.0 7-8|0.0.2.0.1 4-5|0.0.2.0.0.0 3-4|0.0.2.0.0.0.0 0-1|0.0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:15.715
(a / and 
      :op1 (f / function-01 
            :ARG0-of (r / repress-01) 
            :ARG1 (p / ph) 
            :purpose-of (e / essential 
                  :ARG2-of (r2 / report-01 
                        :ARG1 (p3 / polymerization 
                              :poss-of (d / domain 
                                    :mod (s / sam))) 
                        :time (p2 / previous)))) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "TEL")))

# ::snt On the other hand , human lethal ( 3 ) malignant brain tumor ( H-L ( 3 ) MBT ) protein , which also contains a SAM domain at the C-terminus , was reported as a transcriptional repressor and the repressor activity of H-L ( 3 ) MBT required mainly the presence of the MBT repeats but not the SAM domain [ 45 ] .
# ::tok On the other hand , human lethal ( 3 ) malignant brain tumor ( H-L ( 3 ) MBT ) protein , which also contains a SAM domain at the C-terminus , was reported as a transcriptional repressor and the repressor activity of H-L ( 3 ) MBT required mainly the presence of the MBT repeats but not the SAM domain [ 45 ] .
# ::alignments 62-63|0.1.2.3 60-61|0.0.0 57-58|0.1.0.0.4 56-57|0 55-56|0.0 54-55|0.0.1 51-52|0.1.1 49-50|0.1.3 48-49|0.1 47-48|0.1.2.2 45-46|0.1.2.2.0 43-45|0.1.4.1.0.0.1+0.1.4.1.0.0.0+0.1.4.1.0.0+0.1.4.1.0 41-42|0.1.2 40-41|0.1.2.1 38-39|0.1.4 37-38|0.1.4.1.2 33-34|0.1.4.1 30-31|0.1.0.0.1 27-28|0.1.0.0.0 26-27|0.1.0.0.0.0 24-25|0.1.0.0 23-24|0.1.0.0.2 20-21|0.1.0 18-19|0.1.2.4 16-17|0.1.2.5 14-16|0.1.4.1.1.0.1+0.1.4.1.1.0.0+0.1.4.1.1.0+0.1.4.1.1 12-13|0.1.4.0.0.0 11-12|0.1.4.0.0 10-11|0.1.4.0 8-9|0.0.2 6-7|0.1.2.0 5-6|0.1.2.0.0 3-4|0.1.0.0.3 2-3|0.1.0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:18.450
(c / contrast-01 
      :ARG2 (r / repeat-01 
            :ARG0 (d / domain) 
            :ARG1 (m / MBT) 
            :op1-of 3) 
      :purpose-of (r2 / require-01 
            :ARG0 (p2 / protein 
                  :ARG0-of (c3 / contain-01 
                        :ARG1 (d2 / domain 
                              :mod (s / sam)) 
                        :ARG2 (c2 / c-terminu) 
                        :mod (a3 / also) 
                        :op1-of (h2 / hand 
                              :mod (o3 / other)) 
                        :op1-of -)) 
            :ARG1 (p / presence) 
            :ARG2 (a / activity-06 
                  :ARG0 (l / lethal 
                        :mod (h / human)) 
                  :ARG1 (r3 / repressor) 
                  :ARG2 (m3 / MBT 
                        :li 3) 
                  :op1-of 45 
                  :op1-of (m4 / MBT) 
                  :op1-of 3) 
            :mod (m2 / main) 
            :op2-of (a2 / and 
                  :ARG0-of (m5 / malignant-02 
                        :ARG1 (b / brain 
                              :mod-of (t / tumor))) 
                  :op1 (r5 / report-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "H-L" 
                                    :op2 "(")) 
                        :ARG1 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "H-L" 
                                    :op2 "(")) 
                        :ARG2 (r4 / repressor)))))

# ::snt To determine the transcriptional repressor region of the mr-s protein , we performed a luciferase assay using site-directed mutants ( DBD-W404A and DBD-G453A ) .
# ::tok To determine the transcriptional repressor region of the mr-s protein , we performed a luciferase assay using site-directed mutants ( DBD-W404A and DBD-G453A ) .
# ::alignments 22-23|0.2.0.0+0.2.0+0.2 21-22|0 20-21|0.1.0.0+0.1.0+0.1 18-19|0.0.1 17-18|0.0.1.0 16-17|0.0 15-16|0.0.0 12-13|0.0.0.0 11-12|0.0.0.0.0 9-10|0.0.0.0.0.0.0.1 8-9|0.0.0.0.0.0.0.1.0 5-6|0.0.0.0.0.0.0 4-5|0.0.0.0.0.0.0.0 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:18.785
(a / and 
      :op1 (u / use-01 
            :ARG0 (a2 / assay 
                  :ARG1-of (p / perform-02 
                        :ARG0 (w / we 
                              :ARG0-of (d / determine-01 
                                    :ARG1 (r / region 
                                          :mod (r2 / repressor) 
                                          :mod (p2 / protein 
                                                :mod (m2 / mr-))))))) 
            :ARG1 (m / mutant 
                  :mod (s / site-direct))) 
      :op2 (o2 / organization 
            :name (n2 / name 
                  :op1 "DBD-W404A")) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "DBD-G453A")))

# ::snt The result showed that the reduced binding ability of self-association partially compromises the transcriptional repressive activity of mr-s ( Fig. 7D ) .
# ::tok The result showed that the reduced binding ability of self-association partially compromises the transcriptional repressive activity of mr-s ( Fig. 7D ) .
# ::alignments 19-20|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 17-18|0.1.1.2 15-16|0.1.1 14-15|0.1.1.1 11-12|0.1 10-11|0.1.2 7-8|0.1.0 6-7|0.1.0.1 5-6|0.1.0.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:18.975
(s / show-01 
      :ARG0 (r3 / result-01) 
      :ARG1 (c2 / compromise-01 
            :ARG0 (a2 / ability 
                  :ARG1-of (r2 / reduce-01) 
                  :ARG1-of (b / binding-07)) 
            :ARG1 (a / activity-06 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "Fig.")) 
                  :ARG0-of (r / repress-01) 
                  :ARG1 (m / mr-)) 
            :manner (p / partial)))

# ::snt However , the repressive effect was more significant when DBD-tail , which does not contain SAM domain , was co-introduced with the 5xGAL4-pGL3 reporter plasmid .
# ::tok However , the repressive effect was more significant when DBD-tail , which does not contain SAM domain , was co-introduced with the 5xGAL4-pGL3 reporter plasmid .
# ::alignments 23-24|0.1.0.0 16-17|0.0 15-16|0.0.0 14-15|0 13-14|0.2 7-8|0.1.0.1 6-7|0.1.0.1.0 4-5|0.1.0 3-4|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:19.040
(c / contain-01 
      :ARG1 (d / domain 
            :mod (s / sam)) 
      :ARG1-of (r2 / repress-01 
            :ARG0 (e / effect-03 
                  :ARG1-of (r / report-01) 
                  :ARG1-of (s2 / significant-02 
                        :degree (m / more)))) 
      :polarity -)

# ::snt Therefore , we conclude that a region from amino acids 463 to 542 is mainly responsible for the repressor activity in the case of mr-s .
# ::tok Therefore , we conclude that a region from amino acids 463 to 542 is mainly responsible for the repressor activity in the case of mr-s .
# ::alignments 24-25|0.0.0.0.1.0 22-23|0.0.0.0.1 19-20|0.0.0.0 18-19|0.0.0.0.2 15-16|0.0.0 14-15|0.0.0.1 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0.0.0 6-7|0.0.0.0.0 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:19.166
(c2 / conclude-02 
      :ARG0 (w / we 
            :ARG0-of (r2 / responsible-01 
                  :ARG1 (a / activity-06 
                        :ARG0 (r3 / region 
                              :source (a2 / acid 
                                    :mod (a3 / amino))) 
                        :ARG1 (c / case-03 
                              :ARG1 (m / mr-)) 
                        :mod (r / repressor)) 
                  :manner (m2 / main))))

# ::snt Evolutionary conservation of the C-terminal 80 aa region of mr-s from zebrafish through human may underlie the functional importance of this region .
# ::tok Evolutionary conservation of the C-terminal 80 aa region of mr-s from zebrafish through human may underlie the functional importance of this region .
# ::alignments 21-22|0.0.1.0 20-21|0.0.1.0.0 18-19|0.0.1 17-18|0.0.1.1 15-16|0.0 14-15|0 13-14|0.0.0.2 11-12|0.0.0.0.1.0 9-10|0.0.0.0.1 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0 4-5|0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:19.611
(p / possible-01 
      :ARG1 (u / underlie-01 
            :ARG0 (c / conserve-01 
                  :ARG1 (r2 / region 
                        :mod (a / aa 
                              :quant 80) 
                        :mod (m / mr- 
                              :source (z / zebrafish)) 
                        :mod (o / organization 
                              :name (n / name 
                                    :op1 "C-terminal"))) 
                  :mod (e / evolutionary) 
                  :op1-of (h / human)) 
            :ARG1 (i / important 
                  :domain (r / region 
                        :mod (t / this)) 
                  :mod (f / functional))))

# ::snt Two distinct multiprotein PcG complexes , PRC1 and PRC2 , have been identified .
# ::tok Two distinct multiprotein PcG complexes , PRC1 and PRC2 , have been identified .
# ::alignments 12-13|0.1.1.0 8-9|0.1.1.1.0+0.1.1.1+0.1.1 7-8|0.1 6-7|0.0.0+0.0+0 4-5|0.1.0 2-3|0.1.0.0.0 1-2|0.1.0.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:19.663
(t2 / thing 
      :name (n2 / name 
            :op1 "PRC1") 
      :op2-of (a / and 
            :op1 (c / complex 
                  :mod (d / distinct 
                        :mod-of (m / multiprotein)) 
                  :quant 2) 
            :op3 (t / thing 
                  :ARG0-of (i / identify-01) 
                  :name (n / name 
                        :op1 "PRC2"))))

# ::snt PRC2 is involved in the initiation of silencing and contains histone deacetylases ( HDACs ) and histone methyltransferases , which can methylate histone H3 lysine 9 and 27 , marks of silenced chromatin .
# ::tok PRC2 is involved in the initiation of silencing and contains histone deacetylases ( HDACs ) and histone methyltransferases , which can methylate histone H3 lysine 9 and 27 , marks of silenced chromatin .
# ::alignments 32-33|0.1 31-32|0.1.0 29-30|0+0.0 27-28|0.0.0.0.1.0 26-27|0.0.0.0.1.1 25-26|0.0.0.0.3.0.1 24-25|0.0.0.0.3.0.2 22-23|0.0.0.0.3.1.0 20-21|0.0.0.0.1 17-18|0.0.0.1 16-17|0.0.0.1.0 15-16|0.0.0 13-14|0.1.0.0 11-12|0.0.0.0.2 10-11|0.0.0.0.2.0 9-10|0.0.0.0 8-9|0.0.0.0.3 7-8|0.0.0.0.3.1 5-6|0.0.0.0.3.0.0 2-3|0.0.0.0.3.0 0-1|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:21.191
(m / mark-01 
      :ARG0 (t / thing 
            :op2-of (a2 / and 
                  :ARG1-of (c2 / contain-01 
                        :ARG0 (t2 / thing 
                              :name (n / name 
                                    :op1 "PRC2")) 
                        :ARG1-of (p / possible-01 
                              :ARG0 27 
                              :op1-of (a / and)) 
                        :ARG2 (d / deacetylas 
                              :mod (h4 / histone)) 
                        :op2-of (a3 / and 
                              :ARG1-of (i2 / involve-01 
                                    :ARG2 (i / initiation) 
                                    :op1-of 9 
                                    :op1-of (l / lysine)) 
                              :op1 (s2 / silence-01 
                                    :ARG0 (h / histone)))) 
                  :op1 (m2 / methyltransferas 
                        :mod (h2 / histone)))) 
      :ARG1 (c / chromatin 
            :ARG1-of (s / silence-01 
                  :ARG0 (h3 / hdac))))

# ::snt PRC1 , including ph , recognizes the histone H3 lysine 27 mark set by PRC2 and maintains a stable state of gene repression in which PRC1 blocks chromatin remodeling by the trithorax group-related SWI-SNF complex [ 46,47 ] .
# ::tok PRC1 , including ph , recognizes the histone H3 lysine 27 mark set by PRC2 and maintains a stable state of gene repression in which PRC1 blocks chromatin remodeling by the trithorax group-related SWI-SNF complex [ 46,47 ] .
# ::alignments 34-35|0.1.0.1.1.0.0 32-33|0.0.0 28-29|0.1.0.1.0.0 27-28|0.1.0.1.0.0.1 26-27|0.1.0.1.0 22-23|0.1.0.1.1.0 21-22|0.1.0.1.1.0.1 19-20|0.1.0.1 18-19|0.1.0.1.1 16-17|0.1.0 15-16|0.1 14-15|0.1.0.1.1.0.2.0.0+0.1.0.1.1.0.2.0+0.1.0.1.1.0.2 11-12|0.0 10-11|0.0.3 9-10|0.1.0.1.0.0.0 7-8|0.0.2 5-6|0 3-4|0.0.1 0-1|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:22.637
(r3 / recognize-02 
      :ARG1 (m2 / mark-01 
            :ARG1 (g / group-relat) 
            :ARG2 (p / ph) 
            :mod (h / histone) 
            :quant 27) 
      :op1-of (a / and 
            :op2 (m / maintain-01 
                  :ARG0 (t2 / thing 
                        :name (n2 / name 
                              :op1 "PRC1")) 
                  :ARG1 (s / state 
                        :ARG0-of (b / block-01 
                              :ARG1 (r / remodel-01 
                                    :ARG0 (l / lysine) 
                                    :ARG1 (c2 / chromatin))) 
                        :ARG1-of (s2 / stable-03 
                              :ARG2 (r2 / repress-01 
                                    :ARG0 (c / complex) 
                                    :mod (g2 / gene) 
                                    :mod-of (t / thing 
                                          :name (n / name 
                                                :op1 "PRC2"))))))))

# ::snt Therefore , the mechanism of repression by PRC2 is thought to be HDAC-dependent while the mechanism of repression by PRC1 appears to be HDAC-independent .
# ::tok Therefore , the mechanism of repression by PRC2 is thought to be HDAC-dependent while the mechanism of repression by PRC1 appears to be HDAC-independent .
# ::alignments 20-21|0 19-20|0.0.0.0.0+0.0.0.0+0.0.0 17-18|0.0 15-16|0.1 9-10|0.0.1.1 7-8|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 5-6|0.0.1 3-4|0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:22.871
(a / appear-02 
      :ARG0 (r / repress-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 "PRC1")) 
            :ARG1 (r2 / repress-01 
                  :ARG0 (t3 / thing 
                        :name (n2 / name 
                              :op1 "PRC2")) 
                  :ARG1 (t2 / think-01 
                        :ARG1 (m2 / mechanism)))) 
      :ARG1 (m / mechanism))

# ::snt Our luciferase assay also showed that transcriptional repression of DBD-mrs was not affected by the addition of various concentrations of trichostatin A , a potent HDAC inhibitor ( data not shown ) .
# ::tok Our luciferase assay also showed that transcriptional repression of DBD-mrs was not affected by the addition of various concentrations of trichostatin A , a potent HDAC inhibitor ( data not shown ) .
# ::alignments 30-31|0 29-30|0.2 28-29|0.0 26-27|0.1.0.0 25-26|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 24-25|0.1.0 20-22|0.1.2.0.0.1.0.1+0.1.2.0.0.1.0.0+0.1.2.0.0.1.0+0.1.2.0.0.1 18-19|0.1.2.0.0 17-18|0.1.2.0.0.0 15-16|0.1.2.0 12-13|0.1.2 11-12|0.1.2.2 9-10|0.1.1 7-8|0.1 4-5|0.1.2.1 3-4|0.1.2.1.1 2-3|0.1.2.1.0 1-2|0.1.2.1.0.0 0-1|0.1.2.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:23.570
(s / show-01 
      :ARG1 (d / data) 
      :ARG2-of (r / repress-01 
            :ARG0 (p / potent 
                  :mod-of (i / inhibitor 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "HDAC")))) 
            :ARG1 (d2 / dbd-mr) 
            :ARG1-of (a3 / affect-01 
                  :ARG0 (a2 / addition 
                        :mod (c / concentration 
                              :mod (v / various) 
                              :poss (t2 / thing 
                                    :name (n2 / name 
                                          :op1 (t3 / trichostatin) 
                                          :op2 (a / A))))) 
                  :ARG1-of (s2 / show-01 
                        :ARG0 (a5 / assay 
                              :mod (l / luciferase) 
                              :poss (w / we)) 
                        :mod (a4 / also)) 
                  :polarity -)) 
      :polarity -)

# ::snt Therefore , we speculate that the mechanism of repression of mr-s may be HDAC-independent and more similar to that of PRC1 complex .
# ::tok Therefore , we speculate that the mechanism of repression of mr-s may be HDAC-independent and more similar to that of PRC1 complex .
# ::alignments 21-22|0.1.1.1.0 20-21|0.1.1.1.1.0+0.1.1.1.1+0.1.1.1 16-17|0.1.1 15-16|0.1.1.2 14-15|0.1 11-12|0.1.0 10-11|0.0.0.0 8-9|0.0.0 6-7|0.1.1.0 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:23.652
(s / speculate-01 
      :ARG0 (w / we 
            :ARG0-of (r2 / repress-01 
                  :ARG1 (m2 / mr-))) 
      :ARG1 (a / and 
            :ARG1-of (p / possible-01) 
            :op1 (r / resemble-01 
                  :ARG1 (m3 / mechanism) 
                  :ARG2 (t / thing 
                        :mod-of (c / complex) 
                        :name (n / name 
                              :op1 "PRC1")) 
                  :degree (m / more))))

# ::snt In the present study , the biochemical experiments demonstrate that the mr-s protein functions as a transcriptional repressor and possibly down-regulates the spatial and temporal expression of the target genes during retinal photoreceptor development .
# ::tok In the present study , the biochemical experiments demonstrate that the mr-s protein functions as a transcriptional repressor and possibly down-regulates the spatial and temporal expression of the target genes during retinal photoreceptor development .
# ::alignments 33-34|0.2.1.2 32-33|0.2.1.2.0 31-32|0.2.1.1.0.0.0 29-30|0.2.0 28-29|0.2.0.0 25-26|0.2 24-25|0.1 23-24|0 22-23|0.0 19-20|0.2.1.0.2 18-19|0.2.1 17-18|0.2.1.1 16-17|0.2.1.0.0 13-14|0.2.1.0 12-13|0.2.1.0.1 11-12|0.2.1.0.3 8-9|0.2.1.1.0 7-8|0.2.1.1.0.0 6-7|0.2.1.1.0.0.1 3-4|0.2.1.1.0.1 2-3|0.2.1.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:24.001
(a / and 
      :op1 (s / spatial) 
      :op2 (t2 / temporal) 
      :op3 (e / express-01 
            :ARG1 (g / gene 
                  :ARG1-of (t / target-01)) 
            :op3-of (a2 / and 
                  :op1 (f / function-01 
                        :ARG0 (t3 / transcriptional) 
                        :ARG1 (p3 / protein) 
                        :ARG1-of (p2 / possible-01) 
                        :mod (m / mr-)) 
                  :op2 (r2 / repressor 
                        :ARG1-of (d2 / demonstrate-01 
                              :ARG0 (e2 / experiment-01 
                                    :ARG1 (r / retinal) 
                                    :mod (b / biochemical)) 
                              :ARG2 (s2 / study-01 
                                    :time (p4 / present)))) 
                  :op4 (d / develop-02 
                        :ARG1 (p / photoreceptor)))))

# ::snt Our data also revealed that the repressive activity of mr-s is mainly due to the C-terminal region ( amino acids 463 to 542 ) .
# ::tok Our data also revealed that the repressive activity of mr-s is mainly due to the C-terminal region ( amino acids 463 to 542 ) .
# ::alignments 19-20|0.1.1.0 18-19|0.1.1.0.0 16-17|0.1.0.0 15-16|0.1.0.1.0+0.1.0.1+0.1.0 11-12|0.2 9-10|0.1.2 7-8|0.1 6-7|0.1.1 3-4|0 2-3|0.3 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:24.339
(r3 / reveal-01 
      :ARG0 (d / data 
            :poss (w / we)) 
      :ARG2 (a3 / activity-06 
            :ARG0 (o / organization 
                  :mod-of (r / region) 
                  :name (n / name 
                        :op1 "C-terminal")) 
            :ARG0-of (r2 / repress-01 
                  :ARG1 (a / acid 
                        :op1-of (a2 / amino))) 
            :ARG1 (m2 / mr-)) 
      :manner (m / main) 
      :mod (a4 / also))

# ::snt However , downstream targets of mr-s still remain unclear .
# ::tok However , downstream targets of mr-s still remain unclear .
# ::alignments 8-9|0.0.0.1.0+0.0.0.1 7-8|0.0.0 6-7|0.0 5-6|0 3-4|0.0.0.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:24.362
(m / mr- 
      :op1 (s / still 
            :mod-of (r / remain-01 
                  :ARG1 (t / target 
                        :mod (d / downstream)) 
                  :ARG3 (c / clear-06 
                        :polarity -))))

# ::snt In situ hybridization showed that the peak of mr-s expression is around P6 , when retinal photoreceptors undergo terminal differentiation .
# ::tok In situ hybridization showed that the peak of mr-s expression is around P6 , when retinal photoreceptors undergo terminal differentiation .
# ::alignments 19-20|0.1.0.0.0.1 18-19|0.1.0.0.0.1.0 17-18|0.1.0.0.0 16-17|0.1.0.0.0.0 15-16|0.1.0.0.0.0.0 12-13|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 11-12|0.1.0.0.2 9-10|0.1.0 8-9|0.1.0.1 6-7|0.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:24.946
(s / show-01 
      :ARG0 (h / hybridization) 
      :ARG1 (p2 / peak-01 
            :ARG1 (e / express-01 
                  :ARG1 (t2 / thing 
                        :ARG3-of (u / undergo-28 
                              :ARG1 (p / photoreceptor 
                                    :mod (r / retinal)) 
                              :ARG2 (d / differentiation 
                                    :mod (t / terminal))) 
                        :name (n / name 
                              :op1 "P6") 
                        :op1-of (a / around)) 
                  :mod (m / mr-))))

# ::snt We hypothesize that the target genes of mr-s might be non-photoreceptor genes .
# ::tok We hypothesize that the target genes of mr-s might be non-photoreceptor genes .
# ::alignments 11-12|0.0.0.1.0.0 8-9|0.0 7-8|0 5-6|0.0.0.1.0 4-5|0.0.0.1 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:25.096
(m / mr- 
      :ARG1-of (p / possible-01 
            :ARG1-of (h / hypothesize-01 
                  :ARG0 (w / we) 
                  :manner (t / target-01 
                        :ARG1 (g2 / gene 
                              :domain-of (g / gene))))))

# ::snt In this case , mr-s may suppress the expression of non-photoreceptor genes in rod and cone photoreceptors .
# ::tok In this case , mr-s may suppress the expression of non-photoreceptor genes in rod and cone photoreceptors .
# ::alignments 16-17|0.0.1.1.2 15-16|0.0.1.1.1 14-15|0.0.1.1 13-14|0.0.1.1.0 11-12|0.0.1.0 8-9|0.0.1 6-7|0.0 5-6|0 4-5|0.0.0 2-3|0.0.2 1-2|0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:25.314
(p2 / possible-01 
      :ARG1 (s / suppress-01 
            :ARG0 (m / mr-) 
            :ARG1 (e / express-01 
                  :ARG0 (g / gene) 
                  :ARG1 (a / and 
                        :op1 (r / rod) 
                        :op2 (c / cone) 
                        :op3 (p / photoreceptor))) 
            :topic (c2 / case-03 
                  :mod (t / this))))

# ::snt There may be another possibility that mr-s is involved in cell fate determination of rod photoreceptors versus cone photoreceptors .
# ::tok There may be another possibility that mr-s is involved in cell fate determination of rod photoreceptors versus cone photoreceptors .
# ::alignments 18-19|0.0.0 17-18|0.0.0.0 16-17|0.0.0.1 15-16|0.0.1.1.1 14-15|0.0.1.1.1.0 12-13|0.0.1.1 11-12|0.0.1.1.0 10-11|0.0.1.1.0.0 8-9|0.0.1 6-7|0.0.1.0 4-5|0.0 3-4|0.0.2 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:25.622
(p4 / possible-01 
      :ARG1 (p3 / possible-01 
            :ARG0 (p / photoreceptor 
                  :mod (c / cone) 
                  :op1-of (v / versu)) 
            :ARG1 (i / involve-01 
                  :ARG1 (m / mr-) 
                  :ARG2 (d / determine-01 
                        :ARG1 (f / fate 
                              :mod (c2 / cell)) 
                        :ARG2 (p2 / photoreceptor 
                              :mod (r / rod)))) 
            :mod (a / another)))

# ::snt While cone photoreceptors are born during the early embryonic stages of mouse retinogenesis , rod photoreceptors are born primarily in the late embryonic and early postnatal period [ 48 ] .
# ::tok While cone photoreceptors are born during the early embryonic stages of mouse retinogenesis , rod photoreceptors are born primarily in the late embryonic and early postnatal period [ 48 ] .
# ::alignments 28-29|0.0.0.1.0 26-27|0.0.0.1.1.0.1.1.0.0.0 25-26|0.0.0.1.1.0.1.1.0.0 24-25|0.0.0.1.1.0.1.1.0 23-24|0.0.0.1.1.0.1.1 22-23|0.0.0.1.1.0.1 21-22|0.0.0.1.1.0.1.0 18-19|0.0.0.1.1.0.2 17-18|0.0.0.1.1.0 15-16|0.0.0.1.1.0.0 14-15|0.0.0.1.1.0.0.0 12-13|0.0 11-12|0 9-10|0.0.0 8-9|0.0.0.0 7-8|0.0.0.1.3 4-5|0.0.0.1 2-3|0.0.0.1.2 1-2|0.0.0.1.2.0 0-1|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:25.912
(m / mouse 
      :mod-of (r2 / retinogenesi 
            :mod (s / stage 
                  :mod (e3 / embryonic) 
                  :time-of (b2 / bear-02 
                        :ARG0 48 
                        :ARG0-of (w / while-01 
                              :ARG1 (b / bear-02 
                                    :ARG1 (p4 / photoreceptor 
                                          :mod (r / rod)) 
                                    :location (e2 / embryonic 
                                          :mod (l / late) 
                                          :op1-of (a / and 
                                                :op2 (e / early 
                                                      :mod-of (p2 / postnatal 
                                                            :op1-of (p / period))))) 
                                    :mod (p3 / primary))) 
                        :ARG1 (p5 / photoreceptor 
                              :mod (c / cone)) 
                        :time (e4 / early)))))

# ::snt The expression pattern of mr-s may suggest that mr-s is expressed in rod photoreceptors but not in cone photoreceptors as well as Nr2e3 , which is known as a transcriptional repressor and is thought to down-regulate cone photoreceptor-specific genes .
# ::tok The expression pattern of mr-s may suggest that mr-s is expressed in rod photoreceptors but not in cone photoreceptors as well as Nr2e3 , which is known as a transcriptional repressor and is thought to down-regulate cone photoreceptor-specific genes .
# ::alignments 38-39|0.1.0.0 36-37|0.1.0.0.0 33-34|0.1.1 31-32|0.1 30-31|0.1.0.2 26-27|0.1.0 22-23|0.1.0.1 18-19|0.0.3 17-18|0.0.3.0 15-16|0.0.4 14-15|0 13-14|0.0.2 12-13|0.0.2.0 10-11|0.0 8-9|0.0.0 6-7|0.0.1 5-6|0.0.1.1 4-5|0.0.1.0.1 2-3|0.0.1.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:26.228
(c3 / contrast-01 
      :ARG1 (e / express-01 
            :ARG1 (m / mr-) 
            :ARG1-of (s / suggest-01 
                  :ARG0 (p4 / pattern 
                        :ARG1-of (e2 / express-01) 
                        :mod (m2 / mr-)) 
                  :ARG1-of (p3 / possible-01)) 
            :ARG2 (p2 / photoreceptor 
                  :mod (r2 / rod)) 
            :manner (p / photoreceptor 
                  :mod (c2 / cone)) 
            :mod -) 
      :ARG2 (a / and 
            :ARG3-of (k / know-02 
                  :ARG0 (g / gene 
                        :mod (c / cone)) 
                  :ARG1 (n / Nr2e3) 
                  :ARG2 (r / repressor)) 
            :op1 (t / think-01)))

# ::snt To clarify the biological function of mr-s , analysis of mice with targeted disruptions of mr-s will be very important .
# ::tok To clarify the biological function of mr-s , analysis of mice with targeted disruptions of mr-s will be very important .
# ::alignments 19-20|0.0.2.0.1 18-19|0.0.2.0.1.0 15-16|0.0.0 13-14|0.0.0.0 12-13|0.0.0.0.0 10-11|0.0.2.0.0 8-9|0.0.2.0 6-7|0 4-5|0.0 3-4|0.0.1 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:26.417
(m3 / mr- 
      :time-of (f / function-01 
            :ARG0 (m / mr- 
                  :mod-of (d / disruption 
                        :ARG1-of (t / target-01))) 
            :ARG1 (b / biology) 
            :ARG1-of (c / clarify-10 
                  :ARG0 (a / analyze-01 
                        :ARG1 (m2 / mouse) 
                        :domain-of (i / important 
                              :degree (v / very))))))

# ::snt Here we identified mouse mr-s , which is predominantly expressed in retinal photoreceptors and the pineal gland .
# ::tok Here we identified mouse mr-s , which is predominantly expressed in retinal photoreceptors and the pineal gland .
# ::alignments 16-17|0.0 15-16|0 13-14|0.0.0 12-13|0.0.0.0.1 11-12|0.0.0.0.1.0 9-10|0.0.0.0 8-9|0.0.0.0.2 4-5|0.0.0.0.0 3-4|0.0.0.0.0.1 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.0 0-1|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:26.702
(p / pineal 
      :mod-of (g / gland 
            :op2-of (a / and 
                  :op1 (e / express-01 
                        :ARG1 (m / mr- 
                              :ARG1-of (i / identify-01 
                                    :ARG0 (w / we) 
                                    :location (h / here)) 
                              :mod (m2 / mouse)) 
                        :ARG2 (p2 / photoreceptor 
                              :mod (r / retinal)) 
                        :mod (p3 / predominant)))))

# ::snt mr-s is evolutionarily conserved from zebrafish through to human , suggesting a significant role of mr-s in photoreceptor development .
# ::tok mr-s is evolutionarily conserved from zebrafish through to human , suggesting a significant role of mr-s in photoreceptor development .
# ::alignments 18-19|0.0.0.0.2.0 15-16|0.0.0.0.2 13-14|0.0.0.0 12-13|0.0.0.0.0 10-11|0.0.0 8-9|0.0.0.0.1 5-6|0.1 3-4|0 2-3|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:26.796
(c / conserve-01 
      :ARG1 (m2 / mr- 
            :ARG0-of (s2 / suggest-01 
                  :ARG1 (r / role 
                        :ARG1-of (s / significant-02) 
                        :mod (h / human) 
                        :poss (m / mr- 
                              :topic (d / develop-02))))) 
      :ARG2 (z / zebrafish) 
      :manner (e / evolutionarily))

# ::snt Our present data suggest that mr-s protein localizes in the nucleus and can self-associated mainly through the SAM domain .
# ::tok Our present data suggest that mr-s protein localizes in the nucleus and can self-associated mainly through the SAM domain .
# ::alignments 18-19|0.2.0 17-18|0.2 14-15|0.1.0.2 12-13|0.1.1 11-12|0.1 10-11|0.1.0.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1.0.0.0 3-4|0 2-3|0.0 1-2|0.0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:27.090
(s2 / suggest-01 
      :ARG0 (d2 / data 
            :mod (p3 / present) 
            :poss (w / we)) 
      :ARG1 (a / and 
            :op1 (l / localize-01 
                  :ARG0 (p2 / protein 
                        :mod (m2 / mr-)) 
                  :ARG1 (n / nucleus) 
                  :ARG2 (m / main)) 
            :op2 (p / possible-01)) 
      :op1-of (s / sam 
            :mod-of (d / domain)))

# ::snt Moreover , mr-s protein fused to GAL4 DBD functions as a transcriptional repressor .
# ::tok Moreover , mr-s protein fused to GAL4 DBD functions as a transcriptional repressor .
# ::alignments 12-13|0.2 8-9|0.1 6-8|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 4-5|0 3-4|0.0 2-3|0.0.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:27.141
(f2 / fuse-01 
      :ARG0 (p / protein 
            :mod (m / mr-)) 
      :ARG1 (f / function-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 (g / GAL4) 
                        :op2 (d / DBD)))) 
      :ARG2 (r / repressor) 
      :op1-of (m2 / moreover))

# ::snt The repressive activity of mr-s is due to its C-terminal region ( amino acid 463 to 542 ) .
# ::tok The repressive activity of mr-s is due to its C-terminal region ( amino acid 463 to 542 ) .
# ::alignments 13-14|0 12-13|0.0 10-11|0.0.0.0.0.0 4-5|0.0.0.0.0 2-3|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:27.197
(a / acid 
      :mod (a2 / amino 
            :ARG1-of (r2 / repress-01 
                  :ARG0 (a3 / activity-06 
                        :ARG1 (m / mr- 
                              :op1-of (r / region))))))

# ::snt Taken together , mr-s is a novel repressor molecule possibly involved in the development of retinal photoreceptors and pineal gland .
# ::tok Taken together , mr-s is a novel repressor molecule possibly involved in the development of retinal photoreceptors and pineal gland .
# ::alignments 19-20|0.0 18-19|0 17-18|0.0.0 16-17|0.0.0.1.0 15-16|0.0.0.1.0.0 13-14|0.0.0.1 10-11|0.0.0.1.1 9-10|0.0.0.1.1.1 8-9|0.0.0.1.1.0 7-8|0.0.0.2 6-7|0.0.0.1.1.0.1 3-4|0.0.0.1.1.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:27.296
(p / pineal 
      :mod-of (g / gland 
            :op3-of (a / and 
                  :op1 (t2 / take-01 
                        :mod (t / together)) 
                  :op2 (d / develop-02 
                        :ARG1 (p2 / photoreceptor 
                              :mod (r / retinal)) 
                        :ARG2-of (i / involve-01 
                              :ARG1 (m / molecule 
                                    :domain (m2 / mr-) 
                                    :mod (n / novel)) 
                              :ARG1-of (p3 / possible-01))) 
                  :poss-of (r2 / repressor))))

# ::snt Isolation of mouse mr-s cDNA .
# ::tok Isolation of mouse mr-s cDNA .
# ::alignments 4-5|0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:27.304
(i / isolation 
      :mod (m / mouse 
            :mod-of (c / cdna)))

# ::snt We used the bioinformatics method Digital Differential Display ( NCBI , UniGene ) to screen novel mouse genes expressed preferentially in the retina .
# ::tok We used the bioinformatics method Digital Differential Display ( NCBI , UniGene ) to screen novel mouse genes expressed preferentially in the retina .
# ::alignments 22-23|0.0.3 19-20|0 18-19|0.0 17-18|0.0.1 16-17|0.0.1.0 15-16|0.0.0.0.0.0 14-15|0.0.0.0.2 11-12|0.0.2.0.0+0.0.2.0+0.0.2 9-10|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 5-8|0.0.0.1.2+0.0.0.1.1+0.0.0.1.0+0.0.0.1+0.0.0 4-5|0.0.0.0.1 3-4|0.0.0.0.1.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:27.883
(p / preferentially 
      :mod-of (e / express-01 
            :ARG0 (o3 / organization 
                  :manner-of (u / use-01 
                        :ARG0 (w / we 
                              :mod-of (n / novel) 
                              :poss-of (o2 / organization 
                                    :name (n3 / name 
                                          :op1 "NCBI"))) 
                        :ARG1 (m2 / method 
                              :mod (b / bioinformatic)) 
                        :ARG2 (s / screen)) 
                  :name (n4 / name 
                        :op1 "Digital" 
                        :op2 "Differential" 
                        :op3 "Display")) 
            :ARG1 (g / gene 
                  :mod (m / mouse)) 
            :ARG2 (o / organization 
                  :name (n2 / name 
                        :op1 "UniGene")) 
            :manner (r / retina)))

# ::snt Some of the clusters in the UniGene database were mainly from mouse retinal cDNAs .
# ::tok Some of the clusters in the UniGene database were mainly from mouse retinal cDNAs .
# ::alignments 13-14|0.0.1 12-13|0.0.1.0 11-12|0.0.1.0.0 9-10|0.0.0 7-8|0 6-7|0.1.0.0+0.1.0+0.1 3-4|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:27.923
(d / database 
      :location-of (c2 / cluster 
            :mod-of (m2 / main) 
            :mod-of (c / cdna 
                  :mod (r / retinal 
                        :mod (m / mouse))) 
            :quant (s / some)) 
      :mod (o / organization 
            :name (n / name 
                  :op1 "UniGene")))

# ::snt One clone in these clusters ( #Mm .
# ::tok One clone in these clusters ( #Mm .
# ::alignments 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:27.948
(c2 / clone-01 
      :ARG0 1 
      :ARG1 (c / cluster 
            :mod (t / this)))

# ::snt 246385 ) has a weak homology with the polyhomeotic family genes .
# ::tok 246385 ) has a weak homology with the polyhomeotic family genes .
# ::alignments 10-11|0.1 9-10|0.1.0 5-6|0 4-5|0.0 0-1|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:28.023
(h / homology 
      :ARG1-of (w / weak-02 
            :ARG0 (d / date-entity 
                  :day 85 
                  :month 63 
                  :year 2024)) 
      :purpose (g / gene 
            :mod (f / family)))

# ::snt A 735-bp cDNA fragment of this clone , encoding amino acids 140 -- 384 was amplified by RT-PCR from mouse P0 retinal cDNA .
# ::tok A 735-bp cDNA fragment of this clone , encoding amino acids 140 -- 384 was amplified by RT-PCR from mouse P0 retinal cDNA .
# ::alignments 22-23|0.2 21-22|0.2.0 19-20|0.0.0 17-18|0.0.1.0+0.0.1+0.0 15-16|0 11-12|0.1.0 10-11|0.1.1 9-10|0.1.1.1 8-9|0.1.1.0 6-7|0.1.2 5-6|0.1.1.2 3-4|0.1 2-3|0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:28.248
(a / amplify-01 
      :ARG0 (t / thing 
            :location (m / mouse) 
            :name (n / name 
                  :op1 "RT-PCR")) 
      :ARG1 (f / fragment-01 
            :ARG0 140 
            :ARG1 (a2 / acid 
                  :ARG1-of (e / encode-01) 
                  :mod (a3 / amino) 
                  :mod (t2 / this)) 
            :ARG2 (c2 / clone) 
            :mod (c3 / cdna)) 
      :ARG2 (c / cdna 
            :mod (r / retinal)))

# ::snt This fragment was used as the probe for library screening , in situ hybridization and Northern hybridization .
# ::tok This fragment was used as the probe for library screening , in situ hybridization and Northern hybridization .
# ::alignments 16-17|0.0.1 15-16|0.0.1.0 14-15|0.0 13-14|0.0.0 12-13|0.0.0.0 9-10|0.2.0 8-9|0.2.0.0 6-7|0.2 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:28.306
(u / use-01 
      :ARG0 (a / and 
            :op1 (h2 / hybridization 
                  :mod (s / situ)) 
            :op2 (h / hybridization 
                  :mod "Northern_Ireland")) 
      :ARG1 (f / fragment-01 
            :mod (t / this)) 
      :ARG2 (p / probe-01 
            :ARG1 (s2 / screen-01 
                  :ARG1 (l / library))))

# ::snt A mouse P0-P3 retinal cDNA library was screened using this mouse cDNA fragment .
# ::tok A mouse P0-P3 retinal cDNA library was screened using this mouse cDNA fragment .
# ::alignments 12-13|0.0.1 11-12|0.0.1.0 10-11|0.0.1.0.1 9-10|0.0.1.1 8-9|0.0 7-8|0 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:28.535
(s / screen-01 
      :ARG1 (u / use-01 
            :ARG0 (l / library 
                  :mod (c2 / cdna 
                        :mod (r / retinal))) 
            :ARG1 (f / fragment-01 
                  :ARG0 (c / cdna 
                        :domain (m2 / mouse) 
                        :mod (m / mouse)) 
                  :mod (t / this))))

# ::snt Positive bacteriophage clones were isolated and the full-length mr-s fragment was inserted into pBluescriptII ( Stratagene ) .
# ::tok Positive bacteriophage clones were isolated and the full-length mr-s fragment was inserted into pBluescriptII ( Stratagene ) .
# ::alignments 11-12|0.1 9-10|0.1.0 8-9|0.1.0.0 7-8|0.0.0.0 5-6|0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.2 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:28.587
(a / and 
      :op1 (i2 / isolate-01 
            :ARG1 (c / clone-01 
                  :ARG1 (f2 / full-length) 
                  :mod (p / positive) 
                  :mod (b / bacteriophage))) 
      :op2 (i / insert-01 
            :ARG1 (f / fragment-01 
                  :mod (m / mr-))))

# ::snt DNA sequencing was performed on both strands by the cycle sequencing method .
# ::tok DNA sequencing was performed on both strands by the cycle sequencing method .
# ::alignments 11-12|0.2 10-11|0.2.1 9-10|0.2.0 6-7|0.1 5-6|0.1.0 3-4|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:28.673
(p / perform-02 
      :ARG1 (s3 / sequence 
            :mod (d / DNA)) 
      :ARG2 (s2 / strand 
            :mod (b / both)) 
      :manner (m / method 
            :instrument-of (c / cycle-02) 
            :mod (s / sequence)))

# ::snt The nucleotide sequence for mr-s gene has been deposited in the GenBank database under GenBank Accession Number #AY458844 .
# ::tok The nucleotide sequence for mr-s gene has been deposited in the GenBank database under GenBank Accession Number #AY458844 .
# ::alignments 16-17|0.1.0 15-16|0.1.0.0 12-13|0.1 11-12|0.1.1.0.0+0.1.1.0+0.1.1 8-9|0 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:28.784
(d2 / deposit-01 
      :ARG1 (s / sequence 
            :beneficiary (g / gene 
                  :mod (m / mr-)) 
            :mod (n3 / nucleotide)) 
      :location (d / database 
            :domain (n / number-01 
                  :ARG1 (a / accession)) 
            :mod (o / organization 
                  :name (n2 / name 
                        :op1 "GenBank"))))

# ::snt The 735-bp cDNA fragment of mr-s amplified by RT-PCR was used as a probe for in situ hybridization .
# ::tok The 735-bp cDNA fragment of mr-s amplified by RT-PCR was used as a probe for in situ hybridization .
# ::alignments 17-18|0 13-14|0.0 10-11|0.0.0 8-9|0.0.0.0.1.0.0.0.0+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0 6-7|0.0.0.0.1.0 5-6|0.0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:28.995
(h / hybridization 
      :ARG0-of (p / probe-01 
            :ARG2-of (u / use-01 
                  :ARG1 (f / fragment-01 
                        :ARG0 (c / cdna) 
                        :ARG1 (m / mr- 
                              :ARG1-of (a / amplify-01 
                                    :ARG0 (t / thing 
                                          :name (n / name 
                                                :op1 "RT-PCR"))))))))

# ::snt In situ hybridization was performed as described previously [ 49 ] .
# ::tok In situ hybridization was performed as described previously [ 49 ] .
# ::alignments 9-10|0.0.0 7-8|0.1.0 6-7|0.1 4-5|0.0 2-3|0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:29.033
(h / hybridization 
      :ARG1-of (p2 / perform-02 
            :ARG0 49 
            :manner (s / situ)) 
      :ARG1-of (d / describe-01 
            :manner (p / previous)))

# ::snt Cell culture and transfection .
# ::tok Cell culture and transfection .
# ::alignments 2-3|0 1-2|0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:29.042
(a / and 
      :mod (c2 / cell) 
      :op1 (c / culture))

# ::snt HEK293T cells were maintained at 37 C in Dulbecco 's modified Eagle 's medium ( DMEM ) supplemented with 10 % fetal bovine serum ( Sigma ) , 100 IU/ml penicillin and 100 g/ml streptomycin .
# ::tok HEK293T cells were maintained at 37 C in Dulbecco 's modified Eagle 's medium ( DMEM ) supplemented with 10 % fetal bovine serum ( Sigma ) , 100 IU/ml penicillin and 100 g/ml streptomycin .
# ::alignments 34-35|0.0.0.0.0.1 32-33|0.1.4 31-32|0 30-31|0.3 28-29|0.1.3 25-26|0.1.5.0.0+0.1.5.0+0.1.5 23-24|0.2 22-23|0.2.0 21-22|0.2.1 20-21|0.1.2 19-20|0.1.2.0 17-18|0.0 13-14|0.0.0 11-12|0.0.0.0.1 10-11|0.0.0.0 8-9|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 6-7|0.1.1 5-6|0.0.1 3-4|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:29.585
(a / and 
      :ARG1-of (s3 / supplement-01 
            :ARG0 (m / medium 
                  :ARG2-of (m2 / modify-01 
                        :ARG0 (p3 / person 
                              :name (n2 / name 
                                    :op1 "Dulbecco") 
                              :poss-of (s / streptomycin)) 
                        :ARG1 (e / eagle))) 
            :ARG2 37) 
      :op1 (m3 / maintain-01 
            :ARG1 (c2 / cell) 
            :ARG4 (c / C) 
            :op1-of (p2 / percentage-entity 
                  :value 10) 
            :op1-of 100 
            :op1-of 100 
            :op1-of (o / organization 
                  :name (n / name 
                        :op1 "Sigma"))) 
      :op2 (s2 / serum 
            :mod (b / bovine) 
            :mod (f / fetal)) 
      :op3 (p / penicillin))

# ::snt Transient transfection of HEK293T cells was carried out using calcium phosphate method or Fugene6 transfection reagent ( Roche ) .
# ::tok Transient transfection of HEK293T cells was carried out using calcium phosphate method or Fugene6 transfection reagent ( Roche ) .
# ::alignments 17-18|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 15-16|0.0.0.0.1.0.1 12-13|0.0.0.0.1.0 11-12|0.0.0.0.1.0.0 10-11|0.0.0.0.1.0.0.0 9-10|0.0.0.0.1.0.0.1 8-9|0.0.0.0.1 6-7|0.0.0.0 4-5|0.0 3-4|0 1-2|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:30.267
(h / HEK293T 
      :mod-of (c3 / cell 
            :domain-of (t / transfection 
                  :ARG1-of (c2 / carry-out-03 
                        :ARG0 (p / person 
                              :name (n / name 
                                    :op1 "Roche")) 
                        :ARG2 (u / use-01 
                              :ARG1 (o / or 
                                    :op1 (m / method 
                                          :mod (p2 / phosphate) 
                                          :mod (c / calcium)) 
                                    :op2 (r / reagent)))) 
                  :mod (t2 / transient))))

# ::snt Y79 retinoblastoma cells were maintained in Iscove 's modified Dulbecco 's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate , 20 % FBS .
# ::tok Y79 retinoblastoma cells were maintained in Iscove 's modified Dulbecco 's medium with 4 mM L-glutamine adjusted to contain 1.5 g/L sodium bicarbonate , 20 % FBS .
# ::alignments 26-27|0.0.0.0.1.1.0 25-26|0.0.0.0.1.1 24-25|0.0.0.0.1.3 22-23|0.0 21-22|0 19-20|0.0.0.0.1.2 18-19|0.0.0 16-17|0.0.0.0 14-15|0.0.0.0.0.0.1.0 13-14|0.0.0.0.1.1.0.0 11-12|0.0.0.0.0 8-10|0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 6-7|0.0.0.0.0.0.1.1.0+0.0.0.0.0.0.1.1+0.0.0.0.0.0.1 4-5|0.0.0.0.1 2-3|0.0.0.0.1.0 1-2|0.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:30.670
(s / sodium 
      :mod-of (b / bicarbonate 
            :ARG1-of (c / contain-01 
                  :ARG1-of (a / adjust-01 
                        :ARG0 (m2 / medium 
                              :poss (t / thing 
                                    :name (n / name 
                                          :op1 (m3 / modified) 
                                          :op2 (d / Dulbecco)) 
                                    :poss (c2 / country 
                                          :mod (m / mm) 
                                          :name (n2 / name 
                                                :op1 "Iscove")))) 
                        :manner-of (m4 / maintain-01 
                              :ARG1 (c3 / cell 
                                    :mod (r / retinoblastoma)) 
                              :ARG2 (p / percentage-entity 
                                    :mod-of (f / fb 
                                          :poss 4)) 
                              :op1-of 1.5 
                              :op1-of 20)))))

# ::snt Transient transfection was carried out using TransIt LT1 ( Mirus ) .
# ::tok Transient transfection was carried out using TransIt LT1 ( Mirus ) .
# ::alignments 9-10|0 6-8|0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0.0 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:30.760
(m / miru 
      :mod-of (t2 / transient 
            :mod-of (t / transfection 
                  :ARG1-of (c / carry-out-03 
                        :ARG2 (u / use-01 
                              :ARG1 (p / person 
                                    :name (n / name 
                                          :op1 "TransIt" 
                                          :op2 "LT1")))))))

# ::snt RNA was extracted from the tissues of adult mice using Trizol ( Invitrogen ) .
# ::tok RNA was extracted from the tissues of adult mice using Trizol ( Invitrogen ) .
# ::alignments 12-13|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 10-11|0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 9-10|0.1.0.0 8-9|0.1.0 7-8|0.1.0.1 5-6|0.1 2-3|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:30.984
(e / extract-01 
      :ARG1 (o2 / organization 
            :name (n3 / name 
                  :op1 "RNA")) 
      :ARG2 (t / tissue 
            :mod (m / mouse 
                  :ARG0-of (u / use-01 
                        :ARG1 (o / organization 
                              :name (n / name 
                                    :op1 "Invitrogen")) 
                        :ARG2 (p / person 
                              :name (n2 / name 
                                    :op1 "Trizol"))) 
                  :mod (a / adult))))

# ::snt A 5 g of total RNA was electrophoresed in a 1.0 % agarose-formaldehyde gel and transferred to a nylon membrane ( Zeta-Probe GT , Bio-Rad ) .
# ::tok A 5 g of total RNA was electrophoresed in a 1.0 % agarose-formaldehyde gel and transferred to a nylon membrane ( Zeta-Probe GT , Bio-Rad ) .
# ::alignments 24-25|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 21-23|0.1.0.0.0.0.0.1+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 19-20|0.1.2 18-19|0.1.2.0 15-16|0.1 14-15|0 13-14|0.0 11-12|0.1.1 5-6|0.1.0.0.1.0+0.1.0.0.1+0.1.0.0 4-5|0.1.0.0.0 2-3|0.1.0 1-2|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:31.372
(a / and 
      :op1 (g2 / gel) 
      :op2 (t2 / transfer-01 
            :ARG0 (g3 / g 
                  :poss (o2 / organization 
                        :ARG2-of (t3 / total-01 
                              :ARG0 (t / thing 
                                    :name (n2 / name 
                                          :op1 (z / Zeta-Probe) 
                                          :op2 (g / GT))) 
                              :ARG1 (o / organization 
                                    :name (n / name 
                                          :op1 "Bio-Rad"))) 
                        :name (n4 / name 
                              :op1 "RNA")) 
                  :quant 5) 
            :ARG1 (p / percentage-entity) 
            :ARG2 (m / membrane 
                  :mod (n3 / nylon))))

# ::snt The 735-bp cDNA fragment encoding the SAM domain of mr-s was used as a probe for hybridization .
# ::tok The 735-bp cDNA fragment encoding the SAM domain of mr-s was used as a probe for hybridization .
# ::alignments 16-17|0.0.1.0 14-15|0.0.1 11-12|0.0 9-10|0 7-8|0.0.0.0.0 6-7|0.0.0.0.0.0 4-5|0.0.0.0 3-4|0.0.0 2-3|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:31.553
(m / mr- 
      :manner-of (u / use-01 
            :ARG1 (f / fragment-01 
                  :ARG0-of (e / encode-01 
                        :ARG1 (d / domain 
                              :mod (s / sam))) 
                  :ARG1 (c / cdna)) 
            :ARG2 (p / probe-01 
                  :ARG1 (h / hybridization))))

# ::snt Hybridization was performed according to the manufacturer 's protocol .
# ::tok Hybridization was performed according to the manufacturer 's protocol .
# ::alignments 8-9|0.0 6-7|0.0.0 3-4|0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:31.572
(s / say-01 
      :ARG0 (p / protocol 
            :poss (m / manufacture-01)) 
      :ARG1 (p2 / perform-02 
            :ARG1 (h / hybridization)))

# ::snt Washes with increasing stringency were performed , the last being at 50 C in 0.1  standard saline citrate/0 .1 % sodium dodecyl sulfate ( SDS ) .
# ::tok Washes with increasing stringency were performed , the last being at 50 C in 0.1  standard saline citrate/0 .1 % sodium dodecyl sulfate ( SDS ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:31.579
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Total RNA was isolated from each tissue using Trizol .
# ::tok Total RNA was isolated from each tissue using Trizol .
# ::alignments 8-9|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 7-8|0.1.0 6-7|0.1 5-6|0.1.1 3-4|0 1-2|0.0.1.0+0.0.1+0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:31.677
(i / isolate-01 
      :ARG1 (o / organization 
            :ARG1-of (t2 / total-01) 
            :name (n2 / name 
                  :op1 "RNA")) 
      :ARG2 (t / tissue 
            :ARG0-of (u / use-01 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "Trizol"))) 
            :mod (e / each)))

# ::snt A 1 g of total RNA was reverse transcribed using SuperscriptII ( Invitrogen ) .
# ::tok A 1 g of total RNA was reverse transcribed using SuperscriptII ( Invitrogen ) .
# ::alignments 12-13|0.0.0.0.0+0.0.0.0+0.0.0 10-11|0.0.2.0.0+0.0.2.0+0.0.2 9-10|0.0 8-9|0.0.1 7-8|0.0.1.0 5-6|0.1.1.0+0.1.1+0.1 4-5|0.1.0 2-3|0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:31.936
(g / g 
      :ARG0-of (u / use-01 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "Invitrogen")) 
            :ARG1-of (t / transcribe-01 
                  :ARG1-of (r / reverse-01)) 
            :ARG2 (p / person 
                  :name (n2 / name 
                        :op1 "SuperscriptII"))) 
      :poss (o2 / organization 
            :ARG2-of (t2 / total-01) 
            :name (n3 / name 
                  :op1 "RNA")) 
      :quant 1)

# ::snt RT-PCR primers , which span introns , for detection of mr-s cDNA were 5 ' - TGTCCAGCCCAGCCAACCCAAGGAGACGACA-3 ' and 5 ' - TGTGGTCTCCTCATCAGTGAAGA-3 ' .
# ::tok RT-PCR primers , which span introns , for detection of mr-s cDNA were 5 ' - TGTCCAGCCCAGCCAACCCAAGGAGACGACA-3 ' and 5 ' - TGTGGTCTCCTCATCAGTGAAGA-3 ' .
# ::alignments 19-20|0.0.0 18-19|0 13-14|0.0.3.2 11-12|0.0.2 10-11|0.0.1 8-9|0.0 5-6|0.0.3.1 4-5|0.0.3 1-2|0.0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:32.060
(a / and 
      :op1 (d / detect-01 
            :ARG0 5 
            :ARG1 (m / mr-) 
            :ARG2 (c / cdna) 
            :ARG2-of (s / span-01 
                  :ARG0 (p / primer) 
                  :ARG1 (i / intron) 
                  :op1-of 5)))

# ::snt Product size was 292 bp ( positions 965 -- 1256 of Genbank Accession Number #AY458844 ) .
# ::tok Product size was 292 bp ( positions 965 -- 1256 of Genbank Accession Number #AY458844 ) .
# ::alignments 13-14|0.0.0.0 11-13|0+0.0.1+0.0+0.0.0 9-10|0.0.0.0.0.0+0.0.0.0.0 6-7|0.0.0.0.1 1-2|0.0.0.0.2.0 0-1|0.0.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:32.179
(a / Accession 
      :op2-of (n2 / name 
            :name-of (t / thing 
                  :mod-of (n / number-01 
                        :ARG0 (d / date-entity 
                              :year 1256) 
                        :ARG2 (p / position) 
                        :op1-of (p2 / product 
                              :mod-of (s / size)))) 
            :op1 (g / Genbank)))

# ::snt Primer pairs for mouse G3PDH were 5 ' - ACCACAGTCCATGCCATCAC-3 ' and 5 ' - TCCACCACCCTGTTGCTGTA - 3 ' which amplified a 452-bp product ( positions 587 -- 1038 of Genbank Accession Number #BC85275 ) .
# ::tok Primer pairs for mouse G3PDH were 5 ' - ACCACAGTCCATGCCATCAC-3 ' and 5 ' - TCCACCACCCTGTTGCTGTA - 3 ' which amplified a 452-bp product ( positions 587 -- 1038 of Genbank Accession Number #BC85275 ) .
# ::alignments 32-33|0.0.2 30-32|0.0.2.1.0.1+0.0.2.1.0.0+0.0.2.1.0+0.0.2.1 28-29|0.1.3.0+0.1.3 26-27|0.1.0.0 25-26|0.1.0 23-24|0.0.0 20-21|0.0 17-18|0.0.2.0 12-13|0.0.2.2 11-12|0 8-10|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 6-7|0.0.1.1 4-5|0.1.1.1.0+0.1.1.1+0.1.1 3-4|0.1.1.0 1-2|0.1 0-1|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:33.388
(a3 / and 
      :ARG0-of (a2 / amplify-01 
            :ARG1 (p2 / product) 
            :ARG2 (t2 / thing 
                  :name (n3 / name 
                        :op1 - 
                        :op2 (a4 / ACCACAGTCCATGCCATCAC-3)) 
                  :poss 5) 
            :purpose-of (n / number-01 
                  :ARG0 3 
                  :ARG1 (t / thing 
                        :name (n2 / name 
                              :op1 (g / Genbank) 
                              :op2 (a / Accession))) 
                  :op1-of 5)) 
      :op1 (p3 / pair-01 
            :ARG0 (p / position 
                  :mod-of 587) 
            :ARG1 (t3 / thing 
                  :mod (m / mouse) 
                  :name (n4 / name 
                        :op1 "G3PDH")) 
            :mod (p4 / primer) 
            :op1-of (d / date-entity 
                  :year 1038)))

# ::snt Yeast two-hybrid screening and GAL4 assay .
# ::tok Yeast two-hybrid screening and GAL4 assay .
# ::alignments 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:33.400
(s / screen-01 
      :op1-of (a2 / and 
            :op2 (a / assay 
                  :mod (g / GAL4))))

# ::snt We carried out yeast two-hybrid experiments using the MATCHMAKER GAL4 two-hybrid system 3 ( BD Bioscience ) as recommended by the manufacturer .
# ::tok We carried out yeast two-hybrid experiments using the MATCHMAKER GAL4 two-hybrid system 3 ( BD Bioscience ) as recommended by the manufacturer .
# ::alignments 21-22|0.1.0.0.0.0 18-19|0.1.0.0.0 14-16|0.1.0.0.0.0.0.0.1+0.1.0.0.0.0.0.0.0+0.1.0.0.0.0.0.0+0.1.0.0.0.0.0 12-13|0.1.1 11-12|0.1.0.0 8-10|0.1.0.0.1.0.1+0.1.0.0.1.0.0+0.1.0.0.1.0+0.1.0.0.1 6-7|0.1.0 5-6|0.1 3-4|0.1.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:33.728
(c / carry-01 
      :ARG0 (w / we) 
      :ARG1 (e / experiment-01 
            :ARG0-of (u / use-01 
                  :ARG1 (s / system 
                        :ARG0-of (r / recommend-01 
                              :ARG1 (m / manufacture-01 
                                    :ARG1 (o / organization 
                                          :name (n / name 
                                                :op1 "BD" 
                                                :op2 "Bioscience")))) 
                        :mod (t / thing 
                              :name (n2 / name 
                                    :op1 (m2 / MATCHMAKER) 
                                    :op2 (g / GAL4))))) 
            :ARG1 3 
            :mod (y / yeast)))

# ::snt We cloned the full-length mr-s into the pGBKT7 vector and used it to screen a library of mouse P0-P3 retinal cDNAs in the pGADT7 vector .
# ::tok We cloned the full-length mr-s into the pGBKT7 vector and used it to screen a library of mouse P0-P3 retinal cDNAs in the pGADT7 vector .
# ::alignments 24-25|0.0.0.0.0.0 20-21|0.0.0.0.0 19-20|0.0.0.0.0.1 17-18|0.0.0.0.0.2 15-16|0.0.0.0.1.0 13-14|0.0.0.0.1 10-11|0.0.0.0 9-10|0 8-9|0.0.2 4-5|0.0.1 3-4|0.0.1.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:33.901
(a / and 
      :op1 (c2 / clone-01 
            :ARG0 (w / we 
                  :ARG0-of (u / use-01 
                        :ARG1 (c / cdna 
                              :location (v / vector) 
                              :mod (r / retinal) 
                              :mod (m / mouse)) 
                        :ARG2 (s / screen 
                              :op1 (l / library)))) 
            :ARG1 (m2 / mr- 
                  :mod (f / full-length)) 
            :ARG2 (v2 / vector)))

# ::snt Transformants that conferred growth were picked , isolated and re-introduced with the bait into AH109 to confirm interaction .
# ::tok Transformants that conferred growth were picked , isolated and re-introduced with the bait into AH109 to confirm interaction .
# ::alignments 17-18|0.0.2.1 16-17|0.0.2 14-15|0.0.2.0 12-13|0.0.0 8-9|0.0 7-8|0.0.1 5-6|0 3-4|0.0.1.0.0.0 2-3|0.0.1.0.0 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:33.981
(p / pick-up-04 
      :op1-of (a2 / and 
            :manner (b / bait-01) 
            :op2 (i2 / isolate-01 
                  :ARG1 (t / transformant 
                        :ARG0-of (c2 / confer-01 
                              :ARG1 (g / grow-01)))) 
            :op3 (c / confirm-01 
                  :ARG0 (a / AH109) 
                  :ARG1 (i / interact-01))))

# ::snt Plasmid DNA was isolated from yeast using RPM Yeast Plasmid Isolation Kit ( Qbiogene ) .
# ::tok Plasmid DNA was isolated from yeast using RPM Yeast Plasmid Isolation Kit ( Qbiogene ) .
# ::alignments 13-14|0.0.0.0+0.0.0+0.0 7-12|0.2.1.0.4+0.2.1.0.3+0.2.1.0.2+0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 6-7|0.2 5-6|0.2.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:34.107
(i / isolate-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "Qbiogene")) 
      :ARG1 (d / DNA 
            :mod (p / plasmid)) 
      :manner (u / use-01 
            :ARG0 (y / yeast) 
            :ARG1 (o2 / organization 
                  :name (n2 / name 
                        :op1 "RPM" 
                        :op2 "Yeast" 
                        :op3 "Plasmid" 
                        :op4 "Isolation" 
                        :op5 "Kit"))))

# ::snt In order to confirm the protein interactions , single colonies were picked and grown individually in synthetic complete media lacking leucine , tryptophan and containing X-gal .
# ::tok In order to confirm the protein interactions , single colonies were picked and grown individually in synthetic complete media lacking leucine , tryptophan and containing X-gal .
# ::alignments 24-25|0.0.2.0 23-24|0.0.2 22-23|0.0.2.0.0 20-21|0.0.1 19-20|0.0 18-19|0.0.0 17-18|0.0.0.0 16-17|0.2.1.0.0.0 14-15|0.2.0 13-14|0.2.1 12-13|0.2 11-12|0 9-10|0.2.1.0 8-9|0.2.1.0.0 6-7|0.1.0 5-6|0.1.0.0 3-4|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:34.481
(p / pick-up-04 
      :ARG2 (l2 / lack-01 
            :ARG0 (m / media 
                  :ARG1-of (c2 / complete-02)) 
            :ARG1 (l / leucine) 
            :op1-of (a / and 
                  :op2 (c / contain-01 
                        :ARG1 (t / tryptophan)))) 
      :condition (c4 / confirm-01 
            :ARG1 (i2 / interaction 
                  :mod (p2 / protein))) 
      :op1-of (a2 / and 
            :mod (i / individual) 
            :op2 (g / grow-03 
                  :ARG1 (c3 / colony 
                        :ARG1-of (s2 / single-02 
                              :ARG0 (s / synthetic))))))

# ::snt After 4 -- 5 days , X-gal positive clones were selected and analyzed .
# ::tok After 4 -- 5 days , X-gal positive clones were selected and analyzed .
# ::alignments 12-13|0.1 11-12|0 10-11|0.0 8-9|0.0.0 7-8|0.0.0.1 4-5|0.0.0.0.0.0+0.0.0.0.0 3-4|0.0.0.0 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:34.526
(a2 / and 
      :op1 (s / select-01 
            :ARG1 (c / clone-01 
                  :ARG1 (5 / 5 
                        :quant-of (t / temporal-quantity 
                              :unit (d / day))) 
                  :mod (p / positive))) 
      :op2 (a / analyze-01) 
      :time (a3 / after 
            :op1 4))

# ::snt To test self-interaction of mr-s , we subcloned the full-length , N-terminus ( amino acids 1 -- 400 ) and C-terminus ( amino acids 391 -- 542 ) of mr-s into pGBKT7 and pGADT7 vectors .
# ::tok To test self-interaction of mr-s , we subcloned the full-length , N-terminus ( amino acids 1 -- 400 ) and C-terminus ( amino acids 391 -- 542 ) of mr-s into pGBKT7 and pGADT7 vectors .
# ::alignments 34-35|0.0 32-33|0 29-30|0.2 23-24|0.1.3 22-23|0.1.3.0 20-21|0.1.2.0.0+0.1.2.0+0.1.2 19-20|0.1 17-18|0.0.0.0.3 15-16|0.0.0.0.2 14-15|0.0.0.0.1.0 13-14|0.0.0.0.1 11-12|0.1.1.0.0+0.1.1.0+0.1.1 9-10|0.1.0 6-7|0.0.0 4-5|0.0.0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:34.880
(a / and 
      :op1 (v / vector 
            :poss (w / we 
                  :ARG0-of (t3 / test-01 
                        :ARG1 (m2 / mr-) 
                        :ARG2 (a6 / amino 
                              :mod-of (a5 / acid)) 
                        :op1-of 1 
                        :op1-of 400))) 
      :op5-of (a4 / and 
            :op1 (f / full-length) 
            :op2 (t2 / thing 
                  :name (n2 / name 
                        :op1 "N-terminus")) 
            :op3 (t / thing 
                  :name (n / name 
                        :op1 "C-terminus")) 
            :op4 (a2 / acid 
                  :mod (a3 / amino))) 
      :quant (m / mr-))

# ::snt We assessed interactions by scoring blue color on plates of medium containing X-gal .
# ::tok We assessed interactions by scoring blue color on plates of medium containing X-gal .
# ::alignments 11-12|0.2.0.0.0 10-11|0.2.0.0.0.0 8-9|0.2.0.0 6-7|0.2.0 5-6|0.2.0.1 4-5|0.2 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:34.977
(a / assess-01 
      :ARG0 (w / we) 
      :ARG1 (i / interaction) 
      :manner (s / score-01 
            :ARG1 (c2 / color 
                  :location (p / plate 
                        :ARG1-of (c / contain-01 
                              :ARG0 (m / medium))) 
                  :mod (b / blue))))

# ::snt For immunoprecipitation assay , 4  hemagglutinin ( HA ) or 3  Flag tagged cDNA fragment encoding full-length mr-s ( full-HA and Flag-mrs ) , a cDNA fragment encoding amino acids 1 -- 400 ( SAM-HA and Flag-SAM ) , and a cDNA fragment encoding amino acids 400 -- 542 ( Flag-SAM ) were subcloned into the pcDNA3 ( Invitrogen ) expression vector .
# ::tok For immunoprecipitation assay , 4  hemagglutinin ( HA ) or 3  Flag tagged cDNA fragment encoding full-length mr-s ( full-HA and Flag-mrs ) , a cDNA fragment encoding amino acids 1 -- 400 ( SAM-HA and Flag-SAM ) , and a cDNA fragment encoding amino acids 400 -- 542 ( Flag-SAM ) were subcloned into the pcDNA3 ( Invitrogen ) expression vector .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:34.979
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt We also constructed two site-directed mutants , Flag-W404A and Flag-G453A , using PCR .
# ::tok We also constructed two site-directed mutants , Flag-W404A and Flag-G453A , using PCR .
# ::alignments 11-12|0.0.0.0 9-10|0.3.0.0+0.3.0+0.3 8-9|0 7-8|0.2.0.0+0.2.0+0.2 5-6|0.1 4-5|0.1.0 3-4|0.1.1 2-3|0.0 1-2|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:35.404
(a / and 
      :ARG1-of (c / construct-01 
            :ARG0 (w / we 
                  :ARG0-of (u / use-01)) 
            :mod (a2 / also)) 
      :op1 (m / mutant 
            :mod (s / site-direct) 
            :quant 2) 
      :op2 (o2 / organization 
            :name (n2 / name 
                  :op1 "Flag-W404A")) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "Flag-G453A")))

# ::snt Each of these mutations was also introduced into Flag-mr-s .
# ::tok Each of these mutations was also introduced into Flag-mr-s .
# ::alignments 6-7|0 5-6|0.1 3-4|0.0 2-3|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:35.423
(i / introduce-02 
      :ARG1 (m / mutate-01 
            :mod (e / each) 
            :mod (t / this)) 
      :mod (a / also))

# ::snt We transfected HEK293T cells with 5 g of plasmid DNA per 6 cm dish by calcium phosphate method .
# ::tok We transfected HEK293T cells with 5 g of plasmid DNA per 6 cm dish by calcium phosphate method .
# ::alignments 17-18|0.1.0.0 16-17|0.1.0.0.0 15-16|0.1.0.0.1 13-14|0.1.0 12-13|0.1.0.1 11-12|0.1.0.3 9-10|0.0 8-9|0.0.0 6-7|0 5-6|0.2 3-4|0.1.0.2 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:35.737
(g / g 
      :mod (d2 / DNA 
            :mod (p2 / plasmid)) 
      :poss (w / we 
            :op1 (d / dish-01 
                  :ARG0 (m / method 
                        :mod (p / phosphate) 
                        :mod (c / calcium)) 
                  :ARG1 (c2 / cm) 
                  :location (c3 / cell) 
                  :quant 6)) 
      :quant 5)

# ::snt Approximately 48 hr after transfection , cells were harvested in immunoprecipitation buffer ( 50 mM Tris-HCl [ pH 7.5 ] , 1 mM EDTA , 2 mM MgCl2 , 150 mM NaCl , 1 mM phenylmethylsulfonyl fluoride [ Wako ] , 1 % Nonidet P-40 , 10 % glycerol ) in the presence of protease inhibitor cocktail tablets ( Roche ) .
# ::tok Approximately 48 hr after transfection , cells were harvested in immunoprecipitation buffer ( 50 mM Tris-HCl [ pH 7.5 ] , 1 mM EDTA , 2 mM MgCl2 , 150 mM NaCl , 1 mM phenylmethylsulfonyl fluoride [ Wako ] , 1 % Nonidet P-40 , 10 % glycerol ) in the presence of protease inhibitor cocktail tablets ( Roche ) .
# ::alignments 59-60|0.0.0.0.7.0.0.0.0.0.1.4.0.0+0.0.0.0.7.0.0.0.0.0.1.4.0+0.0.0.0.7.0.0.0.0.0.1.4 57-58|0.0.0.0.7.0.0.0.0.0.1.0 56-57|0.0.0.0.7.0.0.0.0.0.1.0.0 55-56|0.0.0.0.7.0.0.0.0.0.1.0.0.0 54-55|0.0.0.0.7.0.0.0.0.0.1.0.1 52-53|0.0.0.0.7.0.0.0.0.0.1 48-49|0 47-48|0.0 46-47|0.0.0 43-45|0.0.0.0.3.0.0.0.1+0.0.0.0.3.0.0.0.0+0.0.0.0.3.0.0.0+0.0.0.0.3.0.0 42-43|0.0.0.0.3.0 41-42|0.0.0.0.3 36-37|0.0.0.0.4 33-34|0.0.0.0.5 29-30|0.0.0.0.2 27-28|0.0.0.0.6.0 25-26|0.0.0.0.6 23-24|0.0.0.0.7.0.0.0.0.0.0.0+0.0.0.0.7.0.0.0.0.0.0+0.0.0.0.7.0.0.0.0.0 21-22|0.0.0.0.7.0.0.0.0.0.2 17-18|0.0.0.0.7.0.0.0.0.0.1.2 15-16|0.0.0.0.7.0.0.0.0.0.1.3.1.0+0.0.0.0.7.0.0.0.0.0.1.3.1+0.0.0.0.7.0.0.0.0.0.1.3 14-15|0.0.0.0.7.0.0.0.0.0.1.3.0 13-14|0.0.0.0.7.0.0.0.0.0.1.1 11-12|0.0.0.0.1 10-11|0.0.0.0.1.0 8-9|0.0.0.0 6-7|0.0.0.0.0 4-5|0.0.0.0.7.0 3-4|0.0.0.0.7 2-3|0.0.0.0.7.0.0 1-2|0.0.0.0.7.0.0.0 0-1|0.0.0.0.7.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:36.610
(g / glycerol 
      :mod (p4 / percentage-entity 
            :value (1 / 10 
                  :op1 (h / harvest-01 
                        :ARG1 (c2 / cell) 
                        :ARG2 (b / buffer-01 
                              :ARG1 (i2 / immunoprecipitation)) 
                        :op1-of 150 
                        :op1-of (12 / 1 
                              :value-of (p6 / percentage-entity 
                                    :mod-of (p5 / person 
                                          :name (n2 / name 
                                                :op1 "Nonidet" 
                                                :op2 "P-40")))) 
                        :op1-of (f / fluoride) 
                        :op1-of 1 
                        :op1-of (2 / 2 
                              :quant-of (m / MgCl2)) 
                        :time (a / after 
                              :op1 (t2 / transfection 
                                    :location-of (h2 / hr 
                                          :quant (4 / 48 
                                                :op1-of (a2 / approximately 
                                                      :quant-of (p7 / person 
                                                            :name (n3 / name 
                                                                  :op1 "EDTA") 
                                                            :poss-of (p3 / presence 
                                                                  :mod (t / tablet 
                                                                        :mod (c / cocktail 
                                                                              :mod (i / inhibitor)) 
                                                                        :mod (p2 / protease)) 
                                                                  :mod-of 50 
                                                                  :mod-of (p8 / ph) 
                                                                  :poss (p9 / person 
                                                                        :mod (m2 / mm) 
                                                                        :name (n4 / name 
                                                                              :op1 "Tris-HCl")) 
                                                                  :poss (p / person 
                                                                        :name (n / name 
                                                                              :op1 "Roche"))) 
                                                            :quant 1))))))))))

# ::snt For each reaction , 1 mg of cell lysate was mixed with 0.5 g of anti-Flag antibody ( SIGMA , F3165 ) and 15 l of protein G-Sepharose ( Amersham ) on a rotating wheel at 4 C for 2 hrs .
# ::tok For each reaction , 1 mg of cell lysate was mixed with 0.5 g of anti-Flag antibody ( SIGMA , F3165 ) and 15 l of protein G-Sepharose ( Amersham ) on a rotating wheel at 4 C for 2 hrs .
# ::alignments 40-41|0.0.3.4.0 39-40|0.0.3.4 37-38|0.0.3.0.0 36-37|0.0.3.0 34-35|0.0.1.1 33-34|0.0.1 29-30|0.0.0.0.0+0.0.0.0+0.0.0 26-27|0 24-25|0.0.3.3.1 23-24|0.0.3.3.1.0 22-23|0.0.3.3 18-19|0.0.3.3.0.0.0+0.0.3.3.0.0+0.0.3.3.0 16-17|0.0.3.2.0 13-14|0.0.3.2 12-13|0.0.1.0 10-11|0.0.3 8-9|0.0.3.1.0 7-8|0.0.3.1.0.0 5-6|0.0.3.1 4-5|0.0.1.2 2-3|0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:37.395
(p / protein 
      :ARG1-of (r2 / react-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "Amersham")) 
            :ARG2 (r / rotate-02 
                  :ARG0 0.5 
                  :ARG1 (w / wheel) 
                  :op1-of 1) 
            :mod (e / each) 
            :purpose-of (m / mix-01 
                  :ARG0 (4 / 4 
                        :quant-of (c / C)) 
                  :ARG1 (m2 / mg 
                        :mod (l2 / lysate 
                              :mod (c2 / cell))) 
                  :ARG2 (g / g 
                        :mod (a2 / antibody)) 
                  :ARG3 (a / and 
                        :op1 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "SIGMA")) 
                        :op2 (l / l 
                              :quant 15)) 
                  :op1-of (2 / 2 
                        :quant-of (h / hr)))))

# ::snt Protein concentration was determined by the BCA protein assay system ( Pierce ) .
# ::tok Protein concentration was determined by the BCA protein assay system ( Pierce ) .
# ::alignments 11-12|0.0.0.0+0.0.0+0.0 9-10|0.2 8-9|0.2.0 7-8|0.2.0.0 6-7|0.2.1.0.0+0.2.1.0+0.2.1 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:37.528
(d / determined-02 
      :ARG0 (p / person 
            :name (n / name 
                  :op1 "Pierce")) 
      :ARG1 (c / concentrate-02 
            :ARG1 (p3 / protein)) 
      :ARG2 (s / system 
            :mod (a / assay 
                  :mod (p2 / protein)) 
            :mod (o / organization 
                  :name (n2 / name 
                        :op1 "BCA"))))

# ::snt The beads were then washed three times with immunoprecipitation buffer and followed by three times with wash buffer ( 50 mM Tris-HCl [ pH 7.5 ] , 150 mM NaCl , 20 mM MgCl2 ) .
# ::tok The beads were then washed three times with immunoprecipitation buffer and followed by three times with wash buffer ( 50 mM Tris-HCl [ pH 7.5 ] , 150 mM NaCl , 20 mM MgCl2 ) .
# ::alignments 33-34|0.0.0.1 31-32|0.0.0.2 27-28|0.1.0 23-24|0.1.1.1 21-22|0.2.1.0+0.2.1+0.2 20-21|0.2.0 19-20|0.1.1.2 17-18|0.1.2.0 16-17|0.1.2 13-14|0.1.1.0 11-12|0.1 10-11|0 9-10|0.0.0 8-9|0.0.0.0 5-6|0.1.2.0.0 4-5|0.0 3-4|0.0.1 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:37.996
(a / and 
      :op1 (w2 / wash-01 
            :ARG1 (b2 / buffer-01 
                  :ARG1 (i / immunoprecipitation) 
                  :op1-of (m / MgCl2) 
                  :op1-of 20) 
            :time (t / then)) 
      :op2 (f / follow-01 
            :ARG0 150 
            :ARG1 (b3 / bead-01 
                  :ARG0 3 
                  :op1-of (p / ph) 
                  :op1-of 50) 
            :purpose (w / wash-01 
                  :ARG1 (b / buffer-01 
                        :ARG0 3))) 
      :op3 (p2 / person 
            :mod (m2 / mm) 
            :name (n / name 
                  :op1 "Tris-HCl")))

# ::snt Proteins were then boiled for 5 min in SDS sample buffer ( 1 % SDS , 1 mM Tris [ pH 6.8 ] , 40 mM DTT , 4 % glycerol , 0.01 % pyronine Y ) .
# ::tok Proteins were then boiled for 5 min in SDS sample buffer ( 1 % SDS , 1 mM Tris [ pH 6.8 ] , 40 mM DTT , 4 % glycerol , 0.01 % pyronine Y ) .
# ::alignments 35-36|0.0.1.0.2.0.0 34-35|0.0.1.0.2.0 33-34|0.0.1.0.2 30-31|0.0.1.0.1.2 29-30|0.0.1.0.1.2.0 28-29|0.0.1.0.1.2.0.0 24-25|0.0.2 20-21|0 18-19|0.0.1.0.1.0.0.0+0.0.1.0.1.0.0+0.0.1.0.1.0 17-18|0.0.3 16-17|0.0.1.0.1.0.1 13-14|0.0.1.0.1.1.0 12-13|0.0.1.0.1.1 10-11|0.0.1.0 9-10|0.0.1.0.1 8-9|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 6-7|0.0.1 5-6|0.0.1.1 3-4|0.0 2-3|0.0.4 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:38.596
(p4 / ph 
      :op1 (b2 / boil-01 
            :ARG1 (p7 / protein) 
            :ARG2 (m2 / min 
                  :beneficiary (b / buffer-01 
                        :ARG0 (o / organization 
                              :name (n2 / name 
                                    :op1 "SDS")) 
                        :ARG1 (s / sample-01 
                              :ARG0 (p5 / person 
                                    :name (n / name 
                                          :op1 "Tris") 
                                    :quant 1) 
                              :ARG1 (12 / 1 
                                    :value-of (p6 / percentage-entity)) 
                              :ARG2 (g / glycerol 
                                    :mod (p3 / percentage-entity 
                                          :value 4))) 
                        :op1-of (p2 / percentage-entity 
                              :quant-of (p / pyronine 
                                    :mod-of (y / y)))) 
                  :quant 5) 
            :op1-of 40 
            :op1-of (m / mm) 
            :time (t / then)))

# ::snt The supernatants were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis ( SDS-PAGE ) and transferred to the nitrocellulose membrane ( Trans-Blot Transfer Medium , Bio-Rad ) .
# ::tok The supernatants were fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis ( SDS-PAGE ) and transferred to the nitrocellulose membrane ( Trans-Blot Transfer Medium , Bio-Rad ) .
# ::alignments 24-25|0.2.0.0+0.2.0+0.2 20-23|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 18-19|0.0.2 17-18|0.0.2.0 14-15|0.0 13-14|0 9-10|0.0.0 8-9|0.0.0.0 6-7|0.0.0.1 5-6|0.0.0.1.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:38.743
(a / and 
      :op1 (t / transfer-01 
            :ARG0 (e / electrophoresi 
                  :mod (g / gel) 
                  :mod (d / dodecyl 
                        :mod (s / sodium))) 
            :ARG1 (s2 / supernatant) 
            :ARG2 (m / membrane 
                  :mod (n3 / nitrocellulose))) 
      :op2 (o2 / organization 
            :name (n2 / name 
                  :op1 "Trans-Blot" 
                  :op2 "Transfer" 
                  :op3 "Medium")) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "Bio-Rad")))

# ::snt Western blotting was performed with rabbit polyclonal anti-HA antibody ( Santa Cruz , #sc -805 ) .
# ::tok Western blotting was performed with rabbit polyclonal anti-HA antibody ( Santa Cruz , #sc -805 ) .
# ::alignments 10-12|0.0.0.1+0.0.0.0+0.0.0+0.0 8-9|0.1.0 5-6|0.1.0.0 3-4|0.1 1-2|0 0-1|0.2.1+0.2.0.0+0.2.0+0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:38.785
(b / blot-01 
      :ARG1 (c / country 
            :name (n / name 
                  :op1 "Santa" 
                  :op2 "Cruz")) 
      :ARG1-of (p / perform-02 
            :ARG2 (a / antibody 
                  :ARG1-of (r / rabbit-01))) 
      :mod (w / world-region 
            :name (n2 / name 
                  :op1 "West") 
            :wiki "Western_world"))

# ::snt Signals were detected with horseradish peroxidase - conjugated goat anti-rabbit IgG and ECL plus Western Blotting Detection System ( Amersham ) .
# ::tok Signals were detected with horseradish peroxidase - conjugated goat anti-rabbit IgG and ECL plus Western Blotting Detection System ( Amersham ) .
# ::alignments 19-20|0.0.0.0.0.1.0.0.0+0.0.0.0.0.1.0.0+0.0.0.0.0.1.0 14-18|0.2.0.3+0.2.0.2+0.2.0.1+0.2.0.0+0.2.0+0.2 13-14|0.0.1 12-13|0.1.0.0+0.1.0+0.1 11-12|0 10-11|0.0 8-9|0.0.0.0.0.0 7-8|0.0.0 5-6|0.0.0.0 4-5|0.0.0.0.1 2-3|0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:38.942
(a / and 
      :op1 (i / igg 
            :ARG1-of (c / conjugate-01 
                  :ARG0 (p2 / peroxidase 
                        :ARG2-of (d / detect-01 
                              :ARG0 (g / goat) 
                              :ARG1 (s / signal-01 
                                    :ARG1 (o / organization 
                                          :name (n / name 
                                                :op1 "Amersham")))) 
                        :mod (h / horseradish))) 
            :op1-of (p / plus)) 
      :op2 (o3 / organization 
            :name (n3 / name 
                  :op1 "ECL")) 
      :op3 (o2 / organization 
            :name (n2 / name 
                  :op1 "Western" 
                  :op2 "Blotting" 
                  :op3 "Detection" 
                  :op4 "System")))

# ::snt We transfected the plasmid encoding HA-tagged full-length mr-s into HEK293T cells , seeded cells on coverslips coated with collagen 48 hr after transfection , fixed with 4 % paraformaldehyde in phosphate-buffered saline ( PBS ) at room temperature for 20 min , and washed with PBS .
# ::tok We transfected the plasmid encoding HA-tagged full-length mr-s into HEK293T cells , seeded cells on coverslips coated with collagen 48 hr after transfection , fixed with 4 % paraformaldehyde in phosphate-buffered saline ( PBS ) at room temperature for 20 min , and washed with PBS .
# ::alignments 43-44|0.4 42-43|0 40-41|0.3 39-40|0.0.0 37-38|0.2 36-37|0.2.0 33-34|0.1.1.2 31-32|0.1.0 30-31|0.1.0.0 27-28|0.0.1.0 26-27|0.0.1.0.0 24-25|0.1 22-23|0.0.2.0 21-22|0.0.2 20-21|0.4.0 19-20|0.4.0.0 18-19|0.1.1.1.0 16-17|0.0 15-16|0.0.1 13-14|0.1.1.1 12-13|0.1.1 10-11|0.1.1.0.2 7-8|0.1.1.0.1 6-7|0.1.1.0.1.0 5-6|0.1.1.0.1.1 4-5|0.1.1.0 3-4|0.1.1.0.3 0-1|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:41.915
(a / and 
      :op1 (c2 / coat-01 
            :ARG0 20 
            :ARG1 (c3 / coverslip 
                  :mod-of (p3 / percentage-entity 
                        :value 4)) 
            :time (a2 / after 
                  :op1 (t2 / transfection))) 
      :op2 (f / fix-03 
            :ARG0 (s / saline 
                  :mod (p2 / phosphate-buffer)) 
            :ARG1 (s2 / seed-01 
                  :ARG0 (e / encode-01 
                        :ARG0 (w2 / we) 
                        :ARG1 (m2 / mr- 
                              :mod (f2 / full-length) 
                              :mod (h2 / ha-tagg)) 
                        :ARG2 (c5 / cell) 
                        :mod (p4 / plasmid)) 
                  :ARG1 (c4 / cell 
                        :location (c / collagen)) 
                  :op1-of (p / pb))) 
      :op3 (t / temperature 
            :consist-of (r / room)) 
      :op4 (m / min) 
      :op5 (w / wash-01 
            :ARG0 (h / hr 
                  :quant 48)))

# ::snt Then we permeabilized cells in PBS containing 0.1 % Triton X-100 for 15 min , washed again with PBS , and incubated in PBS containing 0.1 % bovine serum albumin ( BSA ) for 30 min at room temperature .
# ::tok Then we permeabilized cells in PBS containing 0.1 % Triton X-100 for 15 min , washed again with PBS , and incubated in PBS containing 0.1 % bovine serum albumin ( BSA ) for 30 min at room temperature .
# ::alignments 38-39|0.0.1.0.0 37-38|0.0.1.0.0.0 35-36|0.0.1.0 34-35|0.0.1 31-32|0.0.0.1.3.0.0+0.0.0.1.3.0+0.0.0.1.3 29-30|0.1.0 28-29|0.1.0.0 27-28|0.1.0.1 26-27|0.0.0.1.2 25-26|0.0.0.1.2.0 24-25|0.1 21-22|0.0 20-21|0 16-17|0.0.0.0.2 15-16|0.0.0.0 13-14|0.0.0.0.1 12-13|0.0.0.0.1.0 9-11|0.0.0.1.1.0.1+0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0 6-7|0.0.0.1 5-6|0.0.0.1.0.0 3-4|0.0.0.1.0 1-2|0.0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:43.538
(a2 / and 
      :op1 (i / incubate-01 
            :ARG0 (w2 / we 
                  :ARG0-of (w / wash-01 
                        :ARG1 (p3 / percentage-entity 
                              :value 0.1) 
                        :ARG2 (m2 / min 
                              :quant 15) 
                        :mod (a3 / again)) 
                  :ARG2-of (c2 / contain-01 
                        :ARG0 (c3 / cell 
                              :consist-of (p4 / pb)) 
                        :ARG1 (p2 / person 
                              :name (n2 / name 
                                    :op1 "Triton" 
                                    :op2 "X-100")) 
                        :op1-of (p / percentage-entity 
                              :value 0.1) 
                        :op1-of (o / organization 
                              :name (n / name 
                                    :op1 "BSA")))) 
            :ARG1 (3 / 30 
                  :quant-of (m / min 
                        :poss (t / temperature 
                              :consist-of (r / room))))) 
      :op2 (c / contain-01 
            :ARG1 (a / albumin 
                  :mod (s / serum) 
                  :mod (b / bovine))) 
      :time (t2 / then))

# ::snt We incubated cells with anti-HA antibody overnight at 4 C ( 1:200 in PBS containing 0.2 % BSA ) .
# ::tok We incubated cells with anti-HA antibody overnight at 4 C ( 1:200 in PBS containing 0.2 % BSA ) .
# ::alignments 17-18|0.1.1.0+0.1.1+0.1 16-17|0.1.0 15-16|0.1.0.0 14-15|0 13-14|0.0 9-10|0.2.3 8-9|0.2.3.0 6-7|0.2.2.0 5-6|0.2.2 2-3|0.2.1 1-2|0.2 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:43.828
(c / contain-01 
      :ARG0 (p2 / pb) 
      :ARG1 (o / organization 
            :mod (p / percentage-entity 
                  :value 0.2) 
            :name (n / name 
                  :op1 "BSA")) 
      :manner-of (i / incubate-01 
            :ARG0 (w / we) 
            :ARG1 (c3 / cell) 
            :ARG2 (a / antibody 
                  :location (o2 / overnight)) 
            :manner (c2 / C 
                  :quant 4)))

# ::snt The following day , we washed cells three times with PBS and incubated with a Cy3-conjugated goat IgG against rabbit IgG ( 1:400 in PBS , Jackson ImmunoReseach Laboratories ) for 30 min .
# ::tok The following day , we washed cells three times with PBS and incubated with a Cy3-conjugated goat IgG against rabbit IgG ( 1:400 in PBS , Jackson ImmunoReseach Laboratories ) for 30 min .
# ::alignments 32-33|0.1.0.0.2.0.0.0 31-32|0.1.0.0.2.0.0 27-29|0.2.1.2+0.2.1.1+0.2.1+0.2.1.0 26-27|0.2.2+0.2.0.0+0.2.0+0.2 19-21|0.1.1.2.0.1+0.1.1.2.0.0+0.1.1.2.0+0.1.1.2 17-18|0.1.1 16-17|0.1.1.0 15-16|0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 12-13|0.1 11-12|0 10-11|0.0 7-8|0.1.0.0.1 6-7|0.1.0.0.0 5-6|0.1.0.0 4-5|0.1.0 2-3|0.1.0.0.2 1-2|0.1.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:44.413
(a / and 
      :op1 (p2 / pb) 
      :op2 (i3 / incubate-01 
            :ARG0 (w2 / we 
                  :ARG0-of (w / wash-01 
                        :ARG1 (c / cell) 
                        :frequency 3 
                        :time (d / day 
                              :ARG1-of (f / follow-01 
                                    :ARG0 (3 / 30 
                                          :quant-of (m / min)))))) 
            :ARG1 (i2 / igg 
                  :mod (g / goat) 
                  :mod (t2 / thing 
                        :name (n4 / name 
                              :op1 "Cy3-conjugated")) 
                  :prep-against (t / thing 
                        :name (n3 / name 
                              :op1 (r / rabbit) 
                              :op2 (i / IgG))))) 
      :op3 (p / person 
            :name (n2 / name 
                  :op1 "Jackson") 
            :name (n / name 
                  :name-of (o / organization) 
                  :op1 "ImmunoReseach" 
                  :op2 "Laboratories") 
            :wiki "Michael_Jackson"))

# ::snt We rinsed cells three times with PBS , followed by observation using a confocal microscope FV300 ( Olympus ) equipped with a 60  objective lens .
# ::tok We rinsed cells three times with PBS , followed by observation using a confocal microscope FV300 ( Olympus ) equipped with a 60  objective lens .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:44.415
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt For transcriptional analysis of the 1.2-kb promoter region of mr-s , we constructed a reporter plasmid ( pro1 .2 k ) by subcloning a 1.2-kb upstream genomic fragment of mr-s gene into a pGL3 luciferase reporter plasmid ( Promega ) .
# ::tok For transcriptional analysis of the 1.2-kb promoter region of mr-s , we constructed a reporter plasmid ( pro1 .2 k ) by subcloning a 1.2-kb upstream genomic fragment of mr-s gene into a pGL3 luciferase reporter plasmid ( Promega ) .
# ::alignments 38-39|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 36-37|0.1.1 35-36|0 30-31|0.1 27-28|0.1.0 25-26|0.1.0.0 19-20|0.0.0.0.1 14-15|0.0.0.0 12-13|0.0.0 11-12|0.0 9-10|0.0.0.1.0.1 7-8|0.0.0.1.0 6-7|0.0.0.1.0.0 2-3|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:44.709
(r / report-01 
      :ARG0 (w / we 
            :ARG0-of (c / construct-01 
                  :ARG1 (r2 / report-01 
                        :ARG0 (o / organization 
                              :name (n / name 
                                    :op1 "Promega")) 
                        :ARG1 (k / k)) 
                  :manner (a / analyze-01 
                        :ARG1 (r3 / region 
                              :ARG1-of (p2 / promote-01) 
                              :mod (m / mr-))))) 
      :ARG1 (g / gene 
            :ARG1-of (f / fragment-01 
                  :mod (u / upstream)) 
            :poss (p / plasmid)))

# ::snt The expression vectors were constructed by subcloning full-length Crx , Otx2 , Nrl genes into a pMIK expression vector ( a gift from Dr. K. Maruyama ) , respectively .
# ::tok The expression vectors were constructed by subcloning full-length Crx , Otx2 , Nrl genes into a pMIK expression vector ( a gift from Dr. K. Maruyama ) , respectively .
# ::alignments 28-29|0.0.0.0.0.2 24-26|0.0.3.1+0.0.3.0+0.0.3+0.0 23-24|0 21-22|0.0.2+0.0.2.0 18-19|0.0.1.2 17-18|0.0.1 16-17|0.0.1.0 13-14|0.0.0.0.0.0 12-13|0.0.0.0.0.0.0 8-9|0.0.0.0.0.1.0.0+0.0.0.0.0.1.0+0.0.0.0.0.1 7-8|0.0.1.1 4-5|0.0.0.0.0 2-3|0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:45.014
(d / dr. 
      :mod-of (p / person 
            :ARG0-of (e2 / express-01 
                  :ARG1 (v2 / vector 
                        :ARG1-of (c2 / construct-01 
                              :ARG0 (g2 / gene 
                                    :part-of (n2 / nrl)) 
                              :ARG2 (c / country 
                                    :name (n3 / name 
                                          :op1 "Crx")) 
                              :op1-of (r / respective)))) 
            :ARG0-of (e / express-01 
                  :ARG1 (p2 / pMIK) 
                  :ARG2 (f / full-length) 
                  :mod-of (v / vector)) 
            :ARG0-of (g / gift-01 
                  :ARG1 (t / thing)) 
            :name (n / name 
                  :op1 "K." 
                  :op2 "Maruyama")))

# ::snt For the `` mut1259 '' vector , the Crx binding site at the -1259 bp position was mutated by replacing GGATTA with AGATCT .
# ::tok For the `` mut1259 '' vector , the Crx binding site at the -1259 bp position was mutated by replacing GGATTA with AGATCT .
# ::alignments 19-20|0.1 17-18|0 15-16|0.1.0 10-11|0.0 9-10|0.0.0 5-6|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:45.098
(m / mutate-01 
      :ARG1 (s / site 
            :ARG0-of (b / binding-07)) 
      :ARG2 (r / replace-01 
            :ARG0 (p / position)) 
      :purpose (v / vector))

# ::snt For the `` mut198 '' vector , the Crx binding site at the -198 bp position was mutated by replacing TAATCC with GAATTC .
# ::tok For the `` mut198 '' vector , the Crx binding site at the -198 bp position was mutated by replacing TAATCC with GAATTC .
# ::alignments 19-20|0.1 17-18|0 15-16|0.1.0 10-11|0.0 9-10|0.0.0 5-6|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:45.151
(m / mutate-01 
      :ARG1 (s / site 
            :ARG0-of (b / binding-07)) 
      :ARG2 (r / replace-01 
            :ARG0 (p / position)) 
      :purpose (v / vector))

# ::snt For the `` mut72 '' vector , the Crx binding site at the -72 bp position was mutated by replacing GGATTA with GAATTC .
# ::tok For the `` mut72 '' vector , the Crx binding site at the -72 bp position was mutated by replacing GGATTA with GAATTC .
# ::alignments 19-20|0.1 17-18|0 15-16|0.1.0 10-11|0.0 9-10|0.0.0 5-6|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:45.205
(m / mutate-01 
      :ARG1 (s / site 
            :ARG0-of (b / binding-07)) 
      :ARG2 (r / replace-01 
            :ARG0 (p / position)) 
      :purpose (v / vector))

# ::snt For the `` mut all '' vector , all of three Crx binding sites were mutated .
# ::tok For the `` mut all '' vector , all of three Crx binding sites were mutated .
# ::alignments 15-16|0 13-14|0.0 12-13|0.0.0 10-11|0.1.0.0 8-9|0.0.1 6-7|0.1 4-5|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:45.259
(m / mutate-01 
      :ARG1 (s / site 
            :ARG1-of (b / binding-07) 
            :quant (a / all)) 
      :purpose (v / vector 
            :quant (a2 / all 
                  :op1-of 3)))

# ::snt 5xGAL4-pGL3 Control reporter plasmid , which contains five copies of the GAL4 DNA recognition sequence positioned immediately upstream of SV40 minimal promoter , was kindly gifted from Dr. T. Noguchi and used for analysis of the transcriptional activity of mr-s [ 50 ] .
# ::tok 5xGAL4-pGL3 Control reporter plasmid , which contains five copies of the GAL4 DNA recognition sequence positioned immediately upstream of SV40 minimal promoter , was kindly gifted from Dr. T. Noguchi and used for analysis of the transcriptional activity of mr-s [ 50 ] .
# ::alignments 41-42|0.0.1.0.0.1.3 39-40|0.0.1.0.0.1.2.0.0 37-38|0.0.1.0.0.1.1.0 33-34|0.0.1.0.0.1.1 31-32|0.0.1.0.0.1 30-31|0.0.1.0.0.1.2 28-30|0.0.1.0.0.1.2.0.1.1.1+0.0.1.0.0.1.2.0.1.1.0+0.0.1.0.0.1.2.0.1.1+0.0.1.0.0.1.2.0.1 27-28|0.0.1.0.0.1.2.0.1.0 25-26|0.0.1.0.0.1.2.0 24-25|0.0.1.0.0.1.2.0.2 21-22|0.0.1.1 20-21|0.0.1.1.1 19-20|0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 17-18|0.0.0.0 16-17|0.0.0.1 15-16|0.0.0 14-15|0.0 13-14|0 12-13|0.1 8-9|0.0.1 7-8|0.0.1.0.0.1.0 6-7|0.0.1.0 3-4|0.0.1.0.0 2-3|0.0.1.0.0.0.0 1-2|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:47.166
(r / recognize-01 
      :ARG0 (s / sequence 
            :ARG1-of (p3 / position-01 
                  :ARG2 (u2 / upstream) 
                  :time (i / immediate)) 
            :ARG1-of (c / copy-01 
                  :ARG1-of (c2 / contain-01 
                        :ARG0 (p4 / plasmid 
                              :ARG1-of (c3 / control-01 
                                    :purpose-of (r2 / report-01)) 
                              :ARG1-of (u / use-01 
                                    :ARG0 5 
                                    :ARG2 (a2 / analyze-01 
                                          :ARG1 (a / activity-06)) 
                                    :op2-of (a3 / and 
                                          :op1 (g / gift-01 
                                                :ARG1 (m / mr-) 
                                                :ARG2 (p / person 
                                                      :mod (d / dr.) 
                                                      :name (n / name 
                                                            :op1 "T." 
                                                            :op2 "Noguchi")) 
                                                :manner (k / kindly))) 
                                    :time 50))) 
                  :ARG2 (p2 / promote-01 
                        :ARG1 (t / thing 
                              :name (n2 / name 
                                    :op1 "SV40")) 
                        :ARG1-of (m2 / minimal-02)))) 
      :ARG1 (d2 / DNA))

# ::snt To generate effector plasmids , various deletion fragments were produced by PCR reaction and subcloned into pGBKT7 vector , respectively .
# ::tok To generate effector plasmids , various deletion fragments were produced by PCR reaction and subcloned into pGBKT7 vector , respectively .
# ::alignments 19-20|0.0.1.0 17-18|0.0.1.3 13-14|0 12-13|0.0.0 11-12|0.0.0.0 9-10|0.0 7-8|0.0.1 6-7|0.0.1.1 5-6|0.0.1.2 3-4|0.0.2.0 2-3|0.0.2.0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:47.412
(a / and 
      :op1 (p2 / produce-01 
            :ARG0 (r2 / react-01 
                  :ARG1 (p / PCR)) 
            :ARG1 (f / fragment-01 
                  :ARG0 (r / respective) 
                  :ARG1 (d / deletion) 
                  :mod (v2 / various) 
                  :topic-of (v / vector)) 
            :time (g / generate-01 
                  :ARG1 (p3 / plasmid 
                        :mod (e / effector)))))

# ::snt These fragments were digested with the sequence , which encodes GAL4 DNA binding domain , and inserted into pcDNA3 .
# ::tok These fragments were digested with the sequence , which encodes GAL4 DNA binding domain , and inserted into pcDNA3 .
# ::alignments 18-19|0 16-17|0.0 15-16|0.0.1 13-14|0.0.1.0.0 12-13|0.0.1.0.0.0 11-12|0.0.1.0.0.0.0 9-10|0.0.1.0 6-7|0.0.0 3-4|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:47.565
(p / pcDNA3 
      :ARG1-of (i / insert-01 
            :ARG0 (s / sequence 
                  :ARG2-of (d3 / digest-01 
                        :ARG1 (f / fragment-01 
                              :mod (t / this)))) 
            :op2-of (a / and 
                  :op1 (e / encode-01 
                        :ARG1 (d / domain 
                              :ARG0-of (b / binding-07 
                                    :ARG1 (d2 / DNA)))))))

# ::snt We transfected 0.1 g of reporter plasmid DNA and 2 g of the expression vector DNA per 6 cm dish into HEK293T cells using Fugene6 transfection reagent .
# ::tok We transfected 0.1 g of reporter plasmid DNA and 2 g of the expression vector DNA per 6 cm dish into HEK293T cells using Fugene6 transfection reagent .
# ::alignments 26-27|0.0.1 25-26|0.0.1.0 24-25|0.0.3.0.0.0.0+0.0.3.0.0.0+0.0.3.0.0 23-24|0.0 22-23|0.0.0 21-22|0.0.0.0 19-20|0.0.2 18-19|0.0.2.1 17-18|0.0.4.0 15-16|0.0.3 14-15|0.0.3.1 13-14|0.0.3.0 9-10|0.0.2.2 8-9|0 7-8|0.1 6-7|0.1.0 5-6|0.0.4 3-4|0.2 2-3|0.0.2.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:48.217
(a / and 
      :ARG2-of (u / use-01 
            :ARG0 (c / cell 
                  :mod (h / HEK293T) 
                  :poss (w / we)) 
            :ARG1 (r / reagent 
                  :mod (t / transfection)) 
            :ARG2-of (d / dish-01 
                  :ARG0 0.1 
                  :ARG1 (c2 / cm) 
                  :op1-of 2) 
            :location (d2 / DNA 
                  :ARG1-of (e / express-01 
                        :ARG0 (t2 / thing 
                              :name (n / name 
                                    :op1 "Fugene6"))) 
                  :mod (v / vector)) 
            :manner-of (r2 / report-01 
                  :ARG0 6)) 
      :op1 (d3 / DNA 
            :mod (p / plasmid)) 
      :poss-of (g / g))

# ::snt We analyzed luciferase activity 48 hr after transfection .
# ::tok We analyzed luciferase activity 48 hr after transfection .
# ::alignments 7-8|0.3.0 6-7|0.3 4-5|0.2 3-4|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:48.273
(a3 / analyze-01 
      :ARG0 (w / we) 
      :ARG1 (a2 / activity-06) 
      :ARG2 48 
      :time (a / after 
            :op1 (t / transfection)))

# ::snt Crx , cone-rod homeobox ; Otx2 , orthodenticle-related homeobox 2 ; TR2 , thyroid hormone receptor beta 2 ; Nrl , neural retina leucine zipper ; Nr2e3 , nuclear receptor subfamily 2 group E member 3 ; EST , expressed sequence tag ; EphB2 , ephrin receptor B2 ; EphA4 , ephrin receptor A4 ; TEL , translocation ETS leukemia .
# ::tok Crx , cone-rod homeobox ; Otx2 , orthodenticle-related homeobox 2 ; TR2 , thyroid hormone receptor beta 2 ; Nrl , neural retina leucine zipper ; Nr2e3 , nuclear receptor subfamily 2 group E member 3 ; EST , expressed sequence tag ; EphB2 , ephrin receptor B2 ; EphA4 , ephrin receptor A4 ; TEL , translocation ETS leukemia .
# ::alignments 59-60|0.4.4.0.2+0.4.4.0.1.0+0.4.4.0.1+0.4.4.0 58-59|0.4.4.0.0 57-58|0.4.4 53-54|0.4.3.0 52-53|0.4.3 49-50|0.1.2.0 47-48|0.4.2.0.0 46-47|0.4.2.0 45-46|0.4.2 43-44|0.2 41-42|0.1 40-41|0.1.1 39-40|0 37-38|0.4.1.0 35-36|0.4.1 34-35|0.5.0.1.0.1+0.5.0.1.0 33-34|0.5.0.1.0.0 32-33|0.5.0.1 31-32|0.5.0.1.2 30-31|0.5.0.1.1 29-30|0.5.0.0 28-29|0.5.0 26-27|0.0 24-25|0.1.2.2 23-24|0.1.2 22-23|0.1.2.1 21-22|0.1.2.2.0 19-20|0.5.0.1.0.2.1.0.0 17-18|0.5.0.1.0.2.1.0.1 16-17|0.5.0.1.0.2.1.0 15-16|0.4.5 14-15|0.4 13-14|0.4.0 9-10|0.3 8-9|0.5.1 7-8|0.5 5-6|0.5.0.1.0.2.1 4-5|0.5.0.1.0.2 3-4|0.1.0 0-1|0.5.0.1.0.2.0.0.0+0.5.0.1.0.2.0.0+0.5.0.1.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:50.168
(e5 / express-01 
      :ARG0 (n3 / Nr2e3) 
      :ARG1 (t2 / tag-01 
            :ARG0 (h4 / homeobox) 
            :ARG1 (s / sequence) 
            :ARG2 (l / leucine 
                  :domain-of (e2 / EphA4) 
                  :mod (r4 / retina) 
                  :mod-of (z / zipp 
                        :mod (n4 / neural)))) 
      :ARG2 (e4 / EphB2) 
      :op1-of 2 
      :op1-of (h2 / hormone 
            :mod (t3 / thyroid) 
            :mod (3 / 3 
                  :quant-of (e6 / e)) 
            :mod (e3 / ephrin 
                  :mod-of (r2 / receptor 
                        :mod-of (b / B2))) 
            :mod (r / receptor 
                  :mod-of (a / A4)) 
            :mod (t / translocation 
                  :mod-of (d / disease 
                        :mod (e / et) 
                        :name (n / name 
                              :op1 "Leukemia") 
                        :wiki "Leukemia")) 
            :mod-of (r5 / receptor)) 
      :op1-of (o / orthodenticle-relat 
            :mod (n2 / nucleus 
                  :mod-of (r3 / receptor) 
                  :mod-of (g / group 
                        :ARG1-of (h / have-org-role-91 
                              :ARG0 (e7 / E) 
                              :ARG2 (m / member) 
                              :ARG3 (a2 / and 
                                    :op1 (c / country 
                                          :name (n6 / name 
                                                :op1 "Crx")) 
                                    :op2 (o2 / Otx2 
                                          :mod (b2 / beta 
                                                :mod-of (n5 / nrl) 
                                                :quant 2)))) 
                        :mod (s2 / subfamily) 
                        :quant 2)) 
            :mod-of (h3 / homeobox)))

# ::snt TI and KT performed most of the experiments , interpreted the data and wrote the first draft of the manuscript .
# ::tok TI and KT performed most of the experiments , interpreted the data and wrote the first draft of the manuscript .
# ::alignments 19-20|0.2.0.0.0.0 16-17|0.2.0.0.0 13-14|0.2.0.0 12-13|0 11-12|0.2.1 9-10|0.2 7-8|0.1.1 4-5|0.1.2 3-4|0.1 2-3|0.0.0.0+0.0.0+0.0 1-2|0.1.0 0-1|0.2.0.1.0+0.2.0.1+0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:50.283
(a / and 
      :op1 (o / organization 
            :name (n / name 
                  :op1 "KT")) 
      :op2 (p / perform-02 
            :ARG0 (a2 / and) 
            :ARG1 (e / experiment-01) 
            :degree (m2 / most)) 
      :op3 (i / interpret-01 
            :ARG0 (o2 / organization 
                  :ARG0-of (w / write-01 
                        :ARG1 (d / draft-01 
                              :ARG1 (m / manuscript))) 
                  :name (n2 / name 
                        :op1 "TI")) 
            :ARG1 (d2 / data)))

# ::snt AF prepared retinal tissues and their sections of wild-type and Crx mutant mice .
# ::tok AF prepared retinal tissues and their sections of wild-type and Crx mutant mice .
# ::alignments 12-13|0.1 11-12|0.1.0 10-11|0.0.0.0+0.0.0+0.0 9-10|0 6-7|0.2 4-5|0.2.0 3-4|0.2.1 2-3|0.2.1.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:50.620
(a / and 
      :op1 (t / thing 
            :name (n / name 
                  :op1 "Crx")) 
      :op2 (m / mouse 
            :mod (m2 / mutant)) 
      :quant (s / section 
            :op1-of (a2 / and 
                  :ARG1-of (p / prepare-02)) 
            :poss (t2 / tissue 
                  :mod (r / retinal))))

# ::snt CK performed luciferase assay using Y79 retinoblastoma cells .
# ::tok CK performed luciferase assay using Y79 retinoblastoma cells .
# ::alignments 7-8|0.0.0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 4-5|0.0.0 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:50.837
(a / assay 
      :ARG1-of (p / perform-02 
            :ARG2 (u / use-01 
                  :ARG1 (c / cell 
                        :mod (r / retinoblastoma) 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Y79"))))))

# ::snt YT , MA and TF have made substantial contributions to conception and design of the experiments and drafting of the manuscript .
# ::tok YT , MA and TF have made substantial contributions to conception and design of the experiments and drafting of the manuscript .
# ::alignments 20-21|0.0.0.1.0.0 17-18|0.0.0.1.0.0.0 16-17|0.0.0.1 15-16|0.0.0.1.0 12-13|0 11-12|0.0 10-11|0.0.1 8-9|0.0.0 7-8|0.0.0.2 4-5|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 3-4|0.0.0.0 2-3|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:50.986
(d2 / design-01 
      :op2-of (a2 / and 
            :ARG2-of (c2 / contribute-01 
                  :ARG0 (a3 / and 
                        :op1 (c4 / country 
                              :name (n2 / name 
                                    :op1 "MA")) 
                        :op2 (c3 / country 
                              :name (n / name 
                                    :op1 "TF"))) 
                  :ARG1 (a / and 
                        :op1 (e / experiment-01 
                              :ARG1 (m / manuscript 
                                    :ARG1-of (d / draft-01)))) 
                  :degree (s / substantial)) 
            :op1 (c / conception)))

# ::snt All authors read and approved the final manuscript .
# ::tok All authors read and approved the final manuscript .
# ::alignments 7-8|0.1.0.0 6-7|0.1.0.0.0 4-5|0.1.0 3-4|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:51.053
(r / read-01 
      :ARG1 (a3 / author-01 
            :mod (a4 / all)) 
      :op1-of (a2 / and 
            :ARG0-of (a / approve-01 
                  :ARG1 (m / manuscript 
                        :mod (f / final)))))

# ::snt We thank T. Noguchi for 5xGAL4-pGL3 reporter plasmid ; A. Nishida for discussion and critical reading of the manuscript ; A. Yoshimura for advice on confocal microscopy ; A. Tani , Y. Kambara , M. Murai , Y. Hirao and H. Yoshii for technical assistance .
# ::tok We thank T. Noguchi for 5xGAL4-pGL3 reporter plasmid ; A. Nishida for discussion and critical reading of the manuscript ; A. Yoshimura for advice on confocal microscopy ; A. Tani , Y. Kambara , M. Murai , Y. Hirao and H. Yoshii for technical assistance .
# ::alignments 44-45|0.2.0.1.0 43-44|0.2.0.1.0.0 40-42|0.2.4.0.1+0.2.4.0.0+0.2.4.0+0.2.4 39-40|0.2 37-39|0.2.3.0.1+0.2.3.0.0+0.2.3.0+0.2.3 34-36|0.2.1.1.3.0.1+0.2.1.1.3.0.0+0.2.1.1.3.0+0.2.1.1.3 31-33|0.2.1.1.2.0.1+0.2.1.1.2.0.0+0.2.1.1.2.0+0.2.1.1.2 28-30|0.2.1.1.1.0.1+0.2.1.1.1.0.0+0.2.1.1.1.0+0.2.1.1.1 26-27|0.2.2.1.0 23-24|0.2.2.1 20-22|0.2.2.0.1+0.2.2.0.0+0.2.2.0+0.2.2 18-19|0.1.0 15-16|0.1 14-15|0.1.2 13-14|0.2.1.1 12-13|0.1.1 9-11|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 8-9|0 7-8|0.2.1.1.0 6-7|0.0 2-4|0.2.0.1.1.1+0.2.0.1.1.0+0.2.0.1.1+0.2.0.1 1-2|0.2.0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:52.365
(a5 / and 
      :ARG1-of (r2 / report-01) 
      :op1 (r / read-01 
            :ARG0 (m2 / manuscript) 
            :ARG1 (d / discuss-01) 
            :ARG1-of (c / critical-02)) 
      :op1-of (a2 / and 
            :ARG3-of (t2 / thank-01 
                  :ARG0 (w / we) 
                  :ARG1 (p9 / person 
                        :ARG1-of (a / assist-01 
                              :ARG2 (t / technical)) 
                        :name (n8 / name 
                              :op1 "T." 
                              :op2 "Noguchi"))) 
            :op2 (p7 / person 
                  :name (n7 / name 
                        :op1 "A." 
                        :op2 "Nishida") 
                  :op2-of (a4 / and 
                        :op1 (p8 / plasmid) 
                        :op3 (p5 / person 
                              :name (n5 / name 
                                    :op1 "A." 
                                    :op2 "Tani")) 
                        :op4 (p4 / person 
                              :name (n4 / name 
                                    :op1 "Y." 
                                    :op2 "Kambara")) 
                        :op5 (p3 / person 
                              :name (n3 / name 
                                    :op1 "M." 
                                    :op2 "Murai")))) 
            :op3 (p6 / person 
                  :name (n6 / name 
                        :op1 "A." 
                        :op2 "Yoshimura") 
                  :purpose (a3 / advise-01 
                        :ARG1 (m / microscopy))) 
            :op4 (p2 / person 
                  :name (n2 / name 
                        :op1 "Y." 
                        :op2 "Hirao")) 
            :op5 (p / person 
                  :name (n / name 
                        :op1 "H." 
                        :op2 "Yoshii"))))

# ::snt This work was supported by Precursory Research for Embryonic Science and Technology ( PRESTO ) , Dynamics of Development Systems Molecular Brain Science , Grant-in Aid for Scientific Research ( B ) , Senri Life Science Foundation , and Uehara Foundation .
# ::tok This work was supported by Precursory Research for Embryonic Science and Technology ( PRESTO ) , Dynamics of Development Systems Molecular Brain Science , Grant-in Aid for Scientific Research ( B ) , Senri Life Science Foundation , and Uehara Foundation .
# ::alignments 39-41|0.0.0.0.4.0.1+0.0.0.0.4.0.0+0.0.0.0.4.0+0.0.0.0.4 38-39|0.0.0.0 33-37|0.0.0.0.3.0.3+0.0.0.0.3.0.2+0.0.0.0.3.0.1+0.0.0.0.3.0.0+0.0.0.0.3.0+0.0.0.0.3 30-31|0.2+0.1.0+0.1+0 24-29|0.0.0.0.2.0.4+0.0.0.0.2.0.3+0.0.0.0.2.0.2+0.0.0.0.2.0.1+0.0.0.0.2.0.0+0.0.0.0.2.0+0.0.0.0.2 16-23|0.0.0.0.1.0.6+0.0.0.0.1.0.5+0.0.0.0.1.0.4+0.0.0.0.1.0.3+0.0.0.0.1.0.2+0.0.0.0.1.0.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 13-14|0.0.0.0.1.1.1+0.0.0.0.1.1+0.0.0.0.1.1.0 5-12|0.0.0.0.0.0.6+0.0.0.0.0.0.5+0.0.0.0.0.0.4+0.0.0.0.0.0.3+0.0.0.0.0.0.2+0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 3-4|0.0.0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:07:52.723
(l / location 
      :ARG1-of (w / work-01 
            :ARG1-of (s / support-01 
                  :ARG0 (a / and 
                        :op1 (o6 / organization 
                              :name (n7 / name 
                                    :op1 "Precursory" 
                                    :op2 "Research" 
                                    :op3 "for" 
                                    :op4 "Embryonic" 
                                    :op5 "Science" 
                                    :op6 "and" 
                                    :op7 "Technology")) 
                        :op2 (o4 / organization 
                              :name (n5 / name 
                                    :op1 "Dynamics" 
                                    :op2 "of" 
                                    :op3 "Development" 
                                    :op4 "Systems" 
                                    :op5 "Molecular" 
                                    :op6 "Brain" 
                                    :op7 "Science") 
                              :name (n6 / name 
                                    :name-of (o5 / organization) 
                                    :op1 "PRESTO")) 
                        :op3 (o3 / organization 
                              :name (n4 / name 
                                    :op1 "Grant-in" 
                                    :op2 "Aid" 
                                    :op3 "for" 
                                    :op4 "Scientific" 
                                    :op5 "Research")) 
                        :op4 (o2 / organization 
                              :name (n2 / name 
                                    :op1 "Senri" 
                                    :op2 "Life" 
                                    :op3 "Science" 
                                    :op4 "Foundation")) 
                        :op5 (o / organization 
                              :name (n / name 
                                    :op1 "Uehara" 
                                    :op2 "Foundation")))) 
            :mod (t / this)) 
      :name (n3 / name 
            :op1 "B") 
      :wiki -)

